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ABSTRACT
Chapter 1
A general introduction is given.
Chapter 2
The biscarboxylate species, Mo(NR)(CHCMe 2Ph)(O 2CPh3)2 (R = 2,6-i-Pr2 C6H3, 2,6-
Me2C6H3, 2-t-BuC 6H4, or 1 -adamantyl) are compared to newly synthesized
bis(terphenylcarboxylate) species, Mo(NR)(CHCMe 2Ph)(O 2CTer) 2 (Ter = 2,6-diphenyl-4-
methylphenyl or 2,6-diphenyl-4-methoxyphenyl). Preparation of bis(terphenylcarboxylate)
species was accomplished through protonolysis of Mo(NR)(CHCMe2R')(Me2Pyr) 2 with two
equivalents of TerCO2H and one of them was characterized through X-ray crystallography.
Photolysis experiments of many of the biscarboxylate complexes led to rate constants for the
converstion of anti to syn species, which are much slower than bisalkoxide species.
Trimethylphosphine adducts of selected triphenylacetate complexes have been isolated and
studied in solution. Protonolysis of Mo(NAr)(CHCMe 2R')(Me 2Pyr)2 (Ar = 2,6-i-Pr 2C6H3) with
one equivalent of TerCO2H led to the isolation of a handful of monocarboxylate species,
Mo(NAr)(CHCMe 2Ph)(O 2CAr')(Me2Pyr). An X-ray structure of one of them was also
characterized. Several of the bis(triphenylacetate) complexes and all of the monocarboxylates
are active initiators for the regioselective polymerization of diethyl dipropargylmalonate
(DEPDM). In the case of the latter compounds, activity towards olefins is also observed and
briefly mentioned.
Chapter 3
Monaryloxide pyrrolide (MAP) molybdenum imido alkylidene complexes of the type
Mo(NArx)(CHCMe 2R)(Me2Pyr)(OR') (Me2Pyr = 2,5-dimethylpyrrolide) have been prepared in
which NArx is an ortho-substituted phenylimido group (X = Cl (NArci), CF 3 (NAr ), i-Pr
(NAr"), t-Bu (NArtBu), mesityl (NArM), or TRIP (TRIP = triisopropylphenyl; NArT)) and OR' =
O-2,3,5,6-(C 6H5)4C6H (OTPP), O-2,6-(2,4,6-Me 3C6H2)2C6H3 (OHMT), or O-2,6-(2,4,6-i-
Pr 3C6H2)2 C6 H3 (OHIPT). The object was to explore to what extent relatively "large" NArM or
NArT ligands would alter the performance of MAP catalysts in reactions that have been proposed
to depend upon the relative size of the imido and OR' groups. Preliminary studies employing the
4
ring-opening metathesis polymerization of 5,6-dicarbomethoxynorbornadiene as a measure of
selectivity suggest that a single ortho-substituent in the phenylimido group, even in an NArm or
NArT group, does not produce any unique behavior and that the outcome of the ROMP reaction
correlates with the overall relative size of the imido and OR' group. Single crystal X-ray
structures of six species that contain the new NArM or NArT groups are reported.
Chapter 4
Several bipyridine adducts of molybdenum imido alkylidene bispyrrolide complexes of the
type Mo(NR)(CHCMe 2Ph)(Pyr)2(bipy) (9-15; R = 2,6-i-Pr2C6H3 (Ar), adamantyl (Ad), 2,6-
Me2 C6H3 (Ar'), 2-ClC 6H4 (ArcI), 2-i-PrC6-14 (AriPr), 2-t-BuC 6H4 (ArtBu), 2-MesitylC 6H4 (Arm),
respectively; have been prepared using three different methods. Up to three isomers of the
adducts are observed that are proposed to be the trans and two possible cis pyrrolide isomers of
syn alkylidenes. Sonication of a mixture containing 9-15, HMTOH (2,6-(2',4',6'-
Me3C6H2)2 C6H30H), and ZnCl2(dioxane) led to the formation of MAP species of the type
Mo(NR)(CHCMe 2Ph)(Pyr)(OHMT) (16-22), which were isolated by filtration and purified by
recrystallization. DCMNBD (2,3-dicarbomethoxynorbornadiene) is polymerized employing 16-
22 as initiators to yield >98% cis,syndiotactic poly(DCMNBD). Attempts to prepare bipy
adducts of bisdimethylpyrrolide complexes led to the formation of imido alkylidyne complexes
of the type Mo(NR)(CHCMe 2R')(Me2Pyr)(bipy) (Me2Pyr = 2,5-dimethylpyrrolide); 23-28)
through a ligand-induced migration of an alkylidene a proton to a dimethylpyrrolide ligand. X-
ray structures of Mo(NAr)(CHCMe 2Ph)(Pyr) 2(bipy) (9), Mo(NAriP)(CHCMe 2Ph)(Pyr)(OHMT)
(20), Mo(NAr)(CCMe 2Ph)(Me2Pyr)(bipy) (23), Mo(NAr')(CCMe 2Ph)(Me2Pyr)(bipy) (24),
Mo(NArT)(CCMe 3)(Me 2Pyr)(bipy) (ArT = 2-(2',4',6'-i-Pr 3C6H2)C6H4, 28) showed structures
with the expected characteristic bond lengths and angles.
Chapter 5
The formation of Mo(NAr)(CHCMe 2Ph)(OC(CF 3)2(CH 3))(O2CTerme) (Ar = 2,6-i-Pr2C6H3,
O2 CTerMe= 4,4'-dimethylterphenylcarboxylate, 1) from Mo(NR)(CHCMe 2Ph)(OC(CF3)2(CH 3))2
via protonolys with TerMeCO2H, as well as formation of complexes of the general formula
Mo(NR)(CHCMe 2Ph)(OC(CF3)2(CH 3))(X) (R = 2,6-iPr2C6H3 (Ar), 2; 2,6-Me2C6H3 (Ar'), 3; 2-
iPrC 6H4 (Ar' ), 4; 1-adamantyl (Ad), 5; X = 2,2',4,4',6,6'-hexamethylterphenoxide (HMTO))(2,6-Me 2C6H3 (Ar'), 6, 2-iPrC6H4 (Ar'P'), 7; X = 2,2',4,4',6,6'-hexamethylterphenylamine
(HMT(H)N)) (R = 1-adamantyl, X = 2,2',4,4',6,6'-hexamethylterphenyl (HMT), 8) via salt-
metathesis of Mo(NR)(CHCMe 2Ph)(OC(CF 3)2(CH 3))2 with one equivalent of LiX is presented as
an efficient synthetic route for the preparation of monoalkoxide monoanionic (MAX) complexes.
The X-ray studies of 5, 7, and 8 show that complexes 5 and 8 have similar structures; whereas 7
differs considerably due to the overall spacial arrangement of the N(H)HMT in the complex,
which is orthogonal to the arrangement of OHMT in 5 or HMT in 8. The distance of the
terphenyl backbone is shown to be one Angstrom shorter for 8, in comparison to 5 and 7, which
results in failed attempts to prepare Mo(NR)(CHCMe 2Ph)(OC(CF 3)2(CH 3))(HMT) complexes
with bigger R groups. The catalytic reactivity complexes 1-8 is probed with diallyl ether (DAE),
1 -hexene, 1 -octene, and dicarbomethoxynorbornadiene (DCMNBD). For comparison, the same
olefin-metathesis reactions are carried-out with the analogous monoanionic monopyrrolide
(MXP) complexes of general formula Mo(NR)(CHCMe 2Ph)(Pyr)(X) (Pyr = C4H4N, 2,5-
Me2C4H2N). Overall, the reactivity of MAX and MXP complexes differs least when cis or trans
5
bond formation is involved, and differs most when tacticity is considered, showing that during
catalysis the transition states may differ significantly between the two kinds of complexes.
Appendix
The preparation of pure (R)-Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(OR*) (Ar = 2,6-iPr2C6H3, R*O
(1S,2S,4R)-2-(4-ClC 6H4)-1,7,7-Me 3-bicyclo[2.2.1]heptan-2-oxide), Me2Pyr = 2,5-Me2C4H2N,
1) and Mo(NAd)(CHCMe 2Ph)(OR*) 2 (Ad = 1-adamantyl, R*O = 3,3'-Br2-2'-(OSi(Me2)2(t-Bu))-
5,5',6,6',7,7',8,8'-H-[1,1'-binaphthalen]-2-oxide, 21) are discussed. X-ray studies of both
complexes are also presented. The polymerization of diethyl dipropargylmalonate (DEPDM) is
probed with a variety of monoalkoxidemonopyrrolide (MAP) complexes, including 1, that either
contain PMe3 bound to the metal center or not. In addition, a variety of
bisalkoxide/bisphenoxide complexes, among them 21, are also used to polymerize DEPDM.
Thesis Supervisor: Richard R. Schrock
Title: Frederick G. Keyes Professor of Chemistry
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perfluoro-tert-butoxide
para
phenyl
negative logarithm-base-ten of the acid dissociation constant
negative logarithm-base-ten of the base dissociation constant
pyrrolide
(1S,2S,4R)-2-(4-ClC 6H4)- 1 ,7,7-Me3-bicyclo[2.2. 1 ]heptan-2-oxide
Br 2BITET
ring closing metathesis
ring opening metathesis polymerization
square pyramid
alkylidene rotamer with alkyl group directed towards the imido group
tert-butyldimethylsilyl
trigonal bipyramid
2,6-terphenyl
2,6-bis(4'-methylphenyl)phenyl
2,6-bis(4'-methoxyphenyl)phenyl
2,2',6,6'-tetraisopropylterphenyl
2,2' ,6,6'-tetraisopropylterphenyl-2-iodide
2,2' ,6,6'-tetraisopropylterphen-2-oxide
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TPP 2,3,5,6-tetraphenylphenoxide
Triflate trifluoromethylsulfonate
TRIP 2,4,6-triisopropylphenyl
g microgram
tM micromolar
[tmol micromole
UV-vis ultraviolet and visible light
wk weeks
X anionic ligand
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LIST OF COMPOUND NUMBERS
Compound Name of Formula
CHAPTER 2
la Mo(NAr)(CHCMe 2Ph)(O 2CCPh 3)2*
lb Mo(NAd)(CHCMe 2Ph)(0 2CCPh3)2*
ic Mo(NAr')(CHCMe 2Ph)(O 2CCPh3)2*
ld Mo(NArtB)(CHCMe 3)(O2CCPh 3)2*
2a Mo(NAr)(CHCMe 2Ph)(O 2CTerMe) 2
2b Mo(NAr)(CHCMe 2Ph)(O 2CTeroMe) 2
2c Mo(NAd)(CHCMe 2Ph)(O2CTerMe) 2
2d Mo(NAd)(CHCMe 2Ph)(O2CTerMe) 2
3a Mo(NAr)(CHCMe 2Ph)(Me 2Pyr)(O 2CTRIP)
3b Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(O 2CTerMe)
3c Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(O 2CTeroMe)
3d Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(O 2CHIPT)#
CHAPTER 3
1 Mo(NArCi) 2(Cl)2(DME)
2 Mo(NArM)2(Cl)2(THF)2-2THF
3 Mo(NAr T)2(Cl) 2(DME)
4 Mo(NArCi) 2(CH2CMe2Ph)2
5 Mo(NArm )2(CH 2CMe 2Ph)2
6 Mo(NArT )2 (CH2 CMe 3)2
7 Mo(NAr )2(CH 3)2
8 Mo(NArci)(CHCMe 2 Ph)(OTf)2 (DME)
9 Mo(NArM)(CHCMe 2Ph)(OTf)2(DME)
10 Mo(NArm)(CHCMe 3)(OTf)2(DME)
11 Mo(NArci)(CHCMe 2Ph)(Me2Pyr) 2
12 Mo(NAr CF3)(CHCMe3)(Me2Pyr)2
13 Mo(NAr' )(CHCMe2Ph)(Me 2Pyr)2
14 Mo(NArtBu)(CHCMe3)(Me 2Pyr)2
15 Mo(NArtBu)(CHCMe2Ph)(Me2Pyr)2
16 Mo(NArm)(CHCMe2Ph)(Me 2Pyr)2
17 Mo(NAr T)(CHCMe3)(Me 2Pyr)2
18 Mo(NArm)(CHCMe2Ph)(OTPP)2
19 Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(OTPP)
20 Mo(NArci)(CHCMe2Ph)(Me 2Pyr)(OHMT)
21 Mo(NArCF3)(CHCMe3)(Me2Pyr)(OHMT)
22 Mo(NArCF3)(CHCMe 2Ph)(Me2Pyr)(OHMT)
23 Mo(NAr'p)(CHCMe 2Ph)(Me2Pyr)(OHMT)
24 Mo(NArtBu)(CHCMe3)(Me2Pyr)(OHMT)
25 Mo(NArtB)(CHCMe2Ph)(Me 2Pyr)(OHMT)
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26 Mo(NArM)(CHCMe 2Ph)(Me2Pyr)(OHMT)
27 Mo(NArM)(CHCMe 2Ph)(Me2Pyr)(OHIPT)
28 Mo(NArT)(CHCMe 3)(Me 2Pyr)(OHMT)
29 Mo(NArT)(CHCMe 3)(Me 2Pyr)(OHIPT)
CHAPTER 4
1 [Mo(NArPh)(CHCMe 3)(Pyr)2]2
2 Mo(NAr)(CHCMe 2Ph)(OTf) 2(bipy)
3 Mo(NAd)(CHCMe 2Ph)(OTf) 2(bipy)
4 Mo(NAr')(CHCMe 2Ph)(OTf) 2(bipy)
5 Mo(NArc)(CHCMe 2Ph)(OTf)2(bipy)
6 Mo(NAPr)(CHCMe 2Ph)(OTf)2(bipy)
7 Mo(NArtB)(CHCMe 2Ph)(OTf)2(bipy)
8 Mo(NArM)(CHCMe 2Ph)(OTf) 2(bipy)
9 Mo(NAr)(CHCMe 2Ph)(Pyr)2(bipy)
10 Mo(NAd)(CHCMe 2Ph)(Pyr)2(bipy)
11 Mo(NAr')(CHCMe 2Ph)(Pyr)2(bipy)
12 Mo(NArcl)(CHCMe 2Ph)(Pyr) 2(bipy)
13 Mo(NAriPr)(CHCMe 2Ph)(Pyr)2(bipy)
14 Mo(NArtB)(CHCMe 2Ph)(Pyr)2(bipy)
15 Mo(NArm)(CHCMe 2Ph)(Pyr)2(bipy)
16 Mo(NAr)(CHCMe 2Ph)(Pyr)(OHMT)
17 Mo(NAd)(CHCMe 2Ph)(Pyr)(OHMT)
18 Mo(NAr')(CHCMe 2Ph)(Pyr)(OHMT)
19 Mo(NArci)(CHCMe 2Ph)(Pyr)(OHMT)
20 Mo(NAr'Pr)(CHCMe 2Ph)(Pyr)(OHMT)
21 Mo(NArtB)(CHCMe 2Ph)(Pyr)(OHMT)
22 Mo(NArm)(CHCMe 2Ph)(Pyr)(OHMT)
23 Mo(NAr)(=CCMe 2Ph)(Me2Pyr)(bipy)
24 Mo(NAr')(=CCMe 2Ph)(Me2Pyr)(bipy)
25 Mo(NArCF3)(=CCMe 2Ph)(Me 2Pyr)(bipy)
26 Mo(NAriPr)(=CCMe 2Ph)(Me2Pyr)(bipy)
27 Mo(NArm)(=CCMe 2Ph)(Me 2Pyr)(bipy)
28 Mo(NArT)(=CCMe 2Ph)(Me2Pyr)(bipy)
CHAPTER 5
1 Mo(NAr)(CHCMe 2Ph)(OF)(O2CTerMe)
2 Mo(NAr)(CHCMe 2Ph)(OF6)(OHMT)
3 Mo(NAr')(CHCMe 2Ph)(OF6 )(OHMT)
4 Mo(NAr'P)(CHCMe 2Ph)(OF 6)(OHMT)
5 Mo(NAd)(CHCMe 2Ph)(OF 6)(OHMT)
6 Mo(NAr')(CHCMe 2Ph)(OF 6)(N(H)HMT)
7 Mo(NAriPr)(CHCMe 2Ph)(OF6)(N(H)HMT)
8 Mo(NAd)(CHCMe 2Ph)(OF6 )(HMT)
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9 Mo(NAr')(CHCMe 2Ph)(OF6)(HMT)"
10 Mo(NAr')(CHCMe 2Ph)(OF 6)(HMT)
11 Mo(NAr)(CHCMe 2Ph)(OF 6)(HMT)"
12 Mo(NAd)(CHCMe 2Ph)(OF 6)(TIPT)"
13 Mo(NAr')(CHCMe 2Ph)(OF 6)(TIPT)'
14 Mo(NAr)(CHCMe 2Ph)(OF6)(TIPT)'
15 Mo(NAd)(CHCMe 2Ph)(OF 9)2
16 Mo(NAd)(CHCMe 2Ph)(OF9 )(HMT)
APPENDIX
1 Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(OR*)
2 Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(OR*)*
3 Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(OF 6)*
3a Mo(NAr)(CHCMe 2Ph)(Me4Pyr)(OF 6)(PMe3)*
3b Mo(NAr)(CHCMe 2Ph)(Ph 2Pyr)(OF 6) *
3c Mo(NAr)(CHCMe 2Ph)(Ph 2Pyr)(OF 6)(PMe 3)*
3d Mo(NAr)(CHCMe 2Ph)(iPr 2Pyr)(OF 6)*
3e Mo(NAr)(CHCMe 2Ph)(iPr2Pyr)(OF 6)(PMe 3)*
4 Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(0-iPr)*
5 Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(OAr)*
6 Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(OSi(O-t-Bu) 3)*
7 Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(OSiPh 3)*
8 Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(O-2,4-(t-Bu) 2-6-BrC 6H2)*
9 Mo(NAr)(CHCMe 2Ph)(OR) 2*
10 Mo(NAr)(CHCMe 2Ph)(OC(CH 3)2(CF 3))2*
11 Mo(NAr)(CHCMe 2Ph)(OF9)2*
12 Mo(NAr)(CHCMe 2Ph)(OC(CH 3)(C6F5)2)2*
13 Mo(NAr)(CHCMe 2Ph)(OSi(CH 3)2(t-Bu)) 2*
14 Mo(NAr)(CHCMe 2Ph)(OAr)2*
15 Mo(NAr')(CHCMe 2Ph)(OF6)2*
16 Mo(NAr')(CHCMe 2Ph)(OAr) 2*
17 Mo(NArCF3)(CHCMe 2Ph)(OF6)2*
18 Mo(NAr ,t)(CHCMe2Ph)(OF6)2 *
19 Mo(NArh)(CHCMe 2Ph)(OF 6)2*
20 Mo(NAd)(CHCMe 2Ph)(OF6)2*
21 Mo(NAd)(CHCMe 2Ph)(OR) 2
*compounds were previously reported by other researchers
# compounds were only made in situ
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CHAPTER 1
General Introduction
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Olefin metathesis is a reaction wherein two alkene moieties react to exchange functional
groups,1 as depicted in equation 1. This reaction was the subject of the 2005 Nobel Prize in
Chemistry, which was awarded to Y. Chauvin, R. R. Schrock, and R. H. Grubbs. Olefin
metathesis was first observed as a minor reaction during the polymerization of ethylene in the
presence of certain metals.2 Early attempts to design a better catalytic system involved the use of
MoO 3 , WCl6 , WOCl4 , and Re20 7 in the presence of alkylating agents (e.g. AIR 3, LiR, SnR4) or
alumina in ethyl alcohol or chlorobenzene.3 The systems mentioned above did yield high
turnover numbers (100 TON/sec) for olefin metathesis but their lifetimes were short and the
concentration of active species was too small to determine its nature. In addition, tolerance to
functionalities was limited.
R R
R R
+ 
R1
R R
R R
+
R R
R R
Y. Chauvin first proposed that the active species in the reaction had to involve a metal-
carbon double bond and the reaction would proceed via a [2 + 2] addition of the olefin to the
metal center forming a metallacyclobutane intermediate. The metallacyclobutane can then
undergo a retro [2 + 2] reaction to reform the starting material or generate a new olefin, Scheme
1.4
+ R'HC=CHR'
+ RHC=CHR
M=CHR" a M=CHR
- RHC=CHR"
- RHC=CHR,
M-CHR
I I
R'HC -CHR' - RHC=CHR'
+ R'HC=CHR'
M=CHR' :a M=CHR"
- R'HC=CHR"
M-CHR' + RHC=CHRI I
CHR -CHR
Scheme 1 - Chauvin's proposed mechanism for olefin metathesis.
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(1)
Synthesis of the first metal carbon double bond (carbene) was accomplished by Fisher in
1964. The carbene was characterized by the presence of a 7r-donor group, as in
(CO) 5Cr=C(OMe)(Ph), which makes the carbene of singlet character.19 A decade later, the first
high-oxidation state transition metal carbon double-bond bearing no a-donor group (alkylidene)
was prepared in 1974 by Schrock et. al. by treatment of Ta(CH2-t-Bu) 3(Cl) 2 with two equivalents
of LiCH2-t-Bu to generate Ta(=CH-t-Bu)(CH 2-t-Bu) 3.5 Alkylidenes differ from carbenes in that
the alkylidene has triplet character. Compounds related to tantalum alkylidenes did not react
catalytically with olefins, but formed a metallacyclobutane that rearranged to form an olefin
complex. Similarly, titanium alkylidene complexes were developed and investigated, were
active only for ring-opening metathesis polymerization (ROMP) reactions.6 Titanium and
tantalum alkylidene complexes paved the way for the preparation of the better known Group VIB
metal alkylidene complexes. Preparation of tungsten alkylidene oxo complexes like WO(CH-t-
Bu)C12(PEt3)2 was achieved by Schrock by treating WO(O-t-Bu) 4 with one equivalent of Ta(CH-
t-Bu)Cl3(PEt 3)2.20a Similarly, Osborn prepared M(O)(CH-t-Bu)(CH 2-t-Bu)(X) complexes from
M(O)(CH 2 -t-Bu) 3(X) in the presence of a Lewis acid.2 0b-c Almost a decade later, Group VIB
alkylidene imido of the general formula M(NR)(CHR')(OR") 2, where M = Mo, W; R = alkyl or
phenyl; R' = tert-butyl, CMe2Ph, SiMe 3; and R" = alkyl, phenyl were prepared. Complexes of
this kind can react with olefins catalytically in a metathetical fashion. The metal in these
catalysts are all in the highest oxidation state (+6), which makes the metal relatively Lewis
acidic. The ancillary ligands serve to protect the metal sterically from intermolecular or
intramolecular decomposition.7
Preparation of M(NR)(CHR')(OR") 2 species has been ongoing in the Schrock laboratory
during the last 20 years of the 2 0 th century. The best and most accessible route to catalysts of
this type involves a four-step synthesis when M = Mo and a five-step synthesis when M = W.
The overall synthetic scheme is shown in Scheme 2.8
In the case of M = W, the first step involves preparation of W0 2Cl 2 from WCl1 by treatment
with hexamethyldisiloxane. Preparation of W0 2C 2 is required since the next reaction cannot be
carried out with Na 2WO 4 . The next step is the preparation of M(NR)2Cl2(DME) from W0 2Cl 2
(if M = W) or (NH 4 )2Mo20 7 (if M = Mo) by treatment with RNH2, TMSCL, base in a
coordinating solvent (DME), followed by alkylation with a Grignard reagent to form
M(NR) 2(CH 2R') 2. Treatment of the latter with three equivalents of triflic acid (TfOH) in the
presence of a coordinating solvent (DME) generates the alkylidene complex
M(NR)(CHR')(OTf) 2(DME). This alkylidene complex is often referred to as the universal
catalyst precursor because treatment with two equivalents of LiOR" yields M(NR)(CHR')(OR") 2
complexes. Moreover, treatment of the universal precursor with one equivalent of chiral
binaphtholate or biphenolate dianions yields the corresponding Mo(NR)(CHR')(diolate)
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+ 2 RNH 2
+ 4 NEt 3
+ 7 TMSCI
DME
1/2 (NH4 )2Mo2 07
- 3.5 TMS20
- 4 Et3NHCl
- NH4C1
2 TMS20
WC16  W 0 2C12
- 4 TMSCl
+ 2 RNH2
+ 4 (2,6-lutidine)
+ 4 TMSCl
DME
- 2 TMS20
- 4 (2,6-Me 2C6H2NHC1)
NR C
Cl'-30-- -- M==NR
NR N| /Cl + 2 ClMgCH2 R' NR
-M=NR MNR
- 2 MgC12 R'H2 C /
-DME R'H2C
+3 TfOH
DME
- RNH 30TF
- R'CH 3
NR R' + 2 LOR"TfOI /+LiR
TfO - 2LiOTf
- DME
NR R'
R"O
Scheme 2 - General synthetic route to Mo(NR)2Cl2(DME), top, and bisalkoxide complexes, bottom.
complex. Enatiomerically pure biphenolate and binaphthalate complexes have been used to
generate olefinic products containing a chiral center from achiral precursors.9
The presence of two different groups on the alkylidene ligand and competition for metal
orbitals between the imido and the alkylidene ligands can generate two isomers. In one the R'
group of the alkylidene points towards the imido ligand (syn) and in the other the R' group points
away from the imido ligand (anti), Figure 1." The syn species lies lower in energy, in part
because of an agostic interaction that takes place between the metal center and the C-H bond of
the alkylidene group. In the anti configuration, the alkylidene C-H bond points away and no
such agostic interaction is present." Experimentally, if the isomers are present in solution in
millimolar concentrations, they can be observed and identified by measuring the JCH coupling of
the alkylidene a-carbon to the alkylidene a-proton in a simple 'H NMR experiment. The JCH
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coupling in the syn species typically ranges between 110-130 Hz, while the JCH coupling in the
anti species is > 130 Hz. The JCH value of 110-130 Hz is in agreement with the presence of an
agostic interaction in the syn configuration. 1'' Additionally, X-ray structures of many complexes
not only unambiguously show whether the complex is in the syn or anti configuration, but the
shorter Mo=C bond length and larger Mo=C-R' bond angle of the syn species (in comparison to
the anti isomer) are also consistent with the presence of an agostic interaction in syn
complexes. lc, 12
R R
R
N R' N
Bob. HMo RO Mo
OR" OR" OR"
Syn Anti
JcH 110-130 Hz JCH > 130 
Hz
R R
R
N
R1 H
H R'
Figure 1 - Conversion of syn and anti isomers via rotation of the alkylidene group. An orbital
diagram is shown at the bottom for clarity.
Interconversion of syn and anti isomers has been observed in solution for many
M(NR)(CHR')(OR")2 complexes.ioa Typically, the equilibrium concentration of the anti species
is too small to observe readily, but its concentration can be increased considerably by UV-vis
photolysis of a solution of the complex at 360 nm at - 78 *C. Kinetic data of the nonequilibrium
mixture can be obtained to determine the rate of conversion of anti to syn. It has been found that
species where R" = CMe(CF3)2 or fluorinated alkyl convert at five orders of magnitude slower
than species where R" = CMe3 or nonfluorinated alkyl/phenyl.10a Conversion of one isomer to
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another involves the loss of the metal-imido dative triple bond in order to allow free rotation of
the alkylidene to take place (Figure 1).
Counting all the possible combinations of imido groups that can be used as ligands and
multiplying that number by the vast combination of alkoxides and chiral diolates that can be used
suggets that in situ preparation of catalysts for screening reactions would be desirable. For this
reason catalyst precursors were sought that would generate active catalyst species without
forming salts as byproducts. Ideally the precursor would have to be relatively stable, generate
active catalysts efficiently (in solution), and produce byproducts that would not interfere with the
catalytic reaction. Bispyrrolide complexes of the general formula M(NR)(CHR')(Pyr) 2, where
Pyr = pyrrolide, were the first complexes that satisfied most of the criteria mentioned above, 3 a
while complexes where Pyr = 2,5-dimethylpyrrolide, satisfied all the requirements and
criteria. 13b Bispyrrolide complexes where Pyr = 2,5-diisopropylpyrrolide, 2,5-diphenylpyrrolide,
2,3,4,5-tetramethylpyrrolide, and 2-indolyl were prepared as well, 3,~d but those where Pyr =
pyrrolide and 2,5-dimethylpyrrolide have been the most widely used in the Schrock and Hoveyda
laboratories.
i-Pr i-Pr Cl C1
Ar
R i-Pr F3C t-Bu
N Ad
Mo R' R' = CMe2Ph, CMe 3
i-Pr
R" = C(CF 3)2Me
CMe 3  i-Pr -r
i-Pr
R'" SiPh3  ,,OTBS
2,6-i-Pr2C6H3  i-Pr
i-Pr
HIPT BITETX2
R'"= H, Me, i-Pr, Ph
Figure 2 - General structure of MAP catalysts (left), typical ligands used are shown on the right.
30
Treatment of M(NR)(CHR')(Pyr) 2 complexes with one equivalent of R"OH (where R = alkyl
or aryl) allowed synthesis of monoalkoxide monopyrrolide (MAP) complexes (Figure 2).14' 15
Apart from work presented in this thesis, the majority of MAP catalysts synthesized in the past
are those where the imido ligand is 2,6-i-Pr 2C6H3N (ArN) or 1-adamantyl (AdN). MAP
catalysts, where R = Ar or Ad, have been shown to be effective for the ring closing metathesis
(RCM) of enyne substrates, 3 c, 14a the Z-selective polymerization of 2,3-
dicarbomethoxynorbornadiene (DCMNBD) and 2,3-dicarbomethoxynorbornene
(DCMNB),o1,14-c Development of Z-selective catalysts was first achieved with
Mo(NAd)(CHCMe 2Ph)(Pyr)(OHIPT), where Ad = 1-adamantyl, Pyr = pyrrolide, and OHIPT =
2,6-bis(2',4',6'-triisopropylphenyl)phenoxide. The large OHIPT ligand ensures that incoming
olefins would only bind so that the olefin substituents would point away from the OHIPT ligand
and toward the small imido group, thus yielding cis olefin product (see Figure 4). This catalyst
has been employed to form Z-selective products.10 ' 14b-c
MAP complexes where the phenoxide ligand is chiral are of special interest because
diastereomers are formed that can potentially have different reactivity. The best studied
diastereomeric MAP catalysts are complexes of the type
M(NAr)(CHCMe 2Ph)(Me2Pyr)(OBITETX 2), where M = Mo or W, Ar = 2,6-i-PrC6H3, Me2Pyr =
2,5-dimethylpyrrolide, OBITETX2  = 3,3'-X 2-5,5',6,6',7,7',8,8'-octahydro- 1,1 '-bi-2'-(tert-
butyldimethylsilloxide)naphtha-2-ol, and X halide (shown in Figure 2).is
M(NAr)(CHCMe 2Ph)(Me2Pyr)(OBITETBr 2) diastereomers can be isolated from one another and
their reactions with olefins showed that the configuration at the metal changes with each
metathesis reaction. 15 Inversion of configuration at the metal during a single metathesis reaction
is required by the principle of microscopic reversibility. DFT calculations suggest that inversion
at the metal does take place and that species where all ligands are different (e.g. MAP) are in
many cases more efficient catalysts than bisalkoxides catalysts. In particular, catalysts of the
type M(NR)(CHR')(X)(Y), where X is a good sigma-donor ligand and Y is a poor one, are
predicted to have lower activation barriers for olefin coordination and olefin dissociation. 6
Diastereomeric MAP complexes have been shown to be highly selective for the asymmetric
RCM of a desired intermediate in the total synthesis of (-)-quebrachamine.5b-
A method to evaluate whether or not the inversion of configuration at the metal center affects
selectivity during olefin metathesis reactions is the ring opening metathesis polymerization
(ROMP) of DCMNBD, which can yield up to four regular structures. Regular poly(DCMNBD)
can have cis or trans olefin bonds and have either isotactic or syndiotactic structures (Figure 3).
Examination of the polymer structure by NMR methods gives information about what happens
during insertion of the monomer and propagation of the polymer chain.
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cis syndiotactic
B, .,,,%E B, E
H H -
n/2
cis isotactic
B,, E
H
H
E E n/2
trans isotactic
[M]
Toluene H
n/2
trans syndiotactic
Figure 3 - Four regular structures for poly(DCMNBD).
Poly(DCMNBD) that is formed employing Mo(NR)(CHCMe 2Ph)(Me 2Pyr)(OBITETBr2) is
atactic and contains only 70 % of cis bonds. On the other hand, when
Mo(NAd)(CHCMe 2Ph)(Pyr)(OHIPT) is used, poly(DCMNBD) is isolated as a regular polymer
with cis-syndiotactic structure. 14b Figure 4 shows the proposed mechanism for formation of cis-
syndiotactic poly(DCMNBD). In step 1 syn binding of DCMNBD to syn-(R)-
Mo(NAd)(CHCMe 2Ph)(Pyr)(OHIPT) results in an intermediate molybdacyclobutane that
contains all bulky subsituents pointing toward the imido ligand. Opening of the
metallacyclobutane yields syn-(S)-Mo(NAd)(CHR')(Pyr)(OHIPT). In step 2 a second molecule
of monomer binds syn to syn-(S)-Mo(NAd)(CHR')(Pyr)(OHIPT) from the opposite face of the
catalyst and yields, upon collapse of the metallacyclobutane ring, a propagating chain with
alternating tacticity. In addition, the configuration at the metal returns to (R). Finally, steps 1
and 2 are repeated consecutively yielding cis-syndiotactic poly(DCMNBD). It is worth noting
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that in each insertion step the monomer is expected to bind trans to the pyrrolide, as suggested
by Eisenstein16 and inversion of configuration is required to get syndiotactic polymer, which is in
agreement with experimental results.15 Likewise, formation of a new olefin is also expected to
occur trans to the pyrrolide, which is the reason the metal configuration changes during each
metathesis step.
Ad Ad
E
E inversion
H oE R configuration E/HPTO I,. D o R Pyr -Mo 0 Pyr ",.'
PyrF E HIPTO
1
(R) (S)R
Ad
Ad
Pyr hin-. 0 inversionII
1 2NAd:: of
RO 2 11r-MoN E configuration H APT Y FO E E
R I Pyr - o E Ez E E
(S) E OHIPT
(R)
Figure 4 - Proposed mechanism for ROMP of DCMNBD with Mo(NAd)(CHR)(Pyr)(OHIPT):
(1) syn binding of 1" DCMNBD monomer from the back face of catalyst, and (2) syn binding of
2"i DCMNBD monomer from the front face of the catalyst yielding cis-syndiotactic polymer.
Two other regular poly(DCMNBD) structures have been obtained with other catalysts. Cis-
isotactic-poly(DCMNBD) can be made with Mo(NAr)(CHCMe 2Ph)(diolate*) catalysts and the
polymer structure is proposed to result from enantiomorphic-site control.1a Trans-syndiotactic-
poly(DCMNBD) can be made with Mo(NAr)(CHCMe 2Ph)(0-t-Bu) 2 (Figure 5 ).17b The trans,
syndiotactic structure is suggested to arise by syn-binding of DCMNBD to anti-
Mo(NAr)(CHCMe 2Ph)(O-t-Bu) 2 (step A) to generate the syn-first-insertion product (step B),
followed by conversion to the anti-first-insertion product (step C) before syn-binding of a second
molecule of DCMNBD (step D).1 The tacticity of the polymer is expected to arise the same
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way as depicted in Figure 4; however, since the catalyst is C, symmetric, invertion at the metal
will have no effect on the selectivity. Instead, insertion of subsequent monomer is directed via
chain-end control.
NAr E NAr - NAr
t-Bu-O E1 t-Bu-O R 
t-Bu-O M
R AR B t-Bu-o t-Bu-o
anti syn
anti R
S MO I O _
E R E E 
-4 E E
D t-Bu-0
_j Syn E E RR
Figure 5 - Proposed mechanism for ROMP of DCMNBD with Mo(Nr)(CHR)(O-t-Bu) 2: (A)
Syn-binding of DCMNBD, (B) Propagation, (C) syn to anti interconversion, (D) syn binding of
2nd DCMNBD monomer, and (E) Propagation.
The reactions depicted in Figures 4 and 5 are excellent examples of how ROMP of
DCMNBD can be used to elucidate and deduce how substrates bind to the metal and what
happens to the catalyst during subsequent metathesis reactions. Due to the aforementioned
attributes, DCMNBD is used in this thesis to test the selectivity of a wide variety of catalytically
active complexes.
The dissertation will present the synthesis, characterization, and catalytic activity of
biscarboxylate and monocarboxylate monopyrrolide complexes (Chapter 2), MAP complexes
containing ortho-substituted phenyl imido ligands (Chapter 3), MAP complexes that contain the
unsubstituted-pyrrolide ligand with a small variety of imido ligands (Chapter 4), and
monoalkoxide monoanionic (MAX) complexes where the anionic ligand is a carboxylate, a
phenoxide, an amide, or a terphenyl group (Chapter 5). The appendix will survey the
polymerization of 4,4-diethyldipropargylmalonate (DEDPM) to form polyconjugated polymer
containing ring structures with MAP and bisalkoxide catalysts.
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CHAPTER 2
Molybdenum Imido Alkylidene Complexes Containing Carboxylate Ligands and their
Application for the Ring-Closing Metathesis Polymerization of 4,4-Di-substitutedheptadi-1,6-
yne
Reprinted (adapted) with permission from Schrock, R. R.; Tonzetich, Z. J.; Lichtscheidl, A. G.;
Miller, P.; Schattenmann, F. J. "Carboxylate-Based Molybdenum Alkylidene Catalysts:
Synthesis, Characterization, and Use as Initiators for 1,6-Heptadiyne Cyclopolymerizations"
Organometallics 2008, 27, 3986-3995. Copyright 2008 American Chemical Society.
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INTRODUCTION
Tungsten and molybdenum high oxidation state alkylidene complexes of the type
M(NR)(CHR')(OR") 2 (M = Mo or W; R, R', and R" = various bulky alkyl or aryl groups), have
proven useful for a variety of catalytic metathesis reactions. Examples include the living ring-
opening metathesis polymerization (ROMP) of strained olefins,2 the polymerization of
monoalkynes or dialkynes to yield polyenes,3 and the ring-closing metathesis (RCM) of
dienes.l'b id, 4 Molybdenum-based compounds have been proposed to be less sensitive to
functionalities than tungsten-based species and therefore have been preferred.5 Unsubstituted
tungstacyclobutane complexes also in some cases have been found to be relatively stable toward
loss of ethylene, whereas observable molybdacyclobutanes are rare;6 turnover frequencies with
Mo catalysts therefore can be higher than with W catalysts in certain circumstances. One
valuable asset of M(NR)(CHR')(OR") 2 catalysts is their modularity. Variation of the NR and
OR" ligands can lead to different reactivities and selectivities, often dramatically so, especially
in stereoselective ROMP of strained olefins and asymmetric metathesis reactions. We have
reported the synthesis of Mo(NR)(CHR')(pyrrolide)(OR") species7 through addition of R"OH to
Mo(NR)(CHR')(pyrrolide)2 species,8 where the pyrrolide is the parent pyrrolide (NC4H4 = Pyr)
or 2,5-dimethylpyrrolide (NC4Me2H2 = Me2Pyr). The Mo(NR)(CHR')(pyrrolide)(OR") species
are potentially even more highly variable as well as chiral at the metal center. Preliminary
results suggest that some enyne metathesis reactions are successful with
Mo(NR)(CHR')(Pyr)(OR") species.7
(A)
E E
diyne Mo Mo
a-addition |-|Mo - E E E
E E
E __E E Mo
n
a
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M -addition E E Mo
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En n
Scheme 1 - Structure of propagating polymer unit as a result of (A) a-addition or (B) p-addition of
the diyne substrate.
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An important feature of polymerization reactions involving terminal alkynes is the
(presumably irreversible) addition of the alkyne to place the alkyne substituent in either an a or a
P position in the metallacyclobutene intermediate, the rearrangement of which yields either a
disubstituted (A) or monosubstituted alkylidene (B, Scheme 1). If both addition pathways are
operative, the resulting polyenes will contain a mixture of five-membered rings (as a
consequence of a-addition) or six-membered rings (as a consequence of p-addition) as the repeat
unit. Several Mo3 e' 9 and Rua0 catalysts are known that are capable of producing polyenes that
contain 95% five-membered rings, while we reported (in a preliminary fashion) the synthesis and
polymerization behavior of some molybdenum imido alkylidene complexes that contain two
carboxylate ligands that serve as initiators for the living polymerization of diethyl
dipropargylmalonate to give polyenes that contain >98% six-membered rings." In this chapter
we describe some further studies of biscarboxylates or monocarboxylates and 1,6-heptadiyne
aimed at the synthesis of polymers that contain a high fraction of six-membered rings.
RESULTS AND DISCUSSION
2.1 Molybdenum imido alkylidene biscarboxylate complexes
2.1.1 Synthesis of Bisbenzoate Complexes
Preparation of isolable biscarboxylate complexes was achieved in the past in our laboratory
using the sterically demanding triphenylacetate ligand.11 Carboxylate ligands smaller than
triphenylacetate tended to give "ate" complexes or ill-defined (possibly oligomeric) species that
could not be isolated. Isolable complexes were prepared from bistriflate precursors through salt
metathesis reactions with sodium triphenylacetate (equation 1; Ar = 2,6-i-Pr2C6H 3, Ar' 2,6-
Me2C6H3, Ad = 1-adamantyl, ArtBu = 2-t-BuC 6H4) by Dr. Z. J. Tonzetich.
R R
N CMe 2R' ONa N CMe2R'
TfO 11 -- 0
1-Mo : .OTf + 2 O OC Ph3C 1 < 0 _Mo
- I <~h30
OCPh 3  - 2 LiOTf 0 . (1)
-DME
la R = Ar, R'= Ph CPh3
lb R = Ad, R'= Ph
lc R = Ar', R'= Ph
ld R = ArtBu, R'= Me
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A single crystal X-ray study of id revealed it to be a distorted six-coordinate 18 electron
species in which both carboxylates are bound K2 . However, both are bound somewhat
asymmetrically with Mo-O distances of 2.136 A and 2.261 A for one carboxylate and 2.090 A
and 2.336 A for the other carboxylate. The longer Mo-O bonds are trans to the Mo=C (2.336 A)
or the Mo=N bond (2.261A). The carboxylates are technically inequivalent in this structure,
although all biscarboxylate complexes show time-averaged Cs symmetry in solution at room
temperature, consistent with fluxional coordination geometry on the NMR time scale that may or
may not involve intermediates that contain at least one K1 carboxylate.
Attempts to prepare bisbenzoate complexes utilizing commercially available carboxylates did
not yield isolable products. This behavior is similar to what occurs in the reaction between
bistriflate complexes and small acetate ligands. However, we found that "ate" complexes can be
avoided and bisbenzoate complexes prepared if 2,6-terphenylcarboxylates" are employed. The
two chosen terphenylcarboxylates contain p-methyl or p-methoxy substituents in the phenyl ring
bound in the 2 and 6 positions in the benzoate backbone, (O2CTerme) and (O2CTeroMe),
respectively (Figure 1).
R 14 HO O R
TerMeCO 2H: R =Me
TeroMeCO 2H: R = OMe
Figure 1 - Terphenylcarboxylic acids used for synthesis of carboxylate complexes.
The chosen method of synthesis consisted of addition of two equivalents of the acid to
Mo(NR)(CHCMe 2Ph)(Me2Pyr)2 (Me2Pyr = 2,5-dimethylpyrrolide; equation 2). The complexes
can also be prepared via salt-metathesis starting from the corresponding bistriflate precursor and
two equivalents of NaO2CTer. However, the more complicated work-up involves
recrystallization of the compounds because the initial product obtained from the reaction is
relatively impure. In the case of complexes that contain the adamantylimido ligand (discussed
below), the product of the salt metathesis reaction could not be obtained in a pure form suitable
for further studies. The resulting bisbenzoates, Mo(NAr)(CHCMe 2Ph)(O 2CTere) 2 (2a) and
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Mo(NAr)(CHCMe 2Ph)(O 2CTeroe) 2 (2b) (equation 2) were isolated in yields between 50 and
60%. Similarly, bisbenzoate alkylidene complexes containing the adamantylimido group,
Mo(NAd)(CHCMe 2Ph)(O 2CTerme) 2 (2c) and Mo(NAd)(CHCMe 2Ph)(O 2CTerMe) 2 (2d), were
obtained in yields ranging between 40 and 70% (equation 2). The 'H NMR spectra of all
compounds suggest that a mirror plane is present on the NMR time scale as a consequence of
rapid carboxylate interconversion. Only a syn isomer is observed for each with 8H, 8C', and
JCH values similar to other carboxylates described earlier. The resonances corresponding to the
alkyl groups of the imido substituents, as well as to the alkyl groups of the carboxylate, are
sharp, again consistent with a plane of symmetry being present on the NMR time scale.
R1
R R
N CMe2Ph N CMe 2Ph
---- ' O----
N'...Mo + 2 HOC&TerR1 NMo 0
-2 Me 2PyrH 0 (2)
0-~
NO
TerRi
2a R = Ar, R1 =Me (56%)
2b R = Ar, R1 = OMe (55%)
2c R =Ad, R1 =Me (66%)
2d R = Ad, R1 = OMe (43%)
Crystals of 2a were grown from a saturated methylene chloride solution layered with diethyl
ether. The structure is shown in Figure 2. (See Table 3 for details.) The structure is best
described as a distorted octahedron, with both carboxylate groups bound to the metal in a c2 2
fashion, similar to the biscarboxylate described in the preliminary communication." The
alkylidene is in the syn orientation. The most interesting features are again long Mo(1)-O(l) and
Mo(1)-O(3) bond lengths (2.2867(16) A and 2.3186(16) A, respectively), i.e., those trans to the
imido and alkylidene groups, respectively. In the solid state the two carboxylates are
inequivalent, but equivalent in solution on the NMR time scale.
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Figure 2 - The solid state structure of 2a (50% probability ellipsoids). Selected bond lengths
(A) and bond angles (*): Mol-N1 = 1.7247(16), Mo(1)-C(1) = 1.902(2), Mo(l)-O(1) =
2.2867(16), Mo(1)-O(2) = 2.1160(14), Mo(l)-O(3) = 2.3186(16), Mo(1)-O(4) = 2.1252(14),
Mo(l)-N(l)-C(1 1) = 174.15(13), Mo(l)-C(1)-C(2) = 145.18(14).
2.1.2 Observation of Anti Isomers
The UV-vis spectrum of la is shown in Figure 3. The absorption maximum at 324 nm (E
15000 M-'cm-') is similar to what was found for Mo(NAr)(CH-t-Bu)(OR) 2 complexes in which
R = t-Bu, CMe 2(CF 3), or CMe(CF 3)2.'3 This absorption is ascribed to the M-Nimido 7T J *
transition, in part because a photostationary mixture of syn and anti isomers (equation 3) can be
formed through irradiation of samples with 366 nm light in toluene. Rates of interconversion of
syn and anti alkylidene isomers in bisalkoxide complexes vary by several orders of magnitude,
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RCMe
Mo
R "~ $ ----.. 0 H
O
N
ks/a 0
ka/sR
Syn
JCH = 120-130 Hz
Anti
JCH = 130-140 Hz
with the slowest rates being found for alkylidene complexes that contain relatively electron-
withdrawing alkoxides such as OCMe(CF3)2.13 ' 14 Interconversion of syn and anti isomers
appears to be most facile in 14e species. For example, the base (e.g. PMe3) in a 16e adduct of
Mo(NAr)(CH-t-Bu)[OCMe(CF 3)2]2 must be lost before syn and anti isomers can interconvert. A
coordinating solvent such as THF will also hinder alkylidene rotation to a significant degree in
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chloride (33.9 ptM).
spectrum of Mo(NAr)(CHCMe 2Ph)(O2CCPh3)2 (la) at 23 *C in
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(3)
Figure 3 -
methylene
Mo(NR)(CHR')(OR") 2 species on the basis of slower rates and negative values for the activation
entropy for syn/anti interconversion in THE.15 Since syn and anti isomers can have dramatically
different reactivities,14 the rate of interconversion of syn and anti isomers and the position of that
equilibrium can have important consequences in terms of metathesis with such species.
Photolysis of a sample of la in toluene-d at 366 nm for 3 h at 22 *C yielded a mixture
containing 16% of a new species in which 8Ha = 13.93 ppm and JCH = 138 Hz, characteristic of
an anti isomer. At 22 *C the anti isomer was found to convert to the syn isomer in a first order
manner with ka/s = (8.30 ± 0.93) x 10-6 s-1 (t/ 2 = 23.2 h). A sample of lb irradiated in toluene-d
at 366 nm for 2 h at 22 'C produced a mixture containing 28% of an anti species (8H. = 13.99
ppm, JCH = 140 Hz) that reverted back to the syn isomer at 22 'C with ka/s = (3.08 ± 0.14) x 10-4
s-1 (tv1 2 = 39 minutes). Finally, a sample of Id irradiated in toluene-ds at 366 nm for 2 h at 22 'C
produced a mixture containing 17% of an anti species (8H. = 13.90 ppm, JCH = 137 Hz) that
reverted to the syn isomer at 0 'C with ka/s = (1.55 ±0.12) x 10-5 s-1 and at room temperature with
ka/s = (3.62 ± 0.74) x 10- s-1. Therefore, at room temperature the relative rates of conversion of
anti to syn isomers are 1d > lb > la with tiv2 ranging from ~1 day (for 1a) to -3 minutes (for
1d).
R R
CMe2Ph hv
366 nm
R" MoO R" - ....  Mo (4)
ka/s 0 CMe2Ph
R"f R"f
Syn/anti isomerization reactions of bisbenzoate complexes were studied briefly for 2a and 2c.
A sample of 2a in toluene-d was photolyzed at 22 'C with 366 nm light for 2 hours. The
resulting mixture contained 7% of the anti species (8H" = 13.6 ppm, JCH = 137 Hz), and 93% of
the syn species (bH(= 13.4 ppm, JCH = 126 Hz). The rate constants for the anti to syn conversion
of 2a at 22 *C and 0 *C in toluene-d were found to be (5.31 ± 1.14) x 10~4 s- 1 and (1.28 ± 0.11) x
10-5 s1 respectively. Photolysis of a solution of 2c in toluene-d at room temperature for 2 hours
yielded a mixture of 9% anti (8H,= 13.9 ppm, JCH = 140 Hz) and 91% syn (8Ha= 13.2 ppm, JCH
= 124 Hz) isomers. However, unlike 2a, which proved to have a short half-life for conversion of
anti to syn, anti-2c was virtually unchanged after four hours at 22 0C. Only after 16 hours at 22
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"C did the amount of the anti species decrease to ~3% (30% of the initial amount). All data are
summarized in Table 1.
Table 1 - Analysis of Photolyzed Biscarboxylate Complexes in C7D8.
[Mo] Syn Species Anti Species Photolysis Rates of Conversion from Anti to Syn
time at (sec-)
ppm JCH (Hz) % ppm JCH (Hz) % RT RT 0 0C
la 13.84 123 84 13.93 138 16 3 h (8.30±0.93)-10-6 -----
lb 13.80 123 72 13.99 140 28 2h (3.08±0.14)-10-4 -------
1d 13.77 120 83 13.90 137 17 2 h (3.62±0.74)-10-3 (1.55±0.12)-10-5
2a 13.40 126 93 13.60 137 7 2h (5.31±1.14)-10-4 (1.28±0.11)-10-5
2c 13.20 124 91 13.90 140 9 2h ------ ----
2.1.3 Trimethylphosphine adducts of triphenylacetate complexes
Base adducts of imido alkylidene complexes often can serve as models of the first adduct
formed when a substrate approaches the metal center in a catalytic reaction.12 Although the 18-
electron biscarboxylates are unlikely to bind a Lewis base if the K2, K2 configuration is
maintained, compounds 1b-d do react readily with PMe3 to give mono-adducts (1b-PMe3 -
ld-PMe3 , equation 5). Compound la does not bind PMe3 strongly enough to isolate the adduct,
presumably because of the greater steric demands of the 2,6-diisopropylphenyl imido ligand.
R
N CMe 2Ph
0-----
R"f
R
N CMe2Ph
PMe3  OMe 3P . I r
0...Mo
R" O
The phosphine adducts were initially isolated and characterized by Dr. F. J. Schattenmann
and Dr. Z. J. Tonzetich through crystallization from a mixture of methylene chloride and
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(5)
pentane. They found that the alkylidene protons in 1b-PMe3 - ld-PMe3 are coupled to
phosphorus by 5-6 Hz, which is consistent with the phosphine not dissociating rapidly on the
NMR time scale. Coupling constants of 5-6 Hz are analogous to those found in various
phosphine adducts of imido alkylidene bisalkoxide complexes.1 2 NMR spectra of lc-PMe 3 and
ld-PMe3 reveal that the carboxylates are inequivalent, consistent with one being K2 and the other
being KI, as depicted in equation 5, and shown to be the case in the solid state structure of
ld-PMe3 . 1b-PMe3 has equivalent carboxylate ligands on the NMR time scale. The methyl
groups of the neophylidene ligand are inequivalent in lb-PMe3, which suggests that the
carboxylates must equilibrate without generating a mirror plane that passes through the P carbon
of the alkylidene ligand.
Proton NMR spectra of freshly crystallized 1b-PMe3, lc-PMe 3, and ld-PMe3 show only
the syn isomer. However, over a period of several days the anti isomers appear. For example,
when a solution of freshly prepared syn-1d-PMe3 was kept at -35 'C for a period of 2 days and
the crystals collected, NMR spectroscopy in C6D6 showed them to be a mixture of 41% of the
anti isomer (8HQ= 13.8 ppm, JCH = 135 Hz) and 59% of the syn isomer (8HQ= 13.1 ppm, JCH
116 Hz). After this solution was left at room temperature for 6 days, the mixture consisted of
64% of the anti species and 36% of the syn species (Figure 4). No further change was observed
after 3 weeks; therefore the two appear to be at equilibrium at this point. This general behavior
is analogous to that of Mo(NAr)(CH-t-Bu)[OCMe(CF 3)2] 2(PMe3), which can be isolated as a syn
isomer that slowly converts over a period of days in solution into the anti isomer (completely), a
process that is believed to require loss of trimethylphosphine followed by (inherently slow) syn
to anti rotation about the Mo=C bond in intermediate Mo(NAr)(CH-t-Bu)[OCMe(CF 3)2] 2.12
Overall the structure is reminiscent of the structure of a typical adduct of a bisalkoxide
species such as Mo(NAr)(CH-t-Bu)[OCMe(CF 3)2] 2(PMe 3).1 2 One can imagine that if a terminal
alkyne were to bind to the metal in the same position as the trimethylphosphine, the steric
influence of the t-butyl group in the imido substituent combined with that of the bidentate
triphenylacetate ligand could direct the terminal alkyne substituent (if large enough) to point in a
direction that would yield the p-substituted metallacyclobutene intermediate (Scheme 1).
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Figure 4 - Alkylidene region in the 'H NMR of ld-PMe3 after 2 days
of being dissolved in C6D6 .
(bottom) and 6 days (top)
2.1.4 Cyclopolymerization of 1,6-heptadiynes
None of the biscarboxylate species reported here react readily with olefins, even ethylene or
norbomene. However, several are competent, though slow, catalysts for the cyclopolymerization
of diethyl dipropargylmalonate (DEDPM). Compound la is an impractically slow initiator,
presumably because of the steric demands of the diisopropylphenylimido ligand. Catalysts lb
and 1d produce polymers that contain >98% six-membered rings, according to 13C NMR spectra,
which reveal resonances for quaternary carbons in five-membered rings at 57-58 ppm and in six-
membered rings at 54-55 ppm.3d 13C NMR spectra are much more convenient to obtain, even in
the absence of any relaxation agent such as Cr(acac)3, when the quaternary carbon is 13 C-labeled.
Typical spectra of polymers that contain mostly six-membered rings are shown in Figure 5.
Compound 1c is also an initiator for the cyclopolymerization of DEDPM, but does not show any
advantages over initiators lb and 1d. Polymers prepared with initiators la and 1c contained
only 35% or 90% six-membered rings, according to 13C NMR studies. All polymers prepared
with initiators la-d that contain up to 125 equiv of DEDPM are soluble in toluene,
dichloromethane, and THF, but sparingly soluble in pentane and diethyl ether. Polymers that
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contain exclusively five-membered rings9 C are known to dissolve only in relatively polar solvents
(e.g., CH2Cl 2 and THF). Unlike polymers that contain all five-membered rings, those that
contain all six-membered rings may not be stereoregular in terms of the E/Z configuration in the
exocyclic double bond, since the 13 C quaternary carbon method is not likely to be sensitive
enough to detect different E/Z configurations. Different E/Z configurations also may contribute
to greater structural disorder and therefore higher solubilities of polymers that contain a
significant fraction of six-membered rings.
DEDPM can be cyclopolymerized with initiators 2a-2d, although more slowly than with
initiators of type 1. Polymerization of 10 equivalents of 13DEDPM (in which the quaternary
carbon is 13 C-labeled) by 2a or 2b, produced polymer (~80%) only after -1 week at room
temperature. The amount of P product was ~70% overall when either 2a or 2b was employed.
Similarly, when 20 equivalents of 3 DEDPM were added to 2c or 2d, the reactions were still
slower than with initiators of type 1. For example, after 74 hours 86% of the starting material
was consumed when 2c was employed (83% @ product) and 60% when 2d was employed (77%
@ product).
5(a) M 6 (n)
(a)
(b)
57 - 58 ppm 54-55ppm -
Figure 5 - 3 C NMR spectra of polymers prepared from (quaternary 3 C-labeled)
DEDPM (M) using initiators 2c (a) and lb (b).
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2.2 Molybdenum imido alkylidene monocarboxylate complexes
2.2.1 Synthesis of monocarboxylate complexes
As opposed to the ease of preparation of the biscarboxylate complexes, it was found that
reactions between Mo(NR)(CHCMe 2Ph)(Me2Pyr)2 and one equivalent of aliphatic carboxylic
acid tends to yield a mixture of biscarboxylate, starting material, and very little
monocarboxylate. This is even true for the most sterically-hindered conditions (e.g. R = Ar, acid
= Ph3CCO2H). Likewise, reactions between aromatic carboxylic acids and
Mo(NR)(CHCMe 2Ph)(Me2Pyr)2, where R # Ar, lead to mixtures containing mostly
biscarboxylate species.
Fortunately, when the imido group is Ar the preparation and isolation of monocarboxylate
complexes Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(O 2CR") is possible when R" = 2,4,6-
triisopropylphenyl (TRIP), TerMe, TeroMe, or 2,6-(2',4',6'-i-Pr 3C6H2)2C6H3 (HIPT). Thus,
reaction between Mo(NAr)(CHCMe 2Ph)(Me2Pyr)2 and one equivalent of R"CO2H at -35 C
gave the desired complexes, after recrystallization, in modest yields (equation 6). The low yield
of 3a is due to formation of 5-10% of biscarboxylate, which can be removed only by multiple
recrystallizations. Complex 3d was prepared only in situ in C6D6 at RT because purification by
recrystallization was not possible.
i-Pr i-Pr i-Pr i-Pr
N N
I IlI CMe2PhQN} CMe2Ph + R"CO2H N (6)
M :-- 
- 0 MO 3a R" = TRIP (24%)
Me2Pyr-H 3b R" = TerMe (40%)
3c R" = TeroMe (47%)
3d R" = HIPT (in situ)
R"
Proton NMR of all complexes show only one alkylidene peak with JcH values ranging
between 120-123 Hz, all in agreement with the presence of the syn species. With the exception
of 3a, the spectra of all complexes exhibit broad resonances corresponding to the pyrrolide and
phenylimido ligands at RT. The 'H NMR spectrum of 3b was studied further under variable
temperature from 20 *C down to - 10 *C and the aromatic and aliphatic regions of the spectra are
shown in Figure 6.
The signals corresponding to the pyrrolide and imido ligands begin to decoalesce at 15 C
and the maximum number of inequivalent peaks is clearly observed at 10 "C, while between 0 *C
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and - 10 *C they are all well defined. For example, the broad peaks at 5.6 ppm and 1.9 ppm
(pyrrolide) split into two sharp signals each, suggesting two different environments for this
ligand. Likewise, the very broad signals corresponding to the isopropyl groups of the
phenylimido ligand sharpen into two peaks for the methine protons and 4 peaks for the methyl
protons, suggesting the molecule is Ci-symmetric.
15 $.0 1 10 &a S0 .5 10 1.5 LO t3
Figure 6 - VT 'H NMR of 3b in
containing the broad pyrrolide and
CD 2CL2 from 200C (top) to -10*C (bottom). Only the region
isopropyl peaks is shown.
A typical temperature range for decoalescence of broad signals in the 'H NMR spectra of
bispyrrolide complexes is - 40 "C and - 80 C.8 The fact that for 3b the decoalescence
temperature occurs at much higher values suggests that this complex is more crowded and that
there is a significant amount of steric interactions between the ligands in the complex.
The structure of 3b, as determined in an X-ray study, is shown in Figure 7. The molecule
crystallizes in the orthorhombic space group Pbca. The structure can be best described as a
distorted square pyramid, with the alkylidene ligand located in the apical position. The largest
bond angles of the square pyramid correspond to N(l)-Mo(l)-O(2) (145.06(6)*) and N(2)-Mo(l)-
O(1) (144.92(5)0), while the shortest correspond to C(l)-Mo(l)-O(l) (93.71(6)0) and O(1)-
Mo(1)-O(2) (59.32(4)0).
The Mo(l)-N(l) and Mo(l)-C(l) bond lengths, as well as the Mo(1)-C(l)-C(2) and Mo(l)-
N(l)-C(l 1) bond angles are similar to monoalkoxide-monopyrrolide (MAP) species prepared in
the past.7 One of the isopropyl groups on the phenyl imido ligand is disordered. Overall, the
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structure is consistent with having an asymmetrical environment around the metal center; as
suggested by the low temperature 'H NMR experiments (vide supra).
The carboxylate ligand binds x2 to the metal center with similar Mo-O bond distances (~ 2.2
A), with a Mo-O bond trans to the imido ligand and the other trans to the pyrrolide. The
pyrrolide is found to be bound ' to the metal with a Mo(1)-N(2) distance of 2.0481(14)0,
consistent with what has been found with many MAP complexes.7  The 12_i 1 configuration
makes the catalyst a 16-electron complex. The other alternative, a K i-r1 5 configuration, would
produce an electronically saturated, probably relatively unreactive, 18-electron species.
C(11)
N(1)
0(1)
Figure 7 - The solid state structure of 3b (50% probability ellipsoids). Selected bond lengths(A) and bond angles (0): Mol-Ni = 1.7284(14), Mo(1)-C(1) = 1.8690(17), Mo(1)-O(1) =
2.2066(12), Mo(1)-O(2) = 2.1874(11), Mo(1)-N(2) = 2.0481(14), Mo(l)-N(1)-C(11) =
175.73(13), Mo(1)-C(1)-C(2) = 144.25(13), N(1)-Mo(l)-C(1) 100.48(7), N(1)-Mo(1)-N(2) =
103.88(6), N(1)-Mo(1)-O(1) = 101.51(6), N(1)-Mo(1)-O(2) = 145.06(6), N(2)-Mo(1)-C(1) =
104.92(7), N(2)-Mo(l)-O(1) = 144.92(5), N(2)-Mo(l)-O(2) = 86.30(5), C(1)-Mo(1)-O(1) =
93.71(6), C(1)-Mo(1)-O(2) = 109.13(6), O(1)-Mo(1)-O(2) = 59.32(4).
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2.2.2 Reactivity Studies: Ethylene
The 16-electron monocarboxylate complexes do react with olefins, a property that is not
shared with biscarboxylate catalysts. For example, treatment of 3b with ethylene at RT in C6D6
was monitored during a period of 5 days by 1H NMR spectroscopy. After 10 minutes of
exposure to 1 atmosphere of ethylene no appreciable reaction takes place; however, after 17 h
two doublets (13.05 ppm and 13.95 ppm, JHH = 4.0 Hz) characteristic of the methylidene species
are present with most of the starting material consumed. After 1 day no starting material remains
and only the methylidene doublets are observed. Unfortunately, the stability of the methylidene
complex is limited, presumably due to inadequate steric protection present around the metal
center. As a result, the methylidene species decomposes to uncharacterizable products.
Since decomposition of monocarboxylate catalysts takes place under ethylene, olefin
metathesis reactions that generate ethylene also suffer from decomposition (Scheme 2). For
instance, when 5 mol% of 3b is used for the metathesis of 1-hexene, the catalyst begins to
decompose as ethylene is evolved from the system. After standing the sample for 2 days at RT,
the alkylidene peak of the original catalyst has disappeared and the amount of 5-decene vs. 1-
hexene remains 2:1 (see Chapter 5, Section 5.2 for further studies).
i-Pr i-Pr i-Pr i-Pr
N R N
~ ~ 1 CMe2Ph ______'N IN 'MoP + n y 11 'Mo CH 2  RCH=CHR
W n o +
O- H2C=CCMe2Ph CH 2 CH 2
R"f R"f
Decomposition
Scheme 2 - Pathway showing reaction between complexes 3a-c and terminal olefins, and fate of the
catalysts upon formation of methylene species.
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2.2.3 Reactivity studies: Ring-closing metathesis reactions
Although olefin metatheses that evolves ethylene in the process is detrimental to the stability
of the catalyst, reactions that do not form ethylene tend to preserve the catalyst longevity;
therefore, these reactions are more efficiently catalyzed. For instance, the ring closing
methatesis, RCM, of enyne substrates like diethyl(allylpropargylmalonate) (DEAPM) and the
ring closing metathesis polymerization (RCMP) of DEDPM (shown in Scheme 3) gives products
within a reasonable amount of time for some catalysts, shown in Table 2.
EtO2C CO2Et
n
I EAPl
EtO2C CO 2Et EtO2C CO 2Et
Ar
N CMe2Ph
ON(
R"f
CDC13
I EtO2C CO 2Et
n
DEDPM
CDCl 3
a p
EtO 2C CO 2Et EtO2C CO 2Et
+
x y
a
Scheme 3 - Possible products formed during RCM of DEAPM (top) and RCMP of DEDPM
(bottom) with complexes 3a-d.
RCM of 20 equivalents of DEAPM with catalysts 3a-c is accomplished after 2 h at RT, while
3d requires 3 days to reach completion at the same temperature. The slower reactivity of 3d is
attributed to the greater steric bulk of the carboxylate ligand, which hinders the substrate access
to the metal center more than either TRIPCO 2 or TermCO2. Surprisingly, none of the catalysts
have any selectivity for p-product formation and form roughly equal amounts of five-membered
and six-membered rings in the polymer. This result contrasts those obtained with MAP species,
which tend to be selective for p-product formation.7 Some of these reactions are discussed in
Appendix A.
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Table 2 - RCM of DEAPM and RCMP of DEDPM with catalysts 3a-d.
Catalyst RCM of 20 eq. DEAPM RCMP of 50 eq. DEDPM
a p Time a P Time
3a 45% 55% 2 h 5% 93% 30m
3b 52% 48% 2 h 14% 86% 30 m
3c 52% 48% 2 h 27% 73% 30 m
3d 59% 41% 3 d 14% 86% 19 h
On the other hand, RCMP of DEDPM with catalysts 3a-d give polymer that contains a high
content of six-membered rings (73-95%), with 3a being the most selective. Catalysts 3b and 3d
yield polymer with slightly lower 6-membered rings (86%), while 3c is the least selective of the
group. Figure 8 shows the quaternary carbon region of the 3 C NMR spectra for the polymers
made with catalysts 3a and 3b. Polymerization of 25 equivalents of DEDPM with complexes
3a-c is done within 30 min, whereas the reaction takes 19 hours to reach completion when
complex 3d is used. This result also parallels with the reactivity of RCM of DEAPM observed
above. Thus, monocarboxylates with carboxylates smaller than HIPTCO2 are very fast and
efficient catalysts for the polymerization of DEDPM. This implies that the isopropyl groups of
TRIPCO 2 may provide more steric guidance for substrate-binding than the phenyl rings of TerMe
and TeroMe. In the case of 3d, substrate-binding may be too unfavorable and may require
significant ligand rearrangement (e.g. K2 to K'), which allows for a-binding to occur more
frequently. Interestingly, when MAP species that are selective for RCM of DEAPM are used
for RCMP of DEDPM, the p-selectivity is lost and there is either no preference for either ring
structure or if there is any it is biased towards 5-membered ring formation. All of this data can
be found in Appendix A. From the results provided in this section we can say that electronics
may play a bigger role for p-selectivity of DEAPM, whereas sterics may be more important to
get high p-selectivity in the polymerization of DEDPM.
A closer study of poly(DEDPM) formed with catalysts 3a-b was undertaken by analyzing the
UV-vis spectra of the isolated polymers, as shown in Figure 9. The polymers produced with
catalyst 3a (25mer, 50mer, 75mer, and 125mer) have absorption maxima that approach 533 nm
as the size of the polymer becomes larger; whereas, polymers produced with 3b (75mer, 1 00mer,
and 125mer) have absorption maxima that approach 544 nm.
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Figure 8 - 13C NMR spectra of polymers
using initiators 3b (A) and 3a (B).
prepared from (quaternary 13C-labeled) DEDPM (M)
Buchmeiser reported in the past that poly(DEDPM) containing exclusively all or greater than
95% six-membered structures has a maximum UV-vis absorption at 533 nm, while that of pure c
polymer has a maximum absorption at 600 nm."e Our results corroborate Buchmeiser's
statement because polymer containing 95% six-membered rings (as indicated by 13C NMR;
Table 2) has a maximum at 533 nm and polymer containing only 86% six-membered rings
(Figure 9B) has a maximum absorption peak red-shifted closer to the 600 nm limit. In addition,
a shoulder is observed in the spectra of all polymers prepared with catalyst 3b (Figure 9A). This
shoulder corresponds to fine electronic absorption deriving from short 5-membered ring repeats
throughout the polymer. This feature is absent in the UV-vis spectrum of the polymer made with
catalyst 3a (Figure 9B). In a polymer containing > 95% 6-membered rings, the probability of
having high number of 5-membered ring repeats is low.
Polymerization of 100 equivalents of monomers containing bulkier ester groups (Figure 10),
diisopropylesterdipropargylmalonate (DIDPM) or ditertbutylesterdipropargylmalonate
(DTDPM), with catalyst 3a was performed to test the catalyst's overall selectivity. The resulting
isolated polymers were examined by UV-vis. The spectrum of a 2.0 ig/ml poly(DIDPM)
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solution in CH2Cl 2 shows an absorption band at 533 nm, which correlates well with the results
obtained with DEDPM and a polymer containing ~ 95% @ polymer.
Figure 9 - UV-vis spectra of isolated poly(DEDPM) in CH2Cl 2 prepared by reaction of 25, 50,
75, and 100 equivalents of DEDPM and catalysts 3b (A) and 3a (B). Absorption maxima are
listed in parenthesis.
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Unfortunately, the polymer is not soluble enough to get a good 3 C NMR spectrum. In the
case of poly(DTDPM), a 1.2 [g/ml solution in the same solvent exhibits an absorption band
around 540 nm, suggesting that the amount of P product has been diminished to about 86% (see
Figures 8A and 9A). This polymer is soluble in CDCl 3 and 3 C NMR data can be obtained. In
this case, the quaternary carbon region is in agreement with the UV-vis data and measures up to
86% six-membered rings present in the polymeric structure. These results point out that
increasing the size of the ester groups effects the selectivity of monomer binding and,
consequently, ring-size formation along the propagating unit of the polymer.
0 00 0A000 . 0 0 0
DIDPM DTDPM
Figure 10 - Molecular structures of DIDPM and DTDPM monomers.
CONCLUSIONS
The ability to prepare and isolate stable, well-defined, carboxylate complexes depends
critically on the steric bulk of the carboxylate. Carboxylates that possess smaller substituents
result in "ate" complexes or formation of ill-defined oligomeric species. Binding of the
carboxylates in a K2 fashion is favored, which yields a metal center that is less reactive than
bisalkoxides or MAP species. In the case of biscarboxylates, the complexes are unreactive
towards olefins but in the right circumstances will react with terminal alkynes, possibly through
an unsaturated (K1, K1 or K1, K2 ) intermediate. On the other hand, monocarboxylates react with
terminal olefins such as ethylene because they have a vacant site for substrate binding; however,
their stability in the presence of ethylene is limited. Luckily, ring closing reactions that do not
evolve ethylene are catalyzed effectively by these catalysts. Such is the case with DEAPM and
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DEDPM, in the former no binding selectivity is observed, whereas in the latter selective for p-
binding is observed.
As stated above, the utility of the carboxylate species lies in their ability to selectively
polymerize DEDPM to give a polymer that contains all six-membered rings. Unfortunately,
larger ester groups in the dipropargylmalonate lead to polymers that do not contain exclusively
six-membered rings. Terphenylcarboxylates provide almost too much steric protection at the
metal center in biscarboxylate complexes but perhaps too little in monocarboxylates. Both of
these outcomes have a negative impact on the selectivity of six-membered ring formation. Still,
it is somewhat surprising that polymer that contains only six-membered rings can form at all,
since a4p disubstituted metallacyclobutene intermediates would appear less sterically crowded
than ccc' disubstituted metallacyclobutene intermediates, all else being equal. Therefore we
have little hope that many examples will arise in which only six-membered rings are formed
from 1,6-heptadiynes. In contrast, formation of 1,6-heptadiyne polymers that contain only five-
membered rings through formation of c,a' disubstituted metallacyclobutene intermediates seems
to hold more promise. 3,9b Such polymers also do not contain opportunities for E/Z isomerism
and are relatively linear and rigid.
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EXPERIMENTAL
All manipulations were performed in oven-dried (200 'C) glassware under an atmosphere
of nitrogen on a dual-manifold Schlenk line or in a Vacuum Atmospheres glovebox. HPLC
grade organic solvents were sparged with nitrogen and dried by passage through activated
alumina prior to use, then stored over 4 A Linde-type molecular sieves. Benzene-d6 was dried
over sodium/benzophenone ketyl and vacuum-distilled. Methylene chloride-d 2 was dried over
CaH2, vacuum distilled and stored over 4 A Linde-type molecular sieves. NMR spectra were
recorded on Varian spectrometers operating at 300 or 500 MHz and Bruker spectrometers
operating at 400 MHz. Chemical shifts for 1H and 13C spectra were referenced to the residual
H/13C resonances of the deuterated solvent ('H: C6D6 , 8 7.16; CD 2 Cl2, 6 5.32; 13C: C6 D6 , 6
128.39; CD 2Cl 2, 6 54.00) and are reported as parts per million relative to tetramethylsilane.
UV-vis spectra were recorded on an Agilent 8453 diode array spectrometer. Elemental analyses
were performed by H. Kolbe Microanalytical Laboratory, Mulheim an der Ruhr, Germany.
Mo(NR)(CHCMe 2Ph)(OTf) 2(DME) species (where R = 2,6-i-Pr 2C6H3 (Ar), 2,6-Me2C6H3
(Ar'), 1-adamantyl (Ad), and 2-t-BuC 6H4 (Ar")) 15 and Mo(NAr)(CHCMe 2Ph)(Me2Pyr)27 were
prepared according to published procedures. Syntheses of Mo(NAr)(CHCMe 2Ph)(O 2CCPh 3)2,
Mo(NAr)(CHCMe 2Ph)(O2CCMePh2)2, Mo(NAr")(CH-t-Bu)(O 2CCPh 3)2, and
Mo(NAd)(CHCMe 2Ph)(O2CCPh3)2 have been reported in a preliminary fashion." TermeCO 2H
and TeroMeCO2H were prepared as described in the literature.' 2  All carboxylate salts were
prepared by addition of NaH to a THF solution of the corresponding acid (Aldrich) followed by
crystallization from THF/pentane. All other reagents were purchased from commercial vendors
and used as received.
Mo(NAr)(CHCMe 2Ph)(O2CTere)2 (2a). Mo(NAr)(CHCMe 2Ph)(Me 2Pyr)2 (0.295 g, 0.495
mmol) was dissolved in a minimal amount of diethyl ether and the solution was placed at
-35 'C for 1 h. TerMeCO 2H (0.299 g, 0.990 mmol) was dissolved in a minimal amount of ether
and the solution was placed at -35 'C for 1 h. At the end of the cooling period, the solution
containing the carboxylic acid was added to the other dropwise. The reaction was stirred at RT
for 30 min. The volatiles were removed and the sample was triturated with pentane for 1 h until
an orange powder was obtained. The powder was isolated by filtration. The powder was
redissolved in diethyl ether and placed at -35 'C for 12 h to yield pure orange product upon
filtration (0.279 g, 56%): 'H NMR (400 MHz, CD 2 Cl2) 6 13.13 (s, 1H, MoCHCMe 2Ph, JCH =
124.8 Hz), 7.60-6.80 (m, 30H, aromatics), 3.17 (m, 2H, CHMe 2), 2.19 (s, 12H, Terme Me), 1.30
(s, 6H, MoCHCMe2Ph), 0.835 (d, 12H, CHMe2); 3C NMR (100 MHz, CD 2 Cl 2) 6 309
(MoCHCMe2Ph), 185 (C02), 152.5, 150.3, 148.9, 143.0, 138.6, 136.8, 131.6, 130.3, 129.9,
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129.3, 128.5, 128.3, 128.1, 126.2, 126.0, 122.9, 55.7, 31.3, 28.6, 23.4, 21.2. Anal. Calcd for
C6 5H65MoNO 4 : C, 76.40; H, 6.31; N, 1.39. Found: C, 76.31; H, 6.32; N, 1.42.
A small sample (0.030 g) of the pure compound was dissolved in a saturated solution of
methylene chloride and ether was layered on top at RT to yield small crystals suitable for
diffraction.
Mo(NAr)(CHCMe 2Ph)(O 2CTeroe)2  (2b). Prepared as for 2a from
Mo(NAr)(CHR)(Me 2Pyr)2 (0.250 g, 0.420 mmol) and TeroMeCO 2H (0.281 g, 0.840 mmol). The
volatiles were removed from the reaction mixture and the sample was triturated with pentane for
1 h until an orange powder was obtained. The powder was isolated by filtration and
recrystallized from ether at -35 'C (0.248 g, 55%): 'H NMR (400 MHz, CD 2 Cl 2 ) 8 13.14 (s, 1H,
MoCHCMe 2Ph, JCH 123.28 Hz), 7.8-6.4 (m, 30H, aromatics), 3.59 (s, 12H, TerOMe), 3.24 (m,
2H, CHMe2Ph), 1.29 (s, 6H, MoCHCMe2), 0.85 (d, 12H, CHMe2); "lC NMR (100 MHz, CD 2 Cl 2)
6 307.0 (MoCHCMe 2Ph), 185.3 (C0 2), 159.1, 142.7, 133.7, 130.3, 129.8, 128.3, 126.1, 122.9,
114.4, 113.6, 105.8, 55.2, 28.6, 23.4, 14.1, 12.8. Anal. Calcd for C65H6sMoNO8 : C, 71.83; H,
5.93; N, 1.31. Found: C, 71.80; H, 5.86; N, 1.33.
Mo(NAd)(CHCMe 2Ph)(O 2CTere) 2  (2c). Prepared as for 2a from
Mo(NAd)(CHR)(Me 2Pyr)2 (0.288 g, 0.509 mmol) and TermeCO 2H (0.308 g, 1.02 mmol). After
complete addition of the carboxylic acid, the off-white product precipitated out and was collected
by filtration, washed twice with diethyl ether, and dried in vacuo (0.330 g, 66%): 'H NMR (400
MHz, CDCl3) 6 13.04 (s, 1H, MoCHCMe2Ph, JCH 123.88 Hz), 7.42 (t, 2H, terphenyl), 7.33-
7.14 (m, 17H, aromatics), 6.90 (d, 8H, terphenyl), 2.18 (s, 12H, p-tolylMe), 1.93 (s br, 3H, CH
Ad), 1.64 (s br, 6H, CH Ad), 1.49 (s, 6H, CH Ad); 13C NMR (100 MHz, CDCl 3) 6 307.3, 185.7
(C0 2), 150.7, 141.9, 138.4, 136.6, 132.9, 129.9, 129.3, 129.2, 128.9, 128.4, 126.6, 126.0, 51.4,
43.3, 35.9, 31.4, 29.5, 21.3. Anal. Caled for C62H6 1MoNO4: C, 75.98; H, 6.27; N, 1.43. Found:
C, 75.88; H, 6.35; N, 1.41.
Mo(NAd)(CHCMe 2Ph)(O2CTeroe)2  (2d). Prepared as for 2a from
Mo(NAd)(CHR)(Me 2Pyr)2 (0.250 g, 0.442 mmol) and TeromeCO 2H (0.296 g, 0.885 mmol). The
volatiles were removed and the sample was triturated with pentane for a few minutes. The white
powder was isolated and dried by vacuum filtration (0.200 g, 43%): 'H NMR (400 MHz,
CDC13) 6 13.09 (s, 1H, MoCHCMe 2Ph, JCH 123.40 Hz), 7.46 (t, 2H, terphenyl), 7.32-7.14 (m,
12H, aromatics), 6.63 (d, 8H, terphenyl), 3.58 (s, 12H, TerOMe), 1.89 (s br, 3H, CHAd), 1.60 (s,
6H, CHAd), 1.49 (s, 6H, CHAd); 13 C NMR (100 MHz, CDCl 3) 6 306.4, 185.8 (C0 2), 159.0,
150.4, 141.6, 133.6, 132.8, 130.1, 129.9, 129.2, 128.5, 128.4, 126.6, 126.1, 55.2, 51.3, 43.5, 35.9,
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31.3, 29.5. Anal. Caled for C62H61MoNO8 : C, 71.32; H, 5.89; N, 1.34. Found: C, 71.31; H,
5.95; N, 1.36.
Mo(NAr)(CHCMe 2Ph)(Me 2Pyr)(O2CTRIP) (3a). Mo(NAr)(CHCMe 2Ph)(Me2Pyr)2
(0.225 g, 0.378 mmol) was dissolved in a minimal amount of ether and placed at -35 0C for 1 h.
TRIPCO2 H (0.094 g, 0.378 mmol) was dissolved in a minimal amount of ether and placed at -35
C for 1 h. At the end of the cooling period, the solution containing the carboxylic acid was
added to the solution containing the precatalyst dropwise and it was left stirring at RT for 30
min. At the end of the reaction period, the volatiles were removed and the sample was triturated
with pentane for 1 h until an orange powder precipitated. The powder was isolated by filtration
and it was redissolved in ether and placed at - 35 C for 12 h to yield a precipitate. This product
was once again redissolved in diethyl ether and crystallized out at -35 C to yield orange product
upon filtration (0.031 g, 12%): 'H NMR (400 MHz, CD 2Cl2 ) 6 13.62 (s, 1H, MoCH, JCH 121.5
Hz), 7.48-7.00 (in, 1OH, aromatics), 5.721 (s br, 2H, Me 2C4H2N), 3.04-2.82 (sept, 5H, CHMe2),
2.19 (s br, 6H, Me2C4H2N), 1.77 (s, 3H, MoCHCMe2Ph), 1.76 (s, 3H, MoCHCMe2Ph), 1.25 (d,
6H, TripCHMe2), 1.23 (d, 6H, TripCHMe2), 1.2-1.1 (in, 18H, Trip CHMe2 + imido (CHMe2)2);
13 C NMR (100 MHz, CD 2 Cl 2) 6 297.6 (MoCH1), 191.4 (CO2 ), 152.6, 151,9, 151.5, 151.1, 150.3,
148.8, 147.6, 146.3, 145.4, 131.5, 128.5, 128.4, 128.3, 126.5, 126.1, 123.2, 121.1, 107.6, 105.8,
65.9, 55.7, 34.7, 31.9, 31.6, 29.2, 28.4 (br), 24.2, 23.8, 23.3 (br), 15.3. Anal. Calcd for
C4 4H60MoN 20 2 : C, 70.95; H, 8.12; N, 3.76. Found: C, 70.66; H, 8.00; N, 3.67.
Mo(NAr)(CHCMe 2Ph)(Me 2Pyr)(O2CTerme) (3b). Prepared as for 3a from
Mo(NAr)(CHCMe 2Ph)(Me2Pyr)2 (0.422 g, 0.709 mmol) and TermeCO 2H (0.214 g, 0.709 mmol)
to yield an orange solid upon filtration (0.115 g, 34%). Pure 3b (0.030 g) was dissolved in a
saturated solution of 1:1 methylene chloride/diethyl ether and placed at -35 C over a few days to
yield crystals suitable for diffraction: 'H NMR (400 MHz, CD 2Cl 2) 6 12.99 (s, 1H, MoCH, JCH
122.78 Hz), 7.60-7.00 (in, 19H, aromatics), 5.64 (s br, 2H, Me2C4H2N), 3.19 (d, 2H, CIMe2),
2.30 (s, 6H, TermeCO2), 1.97 (s br, 6H, Me2C4H2N), 1.50 (d, 6H, MoCHCMe2), 0.87 (m, 12H,
CHMe2); "C NMR (100 MHz, CD 2 Cl 2) 6 301.3 (MoCHCMe2Ph), 189.8 (CO2 ), 152.0, 149.7
(br), 148.0, 140.2, 137.8, 137.7, 133.7, 132.3, 129.9, 129.4, 129.2, 129.0, 128.4, 128.1, 126.4,
126.2, 123.4 (br), 122.8 (br), 107.2, 55.9 (MoCHCMe 2Ph), 31.9, 29.2, 27.2 (br), 24.0 (br), 22.6,
17.8 (br), 14.1. Anal. Calcd for C5oH56MoN 20 2: C, 73.67; H, 6.81; N, 3.51. Found: C, 73.56; H,
6.86; N, 3.48.
Mo(NAr)(CHCMe 2Ph)(Me 2Pyr)(O2CTerome) (3c). Prepared as for 3a from
Mo(NAr)(CHCMe 2Ph)(Me2Pyr)2 (0.520 g, 0.873 mmol) and TeromeCO 2H (0.292 g, 0.873 mmol)
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to yield pure orange product upon filtration (0.340 g, 47%): 'H NMR (400 MHz, CD 2Cl2 ) 6
12.93 (s, 1H, MoCH, JCH = 120.25 Hz), 7.64-6.72 (m, 19H, aromatics), 5.68 (s br, 2H,
Me2C4H2N), 3.73 (s, 6H, OMe), 3.20 (d br, 2H, CHMe2), 1.88 (d br, 6H, Me2C4H2N), 1.52 (d,
6H, MoCHCMe2Ph), 0.90 (m, 12H, CHMe2); 13 C NMR (100 MHz, CD 2 Cl2) 6 301.1
(MoCHCMe2Ph), 189.9 (C0 2), 159.6, 152.0, 148.0, 141.4, 139.9, 133.8, 133.7, 132.8, 130.3,
129.9, 129.1, 128.4, 128.3, 128.1, 126.4, 126.2,125.2, 122.8 (br), 114.4, 114.0, 107.3, 56.0, 55.5,
55.4, 55.2, 32.0, 28.9, 24.1 (br), 23.4 (br). Anal. Calcd For C50H56MoN20 4: C, 70.83; H, 6.55;
N, 3.37. Found: C, 70.67%; H, 6.69; N, 3.53.
In situ preparation of Mo(NAr)(CHCMe 2Ph)(Me 2Pyr)(O2CHIPT) (3d).
Mo(NAr)(CHCMe 2Ph)(Me2Pyr)2 (0.010 g, 16.8 mmol) and HIPTCO 2H (0.009 g, 17.1 mmol)
were dissolved in CDC13 (0.7 ml) and charged to a J-Young tube. A new alkylidene peak formed
within 30 min of mixing: 'H NMR (400 MHz, CDC13) 6 13.53 (s, 1H, MoCH), 7.50-7.00 (m,
15H, aromatics), 6.08 (s br, 1H, Me2C4H2N), 5.96 (s br, 1H, Me2C4H2N), 3.13 (m, 2H, CHMe2),
3.06 (m, 2H, CHMe2), 2.97 (m, 2H, CHMe2), 2.04 (s, 6H, Me2C4H2N), 1.91 (s, 3H,
CHCMe2Ph), 1.75 (s, 3H, CHCMe2Ph), 1.55-1.25 (overlapping peaks, 48H, various CHMe2).
Photolysis Experiments
Mo(NAr)(CHCMe 2Ph)(O 2CCPh) 2 (la). In a sample irradiated in toluene-d8 at 366 nm
for 3 h at 22 'C a mixture containing 16% anti was formed (8H, = 13.93 ppm, JCH 138.4 Hz).
At 22 'C conversion of anti to syn was found to take place in a first order manner with ka/s
(8.30 ± 0.93) x 10-6 S1.
Mo(NAd)(CHCMe 2Ph)(O2CCPh 3)2 (1b).
A sample of lc irradiated in toluene-d8 at 366 nm for 2 h at 22 'C produced a mixture
containing 28% anti (8H, = 13.99 ppm, JCH = 140.0 Hz). At 22 'C conversion of anti to syn was
found to take place in a first order manner with ka/s = (3.08 + 0.14) x 10-4S-.
Mo(NArtBu)(CH-t-Bu)(O 2CCPh3 )2 (ld). A sample of ld irradiated in toluene-d8 at 366
nm for 2 h at 22 'C produced a mixture containing 17% anti (8H( = 13.90 ppm, JCH 136.9 Hz).
At 0 'C conversion of anti to syn was found to take place in a first order manner with ka/s = (1.55
t 0.12) x 10~5 s 1 and at room temperature with ka/s = (3.62 ± 0.74) x 10~3 s-1 (t11/2 3 min).
Mo(NAr)(CHCMe 2Ph)(O2CTerme)2 (2a). A sample of 5a irradiated in toluene-d8 at 366
nm for 2 h at 22 'C produced a mixture containing 7% of the anti species (8H, = 13.6 ppm, JCH =
62
137 Hz). At 0 'C conversion of anti to syn was found to take place in a first order manner with
kais = (1.28 ± 0.11) x 10- s-1 and at room temperature ka/s = (5.3 1 1.14) x 10-4 s-.
General procedure for polymerizations. In a representative example, 3.01 mL of a stock
solution of ld (6.76 mM in toluene) was diluted with 3.0 mL of toluene. To the stirring catalyst
solution was added 1.00 mL of a stock solution of DEDPM (0.406 M in toluene) via syringe.
Within 30 seconds the reaction solution became deep red. After 6 hours, 20 tL of benzaldehyde
was added. The mixture was stirred for an additional three hours and then poured into 100 mL
of hexanes causing precipitation of the polymer as a deep red powder. Pertinent spectroscopic
features of the polymer are as follows: 1H NMR (300 MHz, CDCl 3) 8 6.2 (br, 1, CH), 5.9 (br, 1,
CH), 4.2 (m, CH 2CH 3), 3.2 (br, 2, ring-CH2), 2.9 (br, 2, ring-CH 2), 1.2 (t, CH 2 CH 3); 13C NMR
(75 MHz, CDCl 3) 8 171.0 (C0 2), 134.3, 133.9, 132.9, 131.7 (4 vinylic-C), 61.8 (OCH 2 CH 3),
54.6 (Cquat), 35.0 (ring-CH2), 32.2 (ring-CI-12), 14.0 (OCH 2CH3). Minor additional resonances
for the polymer backbone proton and carbon atoms can be detected in polymers containing all
six-membered rings. We attribute these minor resonances to cis/trans isomerism at the exocyclic
double bond.
Description of X-ray Studies. Low temperature diffraction data were collected on a Siemens
Platform three-circle diffractometer coupled to a Bruker-AXS Smart Apex CCD detector with
graphite-monochromated Mo Ka radiation (k = 0.71073 A), performing <p- and w-scans. All
structures were solved by direct methods using SHELXS and refined against F2 on all data by
full-matrix least squares with SHELXL-97. 16  All non-hydrogen atoms were refined
anisotropically. Coordinates for the hydrogen atoms on Ca of the alkylidene groups were taken
from the difference Fourier synthesis and subsequently refined semi-freely with the help of
distance restraints. All other hydrogen atoms were included in the model at geometrically
calculated positions and refined using a riding model. The isotropic displacement parameters of
all hydrogen atoms were fixed to 1.2 times the U value of the atoms they are linked to (1.5 times
for methyl groups). A disordered isopropyl group in the structures of 2a was refined with the
help of similarity restraints on 1-2 and 1-3 distances and displacement parameters as well as rigid
bond restraints for anisotropic displacement parameters. For details of data and refinement
statistics see Tables 3 and 4.
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Table 3. Crystal data and structure refinement for 2a.
Reciprocal net identification code 08026
Empirical formula C64 H63 Mo N 04
Formula weight 1006.09
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Triclinic
Space group P1
Unit cell dimensions a = 12.194(6) A
Volume
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 28.28'
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
b = 12.241(6) A
c = 20.290(11) A
2684(2) A3
a= 88.751(9)'
p= 76.586(9)0
y = 66.079(9)0
2
1.245 Mg/m 3
0.292 mm-1
1056
0.25 x 0.20 x 0.10 mm 3
1.04 to 28.28'
-16<=h<=15, -16<=k<=16, -27<=l<=26
48967
13298 [R(int)= 0.0371]
99.8 %
Semi-empirical from equivalents
0.9713 and 0.9305
Full-matrix least-squares on F2
13298 / 100 / 665
1.027
R1 = 0.0342, wR2 = 0.0804
RI = 0.0441, wR2 = 0.0860
0.939 and -0.633 e.A-3
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Table 4. Crystal data and structure refinement for 3b.
Reciprocal net identification code 08017
Empirical formula C49 H54 Mo N2 02
Formula weight 798.88
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Orthorhombic
Space group Pbca
Unit cell dimensions a = 17.2200(14) A
b = 13.3951(l1) A
c = 35.799(3) A
Volume 8257.6(12) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 30.03'
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
8
1.285 Mg/m3
0.359 mm-1
3360
0.25 x 0.25 x 0.07 mm 3
2.01 to 30.030
-24<=h<=24, -18<=k<=18, -50<=1<=50
216789
12070 [R(int) = 0.0685]
100.0 %
Semi-empirical from equivalents
0.9753 and 0.9157
Full-matrix least-squares on F2
12070 / 286 / 551
1.043
R1 = 0.0339, wR2 = 0.0731
RI = 0.0529, wR2 = 0.0838
0.732 and -0.634 e.A-3
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a= 900
p= 900
y = 900
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CHAPTER 3
Molybdenum Monoaryloxide Pyrrolide Alkylidene Complexes that Contain
Mono-ortho-substituted Phenyl Imido Ligands
Reprinted (adapted) with permission from Lichtscheidl, A. G.; Ng, V. W.; Miller, P.; Takase, M.
K.; Schrock, R. R. "Molybdenum Monoaryloxide Pyrrolide Alkylidene Complexes that Contain
Mono-ortho-substituted Phenyl Imido Ligands" Organometallics 2012, 31, 2388-2394.
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INTRODUCTION
High oxidation state molybdenum and tungsten imido alkylidene complexes with the
generic formula M(NR)(CHR')(X)(Y) (where X and Y are monoanionic ligands, initially both
alkoxides) were first prepared approximately 25 years ago.2 Unlike an oxo ligand, which was
present in the first high oxidation state Group 6 complexes to be discovered,' the isoelectronic
imido ligand can retard bimolecular decomposition of alkylidenes for steric reasons. Imido
ligands also are available in many steric and electronic variations. Phenylimido ligands have
been popular, especially 2,6-disubstituted versions (2,6-i-Pr2CH 3, 232,6-Cl2CH3,,
etc). 2-Substituted imido ligands are less common, while those with no ortho substituents are
rare; one example is N-3,5-Me2C6 H3.4' " Complexes that contain phenylimido ligands with
progressively less steric protection in ortho positions are more difficult to prepare and the
resulting imido alkylidene complexes appear to be less stable toward what is presumed to be
bimolecular decomposition.
In the last several years new types of Mo and W imido alkylidene complexes that have the
formula M(NR)(CHR')(OR")(Pyr), where Pyr is a pyrrolide or substituted pyrrolide ligand and
OR" usually is an aryloxide, have been prepared and explored.!a, s These
MonoAryloxidePyrrolide (MAP) species can be viewed as third generation high oxidation state
imido alkylidene catalysts (after "first generation" bisalkoxides and "second generation"
biphenolates and binaphtholates'). MAP species have many features of fundamental interest.
MAP species contain a stereogenic metal center, MAP species have proven to be much more
efficient (higher turnover) than bisalkoxide catalysts in many cases, and MAP species can be
engineered to be highly Z selective for the coupling of terminal olefins.6 MAP species also have
been the subject of detailed calculations. 7
We have begun to explore the consequences of increasing the size of imido groups in MAP
complexes to the point that their size approaches or exceeds that of sterically demanding 0-2,6-
(2,4,6-Me3C6H2)2C6H3 (OHMT) or O-2,6-(2,4,6-i-Pr 3C6H2)2C6H3 (OHIPT) ligands that have
been employed in order to enforce Z selective reactions.' 8 Phenylimido ligands that are
monosubstituted in the ortho position, N-2-XC6H4 species, especially those in which X is mesityl
(NArm) or triisopropylphenyl (NArT), could prove to be interesting variations of MAP catalysts.
The syntheses of NArM and NArT species and a comparison of them with NArci, NArCF3 , NAr,
and NArtBu species are the subject of this paper. The main questions we wanted to answer are in
what way, if any, compounds that contain NArM or NArT ligands differ from those that contain
NArc , NArCF3 , NAr , or NArBu ligands in some test reactions that may be sensitive to the size
of X in N-2-XC 6H4 MAP species.
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RESULTS AND DISCUSSION
3.1 Synthesis, characterization and structural studies of catalyst precursors
3.1.1 Dichloro bisimido complexes
Anilines that contain either a Mes (2,4,6-trimethylphenyl) or a TRIP (2,4,6-
triisopropylphenyl) substituent were prepared as shown in equation 1. These preparations are
adaptations of known literature reports;10'1 no palladium-catalyzed step is required. The overall
isolated yields of these new crystalline anilines are 81% for ArmNH 2 and 45% for ArTNH 2,
respectively.
Br 1. 2.5 Mg 1. n-BuLi, OoC
R R 2. CI 2. TosN3  NH 2
Br 3. 1.03 LiAlH 4
~ R __ ____ ___ R R(1)
3. 1.5 12 Et2 O
R THF
R R
R =Me (ArmI) 85% (ArMNH 2) 81%
R = i-Pr (Ar TI) 96% (ArTNH 2) 45%
Bisimido dichloride complexes in which the imido ligand is NArcI, NArM, or NArT could be
prepared by the standard method shown in equation 2. When a mixture of two equivalents of
ArmNH 2, Na 2MoO 4 , NEt 3, and TMSC1 in DME is heated at 60 C overnight, an orange product is
formed, but the DME adduct could not be isolated in crystalline form. However,
recrystallization of the crude DME adduct from a mixture of pentane and THF led to red,
crystalline 2 in 84% isolated yield. A proton NMR spectrum of 2 shows that a total of four
equivalents of THF are present, as confirmed through elemental analysis. We propose that two
equivalents of THF are present as solvent of crystallization (vide infra) and that THF exchange is
fast on the NMR timescale at room temperature.
4 NEt 3
8.5 TMSCl
DME R N R
Na 2MoO4 + 2 || /IC
R 60 0C L-M o=N (2)
NH 2  Cl L
R =Cl ArcINH 2  LL = DME 1 (84%)
R = Mes ArmNH 2  L = THF 2 (84%)
R = TRIP ArTNH 2 LL = DME 3 (79%)
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The result of X-ray structural studies of 2 and 3 are shown in Figures 1 and 2, respectively.
As proposed, crystals of 2 contain two THF molecules of crystallization (shown in Figure 1).
The imido ligands in both 2 and 3 are bent at the imido nitrogen; the smaller Mo-N-C angle in 3
(149.39(10)0) versus 2 (160.05(19)0 and 156.4(2)') can be attributed to the greater steric demand
of the TRIP group in 3 compared to the Mes group in 2. Other bond distances and angles are
similar to other complexes of this general type that have been crystallographically characterized.'
/Ori\
Figure 1. The solid state structure of 2 (50% probability ellipsoids). Selected bond lengths (A)
and angles (0): Mo(1)-N(1) = 1.750(2), Mo(1)-N(2) = 1.7535(19), Mo(1)-O(1) = 2.3138(18),
Mo(1)-O(2) 2.3394(6), Mo(1)-Cl(l) = 2.3863(9), Mo(1)-Cl(2) = 2.4119(9), N(1)-Mo(1)-N(2)
= 102.95(10), C(11)-N(1)-Mo(1) = 160.05(19), C(31)-N(2)-Mo(1) = 156.4(2), Cl(1)-Mo(l)-
Cl(2) = 160.63(3).
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0(1A)
Figure 2. The solid state structure of 3 (50% probability ellipsoids). Selected bond lengths (A)
and angles (*): Mo(l)-N(l) = 1.7522(12), Mo(l)-O(1) = 2.3381(11), Mo(1)-Cl(1) 2.4023(4),
N(1)-Mo(1)-N(2) = 101.44(8), C(1 1)-N(l)-Mo(1)= 149.39(10), Cl(1)-Mo(1)-Cl(2) 159.37(2).
3.1.2 Dialkyl bisimido complexes
R N
|1 /Cl
L-Mo=N
L
R 2 R'CH 2MgBr
Et2 O
-350 C
-2 L
1
2
3
3
R N
Mo=N,.
CH 2R' - /
CH 2R'
Cl, R' = CMe2Ph
Mes, R' = CMe2Ph
TRIP, R'= CMe3
TRIP, R'= H
Treatment of compounds 1, 2 and 3 with 2 equivalents of a) neopentyl Grignard, b) neophyl
Grignard, and c) methyl Grignard yield different results, Table 1. Some of the differences are
mainly attributed to crystal packing differences of the compounds, while others are explained in
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R
(3)
4 (68%)
5 (74%)
6(50%)
7(50%)
terms of complex stability towards decomposition. Compounds that were isolated were all red-
orange in color and include Mo(NArCi) 2(CH 2CMe2Ph)2 (4), Mo(NArm )2(CH 2CMe2Ph)2 (5),
Mo(NArT )2(CH 2CMe 3)2 (6), and Mo(NArT )2 (CH3)2 (7), equation 3. The yields are all listed in
Table 1 and range from moderate to good. The compounds are stable indefinitely at -35'C, even
in solution.
One interesting observation is that when 3 reacts with neophyl Grignard the product is not
stable and decomposes, which is probably a result of having a more exposed lone pair on the
imido group and the ligands being too bulky to avoid unwanted interactions. On the other hand,
decomposition also does occur when 1 or 2 is reacted with MeMgBr, suggesting that both the
ArciN and the ArmN groups are not big enough to protect the complex from unwanted side-
reactions. Either decomposition has not been studied any further. To gain some insight of how
the ArTN groups protect the metal sphere and to get an overall depiction of the geometry of
dialkyl complexes, the crystal structure of 7 was obtained and it is presented in Figure 3. The
compound crystallizes in the monoclinic space group P21/c and it is tetrahedral. One amazing
feature observed in the crystal as well as in solution is that even compound 7 that has the
smallest alkyl group possible, is solvent-free. The angle between the alkyl groups is 116.80 and
the Mo(1)-N(1)-C(11) angle is 1600, which is similar to compound 2 but 100 higher than
compound 3. This fact hints compound 7 is less crowded than 3, which is expected for a solvent-
free complex. In addition, the TRIP groups both point down towards the methyl groups, thus
protecting the small ligands and the exposed metal center. This feature is what aids in making
this complex stable and isolable.
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Table 1- Outcomes of the reactions between complexes 1, 2, and 3 with various alkyl
Grignard reagents.
Complex ClMgCH 2CMe 2Ph ClMgCH 2-t-Bu BrMgCH3
1 Orange solid Oil Decomposition
(68 %)
2 Orange solid Oil Decomposition
(74 %)
3 Decomposition Orange-red solid Orange-red solid
_ 
(50 %) (50 %)
CM
Figure 3- The solid state structure of 7 (50% probability ellipsoids). Selected bond lengths (A)
and angles (0) are given: Mo(l)-N(1) = 1.7530(18), Mo(1)-N(2) = 1.7543(19), Mo(1)-C(l) =
2.127(2), Mo(1)-C(2) = 2.121(2), N(1)-Mo(1)-N(2) = 109.46(8), C( 1)-N(1)-Mo(l) =
158.19(16), C(41)-N(2)-Mo(l) = 155.35(2), C(1)-Mo(1)-C(2) = 116.85(11)
3.1.3 Alkylidene imido bistriflate complexes
Compounds 4-6 were then treated with three equivalents of triflic acid to yield 8, 9 and 10
smoothly (equation 4); however, decomposition took place when 7 was treated with TfOH in the
same manner. Attempts to isolate any product were unsuccessful and further reactions with 7
were not pursued. Among the more stable complexes (8-10), separation of 9 from the anilinium
triflate byproduct was difficult. So far, trituration with diethyl ether is the only way to remove
all anilinium triflate; the isolated yield of 9 (28%) suffers as a consequence of it being partially
soluble in ether. Similarly, although the reaction between 6 and triflic acid yields 10 smoothly,
separation of 10 from the anilinium triflate is again problematic; the isolated yield of 10 is only
47%. Bistriflate complexes that contain NArCF, NAr", and NArtBu imido groups have been
reported previously.4 Details can be found in the experimental section.
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C(2)
Et20 R
N R DME|| -s.., - 35 C || R' (4)
Mo N + 3 TfOH TfO'Mo
R Tf
R' R' NH30Tf
R = Cl, R'= Ph 4 8(43%)
R = Mes, R'= Ph 5 9(28%)
R = TRIP, R'= Me 6 10(47%)
CF3 iWr t Cl
Bistriflate complexes that contain NArC, NAr , NArtBu, and NArC' groups all show
resonances for two isomers in solution. Fluorine NMR spectra suggest that these isomers
contain triflate ligands that are either cis, as shown in equation 4, or trans with respect to one
another. Proton NMR data suggest that they are syn isomers (JCH = 125 t3 Hz), in which the
alkylidene group points toward the imido group, as shown in equation 4. In contrast, 'H NMR
spectra (in C6D6) of both 9 and 10 each show more than the expected two alkylidene resonances,
and ratios of the isomers vary depending upon conditions. The three most prominent resonances
for 9 have JCH values that range from 122 to 129 Hz; for 10 (Figure 4a) they range from 122 to
126 Hz. All JCH values that can be measured are characteristic of syn species. Two isomers of
the mixture are isolated upon recrystallizing the compound from diethyl ether at -35 0C. Proton
and fluorine NMR spectra (Figure 4b) are consistent with these isomers of 10 being cis (84%)
and trans (16%) species. Cis and trans mixtures of bistriflate complexes have been observed in
other circumstances.12
The observation of more than two isomers suggests several possibilities. One or more of the
adducts loses DME in the solid state, one or more of the isomers is actually not a solvent adduct,
or the large mesityl and TRIP substituents give rise to isomers in which the mesityl or TRIP
substituents limit free rotation of the imido phenyl group about the Mo=N axis on the NMR time
scale giving rise up to six isomers (Figure 5). Spectra in the alkylidene region did not change
significantly when several equivalents of DME were added and the amount of DME in a
complex mixture could not be measured accurately through integraton. Therefore, we cannot
determine the exact reason for isomer formation. Unfortunately, multiple elemental analyses of
9 and 10 as mixtures of four isomers were variable, as were elemental analyses of the mixture of
cis and trans isomers shown in Figure 4b.
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Figure 4a - The four alkylidene proton resonances in the 'H NMR spectrum of 10.
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Figure 4b - The 'H (top) and 19F (bottom) NMR spectra of two of the isomers of 10.
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3.1.4 Alkylidene imido bispyrrolide complexes
Treatment of the bistriflate complexes with two equivalents of Li-2,5-Me2C4H2N led to
bispyrrolide compounds in yields ranging from 36% to 85% (equation 5). The neophylidene
analog of 12 has been reported previously. The low isolated yield of 17 we propose is the result
of its poor crystallinity. Proton NMR spectra of complexes 11-17 exhibit a single alkylidene
peak and broad peaks corresponding to fluxional pyrrolide ligands, behavior which is analogous
to other bispyrrolide compounds of this general type.1 3
R T
N
TfO R'
TfO V -
2 Me 2PyrLi
Et2O
-35 0C
- 2 LiOTf
N
11
Mo
N
(5)
11 R = C1, R' = Ph; (57%)
12 R = CF 3, R'= Me; (53%)
13 R = i-Pr, R' = Ph; (59%)
14 R = t-Bu, R'= Me; (82%)
15 R = t-Bu, R'= Ph; (68%)
16 R = Mes, R'= Ph; (85%)
17 R = TRIP, R'= Me; (36%)
An X-ray study of 16 was undertaken and it is shown in Figure 6. The compound crystallizes
out in the monoclinic space group P21/n. The pyrrolide ligands are bound 9 and Tr to the metal
respectively, as it was expected. The alkylidene group is observed as syn in this structure. In
addition, the Mo(1)-N(1)-C(1 1) bond is nearly planar and the Mes group is placed on top of the
15 -bound pyrrolide parallel to it. It is quite interesting to note that the Mes group points away
from the alkylidene group, creating a pseudo-small imido group around the N(imido)-C-N( 1 -
pyrrolide) face of the complex.
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C(33) C(3-
N(2)
Figure 6 - The solid state structure of 16 (50% probability ellipsoids). Selected bond lengths (A)
and angles (*): Mo(1)-N(1) = 1.7340(16), Mo(l)-C(l) = 1.940(2), Mo(l)-N(2) = 2.4117(17),
Mo(1)-N(3) = 2.1134(17), Mo(1)-C(32) = 2.391(2), Mo(1)-C(33) = 2.376(2), Mo(1)-C(34)
2.458(2), Mo(1)-C(35) = 2.458(2), C(1 1)-N(1)-Mo(1) = 175.40(15), C(2)-C(1)-Mo(1) =
139.84(15).
3.2 Synthesis, characterization, and structural studies of alkylidene imido
monoaryloxide monopyrrolide catalysts
3.2.1 Catalyst complexes that contain small alkoxide or aryloxide ligands
Addition of t-BuOH, (CF 3)2MeCOH, or Ph3SiOH to complexes 11-17 led to formation of
bisalkoxide complexes as the only observable product, instead of the desired MAP species.
Since N-2,6-i-Pr 2C6H3 (NAr) monoalkoxide pyrrolide (MAP) species that contain t-butoxide,
hexafluoro-t-butoxide, or triphenylsiloxide can be obtained in good yields in similar reactions,5 a
these findings suggest that NArM and NArT ligands offer less steric protection toward rapid
protonation of the second pyrrolide than bispyrrolides that contain the NAr ligand.
Addition of one equivalent of 2,3,5,6-tetraphenylphenol (TPPOH) to 16 led to a mixture that
contains 25% 16, 50% of a MAP product, and 25% of the bisphenoxide. The bisphenoxide
species (18) could be prepared (in 55% yield) from the bistriflate as shown in equation 6. Since
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18 would appear to be a relatively crowded species, an X-ray structural determination (Figure 7)
was carried out.
2 NaOTPP
Et2 0
~- N -3 0
TfO || Ph -35 0C
TfO Mo'OTfO i -- 2 NaOTf
N
| I iPh
TPPO .Mo
TPPO
18 (55%)
Compound 18 is a distorted tetrahedron with the smallest and largest angles being 99.29(12)0
(N(l)-Mo(l)-C(1)) and 120.85(9)0 (N(1)-Mo(1)-O(2)). The Mo(1)-O(1)-C(3 1) and Mo(1)-O(2)-
C(61) bond angles (147.00(17)0 and 148.18(16)0, respectively) are relatively large in view of the
crowded coordination sphere. The Mo(1)-N(1)-C(l 1) bond angle is close to 1800 (173.13(19)0)
The ready formation of 18 confirms that 2,3,5,6-tetraphenoxide ligands are operationally not as
large as one might think, as has been found in other circumstances. In contrast, the reaction
between 17 and one equivalent of TPPOH yields only Mo(NArT)(CH-t-Bu)(Me 2Pyr)(OTPP) (19;
equation 7), i.e., increasing the bulk of the imido group (from ArM to ArT) decreases the rate of
formation of the bisphenoxide, and therefore allows the synthesis of the MAP species.
i-Pr
i-Pr
TPPOH
Et2 0
-35 0C
- Me2PyrH
i-Pr
TPPO
19 (44%)
81
(6)
(7)
Figure 7 - The solid state structure of 18 (50% probability ellipsoids). Selected bond lengths (A)
and angles (*): Mo(1)-N(1) = 1.732(2), Mo(1)-C(l) = 1.880(3), Mo(1)-O(l) = 1.9402(18),
Mo(l)-O(2) = 1.9303(17), Mes-TPP = 4.343, C(1l)-N(1)-Mo(1) = 173.13(19), C(2)-C(1)-Mo(1)
= 141.8(2), C(31)-O(l)-Mo(l)= 147.00(17), C(61)-O(2)-Mo(l) = 148.18(16).
3.2.2 Catalysts that contain bulky aryloxide ligands
Hexamethylterphenol (HMTOH) reacts readily at 22 'C with 11-17 to generate the MAP
product in modest to good yields (equation 8). However, reactions between HMTOH or
hexaisopropylterphenol (HIPTOH) with 16 and 17 are slow. Therefore, their preparation must
be carried out at high temperatures in toluene for hours to days, depending on the phenol. The
reactions at 110 'C between 16 or 17 and one equivalent of HMTOH to give 26 and 28,
respectively, required 18 h, while that between 16 and one equivalent of HIPTOH to give 27
required 5 days. Reaction between 17 and HIPTOH required 14 days at 80 *C to give 97% of
the desired product. These data show that reactions between HMTOH and 16 or 17 clearly take
place more readily. It is noteworthy to note that the MAP products do not decompose under the
relatively harsh conditions required to prepare 26-29. The isolated yields of 26-28 are modest
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R R
N R' Toluene N R'
1o + ArOH Mo- (8)
- Me 2PyrH ArO
N
20 R = ArCl, R'= Ph, Ar = HMT (40%)
21 R = ArCF3, R'= Me, Ar = HMT (76%)
22 R = ArCF3, R'= Ph, Ar = HMT (75%)
23 R = AriPr, R'= Ph, Ar = HMT (48%)
24 R = ArtBu, R'= Me, Ar = HMT (68%)
25 R = ArtBu, R'= Ph, Ar = HMT (67%)
26 R = Arm, R'= Ph, Ar = HMT (51%)
27 R = ArM, R'= Ph, Ar = HIPT (35%)
28 R =ArT, R'= Me, Ar = HMT (57%)
29 R = ArT, R'= Me, Ar = HIPT (in-situ)
(35-57%), the lowest corresponding to 27 as a consequence of its high solubility in solvents like
pentane and tetramethylsilane. Complexes 26 and 28 are more crystalline than 27, which is
mirrored in their yields. Due to the long times required for reactions between 17 and HIPTOH
and possible complications during purification, 29 could not be isolated, but had to be prepared
in situ. All reactions benefit from being run under more concentrated conditions, but a large
excess of HMTOH or HIPTOH cannot be employed without creating problems with isolation of
the desired product. The structures of highly crystalline 26 and 28 are shown in Figures 8 and 9,
respectively. Both are distorted tetrahedra, with angles at the metal ranging from 102.97(5)' to
117.48(5)' and 101.41(12)0 to 116.40(10) 0, respectively. The Mo-N-C(imido) and the Mo(l)-
C(1)-C(2) angles are similar in the two complexes and are similar to analogous angle in other
complexes of this general type.
On the other hand, the Mo(l)-O(l)-C(41) angle of 26 is 158.89(9)0, which is 10' larger than
the Mo-O-C angle in either 28 or 18, but not uncommon among MAP complexes containing
either HMTO or HIPTO. In both 26 and 28 the Mes and TRIP groups point away from the
alkylidene and therefore would not seem to block an olefin from binding to the metal. In 26 an
additional feature worth mentioning is a possible 2-stacking interaction between the mesityl ring
of the NArM ligand and the pyrrolide ring beneath it. However, this interaction is very weak due
to a long distance between them (3.837 A from the centroid of the mesityl ring to the centroid of
the pyrrolide ring).16
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Figure 8 - The solid state structure of 26 (50% probability ellipsoids). Selected bond lengths (A)
and angles (0): Mo(l)-C(l) = 1.8752(13), Mo(1)-N(1) = 2.0230(1 1), Mo(1)-N(2) = 1.7302(11),
Mo(1)-O(l) = 1.8997(9), Mes-Pyr = 3.837, C(21)-N(2)-Mo(1) = 175.50(10), C(2)-C(1)-Mo(1) =
146.02(10), C(41)-O(1)-Mo(1) = 158.89(9).
Compounds 26-29 show different number of isomers in solution, as evidenced by their
respective 1H NMR spectra. A trend is clearly observed between the overall steric hindrance at
the metal center and the number of isomers observed in solution; the greater the steric hindrance
the higher the number of isomers present. Thus, 26, which has the smallest combination of
imido and aryloxide ligands (among these four catalysts), has only one isomer, while 28, which
contains the slightly larger NAr imido group has two isomers. In the case where the aryloxide
is HIPTO there are four isomers present in both NArM and NArT imido complexes. These
findings can be rationalized in terms of steric crowding overall. As steric crowding around the
metal increases, restricted rotation results in locking of the ligands on the NMR time scale in
various positions that give rise to more than the expected number of isomers. On this basis we
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can propose that complex 18 (two observable isomers) is less crowded than 27 or 29 but more
crowded than 26.
Figure 9 - The solid state structure of 28 (50% probability ellipsoids). Selected bond lengths (A)
and angles (*): Mo(1)-C(1) = 1.862(3), Mo(1)-N(l) = 1.736(2), Mo(1)-N(2) = 2.037(2), Mo(1)-
0(1) = 1.9103(19), C(ll)-N(1)-Mo(1) = 170.9(2), C(2)-C(1)-Mo(1) = 147.5(2), C(51)-O(1)-
Mo(l) = 147.32(19).
3.3 Reactivity studies of MAP catalysts
The ROMP of 2,3-dicarbomethoxynorbornadiene (DCMNBD),h shown in equation 9, has
been employed as a means of judging the stereospecificity (cis/trans selectivity and tacticity) of a
MAP metathesis catalyst.' 5 Therefore, all MAP catalysts (19-28 plus 29 prepared in situ) were
treated with 25-100 equivalents of monomer and the resulting polymer was isolated and analyzed
by NMR methods. The results are summarized in Table 2.
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[Mo]
DCMNBD
'CO 2Me
n/2
All ROMP reactions are relatively fast. The use of 19 as an initiator fails to deliver a highly
structured polymer, presumably as a consequence of the imido group being too large relative to
the aryloxide (OTPP). There is a drop in cis-selectivity from >98% to ~70% in MAP species 24-
26 when the imido ligand is larger than NAr . However, increasing the size of the phenoxide
from HMTO to HIPTO (with initiator 27), again leads to a polymer that is >93%
cis,syndiotactic. Initiators 28 and 29 are again unsuccessful, presumably because NArT is
operationally too large, even when the aryloxide is OHMT or OHIPT.
Table 2. ROMP of DCMNBD with MAP initiators 19-29 in toluene at 22 'C.
Catalyst [Catalyst] DCMNBD Reaction Time Polymer
(mM) Equivalents Structure
19 12 50 1 h 50% cis
20 1.9 100 1 h > 98% cis, syndio
21 5.5 50 1 h > 98% cis, syndio
22 5.6 50 1 h > 98% cis, syndio
23 1.9 100 1 h > 98% cis, syndio
24 5.8 50 1 h 76% cis
25 5.2 50 1 h 66% cis
26 13 25 1 h 69% cis
27 48 25 1 h > 93% cis,syndio
28 13 25 1 h 77% cis
29 62 25 1 h 83% cis
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(9)
n
A lower cis-selectivity has also been observed when Mo(NAr)(CHCMe 2Ph)(Pyr)(OHIPT) is
employed as an initiator in place of Mo(NAd)(CHCMe 2Ph)(Pyr)(OHIPT) (Ad = adamantyl and
Ar = 2,6-i-Pr2C6H3).5h The fact that 27 is as Z-selective as Mo(NAd)(CHCMe 2Ph)(Pyr)(OHIPT)
and 20-23 is surprising since it suggests that NArM is in the same category as NAr c, NArCF3, and
NArPr imido ligands as far as producing polymers that have a high cissyndiotactic content, that
is, NArM is operationally relatively "small."
CONCLUSION
We have found that MAP catalysts that contain NArM and NArT ligands can be prepared
through traditional synthetic routes that have been employed to prepare catalysts that contain
NArC , NArCF3 , NAr , and NArBu imido groups. We were surprised to find that no imido
ligands investigated in this report have properties that lead to unusual behavior in ROMP
polymerization of DCMNBD. We conclude that a single ortho substituent in the
2-substituted imido groups explored here can point away from the C-M-Nimido face where the
olefin is proposed to bind, leaving no substituent to impede approach of the olefin. Therefore,
complexes that contain a 2-substituted imido ligand behave like much smaller imido groups in
reactions that have been explored so far. The results reported here seem to imply that any
attempt to employ a highly sterically demanding phenyl imido group will lead to unique
metathesis behavior only if that catalyst contains a 2,6-disubstituted phenylimido ligand such as
2,6-dimesitylphenyl imido.8
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EXPERIMENTAL
General. All reactions and manipulations of air and moisture sensitive compounds were
handled in oven-dried glassware (150 C, 2 hr) under a N2 atmosphere either in a dual Schlenk
line or in a Vacuum Atmosphere glove box. HPLC grade solvents (benzene, toluene, diethyl
ether, tetrahydrofuran, pentane, and methylene chloride), were purge with N2 and passed through
activated alumina and stored over molecular sieves 12 hours prior to use. 1,2-dimethoxyethane
was dried in an oven-dried Schlenk flask with sodium and benzophenone ketal, vacuum-
transferred into another oven-dried Schlenk flask and stored over molecular sieves 12 hours prior
to use. Na2MoO 4 and ClMgCH2CMe2Ph were purchased from Sigma-Aldrich, magnesium
turnings, o-BrClC6H4, MesBr, TRIPBr, 12, NaN3, Tosyl chloride, LiAlH4, TMSC, NEt3, TfOH,
and n-butyllithium were bought from VWR and used as received. 2,5-dimethylpyrrole was
bought from VWR, dried on CaH2, vacuum-distilled, and degassed prior to use. t-BuCH 2Cl was
bought from Alfa Aesar, washed with 95% H2SO 4/5% HNO 3 to remove olefin impurities and
dried over MgSO 4 before use. Tosyl azide , lithium 2,5-Me2Pyrrolide24, neopentyl Grignard2 ,
TPPOH , HMTOH and HIPTOH2 1, and DCMNBD were prepared according to literature
reports. All proteo ligands were placed under high vacuum for 12 hours before use.
Mo(NR)2Cl2DME (R = ArCF3 AriPr AtBu)4 a-b, Mo(NR)(CHCMe 2Ph)(OTf)2DME (R = Arr, R =
Ar'Bu)4a and Mo(NR)(CHCMe 3)(OTf) 2DME (R = ArCF3, R = Ar Bu) 4-d were prepared according
to literature procedures. All deuterated solvents (d6-benzene, d8-toluene, and d2-
dichloromethane) were stored over molecular sieves 12 hours prior to use. All the recorded
NMR spectra were done with Bruker 400 MHz and Varian 500 MHz spectrometers. Elemental
analyses were performed by Midwest Microlab, LLC.
1-Iodo-2-(2',4',6'-Me 3C6H2)C6H4 (Ar"I). Magnesium powder (15.3 g, 0.628 mol) of was
placed in a 500 mL Schlenk flask in the oven (120 C) overnight. The flask was sealed with a
septum and 300 mL of dry THF was added. A few crystals of iodine were added, a refluxed
condenser was attached, and the mixture was heated to 75 C until the color of the solution
changed from pale yellow to colorless. Mesityl bromide (50.0 g, 0.251 mol) was added slowly
and the mixture was refluxed overnight. Ortho-bromochlorobenzene (29.4 mL, 0.251 mol) was
added slowly and refluxing was continued for 12 h. Finally, the flask was cooled to 0 C and
iodine (70.1 g, 276 mmol) was added in small chunks, and the solution was stirred at room
temperature for 30 min. Excess I2 was quenched through addition of a saturated solution of
Na2 SO 3 and the product was extracted with 50 mL of diethyl ether four times. The ether layer
was dried with MgSO 4 and the mixture was filtered. The ether was removed from the filtrate in
vacuo and the solid product was washed with hexane and dried on a frit under a vacuum to yield
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colorless solid (68.7 g, 85% yield): 'H NMR (400 MHz, CDCl 3) 6 7.95 (dd, 1H, CICH), 7.42 (td,
1H, CICHCH), 7.15 (dd, 1H, CCCH), 7.04 (td, 1H, CCCHCH), 6.96 (s, 2H, MesCH), 2.36 (s,
3H, p-CH), 1.94 (s, 6H, o-CH3); 13C NMR (100 MHz, CDCl3) 6 145.9, 141.0, 139.0, 137.2,
135.4, 129.7, 128.5, 128.4, 128.0, 100.8, 21.2 (p-CH 3), 20.3 (o-CH3). Anal. Caled for Ci 5HiI5 :
C, 55.92; H, 4.69. Found: C, 56.32; H, 4.72.
1-Iodo-2-(2',4',6'-i-Pr 3CH 2)C6H4 (ArTI). The procedure was similar to that described
above for the synthesis of ArmI. The reagents consist of magnesium powder (10.7 g, 441 mmol),
2,4,6-triisopropylbromide (50.0 g, 177 mmol), ortho-bromochlorobenzene (20.6 mL, 177 mmol),
and iodine (67.2 g, 265 mmol). The solid product was washed with hexane and dried on a a frit
under vacuum to yield colorless solid (69.0 g, 96%) of Ar T 'H NMR (400 MHz, CDCl 3) 6 7.96
(dd, 1H, CICH), 7.39 (td, 1H, CICHCH), 7.21 (dd, 1H, CCCH), 7.06 (s, 2H, Trip CH), 7.04 (td,
1H, CCCHCH), 2.97 (sept, 1H, p-CH(CH 3)2), 2.34 (sept, 2H, o-CH(CH3)2), 1.32 (d, 6H, o-
CH(CH 3)2), 1.23 (d, 6H, o-CH(CH3)2), 1.02 (d, 6H, p-CH(CH 3)2); 13C NMR (100 MHz, CDCl 3)
6 150.6, 148.4, 145.8, 145.6, 139.1, 138.7, 130.4, 128.2, 127.7, 102.3, 34.2 (p-CH(CH3)2), 30.6
(o- CH(CH3 ) 2), 24.9 (p-CH(CH3)2), 24.1 (o-CH(CH3)), 23.5 (o-CH(CH3). Anal. Calcd For
C2 1H 2 7 I: C, 62.07; H, 6.70. Found: C, 62.47; H, 6.79.
1-Azido-2-(2',4',6'-Me 3C6H2)C6H4 (ArmN3). ArmI (60.0 g, 186 mmol) was suspended in
pentane (300 mL) in a IL Schlenk flask. The suspension was cooled to 0 0C, Li-n-Bu (2.93 M in
hexane, 63.6 ml, 186 mmol) was added dropwise, and the solution was stirred as it was allowed
to warm to RT overnight. The mixture was cooled to 0 "C again and 40.4 g (205 mmol) of
TosN3 was added dropwise. The solution started to turn orange and it left stirring at RT for 12 h.
The reaction was quenched by adding water and the organics were collected via extraction three
times with diethyl ether. The ether extracts were combined and dried with MgSO 4. The
mixtures were filtered and the solvent was removed in vacuo. The crude red product was
purified by column chromatography on alumina (3:1 hexanes: Et2O) to yield a red oil (39.5 g,
89%). This compound was compared to known literature reports via oxidation of the aniline' 8
and found to be the same: 'H NMR (400 MHz, CDCl 3) 6 7.44 (td, 1H, CCCHCH), 7.30 (dd, 1H,
CN 3CH), 7.24 (td, 1H, CN 3CHCH), 7.14 (dd, 1H, CCCH), 7.01 (s, 2H, Mes CH), 2.39 (s, 3H,p-
CH 3), 2.03 (s, 6H, o-CH3). IR (KBr) v 2958, 2923, 2861, 2119 (s, N3 asymm), 1613, 1574, 1474
(m, N3 symm) 1443, 1377, 1305, 1286, 1249, 1005, 850, 754, 720, 704, 649, 583.
1-N 3-2-(2',4',6'-i-Pr3C6H2)C6H4 (ArTNA). This compound was prepared as described for
ArmN 3 from ArTI (50.0 g, 123 mmol) in THF (500 ml) in a IL Schlenk flask, Li-t-Bu (1.70 M in
hexane, 145 mL, 246 mmol), and TosN 3 (24.2 g, 123 mmol). The crude product was purified by
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column chromatography on alumina (3:1 hexanes: Et2O) to yield 33.3 g (84% by total mass) of a
red oil containing 60% of the product (56% accounting for only ArTN 3) and 40% of 2,4,6-i-
Pr3biphenyl. This mixture was used without further purification.
1-NH 2-2-(2',4',6'-Me3C6H2)C6H4 (Ar"NH2). ArMN 3 (10.3 g, 43.4 mmol) was added slowly
to an Et2O solution (500 ml) of LiAlH 4 (1.65 g, 43.4 mmol). The solution became green and it
was left refluxing overnight. The reaction was quenched by adding small amounts of water until
the fizzing stopped. The mixture was extracted three times with Et20 and the combined extracts
were dried over MgSO 4. The MgSO 4 was removed through filtration and the solvent was
removed to yield a crude solid product, which was recrystallized from a mixture of ethyl acetate
and hexane to yield a slightly colored solid (8.39 g, 91%): 'H NMR (400 MHz, CDCl 3) 6 7.18
(td, 1H, CCCHCH), 6.99 (s, 2H, Mes CH), 6.94 (dd, 1H, CNH 2CH), 6.84 (td, 1H, CNH2CHCH),
6.79 (dd, 1H, CCCH), 3.42 (s br, 2H, NH2), 2.35 (s, 3H, p-CH 3), 2.04 (s, 6H, o-CH3); 13 C NMR
(100 MHz, CDCl 3) 6 143.5, 137.0, 136.9, 134.8, 129.9, 128.4, 128.0, 126.1, 118.4, 114.9, 21.0
(p-CU3 ), 20.1 (o-CH 3). Anal. Calcd For C 5H17N: C, 85.26; H, 8.11; N, 6.63. Found: C, 85.47;
H, 8.15; N, 6.57.
1-NH 2-2-(2',4',6'-i-Pr 3CH 2)C6H4 (Ar NH 2). ArTN 3 (33.3 g of a 3:2 mixture of Ar N3,
62.1 mmol, and 2,4,6-i-Pr3biphenyl) was added slowly to a diethyl ether solution (500 ml) of
LiAlH 4 (4.32 g, 114 mmol). The solution turned green and was left refluxing overnight. The
reaction was quenched by adding small amounts of water until the fizzing stopped. The product
was extracted three times with diethyl ether, and the combined ether extracts were dried over
MgSO 4. The magnesium sulfate was removed via filtration and the solvent was removed in
vacuo to yield a crude product, which was purified via silica column chromatography using a 1:9
Et20/hexanes as the eluting solvent. The desired fraction had a Rf value of 0.29 and was
collected to yield 14.7 g of pure product upon removal of solvent (80% accounting only for 62.1
mmol of ArTN 3): 'H NMR (400 MHz, CDCl3) 6 7.16 (td, 1H, CCCHCH), 7.09 (s, 2H, Trip CH),
6.95 (dd, 1H, CNH 2 CH), 6.78 (td, 1H, CNH 2CHCH), 6.74 (dd, 1H, CCCH), 3.41 (s br, 2H,
NH2), 2.94 (sept, 1H, p-(CH3 )2 CH), 2.62 (sept, 2H, o-(CH3)2CH), 1.31 (d, 6H, CHMe2), 1.14 (d,
6H, CHMe2), 1.06 (d, 6H, CH-Me2); 13C NMR (100 MHz, CDCl3) 6 148.3, 147.5, 144.4, 132.6,
130.8, 127.9, 125.6, 121.1, 117.9, 114.5, 34.3 (p-(CH 3)2CH), 30.4 (o-(CH3)2CH), 24.7 (p-
(CH 3)2CH), 24.1, 24.0. Anal. Calcd for C21H29N: C, 85.37; H, 9.89; N, 4.74. Found: C, 85.49;
H, 9.91; N, 4.70.
Mo(NArCI) 2Cl2DME (1) Triethylamine (33.0 mL, 235 mmol), trimethylchlorosilane (64.0
mL, 500 mmol) and 2-chloroaniline (15.0 g, 118 mmol) were added to a stirred slurry of sodium
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molybdate (12.1 g, 58.8 mmol) in dimethoxyethane (200 ml). The resulting orange-red mixture
was stirred for 36 h at 65 'C. The salts were filtered over celite and washed with benzene until
the washings were colorless. Removal of solvent from the filtrate yielded the crude product in
quantitative yield. The product was recrystallized from a mixture of toluene/pentane to give
analytically pure red microcrystalline solids (25.1 g, 84%): 1H NMR (500 MHz, C6D6) b 7.62 (d,
2H, Ar, J= 8.0 Hz), 6.97 (d, 2H, Ar, J= 8.0 Hz), 6.61 (t, 2H, Ar, J= 7.5 Hz), 6.39 (t, 2H, Ar, J~
7.5 Hz), 3.59 (s, 6H, dine), 3.19 (s, 4H, dme); 13 C NMR (125 MHz, C6D6) b 153.8 (C-N), 129.4,
127.3, 125.9, 71.2 (br, dme), 63.6 (br, dine). Anal. Caled for Ci6 HI8N2 Cl20 2Mo: C, 37.82; H,
3.57; N, 5.51. Found: C, 38.08; H, 3.72; N, 5.22.
Mo(NAr M)2Cl2(THF)2-2THF (2). Na2 MoO 4 (4.87 g, 23.7 mmol), ArmNH 2 (10.0 g, 47.3
mmol), NEt3 (13.2 ml, 94.6 mmol), and TMSC (25.5 ml, 201 mmol) were dissolved in dry DME
(300 ml) in a sealed Schlenk flask. The reaction was stirred at 60 C overnight. The salts were
filtered off from the deep red solution and rinsed with benzene. The solvent was removed from
the filtrate at 60 C under reduced pressure. The crude product was triturated with THF and the
excess solvent was removed in vacuo. The mixture was dissolved in a mixture of THF and
pentane and left to crystallize at - 35 'C; red crystalline solid (13.6 g, 84%) was collected upon
filtration. A sample (0.100 g) was dissolved in a THF/pentane solution and the solution was
stood at -35 *C for a couple of days to produce red crystals suitable for X-ray diffraction: 1H
NMR (400 MHz, C6D6 ) 6 7.98 (d, 2H, CNCH), 6.99 (t, 2H, CNCHCH), 6.90-6.82 (m, 8H,
imido), 3.59 (m, 16H, OCH 2), 2.19 (s, 6H, o-CH3), 2,16 (s, 3H, p-CH 3), 1.35 (m, 16H,
OCH 2 CH 2); 13 C NMR (100 MHz, C6D6 ) 6 155.4, 137.0, 136.5, 136.4, 132.6, 130.1, 130.0, 128.3,
127.9, 127.5, 69.4 (OCH2), 25.6 (o-CH3), 21.3 (p-CH3), 21.1 (OCH 2CH2). Anal. Calcd For
C4 6H62Cl 2MoN 20 4 : C, 63.23; H, 7.15; N, 3.21. Found: C, 63.34; H, 7.13; N, 3.19.
Mo(NAr T )2Cl2(DME) (3). The procedure was similar to that of 1 employing Na 2MoO 4
(3.48 g, 16.9 mmol), ArTNH 2 (10.0 g, 33.8 mmol), NEt3 (9.40 ml, 67.5 mmol), and TMSCl (20.0
ml, 158 mmol) in dry DME (300 ml). Upon removal of benzene/DME, the crude is washed with
pentane and collected on a frit under reduced pressure to yield red solid (11.2 g, 79%). A sample
(0.100 g) was dissolved in a Et 20/CH2Cl2 solution and the solution was stood at -35 "C for a
couple of days to produce red crystals suitable for X-ray diffraction: 'H NMR (400 MHz, C6D6)
6 8.18 (d, 2H, CNCH), 7.14 (s, 4H, Trip CH), 7.05 (d, 2H, CCCH), 6.96 (t, 2H, CCCHCH), 6.79
(t, 2H, CNCH), 2.98-2.72 (m, 16H, (CH 3)2CH + DME), 1.42 (d, 12H, CH(CH 3)2), 1.23 (d, 12H,
CH(CH 3 )2 ), 1.11 (d, 12H, CH(CH 3)2); 13C NMR (100 MHz, C6 D6) 6 155.8, 148.6, 147.6, 134.8,
132.3, 131.2, 131.1, 128.1, 127.9, 127.2, 70.6 (DME CH 2), 62.5 (DME CH3), 34.9 ((CH 3)2CH),
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31.0 ((CH 3)2CH), 25.4 (CH(CH 3)2), 24.4 (CH(CH 3)2), 23.6 (CH(CH 3)2). Anal. Calcd for
C4 6 H64 Cl2MoN 2O 2 : C, 65.47; H, 7.64; N, 3.32. Found: C, 65.19; H, 7.52: N, 3.28.
Mo(NArCI) 2(CH 2CMe 2Ph)2 (4) Neophylmagnesium chloride (0.50 M in ether, 39.4 mL, 20
mmol) was added slowly to a chilled suspension of 1 (5.00 g, 10.0 mmol) in ether (100 mL).
After stirring for 18 h, the mixture was filtered through celite. The solvent was removed under
vacuo from the filtrate to give a dark-red oil. Pentane was added to the oil and stirred vigorously
until precipitation of an orange product occurred. The precipitated solids were filtered, washed
with cold pentane and dried under vacuo. Yields: 4.10 g (68%): 'H NMR (500 MHz, CD 6) 6
7.38 (d, 4H, Ar, J= 7.5 Hz), 7.16 (t, 4H, Ar, J= 7.5 Hz), 7.10 (dd, 2H, Ar, J= 7.5, 1.5 Hz), 7.04
(t, 2H, Ar, J= 7.5 Hz), 6.92 (dd, 2H, Ar, J= 7.5, 1.5 Hz), 6.70 (t, 2H, Ar, J= 7.5 Hz), 6.51 (t,
2H, Ar, J= 7.5 Hz), 2.03 (s, 4H), 1.47 (s, 12H); "C NMR (125 MHz, C6D6) 6 153.8, 150.9,
129.7, 128.7, 128.4, 127.9, 127.0, 126.4, 126.24, 126.20, 125.9, 82.2, 41.0, 32.71, 32.66. Anal.
Calcd for C3 2H3 4N2Cl 2Mo: C, 62.65; H, 5.59; N, 4.57. Found: C, 62.43; H, 5.60; N, 4.55.
Mo(NAr") 2(CH 2CMe2Ph)2 (5). The synthesis was essentially the same as for 4 employing
2 (3.33 g, 4.89 mmol) and ClMgCH 2CMe2Ph (0.50 M in Et2O, 19.6 ml, 9.8 mmol) to yield
orange solid product (2.86 g, 74%): 'H NMR (400 MHz, C6D6) 6 7.20-7.08 (m, 1OH, aromatics),
7.04 (dd, 2H, aromatics), 6.99 (td, 2H, aromatics), 6.93-6.83 (in, 8H, aromatics), 2.23 (s, 6H, p-
CH 3), 2.11 (s, 12H, o-CH3), 1.30 (s, 12H, CMe2Ph), 1.07 (s, 4H, MoCH 2); "C NMR (100 MHz,
C6D6) 6 155.8, 151.5, 137.3, 136.7, 136.5, 134.2, 130.0, 128.6, 128.5, 127.6, 126.3, 126.1, 125.9,
125.4, 78.4 (CH 2CMe2Ph), 39.7 (MoCH-2CMe2Ph), 32.4 (CH 2C(CH3)2Ph), 21.2 (Mes CH-3), 21.0
(Mes CH3). Anal. Calcd for C5 oH56MoN 2 : C, 76.90; H, 7.23; N, 3.59. Found: C, 76.86; H, 7.31;
N 3.60.
Mo(NAr )2 (CH 2CMe3 )2 (6). The synthesis was essentially the same as for 4 employing 3
(6.31 g, 7.45 mmol) and ClMgCH2CMe3 (2.73 M in Et20, 5.47 ml, 14.9 mmol), but the
compound was further purified by recrystallization from pentane at - 35 C to yield orange-red 6
(3.11 g, 50%): 'H NMR (400 MHz, C6D6) 6 7.54 (dd, 1H, imido), 7.22 (dd, 1H, imido), 7.20 (s,
2H, TRIP CH), 7.03 (td, 1H, imido), 6.86 (td, 1H, imido), 2.85 (sept, 3H, (CH 3)2CH), 1.57 (s,
2H, CH2t-Bu), 1.35 (d, 6H, CH(CMe3)2), 1.30 (d, 6H, CH(CMe3)2), 1.14 (d, 6H, CH(CMe3)2),
0.99 (s, 9H, CH2CMe); 3 C NMR (100 MHz, C6D6) 6 156.3, 148.9, 148.3, 148.2, 147.0, 145.0,
135.5, 133.8, 133.0, 131.6, 130.9, 128.5, 127.9, 127.7, 125.4, 124.8, 121.4, 120.8, 118.1, 114.7,
80.3 (CH 2CMe3 ), 34.9, 34.8, 34.2, 33.6, 31.0, 30.8, 25.6, 24.9, 24.5, 24.4, 24.3, 23.9. Anal.
Calcd for C52H76MoN 2: C, 75.69; H, 9.28; N, 3.40. Found: C, 75.77; H, 9.08; N, 3.47.
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Mo(NArT )2(CH 3)2 (7). The synthesis was essentially the same as for 4 employing 3 (0.361
g, 0.428 mmol), ClMgCH 3 (3.00 M in THF, 0.29 ml, 0.87 mmol), but the compound was further
purified by recrystallization from pentane at - 35 "C to yield orange-red 7 as a solid (0.152 g,
50%). 7 (0.060 g) was redissolved in a pentane/Et2O solution and left undisturbed at -35 0C for a
few days to yield orange crystals suitable for X-ray diffraction: 'H NMR (400 MHz, C6D6) 6
7.37 (d, 2H, CNCH), 7.20 (s, 4H, Trip CH), 7.11 (d, 2H, CCCH), 6.96 (t, 2H, CCCHCH), 6.87
(t, 2H, CNCHCH),2.92 (m, 4H, CH(CH 3)2), 2.84 (m, 2H, CH(CH 3)2), 1.28 (d, 12H, CH(CH 3)2),
1.25 (d, 12H, CH(CH 3)2), 1.16 (d, 12H, CH(CH 3)2), 0.70 (s, 6H, MoCH3); 13 C NMR (100 MHz,
C6D6) 6 155.5, 148.5, 147.1, 135.1, 133.6, 130.9, 127.9, 126.8, 125.2, 120.8, 36.4 (MoCH3),
34.9, 31.1, 25.0 (CH2CMe3), 24.4 (CH2CMe3), 24.1 (CH 2CMe3). Anal. Calcd For C44H60MoN 2:
C, 74.13; H, 8.48; N, 3.93. Found: C, 73.93; H, 8.39; N 3.90.
Mo(NArcI)(CHCMe 2Ph)(OTf)2(DME) (8). 4 (2.00 g, 3.26 mmol) was suspended in ether
(100 mL) and cooled to - 30 'C. Triflic acid (1.47 g, 9.78 mmol) was added slowly into the
chilled suspension to yield a yellowish-brown solution. The resulting mixture was allowed to
warm gradually to room temperature and stirred for 18 h. The solution was then evacuated to
dryness and extracted with benzene. The triflate salts were removed via filtration through celite
and the benzene was removed under vacuo. Addition of pentane to the residue gave
microanalytically pure pale yellow needles (1.03 g, 43%): 'H NMR (500 MHz, C6D6) (Major
isomer 70%) 6 14.01 (s, 1H, syn Mo=CH, JCH 121.5 Hz), 7.82 (dd, 1H, Ar, J= 8.0, 1.0 Hz),
7.62 (d, 2H, Ar, J= 7.5 Hz), 7.44 (d, 1H, Ar, J= 7.5 Hz), 7.09 (t, 2H, Ar, J= 7.5 Hz), 6.77 (t,
1H, Ar, J= 7.5 Hz), 6.58 (t, 1H, Ar, J= 7.5 Hz), 6.46 (t, 1H, Ar, J= 7.5 Hz), 3.43 (s, 3H, dme),
3.24 (br s, 2H, dine), 2.89 (s, 3H, dine), 2.86 (br s, 2H, dine), 1.80 (s, 6H, CMe2Ph); (Minor
isomer 30%) b 15.00 (s, 1H, syn Mo=CH, JCH 127.0 Hz), 8.10 (d, 1H, Ar, J= 8.0 Hz), 7.07 (t,
2H, Ar, J= 7.5 Hz), 6.86-6.90 (overlapping peaks, 2H, Ar), 6.75 (t, 2H, Ar, J= 7.5 Hz), 6.69 (t,
1H, Ar, J= 7.5 Hz), 6.54 (t, 1H, Ar, J= 7.5 Hz), 3.24 (m, 1H, dine), 3.14 (s, 3H, dine), 3.11(m,
1H, dme), 3.04 (s, 3H, dine), 2.96 (m, 1H, dine), 2.47 (m, 1H, dine), 1.97 (s, 3H, CMe2Ph), 1.51
(s, 3H, CMe2Ph); 13C NMR (125 MHz, C6D6) b 334.0 (Mo=C, minor isomer), 326.2 (Mo=C,
major isomer), 151.9, 151.7, 148.6, 146.4, 132.4, 132.2, 132.1, 130.3, 129.7, 129.4, 128.9, 128.7,
127.3, 126.9, 126.8, 126.7, 124.0, 121.9, 121.6, 121.4, 119.4, 118.9, 116.4, 77.3, 73.7, 70.0, 69.7,
64.4, 62.4, 62.0, 61.5, 58.8, 31.2, 30.6, 30.5, 29.5, 28.8. Anal. Calcd for C2 2 H2 6NS2ClF60Mo:
C, 35.61; H, 3.53; N, 1.89. Found: C, 35.66; H, 3.58; N, 1.71.
Mo(NAr m)(CHCMe 2Ph)(OTf)2DME (9). The synthesis was essentially the same as for 8
employing 5 (9.70 g, 12.4 mmol), dimethoxyethane (5.00 ml, 48.1 mmol), and TfOH (5.59 g,
37.3 mmol). The crude product was precipitated through addition of pentane and triturated with
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Et20 overnight to give clean product (2.88 g, 28%): 'H NMR (400 MHz, CD 6) 6 15.41 (s, 0.2H,
MoCH, JCH = 128 Hz), 14.6 (s, 1H, MoCH, JCH = 129 Hz), 13.4 (s, 0.6H, 0.02H, MoCH, JCH
122 Hz), 12.9 (s, 0.02H, MoCH), 8,42 (d, 1, aromatic), 7.86 (d, 1, aromatic), 7.51-6.74 (in, 9H,
aromatics), 6.68-6.52 (m, 3H, aromatics), 3.43-3.01 (various s, 20H, DME), 2.28-1.61 (various
singlets, 30H, aliphatics); 3 C NMR (100 MHz, C6D6) 6 330.7 (MoCH), 319.9 (MoCH), 315.4
(MoCH), 154.5, 154.1, 149.9, 148.8, 146.8, 138.4, 138.0, 137.7, 137.6, 137.5, 136.6, 136.3,
136.2, 136.1, 135.9, 135.7, 134.2, 133.8, 131.9, 131.7, 131.6, 130.2, 129.1, 128.9, 128.8, 128.5,
126.8, 126.7, 126.4, 126.4, 75.5, 74.4, 70.2, 66.0, 61.3, 59.2, 57.2, 32.5, 31.1, 30.9, 30.4, 30.0,
29.5, 29.1, 28.4, 21.5, 21.3, 21.2, 20.9, 20.8, 20.6, 20.5; '9F NMR (376 MHz, C6 D) 6 - 76.7
(trans), - 77.0 (cis), - 77.9 (cis).
Mo(NAr )(CHCMe)(OTf) 2DME (10). The synthesis was essentially the same as for 8
employing 6 (2.01 g, 2.44 mmol), dimethoxyethane (1.00 ml, 9.62 mmol), and TfOH (1.10 g,
7.33 mmol). The crude was triturated with benzene for 2 h. The yellow solid product was
collected in 2 crops (overall yield: 0.973 g, 47%): 'H NMR (400 MHz, C6 D) 6 14.9 (s, 1H,
MoCH, JCH = 124 Hz), 14.3 (s, 0.6H, MoCH, JCH = 126 Hz), 14.0 (s, 0.12H, MoCH, JCH 122
Hz), 13.2 (s, 0.03H, MoCH), 8.69 (d, 1H, aromatic), 8.51 (d, 0.03H, aromatic), 8.36 (d, 0.12H,
aromatic), 8.12 (d, 0.6H, aromatic), 7.86 (d, 1H, aromatic), 7.40-6.70 (in, 11H, aromatics), 3.52
(s, 3H, DME CH), 3.50 (s, 2H, DME CH 2), 3.45 (s, 2H, DME CH 2), 3.31 (s, 3H, DME CH 3),
3.0-2.3 (various multiplets, 10H, (CH 3)2CH), 1.50 (s, 1.1H, CHCMe), 1.32 (s, 9H, CHCMe),
1.23 (s, 5.4H, CHCMe), 1.41-1.34 (2 d, 3), 1.20-0.70 (in, 30H); 3 C NMR (100 MHz, C6 D) 6
334.8 (MoCH), 322.4 (MoCH), 310.4 (MoCH), 154.9, 154.5, 150.2, 149.9, 149.5, 149.4, 148.8,
148.6, 147.6, 147.5, 146.3, 137.5, 136.1, 135.6, 134.8, 134.2, 134.1, 133.2, 132.9, 132.7, 132.5,
131.5, 131.4, 128.9, 128.8, 128.6, 128.5, 128.1, 127.9, 122.2, 121.8, 121.5, 121.0, 120.9, 120.8,
120.7, 119.0, 118.6, 78.4, 77.6, 76.1, 75.5, 70.0, 69.7, 65.9, 61.1, 60.9, 54.4, 52.7, 52.1, 34.8,
34.7, 34.6, 31.2, 31.1, 31.0 30.7, 30.6, 30.3, 26.3, 25.7, 25.6, 25.2, 24.4, 24.1, 24.0, 23.5, 23.4,
23.0, 22.4, 22.2, 15.6; "9F NMR (376 MHz, C6D6) 6 - 76.7 (s, 1), - 76.8 (in, 1.7), -76.9 (s, 0.09),
- 77.7 (m, 3).
Mo(NArcI)(CHCMe2 Ph)(2,5-Me 2Pyr)2 (11). 8 (1.00 g, 1.35 mmol) was dissolved in
toluene (20 mL) and cooled to - 30 "C. Li(2,5-Me2Pyr) (0.300, 2.97 mmol, 2.20 equivalents) was
added portion wise to the suspension. The reaction was subsequently warmed to and stirred at
room temperature for 24 h. The volatiles were then removed under vacuo. Benzene was added to
the residue, and the mixture was filtered through Celite in order to remove LiOTf. The filtrate
was evacuated to dryness yielding a dark orange-brown oil. The oil was triturated repeatedly
with pentane until an orange-brown solid was obtained. The product was filtered, washed with
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cold pentane and dried under vacuo. The crude product was extracted with tetramethylsilane and
the solvent evaporated to give bright orange microcrystalline solids (0.420 g, 57%): 1H NMR
(500 MHz, C6 D6) b 13.19 (s, 1H, syn Mo=CH, JCH = 131.0 Hz), 7.31 (d, 2H, Ar, J= 8.0 Hz),
7.00 (t, 2H, Ar, J= 8.0 Hz), 6.94 (dd, 1H, Ar, J= 8.0, 1.0 Hz), 6.89 (m, 2H, Ar), 6.55 (t, 1H, Ar,
J= 8.0 Hz), 6.47 (t, 1H, Ar, J= 8.0 Hz), 2.11 (br s, 12H, Pyr), 1.59 (s, 6H, CMe2Ph); 13C NMR
(125 MHz, C6D 6) 6 315.2 (Mo=C), 152.1, 149.7, 136.0 (br), 130.0, 129.6, 129.1, 127.2, 126.0,
106.6 (br), 57.9, 31.6 (br), 17.9 (br). Anal. Calcd for C28H32ClMoN 3: C, 62.05; H, 5.95; N, 7.75.
Found: C, 61.80; H, 5.83; N, 7.68.
Mo(NArCF3)(CHCMe 3)(2,5-Me 2Pyr)2 (12). Mo(NArCF3)(CHCMe 3)(OTf)2(DME) (2.37 g,
3.32 mmol) was dissolved in Et20 and the solution was cooled to - 35 "C for 1 h before addition
of 2,5-Me 2C4H2NLi (0.672 g, 6.65 mmol) in one portion. The reaction was stirred overnight at
RT. The solvent was removed in vacuo. A minimum of CH 2Cl2 was added and the mixture was
passed through a frit to remove LiOTf salts. The salts were washed with CH 2Cl2 until they were
colorless. The solvent was removed from the filtrate in vacuo to yield an oily crude product. A
minimal amount of Et2O and pentane were added to triturate the product for 30 min. The
mixture was stored at - 35 0C overnight to yield an orange solid (0.930 g, 53%): 1H NMR (400
MHz, C6D6) 6 13.5 (s, 1H, MoCHCMe3, JCH 131.8 Hz), 7.21 (d, IH, Ar), 7.11 (d, 1H, Ar), 6.71
(t, 1H, Ar), 6.50 (t, 1H, Ar), 6.4-5.6 (br s, 4H, Me 2C4H2N), 2.15 (s br, 12H, Me2C4H2N), 1.19 (s,
9H, MoCHCMe3 ); 13C NMR (100 MHz, C6D6) 6 322.3 (MoCHCMe3), 152.6, 132.5, 131.8,
125.9, 125.6 (q, CF3), 122.4, 122.1, 106.4, 52.2 (MoCHCMe 3), 32.8 (MoCHCMe3), 18.2 (br, Pyr
CH3). Anal. Calcd for C24H30F3MoN 3: C, 56.14; H, 5.89; N, 8.18. Found: C, 55.88; H, 5.73; N,
8.02.
Mo(NArr)(CHCMe 2Ph)(2,5-Me 2Pyr)2 (13). The synthesis was essentially the same as
for 11 employing Mo(NAriPr)(CHCMe 2Ph)(OTf)2(DME) (1.00 g, 1.34 mmol) and 2,5-
Me 2C4H2NLi (0.300 g, 2.97 mmol). The crude product was recrystallized from a concentrated
solution of pentane at - 30 0C to give orange-red blocks of crystals (0.440 g, 59%): 'H NMR
(500 MHz, C6D6 ) 6 13.11 (s, 1H, syn Mo=CH, JCH 130.0 Hz), 7.31 (d, 2H, Ar, J= 7.5 Hz),
7.10 (overlapping peaks, 3H, Ar), 6.98-7.01 (overlapping peaks, 2H, Ar), 6.88 (t, 1H, Ar, J= 7.5
Hz), 6.80 (t, 1H, Ar, J= 7.5 Hz), 5.95 (br s, 4H, Pyr), 3.47 (sept, 1H, 'Pr, J= 7.0 Hz), 2.07 (br s,
12H, Pyr), 1.65 (s, 6H, CMe2Ph), 1.10 (d, 6H, CHMe2); 13C NMR (125 MHz, C6 D6) 6 312.8
(Mo=C), 153.6, 149.2, 144.2, 129.4, 128.4, 127.5, 126.8, 126.3, 126.0, 125.9, 106.1 (br), 57.5,
31.7, 31.6, 27.9, 27.6, 23.8, 17.8 (br). Anal. Calcd for C31H39N3Mo: C, 67.74; H, 7.15; N, 7.65.
Found: C, 67.47; H, 6.97; N, 7.48.
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Mo(NAr tBu)(CHCMe3)(2,5-Me 2Pyr)2 (14). The synthesis was essentially the same as for 12
employing Mo(NArtB)(CHCMe 3)(OTf) 2(DME) (4.25 g, 6.06 mmol) and 2,5-Me2C4H2NLi
(1.226 g, 12.1 mmol) to yield red orange solid (2.50 g, 82%): 'H NMR (400 MHz, C6D6) 6 13.5
(s, 1H, MoCHCMe 3, JCH= 125.9 Hz), 7.38 (d, 1H, Ar), 7.01 (d, 1H, Ar), 6.76 (t, 1H, Ar), 6.67 (t,
1H, Ar), 6.60-5.20 (d br, 4H, Me2 C4H2N), 2.25 (s br, 12H, Me2C4H2N), 1.30 (s, 9H, ArtBu),1.20
(s, 9H, MoCHCMe); 13 C NMR (100 MHz, C6D6) 6 319.0 (MoCHCMe3), 154.8, 141.8, 134.8,
127.1, 126.9, 125.7, 110.2 (br, Pyr CH), 102.9 (br, Pyr CH), 65.9, 52.9, 35.7, 32.8, 29.8. Anal.
Caled for C27H39MoN 3: C, 64.66; H, 7.84; N, 8.38. Found: C, 64.31; H, 7.66; N, 8.36.
Mo(NArtBu)(CHCMe 2Ph)(2,5-Me 2Pyr)2 (15). The synthesis was essentially the same as for
12 employing Mo(NArtBu)(CHCMe 2Ph)(OTf) 2(DME) (4.10 g, 5.36 mmol) and 2,5-Me2C4H2NLi
(1.08 g, 10.7 mmol) to yield orange solid (3.00 g, 68%): 'H NMR (400 MHz, C6D6) 6 13.3 (s,
lH, MoCHCMe 2Ph JCH 129.7 Hz), 7.42 (d, 1H, Ar), 7.31 (d, 2H, Ph), 7.10 (t, 2H, Ph), 7.04
(dd, 1H, Ar), 7.00 (t, 1H, Ph), 6.79 (t, 1H, Ar), 6.71 (t, 1H, Ar), 6.60-5.20 (d br, 4H, Me2C4H2N),
2.40-1.70 (s br, 12H, Me2C4H2N), 1.65 (s, 6H, MoCHCMe2Ph), 1.31 (s, 9H, ArtBu); 13C NMR
(100 MHz, C6D6) 6 314.2 (MoCHCMe 2Ph), 154.9, 149.0, 142.0, 134.9, 128.5, 127.2, 126.9,
126.6, 126.2, 125.8, 110.2 (s br, Pyr CH), 103.0 (br, Pyr CH), 59.3, 35.7, 29.8, 18.7 (br, Pyr
CL 3 ), 16.3 (br, Pyr Cl 3), 13.1. Anal. Caled for C32H41MoN 3: C, 68.19; H, 7.33; N, 7.46. Found:
C, 67.95; H, 7.31; N, 7.31.
Mo(NArm)(CHCMe 2Ph)(2,5-Me 2Pyr)2 (16). The synthesis was essentially the same as for
12 employing 9 (2.01 g, 2.43 mmol) and 2,5-Me2C4H2NLi (0.493 g, 4.88 mmol) to yield orange
solid (1.25 g, 82%): 'H NMR (400 MHz, C6D6) 6 13.1 (s, 1H, MoCHCMe2Ph JCH 123.9 Hz),
7.40-6.60 (m, 1 1H, aromatics), 6.60-3.00 (br s, 4H, Me 2C4H2N), 2.50-1.20 (br singlets, 27H,
aliphatics); 3 C NMR (100 MHz, C6D6) 6 312. 0 (MoCHCMe2Ph), 153.7, 149.2, 137.8, 136.9,
136.1, 136.0, 130.3, 130.1, 128.4, 127.9, 127.0, 126.8, 126.2, 109.9 (pyr CH), 106.6,102.3 (pyr
CH), 58.2, 31.9, 22.7, 20.9, 18.6, 14.2, 13.0. Anal. Calcd for C39H37MoN 3: C, 71.02; H, 6.93; N,
6.72. Found: C, 70.77; H, 7.03; N, 6.64. Crystals suitable for X-ray diffraction were obtained
through recrystallization from toluene.
Mo(NArT )(CHCMe3 )(2,5-Me 2Pyr)2 (17). The synthesis was essentially the same as for 12
employing. 10 (0.253 g, 0.298 mmol) and 2,5-Me2C4H2NLi (0.060 g, 0.594 mmol). The crude
product was too soluble to recrystallize from pentane or tetramethylsilane even after a period of
weeks at - 35 "C. Therefore, the solvent was simply removed to give a product with only
solvents as impurities (0.070 g, 36%): 'H NMR (400 MHz, C6D6) 6 13.2 (s, 1H, MoCHCMe 3
JCH 129.0), 7.27 (d, 1H, CNCH), 7.13 (s, 2H, Trip CH), 6.95 (d, 1H, CCCH), 6.8-6.7 (m, 2H,
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aromatics), 6.60 (s, 2H, pyrrolide CH), 2.79 (sept, 2H, (CH 3)2CH), 2.64-2.0 (br s, 7H, (CH 3)2CH
+ pyrrolide CH 3), 1.26 (br d, 6H, o-(CH 3)2CH), 1.24 (s, 9H, CHCMe3 ), 1.20 (d, 6H, p-
(CH 3) 2CH), 0.96 (br d, 6H, o-(CH3)2CH); 13 C NMR (100 MHz, C6D6) 6 316.8 (MoCHCMe3 ),
154.8, 150.2, 135.3, 134.7, 132.0, 131.4, 128.3, 126.2, 121.0 (pyrrolide CH), 110.0 (pyrrolide
CH) 106.9, 53.0, 35.9, 33.5, 30.8, 24.5 (br s, pyrrolide CH3 ), 19.4 (pyrrolide CH3), 13.1.
Mo(NAr m)(CHCMe 2Ph)(OTPP)2 (18). A solution of TPPOH (0.103 g, 0.258 mmol) in
Et20 (5.00 ml) was cooled to -35 C and n-BuLi (1.60 M in hexane, 0.16 ml, 0.26 mmol) was
added slowly. The mixture was stirred at RT for 1 h and cooled to -35 C for 1 hour. The
mixture was added to a -35 0C Et20 solution of 9 (0.106 g, 0.128 mmol). After 1 h the solvent
was removed in vacuo. The crude product was redissolved in dichloromethane, the insoluble
salts were removed by filtration, and the solvent was removed in vacuo. The product was
triturated with pentane and collected on a frit as an orange solid (0.084 g, 55%): 'H NMR (400
MHz, C6D6) 6 10.75 (s, 1H, MoCHCMe 2Ph JCH = 123 Hz minor), 10.60 (s, 1.45H,
MoCHCMe 2Ph JCH = 122 Hz major), 7.50-6.50 (m, 106H, aromatics), 3.31 (q, 14H, OCH 2), 2.24
(s, 4.5H, para Mes major), 2.20 (s, 3H, aromatics para Mes), 2.00 (s, 9H, ortho Mes major), 1.95
(s, 9H, MoCHCMe2Ph major), 1.87 (s, 6H, ortho Mes), 1.72 (s, 6H, ortho Mes), 1.58 (s, 3H,
MoCHCMe(CH 3)Ph minor), 1.50 (s, 3H, MoCHCMe(CH 3)Ph minor), 1.17 (t, 21H, OCH 2CH);
3C NMR (100 MHz, C6D6) 6 290.2 (MoCHCMe 3), 288.2 (MoCHCMe3 ), 163.8, 161.8, 156.0,
151.1, 148.8, 148.6, 147.1, 146.7, 146.4, 142.9, 142.3, 142.1, 141.9, 141.7, 138.1, 137.0, 136.5,
134.6, 134.0, 133.9, 133.8, 133,1, 133.6 131.9, 131.5, 130.9, 130.2, 130.1, 129.8, 129.7, 128.7,
128.1, 127.2, 126.8, 126.6, 126.5, 126.4, 126.1, 125.6, 124.8, 121.3, 121.1, 120.5, 108.3, 106.5,
49.4, 48.9, 34.8, 31.3, 30.8, 27.0, 25.6, 25.4, 24.2, 22.7, 21.7. Anal. Caled for C89H79MoNO 3 : C,
81.82; H, 6.09; N, 1.07. Found: C, 81.87; H, 6.31; N, 1.09.
A sample of 18 suitable for an X-ray study was obtained by layering a solution of Et 20 with
pentane and placing the mixture at -35 C for several days.
Mo(NAr T )(CHCMe3 )(2,5-Me 2Pyr)(OTPP) (19). Compound 17 (0.200 g, 0.309 mmol) was
dissolved in Et 20 and the solution was placed at - 35 C for 1 h before addition of TPPOH
(0.123 g, 0.309 mmol) in one portion. The reaction was allowed to warm up to RT and stirred
for 2 h. The solvent was removed in vacuo and the crude product was triturated with pentane
and collected on a frit (0.128 g, 44%): 'H NMR (400 MHz, C6D6) 6 10.87 (s, 1H, MoCHCMe3,
JCH 116.0 Hz), 7.40-6.30 (m, 27H, aromatics), 5.89 (s, 2H, CHPyrr), 2.92 (m, 1H, CH(CH 3)2),
2.81 (m, 1H, CH(CH 3)2), 2.70 (m, 1H, CH(CH 3)2), 1.80 (s, 6H, MePyrr), 1.40 (d, 6H, para
CH(CH3)2 ), 1.28 (d, 3H, ortho CH(CH3)2 ), 1.23 (d, 3H, ortho CH(CH) 2 ), 1.10 (s, 9H,
MoCHCMe), 0.97 (d, 3H, ortho CH(CH 3)2), 0.93 (d, 3H, ortho CH(CH) 2 ); 13C NMR (100
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MHz, C6 D6) 6 288.3 (MoCHCMe3 ), 161.8, 156.0, 151.1, 148.8, 148.6, 147.1, 146.7, 146.4,
142.9, 142.3, 142.1, 141.9, 141.7, 138.1, 137.1, 136.5, 134.6, 134.0, 133.1, 133.1, 131.9, 131.5,
130.9, 130.3, 130.2, 129.8, 129.7, 128.7, 127.4, 127.2, 126.8, 126.6, 125.6, 124.8, 121.4, 121.3,
121.1, 120.7, 48.6, 34.8, 31.3, 30.9, 30.7, 27.0, 25.6, 25.4, 24.4, 22.7, 21.7. Anal. Caled for
C62H66MoN20: C, 78.29; H, 6.99; N, 2.95. Found: C, 77.94; H, 6.67; N, 2.91.
Mo(NArC)(CHCMe 2Ph)(2,5-Me 2Pyr)(OHMT) (20). 11 (0.102 g, 0.188 mmol) and
HMTOH (0.065 g, 0.197 mmol) were dissolved in benzene (15.0 ml) in a round-bottom flask
and stirred at RT for 18 h. The resultant reaction mixture was evacuated to dryness. The brown
oily residue was triturated several times with pentane until orange solids were formed. The pale
orange solids were filtered, washed with cold pentane and dried under vacuo. Microanalytically
pure product can be recrystallized from a mixture of toluene and pentane (0.059 g, 40%): 'H
NMR (500 MHz, C6 D6 ) o 11.34 (s, 1H, syn Mo=CH, JCH 123.5 Hz), 7.30 (d, 2H, Ar, J= 8.0
Hz), 7.08 (t, 2H, Ar, J= 7.5 Hz), 6.88-6.99 (overlapping peaks, 5H, Ar), 6.83 (s, 2H, Ar), 6.77
(s, 2H, Ar), 6.71-6.75 (overlapping peaks, 2H, Ar), 6.51 (m, 1H, Ar), 6.07 (s, 2H, Pyr), 2.14 (s,
6H), 2.05-2.06 (overlapping peaks, 12H), 2.02 (s, 6H), 1.62 (s, 3H), 1.42 (s, 3H); 13 C NMR (125
MHz, C6D6) 6 292.6 (Mo=C), 158.4, 153.4, 148.9, 136.7, 135.6, 134.6, 131.8, 131.2, 130.0,
129.7, 129.3, 128.5, 128.4, 127.4, 126.8, 126.6, 126.2, 122.7, 109.2, 109.0, 54.6, 32.4, 32.3, 29.8,
29.7, 21.9, 21.3, 21.1, 20.3, 17.1. Anal. Calcd for C46H49ClMoN 20: C, 71.08; H, 6.35; N, 3.60.
Found: C, 71.04; H, 6.44; N, 3.44.
Mo(NArCF3)(CHCMeA)(2,5-Me 2Pyr)(OHMT) (21). The synthesis was essentially the same
as for 20 employing 12 (0.101 g, 0.197 mmol) and HMTOH (0.065 g, 0.197 mmol) yielding an
orange solid (0.113 g, 76%): 'H NMR (400 MHz, C6D6 ) ( 11.2 (s, 1H, MoCHCMe 3, JCH = 120.8
Hz), 7.22 (s, 2H, HMTO), 7.18 (d, 1H, Ar), 7.10-6.96 (m, 3H, HMTO + Ar), 6.92-6.86
(overlapping peaks, 3H, HMTO), 6.69 (d, 1H, Ar), 6.66 (t, 1H, Ar), 6.10 (s, 2H, CHPyr), 2.27-
2.23 (overlapping peaks, 12H, Me), 2.17-2.10 (overlapping peaks, 12H, Me), 1.14 (s, 9H, ArtBu);
"C NMR (100 MHz, C6D6) 6 292.6 (Mo=C), 159.1, 137.2, 136.8, 136.6, 136.5, 135.5, 132.0,
131.4, 130.5, 130.3, 129.2, 128.5, 126.3, 122.5, 108.9, 106.5, 48.7, 31.7, 21.4, 21.3, 20.5; 19F
NMR (376 MHz, C6D6 ) -- 60.4. Anal. Calcd for C42H47F3MoN 20: C, 67.37; H, 6.33; N, 3.74.
Found: C, 66.97; H, 6.01; N, 3.59.
Mo(NArCF3)(CHCMe 2Ph)(2,5-Me 2Pyr)(OHMT) (22). The synthesis was essentially the
same as for 20 employing Mo(NAr C3)(CHCMe 2Ph)(2,5-Me2Pyr)2 (0.209 g, 0.363 mmol) and
HMTOH (0.120 g, 0.363 mmol) to yield a red solid (0.220 g, 75%): 'H NMR (400 MHz, C6D6)
( 11.2 (s, 1H, MoCHCMe 2Ph, JCH = 122.5 Hz), 7.24 (d, 2H, HMTO), 7.13-7.03 (overlapping,
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3H, HMTO + Ar), 7.01-6.87 (overlapping, 5H, HMTO + Ar), 6.82 (s, 2H, HMTO), 6.76 (s, 2H,
HMTO), 6.65 (d, 1H, Ar), 6.60 (t, lH, Ar), 6.03 (s, 2H, CHPyr), 2.16 (s, 6H, HMTO Me), 2.05
(s, 6H, HMTO Me), 2.03, (s br, 6H, Pyr Me), 1.99 (s, 6H, HMTO Me), 1.60 (s, 3H,
MoCHCMe2Ph), 1.40 (s, 3H, MoCHCMe2Ph); "C NMR (100 MHz, C6D6) ( 291.2 (Mo=C),
158.5, 148.7, 136.8, 136.7, 136.5, 135.5, 131.8, 131.7, 130.7, 130.2, 129.2, 128.5, 128.4, 126.6,
126.4, 126.3, 122.6, 108.9, 55.1, 32.4, 29.6, 21.3, 21.1, 20.3; '9F NMR (376 MHz, C6D6)
6 - 60.2. Anal. Caled for C47H49F3MoN 20: C, 69.62; H, 6.09; N, 3.45. Found: C, 69.72; H, 6.12;
N, 3.50.
Mo(NAriPr)(CHCMe 2Ph)(2,5-Me 2Pyr)(OHMT) (23). The synthesis was essentially the
same as for 20 employing 13 (0.100 g, 0.182 mmol) and HMTOH (0.060 g, 0.182 mmol);
yielding orange solid (0.068 g, 48%): 'H NMR (500 MHz, C6D6) ( 11.32 (s, 1H, syn Mo=CH,
JCH = 122.5 Hz), 7.29 (d, 2H, J- 7.5 Hz, Ar), 7.13 (t, 2H, J= 7.5 Hz, Ar), 6.91-7.02
(overlapping peaks, 7H, Ar), 6.84-6.87 (overlapping peaks, 3H, Ar), 6.80 (s, 2H, Ar), 6.02 (br s,
2H, Pyr), 3.22 (sept, 1H, J= 6.5 Hz, 'Pr), 2.30-1.74 (overlapping peaks, 301H, OHMT Me + Pyr
Me), 1.65 (s, 3H), 1.45 (s, 3H), 1.01 (d, 3H, J= 7.0 Hz), 0.82 (d, 3H, J= 7.0 Hz); "C NMR (125
MHz, C6D6) ( 291.0 (Mo=C), 158.5, 154.9, 148.8, 147.4, 136.8, 136.6, 135.7, 131.7, 130.0,
129.3, 128.5, 126.6, 126.3, 125.8, 122.4, 109.0, 54.7, 32.7, 29.8, 27.7, 27.5, 23.9, 23.7, 22.8,
21.9, 21.4, 21.2, 20.3. Anal. Caled for C49H56MoN20: C, 74.98; H, 7.19; N, 3.57. Found: C,
74.80; H, 6.81; N, 3.54.
Mo(NArtBu)(CHCMe 3)(2,5-Me 2Pyr)(OHMT) (24). The synthesis was essentially the same
as for 20 employing 14 (0.161 g, 0.32 1 mmol) and HMTOH (0.106 g, 0.32 1 mmol); yielding
orange solid (0.161 g, 68%): 1H NMR (400 MHz, C6D6) ( 11.3 (s, 1H, syn Mo=CH, JCH 118.7
Hz), 7.07 (d, 1H, Ar), 7.03-6.85 (overlapping, 4H, HMTO + Ar), 6.82 (s, 4H, HMTO), 6.57 (d,
1H, Ar), 6.20-5.90 (d br, 2H, CHPyr), 2.38 (s br, 3H, Pyr Me), 2.23 (s, 6H, HMTO Me), 2.21 (s,
6H, HMTO Me), 2.16 (s, 6H, HMTO Me), 1.89 (s br, 3H, Pyr Me), 1.12 (s, 9H, ArtBu), 1.08 (s,
9H, MoCHCMe3 ); 13C NMR (100 MHz, C6 D6) 6 290.7 (Mo=C), 159.8, 156.4, 145.4, 136.8,
136.6, 136.4, 135.6, 134.3, 131.4, 130.4, 129.2, 128.7, 127.4, 126.6, 126.3, 122.1, 108.9 (br,
CHPyr), 49.5, 35.7, 31.9, 30.7, 21.6, 21.4, 20.8. Anal. Caled for C45H56MoN 20: C, 73.35; H,
7.66; N, 3.80. Found: C, 73.47; H, 7.86; N, 3.57.
Mo(NArtBu)(CHCMe 2Ph)(2,5-Me 2Pyr)(OHMT) (25). The synthesis was essentially the
same as for 20 employing 15 (0.315 g, 0.559 mmol) and HMTOH (0.184 g, 0.557 mmol);
yielding orange solid (0.300 g, 67%): 'H NMR (400 MHz, C6D6) ( 11.3 (s, 1H, syn Mo=CH, JCH
= 120.2 Hz), 7.23 (d, 2H, Ph), 7.11 (t, 2H, Ph), 7.08 (d, 1H, Ar), 7.20-6.86 (overlapping, 5H,
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HMTO + Ar), 6.83 (s, 2H, HMTO), 6.77 (s, 2H, HMTO), 6.66 (d, 1H, Ar), 6.20-5.80 (d br, 2H,
CHPyr), 2.36 (s br, 3H, Pyr Me), 2.19 (s, 6H, HMTO Me), 2.10 (s, 6H, HMTO Me), 2.03 (s, 6H,
HMTO Me), 1.74 (s br, 3H, Pyr Me), 1.61 (s, 3H, MoCHCMe2Ph), 1.47 (s, 3H, MoCHCMe2Ph),
1.11 (s, 9, Ar'u); "C NMR (100 MHz, C6D6) 6289.2 (Mo=C), 159.1, 156.3, 148.7, 145.4, 137.2,
136.8, 136.7, 136.5, 135.6, 134.3, 131.6, 130.4, 129.2, 128.6, 128.4, 126.6, 126.5, 126.4, 126.3,
122.5, 109.2 (br, CHPyr), 55.7, 35.7, 32.8, 30.8, 29.8 21.4, 21.2, 20.7. Anal. Caled for
C5 0H 58MoN 20: C, 75.17; H, 7.32; N, 3.51. Found: C, 74.80; H, 7.20; N, 3.45.
Mo(NArm)(CHCMe 2Ph)(2,5-Me2Pyr)(OHMT) (26). Compound 16 (0.050 g, 0.080 mmol)
and HMTOH (0.026 g, 0.080 mmol) were dissolved in toluene (0.70 ml) and the mixture was
heated in a Teflon-sealed Schlenk flask to 110 C for 18 h. Then, the reaction was cooled to RT
and the solvent was removed in vacuo. The crude product was redissolved in minimal amount of
pentane and store at -35 C yielding crystalline red product (0.035 g, 51%): 'H NMR (400 MHz,
C6 D6 ) 6 10.93 (s, 1H, MoCHCMe 2Ph), 7.40-6.40 (in, 18H, aromatics), 6.20-5.60 (s br, 2H,
CHPyr), 2.23-2.17 (overlapping peaks, 15H, PyrMe2 + Arm), 2.07-2.01 (overlapping peaks, 18H,
Mes-HMTO), 1.80 (s, 3H, MoCH(CH3)CH), 1.69 (s, 3H, MoCH(CH)CH3); 13C NMR (100
MHz, C6D6) 6 290.3 (MoCHCMe2Ph), 158.1, 155.5, 149.0, 136.9, 136.7, 136.7, 136.6, 136.5,
136.2, 135.7, 135.4, 134.8, 131.7, 131.3, 130.0, 129.5, 129.2, 128.8, 128.5, 128.4, 127.3, 126.6,
126.2, 53.9, 32.6, 29.7, 21.3, 21.1, 20.4, 20.1. Anal. Calcd for C55H 6oMoN 20: C, 76.72; H, 7.02;
N, 3.25. Found: C, 77.09; H, 7.27; N, 3.00.
Red crystals suitable for X-ray diffraction were obtained by dissolving the product in Et2O,
layering the ether solution with pentane, and storing the sample at -35 C for several days.
Mo(NAr m)(CHCMe 2Ph)(2,5-Me2Pyr)(OHIPT) (27). The synthesis was similar to that of
26 employing 16 (0.061 g, 0.097 mmol) and HIPTOH (0.049 g, 0.098 mmol) and heating for 5
days. Purification required dissolution in TMS, storing at - 35 *C for a few days and filtering to
remove unreacted HIPTOH. Upon removal of solvent from the filtrate clean 27 was collected as
an orange powder (0.035 g, 35%): 1H NMR (400 MHz, C6D6) b 13.12 (s, 0.01H, MoCH), 12.18
(s, 1H, MoCH), 11.13 (s, 0.04H, MoCH), 10.14 (s, 0.07H, MoCH) 7.50-6.60 (m, 25H,
aromatics), 6.50-6.10 (br s, 3.8H, H 2C4Me2N), 3.4-2.8 (m, 11.4H), 2.25-2.10 (various s,
H2 C4Me2N + MoCHCMe2Ph, 22.8H), 1.90-1.70 (various s, 11.2H o-Mes), 1.62-1.60 (various s,
5.7H, p-Mes); 13 C NMR (100 MHz, C6 D6) 6290.4 (MoCHCMe2Ph), 160.2, 155.3, 149.5, 148.2,
147.5, 147.3, 147.2, 147.1, 137.3, 137.0, 136.4, 135.6, 135.4, 134.6, 133.0, 131.6, 131.1, 130.6,
128.1, 127.9, 126.5, 121.8, 121.3, 121.0, 108.8, 106.5, 53.2, 34.4, 31.1, 31.0, 30.8, 30.6, 29.2,
26.2, 25.6, 24.6, 24.2, 24.0, 23.7, 23.4, 21.5, 21.1, 19.8 Anal. Calcd for C67H84MoN 20: C,
78.18; H, 8.23; N, 2.72. Found: C, 78.28; H, 8.30; N, 2.40.
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Mo(NAr )(CHCMe3)(2,5-Me 2Pyr)(OHMT) (28). The synthesis was the same as that of 26
employing 17 (0.103 g, 0.016 mmol) and HMTOH (0.052 g, 0.016 mmol) yielding orange
crystals (0.080 g, 57%): 'H NMR (400 MHz, C6D6) 6 10.91 (s, 1H, MoCH), 10.85 (s, 0.17H,
MoCH), 7.25-7.00 (overlapping peaks, 4.5H, Ar + HMTO), 7.00-6.81 (overlapping peaks, 7H,
Ar + HMTO), 6.80 (s, 2H, HMTO), 6.70 (s, 2H, HMTO), 5.81 (s br, 2H, H2C4Me2N), 2.83 (m,
2H, CHMe 2), 2.43 (in, 1H, CHMe 2), 2.11 (s, 6H, HMTO Me), 2.08 (s, 6H, HMTO Me), 2.06 (s,
6H, HMTO Me), 1.65 (s, 6H, H2C4Me2N), 1.30 (d, 6H, CHMe2), 1.29 (d, 6H, CHMe2), 1.19 (d,
3H, CHMe2 ), 1.17 (s, 9H, MoCHCMe3), 1.15 (d, 3H, CHMe2); 13C NMR (100 MHz, C6D6) 6
288.2 (MoCHCMe 3), 158.9, 155.9, 148.6, 146.7, 146.4, 137.2, 136.8, 136.5, 136.0, 135.9, 135.0,
134.2, 134.0, 132.0, 131.6, 131.4, 131.3, 130.0, 129.9, 129.4, 128.8, 127.1, 125.3, 122.2, 121.2,
121.0, 106.5, 48.4, 34.6, 31.8, 30.7, 30.5, 25.9, 25.7, 24.4, 24.3, 21.8, 21.4, 21.2, 21.1, 20.6, 20.5.
Anal. Caled for C56H7 OMoN 2 0: C, 76.16; H, 7.99; N, 3.17. Found: C, 76.23; H, 7.99; N, 3.14.
Red crystals suitable for X-ray diffraction were obtained by dissolving the product in pentane,
and storing the sample at -35 0C for several days.
In situ preparation of (NArT)(CHCMe 3)(2,5-Me 2Pyr)(OHIPT) (29). 17 (0.020 g, 0.031
mmol) and HIPTOH (0.015 g, 0.031 mmol) were dissolved in C6D6 (0.70 ml) and heated for 14
days at 80 'C: 'H NMR (400 MHz, C6D6 ) 6 12.23 (s, 0.04H, MoCH), 11.80 (s, 1H, MoCH),
11.66 (s, 0.05H, MoCH), 9.85 (s, 0.5H, MoCH), 7.30-6.70 (m, 19.5H, aromatics), 6.50-6.10 (br
s, 3H, H2C4Me2N), 3.10-2.50 (in, 13.5H, CHMe2), 1.50-1.20 (m, 94.5H, CHMe2 terphenyl +
imido + MoCHCMe3).
General procedure for ROMP of DCMNBD MAP catalyst (3-10 mg) is dissolved in 0.50
ml of toluene while the monomer is dissolved in 0.70 ml of toluene and stirred in a separate vial.
To the monomer vial the catalyst solution is added quickly and left stirring for 1 h until it forms a
gel. The reaction is then quenched with 0.50 mL of benzaldehyde and some methylene chloride
is added to solubilize the gel. This solution is stirred for another hour, at which point the
solution is added to a 100 mL RBF containing 50-70 mL MeOH stirring vigorously. The
polymer precipitates instantly and it is collected by filtration after 1 h of stirring. The dry
polymer is examined by 'H and "C NMR to determine the tacticity and cis content according to
known literature reports.5 h
X-ray Structure Determination Low-temperature diffraction data (#-and w-scans) were
collected on a Siemens Platform three-circle diffractometer coupled to a Bruker-AXS Smart
Apex CCD detector with graphite-monochromated Mo Ka radiation (A = 0.71073 A) for the
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structure of compounds 2, 3, 16, and 18 and on a Bruker-AXS X8 Kappa Duo diffractometer
coupled to a Smart Apex2 CCD detector with Mo K radiation (A = 0.71073 A) from an IpS
micro-source for the structure of compounds 26, and 28. All structures were solved by direct
methods using SHELXS" and refined against F2 on all data by full-matrix least squares with
SHELXL-972 0 using established refinement techniques. 2 ' All non-hydrogen atoms were refined
anisotropically. All hydrogen atoms were included into the model at geometrically calculated
positions and refined using a riding model unless otherwise noted. The isotropic displacement
parameters of all hydrogen atoms were fixed to 1.2 times the U value of the atoms they are linked to
(1.5 times for methyl groups). All disordered atoms were refined with the help of similarity
restraints on the 1,2- and 1,3-distances and displacement parameters as well as rigid bond restraints
for anisotropic displacement parameters.
Compound 2 crystallizes in the triclinic space group P1 with one molecule in the asymmetric
unit along with two molecules of THF. The THF molecules and imido ligands were refined with
the help of similarity restraints on the 1,2- and 1,3-distances. Mild similar anisotropic displacement
parameter as well as rigid bond restraints were applied to all atoms.
Compound 3 crystallizes in the monoclinic space group C2/c with half a molecule in the
asymmetric unit. The molybdenum atom is located on the crystallographic two-fold axis.
Compound 7 crystallizes in the monoclinic space group P21/c with one molecule in the
asymmetric unit. Coordinates for the methyl hydrogen atoms on C(1) and C(2) were taken from
the difference Fourier synthesis. The hydrogen atoms in question were subsequently refined
semi-freely with the help of distance restraints on C-H and H ...H distances while constraining the
Uso values of the hydrogen atoms to 1.5 times the value of Ueq of the corresponding carbon
atoms.
Compound 16 crystallizes in the monoclinic space group P2,/n with one molecule in the
asymmetric unit. Coordinates for the hydrogen atom on C1 were taken from the difference Fourier
synthesis and refined semi-freely with the help of a distance restraint while constraining the U,,
value of the hydrogen atom to 1.2 times the Uq value of C1.
Compound 18 crystallizes in the monoclinic space group P21/n with one molecule in the
asymmetric unit along with one molecule of diethylether. Coordinates for the hydrogen atom on
C1 were taken from the difference Fourier synthesis and refined semi-freely with the help of a
distance restraint while constraining the U 0,, value of the hydrogen atom to 1.2 times the Uq value
of Cl. The diethylether was refined with the help of similarity restraints on the 1,2- and 1,3-
distances and displacement parameters as well as rigid bond restraints for anisotropic displacement
parameters.
Compound 26 crystallizes in the monoclinic space group P21/n with one molecule in the
asymmetric unit along with half a molecule of hexane. Coordinates for the hydrogen atom on C1
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were taken from the difference Fourier synthesis and refined semi-freely with the help of a distance
restraint while constraining the U 0,, value of the hydrogen atom to 1.2 times the Uq value of C1.
The hexane molecule was found to be located near a crystallographic inversion center and is
disordered accordingly.
Compound 28 crystallizes in the orthorhombic space group Pbca with one molecule in the
asymmetric unit. Coordinates for the hydrogen atom on C1 were taken from the difference Fourier
synthesis and refined semi-freely with the help of a distance restraint while constraining the Ui,,
value of the hydrogen atom to 1.2 times the U,, value of C1.
Crystal information can be found in Tables 3 to 9 below.
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Table 3. Crystal data and structure refinement for 2.
Identification code 09217
Empirical formula C46 H62 C12 Mo N2 04
Formula weight 873.82
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Triclinic
Space group Pi
Unit cell dimensions a= 12.8333(12) A
Volume
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 30.55'
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
b = 13.8685(14)
c = 14.858(2) A
2167.3(5) A3
A
a 113.617(3)0
p= 107.683(3)0
y = 100.305(2)0
2
1.339 Mg/m 3
0.470 mm-l1
920
0.35 x 0.30 x 0.18 mm3
1.65 to 30.55'
-18<=h<=18, -13<=k<=19, -19<=l<=19
11907
8854 [R(int) = 0.0280]
66.5 %
Semi-empirical from equivalents
0.9202 and 0.8528
Full-matrix least-squares on F2
8854 / 638 / 502
1.037
RI = 0.0427, wR2 = 0.1067
RI = 0.0511, wR2 = 0.1140
1.104 and -0.745 e.A-3
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Table 4. Crystal data and structure refinement for 3.
Identification code 09419
Empirical formula C46 H64 C12 Mo N2 02
Formula weight 843.83
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group C2/c
Unit cell dimensions a = 26.538(3) A
b = 8.9534(10) A
c = 20.104(2) A
Volume 4457.7(9) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 29.570
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
4
1.257 Mg/m 3
0.451 mm-1
1784
0.32 x 0.26 x 0.12 mm3
1.64 to 29.57'
-36<=h<=36, -12<=k<=12, -27<=l<=27
52820
6202 [R(int) = 0.0409]
99.1 %
Semi-empirical from equivalents
0.9478 and 0.8690
Full-matrix least-squares on F2
6202 / 0 / 247
1.065
R1 = 0.0296, wR2 = 0.0748
R1 = 0.0341, wR2 = 0.0780
0.677 and -0.351 e.A-3
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a= 90'
S111.058(2)
y = 900
Table 5. Crystal data and structure refinement for 7.
Identification code d09095
Empirical formula C44 H60 Mo N2
Formula weight 712.88
Temperature 100(2) K
Wavelength 1.54178 A
Crystal system Monoclinic
Space group P2 1/c
Unit cell dimensions a = 12.8086(3) A
b = 17.0410(3) A
c = 19.1969(4) A
Volume 4143.40(15) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 68.240
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
a= 90'
p= 98.5650(10)0
y = 900
4
1.143 Mg/m 3
2.794 mm-1
1520
0.15 x 0.09 x 0.05 mm3
3.49 to 68.240
-1 5<=h<=15, -20<=k<=20, -18<=l<=22
78263
7540 [R(int) = 0.0552]
99.4 %
Semi-empirical from equivalents
0.8729 and 0.6793
Full-matrix least-squares on F2
7540 / 21 / 454
1.034
R1 = 0.0303, wR2 = 0.0733
R1 = 0.0384, wR2 = 0.0775
0.563 and -0.456 e.A-3
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Table 6. Crystal data and structure refinement for 16.
Identification code 09274
Empirical formula C37 H43 Mo N3
Formula weight 625.68
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P2 1/n
Unit cell dimensions a = 13.524(2) A
b = 15.067(3) A
c = 15.784(3) A
Volume 3213.1(10) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 29.57'
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
a= 90'
p= 92.594(3)0
y 900
4
1.293 Mg/m 3
0.437 mm-1
1312
0.25 x 0.20 x 0.10 mm3
1.87 to 29.57'
-18<=h<=18, 0<=k<=20, 0<=l<=21
8997
8997 [R(int) = 0.1168]
100.0 %
Semi-empirical from equivalents
0.9576 and 0.8986
Full-matrix least-squares on F2
8997/1/382
1.096
RI = 0.0385, wR2 = 0.0856
RI = 0.0545, wR2 = 0.0910
1.220 and -0.511 e.A-3
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Table 7. Crystal data and structure refinement for 18.
Identification code 09409
Empirical formula C89 H79 Mo N 03
Formula weight 1306.47
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P2 1/n
Unit cell dimensions a= 16.9320(16) A
b = 21.5492(19) A
c = 19.4983(18) A
Volume 6906.0(11) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 29.57'
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
a= 900
p= 103.902(2)0
y = 900
4
1.257 Mg/m 3
0.243 mm-1
2744
0.25 x 0.15 x 0.10 mm3
1.43 to 29.57'.
-23<=h<=23, -29<=k<=29, -27<=l<=26
139120
19378 [R(int) = 0.1126]
100.0 %
Semi-empirical from equivalents
0.9761 and 0.9418
Full-matrix least-squares on F2
19378 / 33 / 855
1.018
R1 = 0.0551, wR2 = 0.1145
R1 = 0.0975, wR2 = 0.1354
0.884 and -0.751 e.A-3
108
Table 8. Crystal data and structure refinement for 26.
Identification code x10052
Empirical formula C57.50 H66 Mo N2 0
Formula weight 897.06
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P21/n
Unit cell dimensions a= 11.4726(7) A
b = 24.6541(15) A
S= 17.341416(1)^ A
Volume 4826.2(5) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 31.30'
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
a= 90'
p 99.7690(10)0
y = 900
4
1.235 Mg/m 3
0.313 mm-1
1900
0.25 x 0.15 x 0.10 mm3
1.45 to 31.300
-1 6<=h<=16, -36<=k<=35, -13<=I<=25
115720
15786 [R(int) = 0.0418]
99.9%
Semi-empirical from equivalents
0.9694 and 0.9259
Full-matrix least-squares on F2
15786 / 41 / 593
1.036
R1 = 0.0307, wR2 = 0.0734
R1 = 0.0401, wR2 = 0.0782
0.390 and -0.555 e.A-3
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Table 9. Crystal data and structure refinement for 28.
Identification code xl 1164
Empirical formula C56 H70 Mo N2 0
Formula weight 883.08
Temperature 100(2) K
Wavelength 1.54178 A
Crystal system Orthorhombic
Space group Pbca
Unit cell dimensions a = 9.9364(2) A
b = 20.6357(5) A
c = 47.6772(l1) A
Volume 9775.9(4) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 67.560
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
8
1.200 Mg/m 3
2.482 mm-1
3760
0.05 x 0.02 x 0.02 mm 3
1.85 to 67.56'
-1 1<=h<= 11, -24<=k<=18, -51<=l<=56
67453
8813 [R(int) = 0.1004]
99.9 %
Semi-empirical from equivalents
0.9520 and 0.8859
Full-matrix least-squares on F2
8813/1/561
1.012
R1 = 0.0403, wR2 = 0.0853
R1 = 0.0701, wR2 = 0.0961
0.542 and -0.437 e.A-3
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a= 90'
p= 900
y = 900
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CHAPTER 4
Bipyridine Adducts of Molybdenum Alkylidene and Molybdenum Alkylidyne Complexes:
Their Use for Preparation of New Active Catalyst Species
Reprinted (adapted) with permission from Lichtscheidl, A. G.; Ng, V. W.; Miller, P.; Takase, M.
K.; Schrock, R. R.; Malcomson, S. J.; Meek, S. J.; Li, B.; Kiesewetter, E. T.; Hoveyda, A. H.
"Bipyridine Adducts of Molybdenum Imido Alkylidene and Molybdenum Imido Alkylidyne
Complexes" Organometallics 2012, 31, ASAP. Copyright 2012 American Chemical Society.
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INTRODUCTION
High oxidation state molybdenum and tungsten imido alkylidene complexes' with the
generic formula M(NR)(CHR')(X)(Y) (where X and Y are monoanionic ligands) were
discovered approximately 25 years ago.2 In the last several years new types of Mo and W imido
alkylidene complexes that have the formula M(NR)(CHR')(OR")(Pyr), where Pyr is a pyrrolide
or substituted pyrrolide ligand and OR" usually is an aryloxide, have been prepared and
explored; we refer to these monoaryloxide monopyrrolide complexes as MAP.1a, 3 Preparation of
such compounds was the result of the development of bispyrrolide complexes of the general
formula M(NR)(CHR')(Pyr) 2,4a-b which serve as efficient catalyst precursors due to easy
protonolysis and displacement of the pyrrolide ligand by alcohols and phenols. In addition, both
unsubstituted and substituted pyrrole (byproduct of protonolysis) were shown to remain as
innocent spectator molecules in the presence of active olefin metathesis catalysts. This inertness
rendered bispyrrolide complexes most useful during screening of catalyst activity for various
bisalkoxide and MAP species because they can be generated trivially in situ and used without
purification.3ce, 3g 3j
A large variety of bispyrrolide complexes have been made in the past (where Pyr
pyrrolide; 4a 2,5-Me2-pyrrolide; 4b 2,3,4,5-Me4-pyrrolide; 2,5-i-Pr 2-pyrrolide; 2,5-Ph2pyrrolide; 4c
2-Mes-pyrrolide 4d) and it has been shown that they can be protonated; however, when the
alcohol or phenol, used for protonolysis, is bulky then only the smallest (pyrrolide and 2,5-Me2-
pyrrolide) can be easily protonated and substituted. As a result, the majority of MAP species that
have been made contain the smallest pyrrolides from the aforementioned list, with mostly 2,5-
Me2-pyrrolide MAP's being made to date (see Chapter 3, Section 3.2.2 for a representive
sample).3 The low number of MAP compounds containing unsubstituted pyrrolide is due to the
poor crystallinity and fast decomposition of Mo(NR)(CHR')(pyrrolide) 2 species. Two notable
exceptions are the compounds where R = 2,6-i-Pr 2C6H3 and adamantyl, which are stable for
many days at -35 C. 4a The latter has been used to synthesize
Mo(NAd)(CHCMe 2Ph)(NC4H4)(OAr) catalysts, where Ar is a large hexa-substituted terphenyl,
that are Z-selective in general.3 i' 5
In this report we investigate the role of bipyridine as a base-adduct stabilizer for the synthesis
of bispyrrolide complexes containing seven different imido groups and their use as catalyst
precursors for the preparation of new Mo(NR)(CHCMe 2Ph)(NC4H4)(OAr) species, which
reactivity is briefly studied. In addition, the preparation of Mo(NR)(=CCMe 2R')(Me2Pyr)(bipy)
species from Mo(NR)(CHCMe 2R')(Me2Pyr)2 is presented, along with preliminary reactions.
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RESULTS AND DISCUSSION
4.1 Preparation of bispyrrolide complexes
4.1.1 Attempts at preparing molybdenum alkylidene imido bispyrrolide complexes
As stated in the introduction, a small number of bispyrrolide complexes,
Mo(NR)(CHCMe 2Ph)(Pyr)2 (R = 2,6-i-Pr2C6H3 (Ar), 2,6-Br 2-4-MeC 6H2, or 1-adamantyl (Ad);
Pyr = NC4H4) have been made and isolated successfully in the past4a (hereafter, Pyr = pyrrolide
and Me2Pyr = 2,5-Me2-pyrrolide). Attempts to prepare analogous species containing other imido
groups generally yielded non-crystalline samples that tended to decompose easily. For instance,
when Mo(NArPh)(CHCMe3)(OTf)2DME (ArPh = 2-phenylC 6H4) was treated with 2 equivalents
of lithium pyrrolide, in Et20, Mo(NArPh)(CHCMe 3)(Pyr)2, 1, is obtained in low yield (10%)
upon work-up and purification. On the other hand, when Mo(NArm)(CHCMe 2Ph)(OTf)2DME
(Arm = 2-mesitylC6H 4) is treated with 2 equivalents of lithium pyrrolide no crystalline compound
is obtained and decomposition is observed both in solution and upon solvent removal.
The 'H NMR spectrum (in CD 2Cl 2) of compound 1 contains only broad resonances at RT,
but upon cooling the solution down to - 30 0C the broad alkylidene peak decoalesces into two
separate peaks. The same is observed with the tert-butyl resonance, while the pyrrolide
resonance splits into various peaks (Figure 1). This behavior has also been observed for
Mo(NAr)(CHCMe 2Ph)(Pyr)2 in the past and it was shown that the complex exists as a
unsymmetrical dimer in the solid state;4a therefore, complex 1 is suggested to also exist in
solution as an equilibrium mixture of the monomeric and unsymmetrical dimer (Scheme 1).
ArPh
N Mo
2 11
20/ Mo.
N N 'ArPh
Scheme 1 - Solution equilibrium of 1 showing formation of an asymmetrical dimer.
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Figure 1 - VT 'H NMR of 1 in CD2Cl 2 from 20 C (top) to - 30 C (bottom). +CH2Cl2; *Et20.
Overall, formation of the asymmetrical dimer shows that when the pyrrolide has no
substituents bimolecular decomposition can take place more readily, which explains the low
stability of this type of complex. In the case of 1, the low yield and the possibility of C-H
activation of the ortho-phenyl group render the complex useless for subsequent studies. When
the more robust ortho-mesityl group is used instead, no isolable bispyrrolide species can be
obtained, but because it is substantially more stable than ortho-phenyl it will be discussed and
studied in Sections 4.1.3-4.1.4. Since Mo(NR)(CHCMe 2Ph)(Pyr) 2 (R = Ar and Ad) can be
obtained in good yield, they are used for subsequent studies mentioned in the next sections.
4.1.2 Preparation of stable bispyrrolide complexes containing bipy as a base adduct.
Recently, Ftirstner reported the preparation of molybdenum alkylidene bisalkoxide catalysts
containing bipyridine as a base-adduct and their enhanced air stability.6 These complexes are
shown in Figure 2. All were prepared by treatment of the corresponding bisalkoxides with one
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equivalent of 2,2'-bipyridine (bipy). The most striking feature of these complexes is that they
are stable in the solid state for weeks in the presence of air and that in solution they can liberate
the active metathesis complex upon treatment with ZnCl 2 at high temperatures.
Ar Ar Ar
F3C CF 3  I P PN N N
PhO Ph3 SiO" -MPh 0 I --MPh
F3 C- N Ph 3 SiO 1 MoN NSN \ N N
Figure 2 - Frstner's molybdenum alkylidene bisalkoxide bipyridine adduct complexes.
Since Mo(NR)(CHCMe 2Ph)(Pyr)2 complexes have small ligands, it was reasoned that
bispyrrolide bipy adducts might be prepared, which would not only avoid formation of an
asymmetric dimer in the solid state, but also improve the stability of the complexes overall.
Thus, when Mo(NR)(CHCMe 2Ph)(Pyr) 2 was treated with one equivalent of bipy in Et 20 a
precipitate resulted, which upon filtration gave complexes of general formula
Mo(NR)(CHCMe 2Ph)(Pyr)2(bipy) (R = Ar, 9; R = Ad, 10) in good yields, equation 1. In the
remainder of the chapter, this procedure will be referred as method A.
Compound 10 is not very soluble in common NMR solvents and as a result no 13C NMR
could be obtained; however, enough dissolves to obtain a proton NMR spectrum. This lack of
solubility is a feature that is common for many of the bipy complexes to be presented in the next
remaining sections of the chapter. The most striking feature in the 1H NMR of 10 is the presence
of three alkylidene peaks; which could arise from cis and trans isomerism of the pyrrolide
ligands and possible syn (alkylidene pointing towards the imido group) to anti (alkylidene
pointing away from the imido group) isomerism of one of the former geometric isomers.
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Ph
R I R
N Ph Et20
Mo N RT N Ph1/2 / (1)
NY / N No
Mo% KN "N N ----
IN R
9 R = Ar, (45%)
10 R = Ad, (75%)
Unlike 10, compound 9 dissolves more readily and both 1H and 13C NMR spectra can be
obtained in CD 2Cl2. There is only one alkylidene peak present in its 1H NMR, implying that
there is only one isomer in solution. In order to investigate the nature of the isomer, crystals of 9
were grown from CH2Cl2 at - 35 C and analyzed by X-ray crystallography; the solved structure
is shown in Figure 3 (provided generously by the Hoveyda Lab at Boston College). The
complex has a pseudo octahedral structure with the pyrrolide ligands located trans to each other
and bipyridine located trans to the imido and alkylidene groups. The trans influence of the
pyrrolide ligands gives slightly longer Mo-Npy, bonds than those found in analogous compounds
(2.135(3)' and 2.143(2) in 9 vs. 2.082(4), 2.097(4)0, and 2.060(4)0 in
[Mo(NAr)(CHCMe 2Ph)(Pyr)2]24a or 2.1134(17)0 in Mo(NArm )(CHCMe 2Ph)(Me2Pyr).
Interestingly, Ftirstner's Mo(NAr)(CHCMe 2Ph)(OC(CF 3)2CH 3)2(bipy) compound adopts the cis
configuration and bipyridine does not bind trans to the imido ligand. As a result, the Mo(1)-N(l)
bond length in 9 (2.330(3)A) is similar to the corresponding bond in FtIrstner's compound
(2.3503(1 1)A) because they are both trans to the alkylidene group; however, the Mo(l)-N(2)
bond length in 9 (2.354(3)A), which is trans to the imido ligand, is substantially longer than in
Ftirstner's compound (2.2462(l0)A), which is trans to the alkoxide ligand. The Mo(1)-N(3)-
C(2 1) and Mo(1)-C( 11)-C(12) bond angles are similar to those observed in other bispyrrolide
complexes 4a-b, 13b and the N(4)-Mo(l)-N(5) bond angle is slightly bent (155.75(10)), facing
away from the imido group.
The stability of both 9 and 10 towards air is dramatically enhanced compared to their non-
bipy adduct counterparts; however, preparation of similar complexes that contain other imido
groups is the major drawback because it is required that Mo(NR)(CHCMe 2Ph)(Pyr)2 be isolated
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first. In Sections 4.1.3 and 4.1.4 different methods to circumvent this synthetic problem and a
new variety of complexes will be presented.
4.1.3 Bispyrrolide bipyridine adduct complexes: preparation from bistriflate bipyridine
adducts: Method B.
Attempts to prepare Mo(NR)(CHCMe 2Ph)(OTf)2(bipy) directly from
Mo(NR)2(CH 2CMe2Ph)2, by reacting the dialkyl species with acids in the presence of bipy, were
not successful. Instead, the preparation of Mo(NR)(CHCMe 2Ph)(OTf) 2(bipy) complexes from
the Mo(NR)(CHCMe 2Ph)(OTf)2(dimethoxyethane) starting materials can be achieved simply by
suspending the latter with one equivalent of bipyridine in benzene at RT (R = 2,6-iPr 2C6H3 (Ar),
1-adamantyl (Ad), 2,6-Me2C6H3 (Ar'), and 2-MesC 6H4 (Arm)), or in Et2O at - 35 C (R = 2-
ClC 6H4 (Arc), 2-i-PrC6H4 (AriPr), 2-t-BuC 6H4 (ArtB)) and stirring the mixture for 12 h at RT. In
1)
Figure 3 - Solid state structure of 9 (50% probability ellipsoids). Selected bond lengths (A) and
angles ('): Mo(1)-C(11) = 1.932(3), Mo(1)-N(1) = 2.330(3), Mo(1)-N(2) = 2.354(3), Mo(l)-
N(3) = 1.730(2), Mo(1)-N(4) = 2.135(3), Mo(1)-N(5) = 2.143(2), C(12)-C(11)-Mo(1) = 138.3(2),
C(21)-N(3)-Mo(1) = 171.0 (2), N(5)-Mo(1)-N(4) = 155.75(10).
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C6H6 at RT R
or N
Et20 at -35 0C TfO --.. Ph
no. TfOo.. PTfO N\
-DME N
2 R=Ar,(84%)
3 R=Ad,(91%)
4 R Ar', (67 %)
5 R Arc', (66 %)
6 R = AriPr, (76 %)
7 R = ArtBu, (76 %)
8 R =Arm, (73 %)
(2)
all cases, solid product precipitates out that can be collected by vacuum filtration in good yields
(equation 2). In the case of complexes 5, 6 and 7 the bistriflate solutions must be cooled down
first to avoid major decomposition; also Et2O helps remove the decomposed impurities better
than other solvents. It is worth noting that decomposition is only a problem when the metal is
bound to a relative small and unhindered aryl imido; whereas with larger, bulkier aryl imidos or
alkyl imidos there is no need to take these precautions.
All complexes are very soluble in CH 2Cl 2 with the exception of 2 and 3, which are only
sparingly soluble and for which 3 C NMR could not be obtained. 'H NMR of the complexes
shows the presence of either 1 or 2 alkylidene peaks in CD2Cl2, which arise from cis and trans
configurational isomerism, which is corroborated by the fluorine NMR of each compound.
Interestingly, two isomers are observed only when the imido group has only one substituent,
whereas 2,6-i-Pr 2C6H 3, 2,6-Me2C6H3, and 1-adamantyl complexes have only one isomer.
Bistriflate complexes 2, 4 and 6 react with 2 equivalents of LiNC 4H4 to generate the analogous
bispyrrolide species 9, 11 and 13. These molecules are even more insoluble than compounds 2-8
and can be isolated in moderate to good yields by running the reaction in Et2O solutions for 12 h,
collecting the precipitate product by filtration and washing the solids with Et20 (equation 3).
This method improves on the synthesis of 9, via method A, where Mo(NR)(CHCMe 2Ph)(Pyr) 2
had to be isolated (Section 4.1.2).
'H NMR in CD 2 Cl 2 of 11 shows only one isomer in solution; while that of 13 shows 2
isomers, which could arise from cis and trans isomerism. 3 C NMR could not be obtained for
either 11 or 13 because of their high insolubility in common organic solvents.
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9 R = Ar, (61 %)
11 R = Ar', (77 %)
13 R = AriPr, (85 %)
Unfortunately, when complexes 3, 5, and 7-8 are treated with 2 equivalents of LiNC4H4
impure product is obtained as a result of incomplete substitution; since all complexes are very
insoluble, purification is not possible. The reaction is not driven to completion by letting the
mixture react for longer times (1-2 days) and complications arise in subsequent reactions if these
impure mixtures are used as starting materials.
Although method B allows access to two new bispyrrolide bipy adduct complexes, the
procedure is not general and many other imido groups do not seem to give clean product.
Because of these limitations, a different method of synthesis was sought. As it was mentioned
earlier, Mo(NR)(CHCMe 2Ph)(Pyr)2 complexes are very prone to decomposition upon work-up
or removal of solvent, but if one can trap the species in solution before they decompose then it
would be possible to access a variety of different imido groups. This idea is investigated in the
next section.
4.1.4 Bispyrrolide bipyridine adduct complexes: preparation from bispyrrolide
complexes formed in situ: Method C.
After the disappointing results presented in Section 4.1.3 it became clear that
Mo(NR)(CHMe 2Ph)(Pyr)2 species would need to be made first in order to access the
corresponding bipy-bound complexes. The idea mentioned in the last section was to prepare the
bispyrrolide species from the corresponding Mo(NR)(CHCMe 2Ph)(OTf)2DME complexes and to
trap them by adding bipyridine to the solution mixture. Thus, Mo(NR)(CHCMe 2Ph)(OTf)2DME
was dissolved in toluene at -35 0C and two equivalents of LiPyr were added. The mixture was
allowed to react for no longer than 2 hours to avoid substantial decomposition, filtered to remove
salts, and immediately treated with 0.8-0.9 equivalents of bipy to produce insoluble products
(equation 4).
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10 R = Ad, (36%)
In-situ 11 R = Ar', (96%)
12 R = Arc', (87%)
13 R = AriPr, (96%)
14 R = ArtBu (24%)
15 R = Arm, (74%)
Compounds 10-15 were obtained analytically pure upon collecting the precipitate product by
filtration and drying under vacuum. The yields of most complexes (counting bipy as the limiting
reactant) are high (74-96%) as a consequence of how insoluble all complexes are; however,
complex 14 suffers in yield because it is slightly more soluble in toluene than the rest of the
complexes. Likewise, complex 9, which is soluble enough to get a 13C NMR spectrum, is not
efficiently made through this method; either method A or B is recommended.
The alkylidene region in the 1H NMR (in CD2Cl2) of 11 and 14 shows only one isomer to be
present in solution, while the spectra for 12 and 13 show two isomers and that of 15 shows up to
three isomers. All isomers are presumed to arise from cis and trans isomerism of the pyrrolide
ligands in the syn configuration. The third isomer of 15 can either arise from anti isomerism of
the alkylidene, as suggested for 10, or by restricted rotation of the NArM imido ligand.
Unfortunately, due to the insolubility of samples 10-15 no JCH coupling could be obtained to
confirm our hypothesis. For the same reason, no high quality 3C NMR spectra could be
obtained for complexes 10-15.
Method C works effectively for six out of seven imido ligands investigated and although not
universal, it complements methods A and B. A moderately sized library of catalyst precursors
can be prepared, which is more than double the number of previously known bispyrrolide
complexes. The advantage of using bipy for isolation of these complexes is that it not only
stabilizes the metal complex by completing the coordination sphere, but also enhances the
crystallinity of the sample. The bipy complexes are easy to isolate, handle, and store without
122
decomposition problems that are usually experienced with Mo(NR)(CHCMe 2Ph)(Pyr)2
complexes.
4.2 Preparation and reactivity studies of active MAP catalysts
4.2.1 Synthesis and structural studies of MAP complexes
It was mentioned in Section 4.1.2 that Frstner was able to remove bipy from bisalkoxide
complexes of the general formula Mo(NAr)(CHR)(OR') 2(bipy) by heating the complexes at
temperatures up to 100 C in the presence of ZnCL2 for 30 min.6 In the case of complexes 9-15,
our goal is not only to produce bispyrrolide complexes in solution by removing bipy, but also to
employ them as effective starting materials for the synthesis and isolation of active MAP
catalysts. Thus, there are a few points that need to be taken into consideration: a) bipy must be
removed under milder conditions in order to avoid decomposition of bipy-free bispyrrolide
complexes, b) in order to keep the concentration of bipy-free bispyrrolide complexes low and to
maximize the conversion to MAP catalysts, the desired alcohol/phenol must be present in
solution while bipy is being removed; c) the solvent must dissolve the alcohol/phenol and the
resulting MAP catalyst while all other byproducts or unreacted starting materials must remain
insoluble. All of these points are addressed below.
The best way to avoid using high temperatures while encouraging insoluble materials to
dissolve is to place them in an ultra-sonicator during the course of the reaction. The phenol that
we chose to use was 2,6-bis(2',4',6'-trimethylphenyl)phenol (HMTOH) and the solvent was
toluene, since HMTOH and the resulting MAP species dissolve in toluene and all bipy-
containing compounds remain insoluble or very slightly soluble. ZnCl2(dioxane) was employed
because it is slightly more soluble than anhydrous ZnCl2, which facilitates the use of relatively
mild conditions. Sonication of complexes 9-15 at RT in the presence of one equivalent of
HMTOH and one equivalent of ZnCl 2(dioxane) in toluene yields the desired MAP complexes in
modest yields (equation 5). All catalysts are obtained in crystalline form by filtering off the
insoluble salts over Celite and recrystallizing the solute from pentane at - 35 C. Proton and
carbon NMR spectra of complexes 16-22 are consistent with the presence of only one isomer in
solution, which is similar to what was observed for Mo(NArm)(CHCMe 2Ph)(Me2Pyr)(OHMT) in
Chapter 3.
The key features of the successful catalyst synthesis shown in equation 5 are a) removal
of bipyridine by use of a bipy sponge such as ZnCl2(dioxane); b) facile reaction between in situ
generated Mo(NR)(CHCMe 2Ph)(NC4H4)2 and HIMTOH; and c) solubility differences between
MAP catalysts and ZnCl2(bipy), which simplifies purification and separation of byproducts.
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16 R = Ar, (46 %)
17 R = Ad, (64 %)
18 R = Ar', (79 %)
19 R=Arci,(47%)
20 R = AriPr, (42 %)
21 R = ArtBu, (36 %)
22 R = Arm, (37 %)
The synthesis of 17 directly from Mo(NAd)(CHCMe 2Ph)(NC 4H4)2 has already been
reported5 and this catalyst has been used effectively for numerous cis-selective olefin metathesis
reactions; however, it is the only one that has been prepared directly from the isolated
bispyrrolide.
The X-ray crystal structure of 20 was obtained. The complex crystallized out in the space
group PI with both the R and S enantiomers present in the unit cell. For a clear view, R-20 and
S-20 are shown in Figures 4a and 4b respectively. Both enantiomers have similar bond lengths
and angles. The Mo=N(imido) angle is very close to linear (178.12(1 1)' and 177.45(11)0) while
the Mo=CR" (145.61(11)0 and 143.31(11)0) and Mo-O(HMT) (143.14(9)' and 150.15(9)')
angles are bent. The Mo(1)-C(l) and the Mo(2)-C(101) bond lengths (1.8769(15) A and
1.8759(15) A respectively), as well as the Mo(1)-N(1) and the Mo(2)-N(3) bond lengths
(1.7300(12) A and 1.7263(12) A respectively) are reminiscent of Mo-C double bond and Mo-N
triple bond character found in other molybdenum imido alkylidene complexes. 3 The isopropyl
group on the imido ligand points away from where an incoming olefin is hypothesized to bind to
the metal during the course of an olefin metathesis reaction. This is a structural feature that was
also observed in Chapter 3 and that makes this type of imido ligand "small." In combination
with the large HMTO ligand, these catalysts are best suited to perform Z-selective reactions
because in the metallacyclobutane transition state there is little steric hindrance encountered by
substituents located syn with respect to the imido group. Therefore, formation of cis bonds
should be favored kinetically.
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4.2.2 Reactivity studies of MAP catalysts
To test the reactivity of catalysts 16 and 18-22, 50 equivalents of 2,3-
dicarbomethoxynorbornadiene (DCMNBD) were treated with each catalyst at RT for 1-2 h. The
polymer was subsequently quenched with benzaldehyde, isolated, purified, and examined by 'H
and 13C NMR spectroscopy. The results are summarized in Table 1 and the representative 'H
NMR spectrum of isolated polyDCMNBD made with 16 is shown in Figure 5. All ROMP
reactions are relatively fast and all cases yield polymer with > 98% cis-bonds, which can be
clearly seen in the enlarged region of Figure 5.
Figure 4a - The solid state structure of R-20 (50% probability ellipsoids). Selected bond lengths(A) and angles (0): Mo(l)-C(l) = 1.8769(15), Mo(l)-N(l) = 1.7300(12), Mo(l)-N(2) =
2.0198(13), Mo(l)-O(1) = 1.9186(10), C(2)-C(l)-Mo(1) = 145.61(11), C(1l)-N(1)-Mo(l) =
178.12(11), C(31)-O(1)-Mo(1) = 143.14(9).
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The high Z-selectivity of catalysts 19-22 was expected due to the analysis of the crystal
structure of 20 and also from the known polymerization of DCMNDB with 1 7 ,5b which gave
polymer with > 98% cis bonds. However, since catalysts 16 and 18, which have larger imido
ligands also give the same selectivity upon polymerization of DCMNBD, other reasons are at
play as well. The 13 C NMR spectra of all polymers show peaks (44.4 and 37.9 ppm) that match
with the resonances for cis-syndiotactic polymer, formed with 17.
C(1
0(2)
Figure 4b - The solid state structure of S-20 (50% probability ellipsoids). Selected bond lengths
(A) and angles (*): Mo(2)-C(101) = 1.8759(15), Mo(2)-N(3) = 1.7263(12), Mo(2)-N(4) =
2.0294(13), Mo(2)-O(2) = 1.9168(10), C(1 02)-C(101)-Mo(2) = 143.31(11), C(1 11)-N(3)-Mo(2)
= 177.45(11), C(l 31)-O(2)-Mo(2) = 150.15(9).
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Table 1 - ROMP of DCMNBD with MAP catalysts 16-22.
Catalyst [Mo] (mM) Monomer Equivalents Time Polymer Structure
16 5.2 50 2 h > 98% cis, syndiotactic
18 5.6 50 2 h > 98% cis, syndiotactic
19 5.5 50 2 h > 98% cis, syndiotactic
20 5.4 50 2 h > 98% cis, syndiotactic
21 5.6 50 2 h > 98% cis, syndiotactic
22 5.0 50 2 h > 98% cis, syndiotactic
MAP complexes 16-22 are efficient Z-selective catalysts for the polymerization of
DCMNBD, in contrast to the catalysts mentioned in Chapter 3. This difference in reactivity
implies that the pyrrolide ligand plays a major role on the Z-selectivity of MAP catalysts and an
unsubstituted pyrrolide facilitates olefin binding syn to the imido ligand.
cis
trans
I I I 5
5.70 5.60 5.50 5.40 5.30
3.0 2.0 1.0
Figure 5 - 'H NMR of isolated poly-DCMNBD
is shown in greater detail and the integrations
peaks.
in CDCl3, prepared with 16. The olefinic region
are shown for the corresponding trans and cis
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4.3 Preparation and structural studies of molybdenum alkylidyne bipyridine adduct
complexes
After the successful preparation of bipy adducts of bispyrrolide complexes and their use as
catalyst precursors, we were interested in preparing analogous species with 2,5-
dimethylpyrrolide (Me2Pyr) instead of Pyr as the ligand. Therefore, one equivalent of bipy was
added to six representative Mo(NR)(CHCMe 2R')(Me2Pyr)2 species (R = Ar, R' = Ph (A); R =
Ar', R' = Ph (B); R = 2-(CF 3)C6H4 (ArCF3 ), R' = Me (C); R = Ar", R' =Ph (D); R = Arm, R' =
Ph (E); and R = 2-(2',4',6'-iPr 3 C6H2)C6H4 (Ar), R' = Me (F)). Only the reaction between D
and one equivalent of bipy can be carried out to completion at RT in a 1:1 mixture of toluene and
pentane. The reactions between A, B, and C and one equivalent of bipy must be carried out in
toluene at 60 *C for 18 h, while those of E and F and bipy must be carried out in toluene at 60 oC
for 2 d in order to reach completion. In all cases the color of the reaction mixture changes from
orange-brown to red-purple.
Monitoring the reactions by 'H NMR (in C6D6 ) shows that upon completion of the reaction,
one equivalent of Me 2PyrH is present in solution, the alkylidene peak of the starting material (A-
F) is gone and no new alkylidene peak is observed. The spectrum of the product has sharp
peaks, consistent with formation of a new stable product containing bipy, no alkylidene ligand,
and one less dimethylpyrrolide ligand. The best molecular candidate would be a complex with
the general formula Mo(NR)(=CCMe 2R')(2,5-Me2Pyr)(bipy). Upon solvent removal and
washing with pentane, compounds 23-28 can be obtained as purple or red-purple solids in good
to very good yields (equation 6).
R R' RI ('wToluene I
N---N RT or 60 C R
N-Mo + .Mo- (6)
N -2,5-Me 2PyrH N N
N
A 23 R = Ar, R' = Ph, T =60 OC, (46%)
B 24 R = Ar', R' = Ph, T =60 OC, (60%)
C 25 R = ArCF3, R' = Me, T =60 OC, (69%)
D 26 R = AriPr, R' = Ph, T = RT, (86%)
E 27 R = Arm, R' Ph, T 60 OC, (53%)
F 28 R = ArT, R'= Me, T -60 OC, (69%)
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X-ray studies of 23 and 24 (provided generously by the Hoveyda lab), as well as 28 were
undertaken. Compounds 23 and 24 were grown from a CH2Cl2:pentane mixture at - 45 C while
28 was grown from benzene at RT. Complex 23 crystallized in the monoclinic group P2 1/n,
whereas 24 and 28 crystallized out in the monoclinic group P2 1/c. The structures are shown in
Figures 6-8 respectively. In the case of 28 two independent molecules are present in the
asymmetric unit along with six benzene molecules. The Mo-Mo distance between the two
complexes is 17.144 A. One of the molecules shows considerable disorder throughout the
phenyl imido ligand (not shown) while the order does not. Compounds 23, 24 and 28 can be best
regarded as distorted square pyramids with the alkylidyne ligand located in the apical position.
There is only one pyrrolide ligand bound to the metal, as well as a single bipy molecule, which is
in agreement with the NMR data. The most striking features are the bond lengths Mo(1)-C(29)
of 23 (1.764(3)A), Mo(1)-C(1) of 24 (1.7643(17) A) and 28 (1.780(5)A), which are much shorter
than a regular Mo-C double bond, but consistent with a Mo-C triple bond.7 In addition, the
Mo(1)-C(29)-C(30) bond angle of 23 (161.5(2)0), as well as the Mo(l)-C(1)-C(2) bond angles of
24 (159.05(14)') and 28 (167.1(4)0) are large and close to linear, which is in agreement with an
expected alkylidyne Mo-C triple bond. The Mo=NR bond lengths of 23 (1.804(3)A), 24
(1.7958(14)A) and 28 (1.823(4)A) are longer than in analogous alkylidene complexes; likewise,
the Mo(1)-N(3)-C(11) bond angle of 23 (159.6(2)0), the Mo(1)-N(1)-C(11) bond angle of 24
(162.64(12)0) and the Mo(1)-N(4)-C(3 1) bond angle of 28 (152.6(3)0) resemble a Mo-N double
bond more than a triple bond. However, the imido ligand in {Mo(NAr)(C-t-
Bu)[OCMe(CF 3)2 ]2} is more bent1 4 (Mo-N-C = 141.16(17)') than any in 23, 24, or 28. We
propose that steric interactions between ligands in five-coordinate 23, 24 and 28 prevent the
imido ligands from being as bent as the imido ligand in four-coordinate {Mo(NAr)(C-t-
Bu)[OCMe(CF 3)2]2 1}.
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Figure 6 - The solid state structure of 23 (50 % probability ellipsoids). Selected bond lengths(A) and angles (0): Mo(1)-C(29) = 1.764(3), Mo(1)-N(1) = 2.326(3), Mo(1)-N(2) = 2.209(3),
Mo(1)-N(3) = 1.804(3), Mo(1)-N(4) = 2.098(3), C(30)-C(29)-Mo(1) = 161.5(2), C(11)-N(3)-
Mo(1) = 159.6(2), N(1)-Mo(1)-N(3) = 144.12(10), N(2)-Mo(1)-N(4) = 153.05(10).
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C(11)
N(1)
Figure 7 - The solid state structure of 24 (50 % probability ellipsoids). Selected bond lengths
(A) and angles (*): Mo(1)-C(1) = 1.7643(17), Mo(1)-N(1) = 1.7958(14), Mo(l)-N(2) =
2.1228(14), Mo(1)-N(3) = 2.3165(13), Mo(l)-N(4) = 2.2100(13), C(2)-C(l)-Mo(1) =
159.05(14), C(11 )-N(1)-Mo(1) = 162.64(12), N(1)-Mo(1)-N(3) = 137.44(6), N(2)-Mo(1)-N(4) =
153.09(15).
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N(4)
2)
Figure 8 - The solid state structure of 28 (50 % probability ellipsoids). All solvent molecules
and the disordered molecule are omitted for clarity. Selected bond lengths (A) and angles (0):
Mo(l)-C(l) = 1.780(5), Mo(1)-N(l) = 2.105(4), Mo(l)-N(2) = 2.306(3), Mo(l)-N(3) = 2.225(4),
Mo(l)-N(4) = 1.823(4), C(2)-C(l)-Mo(l) = 167.1(4), C(31)-N(4)-Mo(l) = 152.6(3), N(l)-
Mo(l)-N(3) = 153.28(14), N(2)-Mo(l)-N(4) = 140.98(15).
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The lengthening and bending of the imido group in complexes 23, 24, and 28 is a direct
result of electron-saturation of the metal orbitals to which the imido ligand would have to bind to
form a triple bond. In molybdenum imido alkylidene complexes, where the alkylidene is not
rotating, the imido group is linear because the a-bond responsible for triple-bond character is
orthogonal to the alkylidene p-orbital (Figure 9). On the other hand, in molybdenum imido
alkylidyne complexes, the a-bond responsible for triple-bond character of the imido ligand
overlaps with one of the p-orbitals of the alkylidyne ligand. As a result, the Mo-N(imido) bond
becomes more like a double bond in the presence of a Mo-C triple bond (Figure 9).
Alkylidene MoC CMeR'
H
CMe2R'
H
Alkylidyne
R
N
Mo -C
C-CMe2R'
-CMe 2R'
Figure 9 - Diagram depicting how the alkylidene (top) and alkylidyne (bottom) ligands affect
the shape of the imido ligand as a result of metal-ligand orbital overlap.
The crystal structures of 23, 24, and 28 and the 1H NMR data of 23-28 conclusively
demonstrate that an alkylidyne complex is formed when Mo(NR)(CHCMe 2R')(Me2Pyr)2 reacts
with bipy. It is hypothesized that complexes A-F initially form a bipy adduct just like species 9-
15. It is at this stage that the Me2Pyr ligands experience a significant amount of steric crowding
and a-abstraction of the alkylidene C-H bond by one of the dimethylpyrrolide ligands takes place
forming Me2PyrH and an alkylidyne complex (Scheme 2).
133
R
RR I R' R
( N R' a-abstraction N
NMo + Mo H Mof
N 'N' H N sN
4. ~ N N%
Scheme 2 - Proposed mechanism leading to formation of Mo(NR)(CCMe 2R')(Me2Pyr)(bipy)
complexes.
High oxidation state alkylidyne complexes of tantalum, tungsten, molybdenum and rhenium
have been synthesized through several routes in the last thirty years.7a-e Formation of a
neopentylidyne ligand through deprotonation of a neopentylidene ligand was first demonstrated
in a reaction between Ta(CHCMe3)(CH 2CMe3)3 and butyllithium to give a lithium salt of
{Ta(CCMe 3)(CH2CMe3)3 .7 d A dehydrohalogenation of W(NPh)(CHCMe 3)(PEt 3)2Cl2 by
Ph3P=CH2 led to W(NPh)(CCMe 3)(PEt) 2C,'' a compound that is most similar to 23-28,
although no X-ray structure of W(NPh)(CCMe3)(PEt 3)2Cl was determined. Deprotonation of
Mo(NAr)(CHCMe 3)[OCMe(CF 3)2] 2 by Ph3P=CH2 led to the alkylidyne complex,
{Ph3PMe}{Mo(NAr)(CCMe 3)[OCMe(CF 3)2]2}," as noted above. Attempts to prepare certain
types of imido neopentylidene complexes have resulted in formation of amido neopentylidyne
complexes as a consequence of migration of a proton from an alkylidene to an imido ligand, or to
an actual deprotonation/readdition sequence.7 e Neopentylidyne ligands have been generated
from neopentyl ligands early in the development of high oxidation state organometallic
chemistry of tungsten and molybdenum, a circumstance that has allowed tungsten and
molybdenum alkylidyne complexes of the type M(C-t-Bu) 3(CH 2-t-Bu) 3 to be synthesized ;7-
a deprotonation of a neopentyl ligand to give an intermediate neopentylidene ligand is probably
the rate limiting deprotonation in these reactions. Rhenium neopentylidyne complexes have
been prepared through deprotonation of neopentylidene ligands, either by transfer of a proton to
a neopentyl group or to an imido or amido group;7h~' reactions are complex and details are not
known. A proton also has been added to an alkylidyne a carbon atom in several circumstances
to give an alkylidene complex. For example, transfer of a proton from an amido ligand to a
neopentylidyne a carbon atom was the first general method of preparing imido alkylidene
complexes of tungsten."'-" Intramolecular a proton migration has been known to be promoted
in more sterically crowded circumstances, the first being ligand induced formation of tantalum
neopentylidene complexes from tantalum dineopentyl complexes through addition of various
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phosphines or even simply THF.7 "P On the basis of all of the above reports, it is fair to say that
there is ample precedent for intramolecular migration of a proton from a neopentylidene ligand
to a dimethylpyrrolide ligand, even though there is no specific example of this type to our
knowledge in the literature. No details as to whether the proton migrates to the pyrrolide
nitrogen directly or to a pyrrolide a or P carbon atom" can be determined on the basis of data in
hand.
Having established the structural features of complexes 23-28 we wanted to know whether
these compounds could be used to generate MAP species in the same manner that 16-22 were
synthesized. Preliminary work shows that reactions between complexes 23-28 with one
equivalent of HMTOH and one equivalent of ZnCl 2(dioxane) do generate MAP species
containing an alkylidene ligand as a result of proton-exchange from the phenol to the alkylidyne.
However, the reactions are not clean and a significant amount of side products are also observed.
It is believed that proton-exchange does not only take place between HMTOH and the alkylidyne
ligand, but also with the pyrrolide itself. As a result, direct reaction with HMTOH or other
phenols/alcohols is not an efficient or selective method to prepare active MAP species from
Mo(NR)(CCMe 2R')(Me2Pyr)(bipy) complexes. On the other hand, reactions of complexes 23-
28 with small alcohols in the absence of ZnCl 2(dioxane) could generate bipy-bound MAP
species of the general formula Mo(NR)(CHCMe 2R')(Me 2Pyr)(OR")(bipy), but this methodology
has not yet been fully investigated, but it may be the topic of future studies.
CONCLUSION
The use of bipyridine as a base adduct was vital to the isolation of 9-15 as stable
molybdenum complexes using three different methods with varying degree of success. All seven
bispyrrolide complexes exhibit different number of isomers present in solution, which arise from
cis and trans pyrrolide isomerism, as well as possible syn and anti alkylidene isomerism. The X-
ray analysis of 9 shows that its only isomer corresponds to the trans isomer. Sonication of a
mixture containing a Mo(NR)(CHCMe 2Ph)(Pyr) 2(bipy) complex (9-15), HMTOH, and
ZnCl 2(dioxane) led to the formation of MAP species 16-22, which can be isolated by filtration
and purified by recrystallization. Both R and S enantiomers of 20 co-crystallized together and
their structures have been determined; in both molecules the substituent on the imido ligand
points away from the alkylidene ligand. Reactivity studies of 16-22 with DCMNBD suggest that
all compounds are efficient Z-selective catalysts leading to formation of > 98% cis syndiotactic
polymeric structures. Finally, preparation of complexes 23-28, containing an alkylidyne ligand
has been done by adding bipy to bispyrrolide complexes where the pyrrolide ligand is Me 2Pyr.
The reaction is believed to occur via a-abstraction of the alkylidene proton by one of the Me 2Pyr
ligands as a result of significant steric crowding at the metal. The X-ray structures of 23, 24 and
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28 were presented and showed characteristic bond lengths and angles corresponding to
alkylidyne ligands and imido ligands with only double-bond character.
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EXPERIMENTAL
General. All reactions and manipulations of air and moisture sensitive compounds were handled
in oven-dried glassware (150 'C, 2 hr) under a N2 atmosphere either in a dual Schlenk line or in
vacuum atmosphere glove box. HPLC grade solvents (benzene, toluene, diethyl ether,
tetrahydrofuran, pentane, and methylene chloride), were purge with N2 and passed through
activated alumina and stored over molecular sieves prior to use. 2,2'-bipyridine and
benzaldehyde were purchased from Alfa-Aesar and used without further purification. LiNC 4H4,8
ZnCl2(dioxane),9 HMTOH,1" and DCMNBD" were prepared according to literature reports.
HMTOH was placed under high vacuum for 12 hours before use. All
Mo(NR)(CHCMe 2Ph)(OTf) 2DME, Mo(NR)(CHCMe 2Ph)(Pyr)2  (R = 2,6-iPr2C6H3,
adamantyl), 4a and Mo(NR)(CHCMe 2R')(NC4H 2Me2)23a, 1 complexes were prepared according to
literature procedures. All deuterated solvents (d6-benzene, d8-toluene, and d2-dichloromethane)
were stored over molecular sieves 12 hours prior to use. All the recorded NMR spectra were
done with Bruker 400 MHz and Varian 500 MHz spectrometers. Sonications were performed on
a Bransonic Ultrasonic Cleaner 151OR-MT purchased from Branson Ultrasonics Corporation.
Elemental analyses were performed by Midwest Microlab, LLC.
Mo(NAr Ph)(CHCMe 3)(Pyr)2 (1) Mo(NArPh)(CHCMe 3)(OTf)2DME (1.50 g, 2.08 mmol)
were dissolved in ether and subsequently cooled down to -35 C for 1 h. Then, LiPyr (0.304 g,
4.16 mmol) was added in one portion and the mixture was allowed to stir at RT for 2 h.
Removal of solvent, dissolution in CH2Cl2, and filtration through Celite was done to remove
LiOTf salts. The salts were washed with more CH2 Cl 2 until colorless and all organic fractions
collected and concentrated to dryness to yield crude brown solid. Finally, recrystallization from
a concentrated ether-pentane solution at -35 C after more than a week yielded 0.097 g of pure
orange material upon filtration and vacuum drying (10%): 1H NMR (400 MHz, CD 2Cl 2) 6
14.00-12.00 (s br, 1H, Mo=CH), 7.60-6.80 (in, 9H, aromatics), 6.70-5.30 (s br, 8H, NC4H4),
1.40-0.60 (s br, 9H, t-butyl). Anal. Calcd C25H27F6MoN 3: C, 64.51; H, 5.85; N, 9.03. Found: C,
64.16; H, 5.83; N, 8.81. 13C NMR could not be obtained at RT due to broadening of peaks.
Mo(NAr)(CHCMe 2Ph)(OTf)2(bipy) (2) Mo(NAr)(CHCMe 2Ph)(OTf)2(DME) (0.500 g,
0.632 mmol) was dissolved in benzene and bipyridine (0.099 g, 0.633 mmol) was added in one
portion. After a few minutes a yellow precipitate began forming. The mixture was allowed to
stir for 12 h and then it was filtered and dried under vacuo; yield 0.457 g (84%): 'H NMR (400
MHz, CD 2 Cl2) 6 14.59 (s, 1H, Mo=CH, JCH = 126.4 Hz), 8.85 (d, 1H, bipy), 8.25-8.18
(overlapping peaks, 2H, aromatic), 8.14 (m, 1H, aromatic), 8.08 (in, 1H, aromatic), 7.72 (in, 1H,
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aromatic), 7.56 (d, 2H, aromatic), 7.47 (t, 2H, aromatic), 7.35 (t, 1H, aromatic), 7.24-7.13
(overlapping peaks, 3H, aromatic), 7.05-6.92 (overlapping peaks, 2H, aromatic), 3.94 (s br, 1H,
CHMe 2), 2.70 (s br, 1H, CHMe2), 2.10 (s, 3H, MoCHCMe2Ph), 1.59 (s, 3H, MoCHCMe2Ph),
1.34 (s br, 3H, CHMe2), 1.14 (d, 6H, CHMe2), - 0.05 (s br, 3H, CHMe2). Anal. Calcd
C3 4H3 7F6MoN 30 6 S2 : C, 47.61; H, 4.35; N, 4.90. Found: C, 47.65; H, 4.40; N, 5.01. 13 C NMR
could not be obtained due to insolubility of complex.
Mo(NAd)(CHCMe 2Ph)(OTf) 2(bipy) (3) The procedure is identical to the synthesis of 2,
employing Mo(NAd)(CHCMe 2Ph)(OTf)2(DME) (0.500 g, 0.654 mmol) and bipyridine (0.102 g,
0.653 mmol); yield 0.496 g (91%): 'H NMR (400 MHz, CD 2Cl 2) 6 14.29 (s, 1H, Mo=CH, JCH
123.6 Hz), 8.94 (d, 1H, bipy), 8.40-8.18 (overlapping peaks, 3H, aromatics), 8.06 (t, 1H,
aromatic), 7.78 (m, 1H, aromatic), 7.65-7.10 (overlapping peaks, 5H, aromatics), 6.99 (in, 1H,
aromatic), 6.59 (br, lH, aromatic), 2.40 (s, 3H, Ad), 1.95 (s, 3H, CMe2Ph), 1.78 (s, 6H, Ad),
1.65-1.40 (overlapping peaks, 9H, CMe2Ph + Ad). Anal. Calcd C3 2H2 5F6MoN 30 6 S2 : C, 46.21;
H, 4.24; N, 5.05. Found: C, 45.82; H, 4.09; N, 5.19. "C NMR could not be obtained because
sample is too insoluble.
Mo(NAr')(CHCMe 2Ph)(OTf) 2(bipy) (4) The procedure is identical to the synthesis of 2,
employing Mo(NAr')(CHCMe 2Ph)(OTf)2(DME) (0.400 g, 0.544 mmol) and bipyridine (0.085 g,
0.544 mmol); yield 0.291 g (67%): 1H NMR (400 MHz, CD 2Cl 2) 6 14.55 (s, 1H, Mo=CH, JCH
130.4 Hz), 8.83 (d, 1H, bipy), 8.23 (t, 2H, aromatic), 8.10 (m, 2H, aromatic), 7.68 (t, 1H,
MoCHCMe 2Ph), 7.57 (m, 2H, MoCHCMe 2Ph), 7.44-7.32 (overlapping peaks, 3H, aromatics),
7.24 (t, 1H, aromatic), 7.02 (t,lH, aromatic), 6.96 (t, 1H, aromatic), 6.89 (s br, 2H, Ar'), 2.53 (s
br, 3H, Ar' Me), 2.00 (s, 3H, MoCHCMe2Ph), 1.57 (s, 3H, MoCHCMe2Ph), 1.43 (s br, 3H, Ar'
Me); 3C NMR (100 MHz, CD 2Cl 2) 6 332.4 (Mo=CH), 160.3, 155.4, 152.5, 148.6, 147.1, 142.9,
141.7, 129.4, 129.0, 128.8, 127.9, 127.3, 127.2, 127.2, 123.9, 123.4, 58.0, 30.4, 28.8, 19.7 (br).
Anal. Calcd C30H29F6MoN30 6S2: C, 44.95; H, 3.65; N, 5.24. Found: C, 44.57; H, 3.64; N, 5.32.
Mo(NArcI)(CHCMe2Ph)(OTf) 2(bipy) (5) Mo(NArC)(CHCMe 2Ph)(OTf)2(DME) (0.166 g,
0.224 mmol) was dissolved in Et20 and chilled to -35 C for 1 hr. Then, bipyridine (0.035 g,
0.224 mmol) was added in one portion. After a few minutes a green precipitate began forming.
The mixture was allowed to stir for 12 h and then it was filtered and dried under vacuo; yield
0.120 g (66%): 'H NMR (400 MHz, CD 2Cl 2) 6 14.39 (s, 1H, Mo=CH major, JCH = 127.1 Hz),
14.20 (s, 0.28H, Mo=CH minor, JCH = 118.9 Hz), 8.86 (d, 0.28H, bipy minor), 8.81 (d, 1H, bipy
major), 8.77 (d, 0.28H, aromatic minor), 8.73 (d, 0.28H, aromatic minor), 8.59 (m, 0.56H,
aromatic minor), 8.53 (m, 0.56H, aromatic minor), 8.47 (m, 0.28H, aromatic minor), 8.30 (d, 1H,
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aromatic major), 8.27 (d, iH, aromatic major), 8.24 (m, 0.28H, aromatic minor), 8.18-8.06
(overlapping peaks, 2.56H, aromatic major + minor), 7.96 (d, 0.28H, aromatic minor), 7.90 (m,
0.28H, aromatic minor), 7.84 (m, 0.28H, aromatic minor), 7.80 (d, 1H, aromatic major), 7.71-
7.63 (overlapping peaks, 1.56H, aromatic major + minor), 7.62-7.54 (overlapping peaks, 2.56H,
aromatic major + minor), 7.50 (m, 0.56H, aromatic minor), 7.41 (overlapping peaks, 2.56H,
aromatic major + minor), 7.36-7.22 (overlapping peaks, 4H, aromatic major), 7.20-7.10
(overlapping peaks, 4.28H, aromatic major + minor), 7.01 (m, 1H, aromatic major), 2.15 (s, 3H,
MoCHCMe2Ph major), 1.89 (s, 0.84H, MoCHCMe2Ph minor), 1.76 (s, 0.84H, MoCHCMe2Ph
minor), 1.59 (s, 3H, MoCHCMe2Ph major); 13 C NMR (100 MHz, CD 2Cl2 ) 6 332.7 (Mo=CH),
161.3, 159.8, 155.4, 155.3, 153.6, 153.4, 152.6, 152.0, 151.7, 151.3, 150.5, 148.6, 148.4, 147.1,
145.9, 145.8, 143.7, 143.3, 142.8, 141.9, 133.8, 131.9, 131.7, 131.6, 131.3, 131.2, 130.3, 130.2,
129.6, 129.5, 128.9, 128.7, 128.2, 127.8, 127.7, 127.3, 127.3, 126.9, 126.7, 126.5, 125.4, 125.3,
123.9, 123.3, 121.7. 118.5, 58.9, 58.4, 30.7, 30.2, 29.6, 29.5; '9F NMR (376 MHz, CD 2Cl 2) 6 -
77.1 (s, 1F, cis), -78.7 to -79.7 (overlapping peaks, 1.28F, cis + trans). Anal. Calcd
C2 8H2 4 ClF6MoN 30 6 S2 : C, 41.62; H, 2.99; N, 5.20. Found: C, 41.50; H, 3.10; N, 5.31.
Mo(NAr'')(CHCMe 2Ph)(OTf)2(bipy) (6) The procedure is identical to the synthesis of 5,
employing Mo(NArP)(CHCMe 2Ph)(OTf) 2(DME) (0.247 g, 0.330 mmol) and bipyridine (0.051
g, 0.327 mmol); yield 0.205 g of a yellow solid (76%): 1H NMR (400 MHz, CD 2Cl 2) 6 14.46 (s,
1H, Mo=CH, JCH = 125.7 Hz, major), 14.23 (s, 0.12H, Mo=CH, minor), 8.85 (d, 1H, bipy
major), 8.80 (d, 0.12H, bipy minor), 8.74 (d, 0.12H, aromatic minor), 8.60 (d, 0.12H, aromatic
minor), 8.55 (m, 0.24H, aromatic minor), 8.48 (m, 0.12H, aromatic minor), 8.44 (m, 0.12H,
aromatic minor), 8.29 (d, 1H, aromatic major), 8.24 (d, 1H, aromatic major), 8.12 (m, 2.24H,
aromatic major + minor), 7.95 (m, 0.12H, aromatic minor), 7.85 (m, 0.12H, aromatic minor),
7.82 (m, 0.12H, aromatic minor), 7.68 (m, 1H, aromatic major), 7.65 (m, 0.12H, aromatic
minor), 7.57 (m, 2.12H, aromatic major + minor), 7.45 (t, 2H, aromatic major), 7.34 (t, 1H,
aromatic major), 7.30-7.08 (overlapping peaks, 5.36H, aromatic major + minor), 7.02 (t, 1H,
aromatic major), 3.13 (m, 1H, CHNMe 2 major), 2.98 (m, 0.12H, CHMe 2 minor), 2.18 (s, 3H,
MoCHCMe2Ph major), 1.83 (s, 0.72H, CMe2Ph minor), 1.58 (s, 3H, CMe2Ph major), 1.03 (d,
3H, CHMe2 major), 0.96 (d, 0.36H, CHMe2 minor), 0.74 (d, 3H, CHMe2 major), 0.44 (d, 0.36H,
CHMe2 minor); 13 C NMR (100 MHz, CD 2 Cl2) 6 331.9 (syn MoCH), 160.9, 159.2, 155.5, 155.4,
153.5, 152.9, 152.8, 152.3, 151.6, 151.3, 149.3, 148.6, 148.5, 148.4, 147.3, 146.0, 145.9, 143.7,
143.3, 142.8, 141.9, 131.7, 130.9, 130.2, 130.0, 129.7, 129.5, 128.7, 128.0, 127.9, 127.8, 127.4,
127.3, 127.0, 126.9, 126.7, 126.6, 126.6, 126.4, 125.5, 125.4, 124.1, 123.3, 121.7, 118.6, 155.4,
58.6, 58.3, 30.8, 30.4, 29.7, 29.5, 29.3, 23.7, 23.6, 23.5, 22.8; '9F NMR (376 MHz, CD 2 Cl 2) 6 -
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77.3 (s, 0.5F, cis), - 79.1 (s br, 0.12F, trans), - 79.4 (s, 0.5F, cis). Anal. Caled
C3 1H3 1F6MoN 3 0 6 S2 : C, 45.65; H, 3.83; N, 5.15. Found: C, 45.89; H, 3.90; N, 4.92.
Mo(NArBm)(CHCMe 2Ph)(OTf)2(bipy) (7) The procedure is identical to the synthesis of 5,
employing Mo(NArtB)(CHCMe 2Ph)(OTf)2(DME) (0.543 g, 0.711 mmol) and bipyridine (0.111
g, 0.711 mmol); yield 0.450 g of a red solid (76%): 1H NMR (400 MHz, CD 2 Cl2) 6 14.52 (s, 1H,
Mo=CH, JCH = 125.1 Hz, major), 13.94 (s, 0.13H, Mo=CH, minor), 9.55 (dd, 0.13H, bipy
minor), 8.97 (dd, 0.28H, aromatic minor), 8.84 (dd, lH, bipy major), 8.50-6.80 (overlapping
peaks, 18H, aromatics), 2.18 (s, 3H, CMe2Ph major), 1.91 (s, 0.42H, CMe2Ph minor), 1.64 (s,
0.42H, CMe2Ph minor), 1.57 (s, 3H, CMe2Ph major), 1.15 (s, 9H, t-Bu major), 0.98 (s, 1.26H, t-
Bu minor); 13C NMR (100 MHz, CD 2Cl2 ) 6 331.6 (syn MoCH), 159.9, 159.5, 155.5, 155.4,
153.7, 153.6, 152.5, 150.5, 148.7, 147.4, 147.3, 147.2, 147.1, 143.7, 143.5, 142.8, 142.5, 141.9,
141.3, 134.0, 133.0, 130.1, 129.8, 129.5, 129.1, 128.7, 128.2, 127.8, 127.7, 127.4, 127.3, 126.9,
126.8, 124.0, 123.6, 123.2, 122.8, 121.6, 118.5, 58.8, 58.1, 35.7, 35.1, 31.2, 30.8, 30.6, 29.2.
Anal. Calcd C32H 33F 6MoN 30 6S2 : C, 46.32; H, 4.01; N, 5.06. Found: C, 46.42; H, 4.21; N, 5.01.
Mo(NAr")(CHCMe 2Ph)(OTf)2(bipy) (8). The procedure is identical to the synthesis of 2,
employing Mo(NArm)(CHCMe 2Ph)(OTf) 2DME (0.215 g, 0.260 mmol) and bipy (0.041 g, 0.263
mmol); yield 0.170 g of a green solid (73%): 'H NMR (400 MHz, CD 2 Cl2) 6 14.3 (s, 1H, MoCH
JCH = 128 Hz major), 13.9 (s, 0.03H, MoCH minor), 8.64 (d, 1H, aromatic), 8.29 (d, 1H,
aromatic), 8.11 (t, 1H, aromatic), 8.00 (d, 1H, aromatic), 7.88 (d, 2H, aromatic), 7.59, (t, 1H,
aromatic), 7.49 (d, 2H, aromatic), 7.46 (t, 1H, aromatic), 7.41 (t, 2H, aromatic), 7.31 (dd, 2H,
aromatic), 6.77 (d, 2H, aromatic), 6.69 (dd, 1H, aromatic), 6.153 (s, 1H, Mes), 5.901 (s, 1H,
Mes), 2.38 (s, 3H, MoCHCMe2Ph), 1.97 (s, 3H, MoCHCMe2Ph), 1.78 (s, 3.27H, Mes), 1.57 (s,
3H, Mes), 0.99 (s, 3H, Mes); "C NMR (100 MHz, C6D6) 6 329.7 (syn, MoCH), 329.3 (MoCH),
158.1, 154.3, 153.1, 152.2, 148.0, 146.5, 141.2, 140.8, 138.3, 136.7, 135.7, 135.3, 134.1, 132.1,
130.4, 129.4, 129.2, 129.0, 128.7, 128.2, 128.0, 127.9, 127.2, 126.9, 126.8, 126.6, 126.0, 125.8,
125.6, 123.5, 123.5, 122.9, 120.9, 118.4, 58.4, 30.3, 29.6, 20.8, 20.6, 19.6; "9F NMR (376 MHz,
CD 2Cl 2) 6 -77.1 (s, 1F, cis), - 78.6 (s, 0.06, trans), - 79.5 (s br, IF, cis). Anal. Calcd
C3 7H3 5F6MoN 30 6 S2 : C, 49.83; H, 3.96; N, 4.71. Found: C, 50.01; H, 3.96; N, 4.56.
Mo(NAr)(CHCMe 2Ph)(Pyr)2(bipy) (9) Method A: [Mo(NAr)(CHCMe 2Ph)(Pyr)2] 2 (0.100
g, 0.187 mmol) was dissolved in Et 20 and bipy (0.029 g, 0.186 mmol) was added. The solution
was stirred for 2 h. The precipitate was collected and dried by vacuum filtration to yield 0.058 g
of an orange solid (45%) Method B: 2 (1.11 g, 1.29 mmol) was suspended in Et 20 and LiNC 4H4
(0.189 g, 2.59 mmol) was added in one portion. The solution was left stirring for 12 hours at RT
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and the orange precipitate was collected and dried by vacuum filtration to yield 0.549 g (61%).
X-ray quality crystals were obtained by crystallization from 1:1 CH 2Cl2:n-pentane at -35 'C for
48 hours: 1H NMR (400 MHz, CD 2Cl 2) 6 13.87 (s, 1H, MoCH, JCH 116.3 Hz), 9.26 (d, 1H,
aromatic), 9.00 (d, 1H, aromatic), 8.20-8.08 (overlapping peaks, 2H, aromatics), 7.83 (d, 1H,
aromatics), 7.75-.7.57 (overlapping peaks, 4H, aromatics), 7.44-7.32 (overlapping peaks, 3H,
aromatics), 7.30-7.20 (overlapping peaks, 2H, aromatics), 7.20-7.14 (overlapping peaks, 2H,
aromatics), 5.89 (s, 4H, NC4H4), 5.61 (s, 4H, NC4H4), 3.48 (in, 2H, CHMe2), 1.94 (s, 6H,
MoCHCMe2Ph), 0.98 (d, 6H, CHMe2), 0.90 (d, 6H, CHMe2); "C NMR (100 MHz, CD 2Cl2) 6
316.9 (Mo=CH), 153.5, 151.9, 151.5, 151.4, 150.7, 148.4, 141.2, 139.4, 134.3, 128.9, 128.3,
126.9, 126.8 126.4, 124.1, 123.5, 122.9, 106.8, 57.2, 31.9, 27.7, 26.2, 24.0. Anal. Calcd
C4 0H 4 5MoN 5: C, 69.45; H, 6.56; N, 10.12. Found: C, 69.45; H, 6.41; N, 10.02.
Mo(NAd)(CHCMe 2Ph)(Pyr)2(bipy) (10) Method A: The procedure is the same as the
synthesis of 9, employing [Mo(NAd)(CHCMe 2Ph)(Pyr)2]2 (0.488 g, 0.958 mmol) and bipy
(0.150 g, 0.960 mmol) to yield a yellow solid (0.478 g, 75%). Method C:
Mo(NAd)(CHCMe 2Ph)(OTf)2(DME) (0.353 g, 0.462 mmol) was dissolved in toluene (15.0 ml)
and cooled down to - 35 0C for 1 h. Then, LiNC4H4 (0.067 g, 0.918 mmol) was added in one
portion and the mixture was allowed to stir at RT for 2 h, during which time salts precipitated
out. The salts were removed by filtering the solution through celite and washing with toluene
until colorless. Finally, bipy (0.067 g, 0.429 mmol) was added to the solution and the mixture
was allowed to stir at RT overnight. Collection and drying of the resulting precipitate by
vacuum filtration yielded a yellow solid (0.101 g, 36%): 1H NMR (400 MHz, CD 2 Cl2) 6 13.99
(s, 1H, MoCH), 13.40 (s, 1H, MoCH), 12.97 (s, 0.9H, MoCH), 9.53 (dd, 1H, bipy), 9.00 (dd,
0.9H, bipy), 8.69 (dd, 1H, bipy), 8.61 (dd, 0.9H, bipy), 8.10-7.85 (overlapping peaks, 11.9H,
aromatics), 7.65-6.70 (overlapping peaks, 22.1H, aromatics), 6.24 (t, 4H, NC4H4), 6.20 (t, 4H,
NC4H4), 6.15 (t, 4H, NC4H4), 6.06 (t, 1.6H, NC4H4), 6.04 (t, 1.6H, NC4H4), 5.67 (t, 4H, NC4H4),
5.55 (t, 1.6H, NC4H 4), 5.54 (t, 1.6H, NC4H4), 2.40-1.30 (overlapping peaks, 61H, aliphatics).
Anal. Caled C38H43MoN5: C, 68.56; H, 6.51; N, 10.52. Found: C, 68.33; H, 6.61; N, 10.62. 13C
NMR could not be obtained due to the insolubility of complex.
Mo(NAr')(CHCMe 2Ph)(Pyr)2(bipy) (11) Method B: The procedure is the same as the
synthesis of 9 employing 4 (0.108 g, 0.135 mmol) and LiNC4H4 (0.020 g, 0.274 mmol) to yield
0.066 g of a yellow solid (77%). Method C: The procedure is the same as the synthesis of 10
employing Mo(NAr')(CHCMe 2Ph)(OTf)2(DME) (0.307 g, 0.418 mmol), LiNC 4H4 (0.061 g,
0.835 mmol) and bipy (0.052 g, 0.333 mmol) to get a yellow solid (0.205 g, 96%): 'H NMR
(400 MHz, CD 2 Cl 2) 6 13.78 (s, 1H, MoCH), 9.39 (d, 1H, bipy), 8.90 (d, 1H, bipy), 8.18-8.10
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(overlapping peaks, 2H, aromatic), 7.96 (d, 1H, aromatic), 7.87 (m, iH, aromatic), 7.63-7.55
(overlapping peaks, 3H, aromatic), 7.50 (m, iH, aromatic), 7.24 (t, 2H, aromatic), 7.10-6.93
(overlapping peaks, 5H, aromatic), 5.93 (s, 4H, NC4H4), 5.58 (s, 4H, NC4H 4), 2.03 (s, 6H, Ar'
Me), 1.85 (s, 6H, MoCHCMe2Ph). Anal. Calcd C36H37MoN5: C, 68.02; H, 5.87; N, 11.02.
Found: C, 67.86; H, 5.66; N, 11.04. 13C NMR could not be obtained due to insolubility of the
complex.
Mo(NArci)(CHCMe 3)(Pyr)2(bipy) (12) Method C: The procedure is the same as the
synthesis of 10, employing Mo(NArcI')(CHCMe 2Ph)(OTf)2(DME) (0.304 g, 0.410 mmol),
LiNC 4H4 (0.060 g, 0.822 mmol) and bipy (0.051 g, 0.327 mmol) to yield 0.184 g of orange-
yellow 12 (87%): 'H NMR (400 MHz, CD 2 Cl 2) 6 13.57 (s, 1H, MoCH), 12.66 (s, 0.2H, MoCH),
9.50 (dd, 1H, bipy), 8.97 (dd, 1H, bipy), 8.18-7.86 (overlapping peaks, 5H, aromatics), 7.58 (m,
2H, CMe2Ph), 7.46 (dd, 2H, CMe2Ph), 7.40-7.35 (overlapping peaks, 1H, CMe2Ph minor
isomer), 7.28-6.90 (overlapping peaks, 8H, aromatics), 6.39 (t, 0.2H, NC4H4), 6.17 (t, 4H,
NC4H4), 6.06 (t, 0.2H, NC4H4), 5.93 (t, 0.2H, NC4H4), 5.73 (t, 0.2H, NC4H4), 5.67 (t, 4H,
NC4H4), 2.34 (s, 1.2H, CMe2Ph minor isomer), 1.76 (s, 6H, CMe2Ph minor isomer). Anal.
Calcd C34H32ClMoN5 : C, 63.60; H, 5.02; N, 10.91. Found: C, 63.39; H 5.05; N 10.67. 13C
NMR could not be obtained due to insolubility of complex.
Mo(NArP')(CHCMe 2Ph)(Pyr)2(bipy) (13) Method B: The procedure is the same as the
synthesis of 9, employing 6 (1.100 g, 1.35 mmol) and LiNC4H4 (0.197 g, 2.70 mmol) to yield
0.680 g of a yellow solid (85%). Method C: The procedure is the same as the synthesis of 10,
employing Mo(NArP)(CHCMe 2Ph)(OTf) 2(DME) (0.323 g, 0.431 mmol), LiNC4H4 (0.063 g,
0.863 mmol), and bipy (0.054 g, 0.346 mmol) to get 0.215 g of yellow 13 (96%): 1H NMR (400
MHz, CD 2Cl 2 ) 6 13.61 (s, 1H, MoCH major isomer), 12.75 (s, 0.11H, MoCH minor isomer), 9.47
(dd, 1H, bipy), 8.93 (dd, 1H, bipy), 8.85 (d, 0.1H, bipy), 8.66 (d, 0.2H, CMe2Ph), 8.42 (d, 0.2H,
CMe2Ph), 8.12 (m, 0.2H, aromatic), 8.60-7.94 (overlapping peaks, 2H, aromatic), 7.86-7.76
(overlapping peaks, 2H, aromatic), 7.58-7.44 (overlapping peaks, 4H, aromatic), 7.38-7.10
(overlapping peaks, 8H, aromatic), 7.00-6.88 (overlapping peaks, 1H, aromatic), 6.18 (t, 0.2H,
NC4H4), 6.09 (t, 4H, NC4H 4), 6.01 (t, 0.2H, NC4H4), 5.93 (t, 0.2H, NC4H4), 5.76 (t, 0.2H,
NC4H4), 5.68 (t, 4H, NC4H4), 3.69 (m, 0.1H, CHMe2), 3.55 (m, 1H, CHMe 2), 1.87 (s, 0.3H,
CMe2Ph), 1.79 (s, 6H, CMe2 Ph), 1.47 (s, 0.3H, CMe2Ph), 1.07 (d, 6H, CHMe2), 0.95 (d, 6H,
CHfe2), 0.85 (d, 6H, CHMe2 ). Anal. Calcd C37H 39MoN5 : C, 68.40; H, 6.05; N, 10.78. Found:
C, 68.30; H, 6.04; N, 10.56. 13 C NMR could not be obtained due to insolubility of complex.
142
Mo(NArtBu)(CHCMe 2Ph)(Pyr)2(bipy) (14) Method C: The procedure is the same as the
synthesis of 10, employing Mo(NArtB)(CHCMe 2Ph)(OTf)2(DME) (0.150 g, 0.196 mmol),
LiNC 4H4 (0.029 g, 0.397 mmol), and bipy (0.024 g, 0.154 mmol) to get 0.025 g of yellow 14
(24%): 'H NMR (400 MHz, CD 2 Cl 2) 6 13.72 (s, 1H, MoCH), 9.33 (dd, 1H, bipy), 9.04 (dd, 1H,
bipy), 8.12-8.08 (overlapping peaks, 2H, aromatic), 7.96 (d, 1H, aromatic), 7.88 (td, 1H,
aromatic), 7.60-7.56 (overlapping peaks, 3H, aromatic), 7.50 (m, 1H, aromatic), 7.40 (dd, 1H,
aromatic), 7.36-7.30 (overlapping peaks, 2H, aromatic), 7.24-7.15 (overlapping peaks, 4H,
aromatic), 7.10 (td, 1H, aromatic), 5.96 (d, 4H, NC4H4), 5.62 (d, 4H, NC4H4), 1.84 (s, 6H,
CMe2Ph), 1.34 (s, 9H, t-Bu). Anal. Calcd C38H41MoN 5: C, 68.77; H, 6.23; N, 10.55. Found: C,
68.82; H, 6.24; N, 10.37. 1C NMR could not be obtained due to insolubility of complex.
Mo(NAr")(CHCMe 2Ph)(Pyr)2(bipy) (15) Method C: The procedure is the same as the
synthesis of 10, employing Mo(NAr m)(CHCMe 2Ph)(OTf)2(DME) (0.320 g, 0.388 mmol),
LiNC4H4 (0.057 g, 0.781 mmol), and bipy (0.048 g, 0.307 mmol) to get 0.167 g of orange 15
(74%): 'H NMR (400 MHz, CD 2 Cl 2) 6 13.97 (s, 1H, MoCH major isomer), 13.39 (s, 0.7H,
MoCH), 12.54 (s, 0.4H, MoCH minor isomer), 9.38 (dd, 0.7H, bipy), 8.94 (dd, 0.7H, bipy), 8.71
(dd, 0.7H, aromatic), 8.10-6.70 (overlapping peaks, 37.8H, aromatic), 6.35 (m, 0.8H, NC4H4
minor isomer), 6.15 (t, 2H, NC4H4 major isomer), 6.08 (m, 0.8H, NC4H4 minor isomer), 5.94 (in,
0.8H, NC4H4 minor isomer), 5.90 (t, 2H, NC4H4 major isomer), 5.77 (t, 2.8H, NC4H4), 5.70 (in,
0.8H, NC4H4 minor isomer), 5.56 (t, 2.8H, NC4H4), 5.39 (m, 2H, NC4H4 major isomer), 5.33-
5.31 (m, 2H, NC4H4 major isomer), 2.46 (s, 1.2H, aliphatic minor isomer), 2.34 (s, 1.2H,
aliphatic minor isomer), 2.27 (s, 2.1H, aliphatic), 2.16-2.12 (overlapping peaks, 4.2H, aliphatic
major + minor isomers), 2.07 (s, 1.2H, aliphatic minor isomer), 2.03 (s, 2.1H, aliphatic), 2.01 (s,
2.1H, aliphatic), 1.80 (s, 6H, aliphatic major isomer), 1.79 (s, 3H, aliphatic major isomer), 1.71
(s, 1.2H, aliphatic minor isomer), 1.54 (s, 3H, aliphatic major isomer), 1.17 (s, 4.2H, aliphatic)
Anal. Calcd C43H43MoN5 : C, 71.16; H, 5.97; N, 9.65. Found: C, 70.84; H, 5.86; N, 9.41. 1c
NMR could not be obtained due to insolubility of complex.
Mo(NAr)(CHCMc 2Ph)(Pyr)(OHMT) (16) 9 (0.156 g, 0.226 mmol), HMTOH (0.074 g,
0.224 mmol), and ZnCl 2(dioxane) (0.055 g, 0.245 mmol) were placed in a 25 mL Schlenk flask
(Teflon-sealed cap) and toluene was added until all solids were at the bottom of the flask (10.0
mL). The flask was sealed and sonicated at RT for 4 h. Then, the solution was filtered through
Celite and the salts rinsed with toluene. The solvent was removed from the filtrate and the crude
was redissolved in pentane and passed through a second plug of Celite, and the salts were
washed with pentane. The solvent was removed and the crude dissolved in a minimal amount of
pentane before placing at -35 0C for 2 days. 16 was obtained as red crystals upon filtration; yield
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0.083 g (46%): 'H NMR (400 MHz, C6D6 ) 6 11.72 (s, 1, MoCH JCH = 125.5 Hz), 7.20-7.12
(overlapping peaks, 5H, aromatic), 7.50-6.90 (overlapping peaks, IH, aromatic), 6.83 (t, 2H,
NC4H4), 6.78 (t, 2H, NC4H4), 3.30 (m, 2H, CHMe2), 2.16 (s, 6H, Mes), 2.10 (s, 6H, Mes), 2.04
(s, 6H, Mes), 1.51 (s, 3, CMe2Ph), 1.46 (s, 3, CMe2Ph), 1.11 (d, 6H, CHMe2), 1.03 (d, 6H,
CHMe2 ); 13C NMR (100 MHz, C6D6) 8 293.3 (MoCH), 158.2, 153.7, 148.5, 145.9, 136.8, 136.7,
136.6, 135.9, 132.6, 132.2, 130.0, 129.0, 128.9, 128.4, 127.3, 126.4, 126.2, 123.0, 110.2, 55.7,
31.1, 30.5, 28.6, 24.3, 23.4, 21.1, 20.9, 20.5. Anal. Calcd C5 oH5 8MoN 20: C, 75.17; H, 7.32; N,
3.51. Found: C, 75.16; H, 7.21; N, 3.66.
Mo(NAd)(CHCMe 2Ph)(Pyr)(OHMT) (17) The procedure is the same as the synthesis of
16, employing 10 (0.113 g, 0.170 mmol), HMTOH (0.056 g, 0.169 mmol), and ZnCl2(dioxane)
(0.038 g, 0.169 mmol) to yield 0.084 g of yellow crystalline solid (64%). Characterization of
this compound has appeared before in the literature and here we give only proton NMR as a
reference: 'H NMR (500 MHz, C6D6) 6 11.04 (s, 1H, MoCH, JCH = 121.8 Hz), 7.28-6.75
(overlapping peaks, 12 H, aromatics), 6.73 (t, 2H, NC4H4), 6.50 (t, 2H, NC4H4), 2.20 (s, 6H,
Mes), 2.04 (s, 6H, Mes), 2.02 (s, 6H, Mes), 1.78 (br t, 3H NAd), 1.66 (s, 3H, CHCMe2Ph), 1.62
(br, 3H, NAd), 1.53 (br, 3H, NAd), 1.48 (s 3H, CHCMe2Ph), 1.38 (brs, 6H, NAd).
Mo(NAr')(CHCMe 2Ph)(Pyr)(OHMT) (18) The procedure is the same as the synthesis
of 16, employing 11 (0.200 g, 0.315 mmol), HMTOH (0.115 g, 0.348 mmol), and
ZnC12(dioxane) (0.080 g, 0.356 mmol) to yield 0.185 g of yellow solid (79%): 'H NMR (500
MHz, C6D6) 6 11.53 (s, 1H, MOCH JCH = 123.0 Hz), 7.15 (d, 2H, MoCHCMe2Ph), 7.07 (t, 2H,
MoCHCMe 2Ph), 7.00-6.92 (overlapping peaks, 4H, aromatic), 6.75-6.68 (overlapping peaks,
9H, aromatic), 6.47 (m, 2H, NC4H4), 2.11 (s, 6H, HMTO), 2.05 (s, 6H, HMTO), 2.00 (s, 6H,
HMTO), 1.94 (s, 6H, Mo=NAr'), 1.44 (s, 3H, MoCHCMe2Ph), 1.36 (s, 3H, MoCHCMe2Ph); 13C
NMR (125 MHz, C6D6) 6 291.3 (syn, MoCH), 158.1, 155.9, 148.4, 136.9, 136.8, 136.7, 135.8,
135.4, 132.2, 132.0, 128.7, 129.2, 128.6, 127.2, 126.5, 126.3, 122.8, 110.3, 30.7, 29.8, 21.1, 21.0,
20.8, 20.5, 18.9, 18.2. Anal. Calcd C4 6H 5 OMoN 2 0: C, 74.37; H, 6.78; N, 3.77. Found: C, 74.53;
H, 6.85; N, 3.74.
Mo(NArcI)(CHCMe 2Ph)(Pyr)(OHMT) (19) The procedure is the same as the synthesis of
16, employing 12 (0.100 g, 0.156 mmol), HMTOH (0.052 g, 0.157 mmol), and ZnCl2(dioxane)
(0.035 g, 0.156 mmol) to yield 0.055 g of yellow solid (47%): 'H NMR (400 MHz, C6D6 ) 6
11.53 (s, 1H, MoCHJCH= 126.3 Hz), 7.19 (dd, 2H, CMe2Ph), 7.08 (td, 2H CMe2Ph), 7.00-6.78
(overlapping peaks, 6H, aromatic), 6.76 (t, 2H, NC4H4), 6.72 (s, 2H, Mes), 6.69 (s, 2H, Mes),
6.63 (td, 1H, aromatic), 6.51 (td, 1H, aromatic), 6.46 (t, 2H, NC4H 4), 2.06-1.97 (overlapping
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peaks, 18H, Mes), 1.53 (s, 3H, CMe2Ph), 1.42 (s, 3H, CMe2Ph); 3 C NMR (100 MHz, C6D6) 6
291.7 (syn, MoCH), 157.9, 153.6, 148.4, 137.3, 137.1, 136.8, 136.6, 136.4, 135.3, 132.2, 132.1,
129.9, 129.5, 129.4, 129.3, 129.0, 128.8, 128.6, 128.4, 126.7, 126.3, 123.2, 110.3, 54.6, 34.4,
30.9, 29.5, 22.7, 21.9, 20.8, 20.5, 14.3. Anal. Caled C44H45ClMoN 20: C, 70.53; H, 6.05; N,
3.74. Found: C, 70.29; H, 5.91; N, 3.83.
Mo(NArwr)(CHCMe 2Ph)(Pyr)(OHMT) (20) The procedure is the same as the synthesis
of 16, employing 13 (0.157 g, 0.242 mmol), HMTOH (0.080 g, 0.242 mmol), and
ZnCl 2(dioxane) (0.054 g, 0.242 mmol) to yield 0.077 g of yellow crystalline solid (42%). This
crystalline material was used to get the X-ray structure of 20: 'H NMR (400 MHz, C6D6) 6
11.46 (s, 1H, MoCHJCH= 123.9 Hz), 7.25-6.65 (overlapping peaks, 16H, aromatic), 6.58 (t, 2H,
NC4H4), 6.39 (t, 2H, NC4H4), 3.18 (m, 1H, CHMe2), 2.09-2.02 (overlapping peaks, 18H, Mes),
1.53 (s, 3H, CMe2Ph), 1.45 (s, 3H, CMe2Ph), 0.93 (d, 6H, CHCMe2). ); 13C NMR (100 MHz,
C6D6) 6 289.0 (syn, MoCH), 158.1, 155.1, 148.5, 146.1, 137.2, 137.1, 136.8, 136.5, 135.4, 133.8,
131.9, 131.9, 129.9, 129.6, 129.2, 128.8, 128.6, 128.5, 127.4, 126.3, 125.7, 125.5, 122.8, 110.0,
54.9, 31.5, 30.2, 28.1, 24.3, 22.5, 21.2, 20.9, 20.5, 20.4. Anal. Calcd C47H52MoN20: C, 74.58;
H, 6.92; N, 3.70. Found: C, 74.16; H, 6.86; N, 3.35.
Mo(NArtB)(CHCMe 2Ph)(Pyr)(OHMT) (21) The procedure is the same as the synthesis
of 16, employing 14 (0.119 g, 0.179 mmol), HMTOH (0.059 g, 0.179 mmol), and
ZnCl 2(dioxane) (0.040 g, 0.178 mmol) to yield 0.050 g of yellow crystalline solid (36%): '1H
NMR (400 MHz, C6D6) 6 11.30 (s, 1H, MoCH, JCH 122.8 Hz), 7.19 (dd, 2H, CMe 2Ph), 7.12
(dd, 2H, CMe2Ph), 7.06 (dd, 1H, CMe2Ph), 7.30-6.80 (overlapping peaks, 7H, aromatic), 6.69 (s,
4, Mes), 6.66 (td, 2H, NC4H4), 6.44 (td, 2H, NC4H4), 2.07 (s, 6H, Mes), 2.02 (s, 6H, Mes), 2.01
(s, 6H, Mes), 1.58 (s, 3H, CMe2Ph), 1.44 (s, 3H, CMe2Ph), 1.19 (s, 9H, t-Bu); 13C NMR (100
MHz, C6D6) 6 288.9 (syn, MoCH), 158.0, 156.0, 148.6, 144.4, 136.7, 136.3, 135.3, 133.3, 132.0,
132.0, 129.6, 129.4, 128.5, 126.8, 126.4, 126.3, 126.2, 125.9, 122.9, 110.0, 55.5, 35.3, 34.4, 31.6,
30.4, 30.2, 22.7, 21.2, 20.9, 20.3. Anal. Calcd C48H54MoN 20: C, 74.78; H, 7.06; N, 3.63.
Found: C, 74.63; H, 6.91; N, 3.42.
Mo(NAr")(CHCMe 2Ph)(Pyr)(OHMT) (22) The procedure is the same as the synthesis of
16, employing 15 (0.100 g, 0.138 mmol), HMTOH (0.046 g, 0.139 mmol), and ZnCl2(dioxane)
(0.031 g, 0.138 mmol) to yield 0.037 g of yellow crystalline solid (33%): '1H NMR (400 MHz,
C6D6) 6 11.00 (s, 1H, MoCH, JCH 121.7 Hz), 7.20-7.10 (overlapping peaks, 3H, aromatic),
7.06-6.84 (overlapping peaks, 8H, aromatic), 6.78-6.56 (overlapping peaks, 7H, aromatic), 6.19
(t, 2H, NC4H4), 5.97 (t, 2H, NC4H4), 2.18 (s, 3H, NArM Mes), 2.04 (s, 6H, OHMT Mes), 2.01 (s,
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6H, OHMT Mes), 1.99 (s, 6H, OHMT Mes), 1.90 (s, 3H, NArm Mes), 1.85 (s, 3H, NArM Mes),
1.55 (s, 3H, CMe2Ph), 1.45 (s, 3H, CMe2Ph); 13 C NMR (100 MHz, C6D6) 6 286.1 (syn, MoCH),
158.1, 155.5, 148.3, 137.0, 136.6, 136.5, 136.4, 135.9, 135.5, 135.3, 135.2, 131.7, 131.3, 130.6,
129.8, 129.6, 128.9, 128.8, 128.5, 127.2, 126.5, 126.4, 126.4, 109.0, 54.3, 31.2, 30.2, 21.2, 21.2,
21.0, 20.7, 20.6, 20.3. Anal. Calcd C53H56MoN20: C, 76.42; H, 6.78; N, 3.36. Found: C, 76.41;
H, 6.81; N, 3.32.
Mo(NAr)(=CCMe 2Ph)(NC 4H2Me 2)(bipy) (23) Mo(NAr)(CHCMe 2Ph)(NC 4H2Me2)2
(0.500 g, 0.840 mmol), bipy (0.131 g, 0.839 mmol) and benzene (5.00 mL) were placed in a 25.0
mL Schlenk flask and sealed with a Teflon-seal cap. The mixture was heated at 60 *C for 18 h
and then cooled down to RT. The solvent was removed under vacuum and the crude was
triturated with pentane and filtered-off to yield 0.252 g of purple solid (46%). X-ray quality
crystals were obtained by crystallization from 1:7 CH 2Cl 2:n-pentane at -35 'C for 48 hours: 1H
NMR (600 MHz, C6D6) 6 8.11 (dd, 1H, bipy), 7.34 (dd, 2H, CMe 2Ph), 7.13 (t, 1H, aromatic),
7.08 (in, 1H, aromatic), 6.99 (dd, 2H, CMe2Ph), 6.78-6.64 (overlapping peaks, 8H, aromatic),
6.47 (dd, 1H, aromatic), 6.44 (td, 1H, NC4H2Me2), 6.18 (td, 1H, NC4H2Me2), 4.35 (in, 2H,
CHMe2), 3.17 (s, 3H, NC4H2Me2), 2.59 (s, 3H, NC4H2Me2), 1.74 (s, 3H, CMe2Ph), 1.39 (d, 6H,
CHMe2), 1.32 (s, 3H, CMe2Ph), 1.14 (d, 6H, CHMe2). Anal. Calcd C38H44MoN4 : C, 69.92; H,
6.79; N, 8.58. Found: C, 69.63; H, 6.59; N, 8.36. 3 C NMR could not be obtained due to
insolubility of complex.
Mo(NAr')(=CCMe 2Ph)(NC 4H2Me 2)(bipy) (24) The procedure is the same as the synthesis
of 23, employing Mo(NAr')(CHCMe 2Ph)(NC 4H2Me2)2 (0.221 g, 0.413 mmol) and bipy (0.065 g,
0.416 mmol) to yield 0.147 g of purple solid (60%). X-ray quality crystals were obtained by
crystallization from 1:7 CH 2Cl2:n-pentane at -35 'C for 48 hours: 1H NMR (600 MHz, C6D6 ) 6
8.16 (dd, 1H, bipy), 7.22 (d, 2H, CMe2Ph), 7.05 (d, 1H, aromatic), 6.99 (d, 2H, aromatic), 6.93
(td, 1H, aromatic), 6.80 (dd, 1H, aromatic), 6.77-6.64 (overlapping peaks, 7H, aromatic), 6.46 (d,
2H, NC4H2 Me2), 6.01 (td, 1H, aromatic), 3.16 (s, 3H, NC4H2Me2), 2.52 (s, 31H, NC4H2Me2), 1.93
(s, 6H, NAr' Me), 1.78 (s, 3H, CMe2Ph), 1.33 (s, 3H, CMe2Ph). Anal. Calcd C34H36MoN4: C,
6845; H, 6.08; N, 9.39. Found: C, 68.35; H, 6.07; N, 9.38. 13 C NMR could not be obtained due
to insolubility of complex.
Mo(NArCF3 )(=CCMe 3)(NC 4H2 Me2)(bipy) (25) The procedure is the same as the synthesis
of 23, employing Mo(NArF3 )(CHCMe 3)(NC 4H2Me2)2 (0.3 74 g, 0.728 mmol) and bipy (0.114 g,
0.730 mmol) to yield 0.290 g of purple solid (69%): 1H NMR (600 MHz, C6D6) 6 8.95 (dd, 1H,
bipy), 8.16 (dd, 1H, aromatic), 7.63 (in, 1H, aromatic), 7.21 (td, 1H, aromatic), 6.90-6.60
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(overlapping peaks, 7H, aromatic), 6.43 (t, 2H, NC4H2Me2), 6.39 (dd, I H, aromatic), 6.25 (d, 2H,
NC4H2Me2), 3.11 (s, 3H, NC4H2Me2), 2.62 (s, 3H, NC4H2Me2), 1.12 (s, 9H, t-Bu). Anal. Calcd
C2 8H2 9F3MoN 4 : C, 58.54; H, 5.09; N, 9.75. Found: C, 58.38; H, 5.11; N, 9.63. 13C NMR could
not be obtained due to insolubility of complex.
Mo(NAr ')(:CCMe2Ph)(NC 4H2Me2)(bipy) (26) (NArr)(CHCMe 2Ph)(NC4H2Me2)2
(0.255 g, 0.464 mmoles) and bipy (0.073 g, 0.467 mmoles) in a 1:1 toluene/pentane mixture
(7.00 ml) were stirred at RT for 12 h, during which time a red precipitate formed. Filtration
yielded 0.244 g of red-purple solid (86%): 'H NMR (600 MHz, CD 2 Cl 2) 6 8.45 (dd, IH, bipy),
8.14 (dd, IH, aromatic), 8.09 (dd, 1H, aromatic), 8.02 (td, IH, aromatic), 7.87 (td, iH, aromatic),
7.44 (dd, IH, aromatic), 7.40 (m, IH, aromatic), 7.18 (dd, IH, aromatic), 7.14 (m, IH, aromatic),
7.01 (m, iH, aromatic), 6.93 (dd, 2H, CMe2Ph), 6.90-6.88 (overlapping peaks, 5H, aromatic),
5.91 (dd, IlH, NC4H2Me2), 5.75 (t, 2H, NC 4H2Me2), 3.50 (m, 1H, CHMe2), 2.49 (s, 3H,
NC4H2Me2), 2.15 (s, 3H, NC4H2Me2), 1.56 (s, 3H, CMe2Ph), 1.34 (s, 3H, CMe2Ph), 1.06 (d, 3H,
CHMe2), 0.85 (d, 31H, CH-Me2). Anal. Calcd C35H38MoN4: C, 68.84; H, 6.27; N, 9.18. Found: C,
68.46; H, 6.18; N, 9.03. 13C NMR could not be obtained due to insolubility of complex.
Mo(NAr")(=CCMe 2Ph)(NC 4H2Me 2)(bipy) (27) Mo(NArm)(CHCMe 2Ph)(NC4H2Me 2)2
(0.052 g, 0.083 mmol) and bipy (0.013 g, 0.083 mmol) were dissolved in C6H6, placed in a 25.0
mL Schlenk flask, and sealed with a teflon cap. The mixture was left heating at 60 "C for 2 days
and then it was cooled down to RT, the solvent was removed under vacuo and the product
recrystallized from Et2O at - 35 0C to yield 0.030 g of dark purple solid product (53%): 1H
NMR (400 MHz, C6D6) 6 8.1 (d, 1H, aromatic), 7.7 (d, 1H, aromatic), 7.50-6.00 (m, 17H,
aromatics), 5.90 (s, 2H, Me2C4H2N), 2.50-1.20 (br singlets, 21H, aliphatics). Anal. Calcd
C3 9H3 7MoN 3 : C, 71.71; H, 6.16; N, 8.16. Found: C, 71.61; H, 6.15; N, 8.18. 3 C NMR could not
be obtained due to insolubility of complex.
Mo(NAr T )(=CCMe)(NC 4H2Me 2)(bipy) (28) The procedure is the same as the synthesis of
27, employing Mo(NArT)(CHCMe 3)(NC 4H2Me2)2 (0.053 g, 0.082 mmol) and bipy (0.013 g,
0.082 mmol) to yield 0.040 g of crystalline purple solid (69%). A small portion of these crystals
were used for X-ray chemical structure determination: 1H NMR (400 MHz, C6 D6 ) 6 8.4 (m, IH,
aromatic), 8.1 (m, 2H, aromatic), 7.80 (m, 3H, aromatic), 7.50 (m, iH, aromatic), 7.25 (m, 3H,
aromatic), 7.05 (m, iH, aromatic), 6.95 (m, 3H, aromatic), 6.88 (m, 1H, aromatic), 6.82 (m, 2H,
aromatic), 6.60 (m, 2H, aromatic), 5.65 (s, 2H, Me2C4H2N), 2.90 (m, 3H, CHMe2), 2.28 (s, 3H,
Me2C4H2N), 2.20 (s, 3H, Me2C4H2N), 1.2 (d, 3H, i-Pr), 0.94 (s, 9H, t-Bu), 0.87 (d, 3H, i-Pr), 0.75
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(d, 3H, i-Pr). Anal. Caled C3 9H37 MoN 3 : C, 71.17; H, 7.39; N, 7.90. Found: C, 70.81; H, 7.47;
N, 7.91. 13 C NMR could not be obtained due to insolubility of complex.
General procedure for ROMP of DCMNBD MAP catalyst (0.005 g) is dissolved in
0.500 ml of toluene while 50 equivalents of the monomer are dissolved in 0.700 ml of toluene
and stirred in a separate vial. To the monomer vial the catalyst solution is added quickly and left
stirring for 2 h until it forms a gel. The reaction is then quenched with 0.500 mL of
benzaldehyde and some methylene chloride is added to solubilize the gel. This solution is stirred
for another hour, at which point the solution is added to a 100 mL RBF containing 50.0-70.0 mL
MeOH stirring vigorously. The polymer precipitates instantly and it is collected by filtration
after 1 h of stirring. The dry polymer is examined by 'H and 3 C NMR to determine the tacticity
and cis content according to known literature reports.
X-ray Crystallographic Procedures
Low-temperature diffraction data (0- and co-scans) were collected on a Bruker-AXS X8
Kappa Duo diffractometer coupled to a Smart Apex2 CCD detector with Mo Ka radiation (. =
0.71073 A) from a Si-monochromated sealed tube for compounds 9, 23, and 24, on a Bruker D8
three circle diffractometer coupled to a Bruker-AXS Smart Apex CCD detector with graphite-
monochromated Cu Ka radiation (k = 1.54178 A) for the structure of compound 28, and on a
Bruker-AXS X8 Kappa Duo diffractometer coupled to a Smart Apex2 CCD detector with Mo Ka
radiation (k = 0.71073 A) from a IpS micro-source for the structure of compound 20.
For all structures, data reduction was performed with the program SAINT,15 absorption
correction and scaling were performed with the program SADABS." The structures were solved
by direct methods using SHELXS1 7 and refined against F 2 on all data by full-matrix least squares
with SHELXL-97,' 8 following established refinement strategies.' 9 All non-hydrogen atoms were
refined anisotropically. Unless noted otherwise below, all hydrogen atoms were included into
the model at geometrically calculated positions and refined using a riding model. The isotropic
displacement parameters of all hydrogen atoms were constrained to 1.2 times the Ueq value of the
atoms they are linked to (1.5 times for methyl groups). Crystal and structural refinement results
are listed in Tables 2-6.
Description of Structure of 9
Compound la crystallizes in the monoclinic space group C2/c with one molecule of la
and one molecule of dichloromethane in the asymmetric unit. Coordinates for the hydrogen
atom on C 11 which binds directly to Mo, were taken from the difference Fourier synthesis.
This hydrogen atom was subsequently refined semi-freely with the help of distance restraints
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while constraining their Uso to 1.2 times the Ueq value of the atoms they are linked to. Phenyl
ring on one of the ligands and the solvent dichloromethane were modeled as a two part
disorder. The disorder was refined with the help of similarity restraints on 1-2 and 1-3
distances and displacements parameters as well as rigid bond restraints for anisotropic
displacement parameters. The ratio between the two components was refined freely and
converged at 0.498(10) and 0.447(10), respectively.
Description of Structure of 20
Compound 20 crystallizes in the triclinic space group P1 with two molecules of 20 in the
asymmetric unit. Coordinates for the hydrogen atoms on carbon binding directly to Mo, Cl
and C 101, respectively, were taken from the difference Fourier synthesis. Those hydrogen
atoms were subsequently refined semi-freely with the help of distance restraints while
constraining their Uso to 1.2 times the Ueq value of the atoms they are linked to. The
structure contains two independent molecules (Z=4); bond lengths are identical within one to
three standard uncertainties and for discussion parameters from the first independent
molecule were used.
Description of Structure of 23
Compound 23 crystallizes in the monoclinic space group P21/n with one molecule of 23
in the asymmetric unit.
Description of Structure of 24
Compound 24 crystallizes in the monoclinic space group P21/c with one molecule of 24
in the asymmetric unit.
Description of Structure of 28
Compound 28 crystallizes in the monoclinic space group P21/c with two molecules of 28 and
six molecules of benzene in the asymmetric unit (Z=8). One of the ligands on the second
molecule was modeled as a two part disorder and all structural parameters discussed in the paper
refer to the un-distorted molecule. The disorder was refined with the help of similarity restraints
on 1-2 and 1-3 distances and displacements parameters as well as rigid bond restraints for
anisotropic displacement parameters. The ratio between the two components was refined freely
and converged at 0.647(10).
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Table 2. Crystal data and structure refinement for 9.
Identification code (C40H45MoN5)(CH2Cl2)
Empirical formula C41 H47 C12 Mo N5
Formula weight 776.68
Temperature 130(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group C2/c
Unit cell dimensions a = 15.8436(8) A a= 900
b = 14.1814(7) A P= 94.318(3)0
c = 34.0620(16) A Y= 90'
Volume 7631.5(6) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 26.00'
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Extinction coefficient
Largest diff. peak and hole
8
1.352 Mg/m 3
0.519 mm- 1
3232
0.04 x 0.03 x 0.02 mm3
1.93 to 26.000
- 19<=h<= 19, -17<=k<=17, -41<=l<=40
71876
7486 [R(int) = 0.1135]
99.9 %
Semi-empirical from equivalents
0.9897 and 0.9795
Full-matrix least-squares on F2
7486 / 67 / 489
1.007
RI = 0.0416, wR2 = 0.0775
R1 = 0.0759, wR2 = 0.0888
na
0.410 and -0.496 e.A-3
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Table 3. Crystal data and structure refinement for 20.
Identification code xl 1172
Empirical formula C47 H52 Mo N2 0
Formula weight 756.85
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Triclinic
Space group P1
Unit cell dimensions a= 10.6943(6) A
Volume
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 30.32'
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
b = 11.4798(6) A
c = 34.8506(19) A
3962.9(4) A3
a= 94.8550(10)0
p= 91.9520(10)0
7=11 1.2780(1 0)0
4
1.269 Mg/m3
0.368 mm-1
1592
0.20 x 0.20 x 0.15 mm3
1.18 to 30.32'
-15<=h<=15, -16<=k<=16, -49<=l<=49
181235
23780 [R(int) = 0.0322]
99.9 %
Semi-empirical from equivalents
0.9469 and 0.9301
Full-matrix least-squares on F2
23780 / 2 / 945
1.114
RI = 0.0328, wR2 = 0.0758
R1 = 0.0374, wR2 = 0.0783
0.959 and -0.838 e.A-3
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Table 4. Crystal data and structure refinement for 23.
Identification code C38H44MoN4
Empirical formula C38 H44 Mo N4
Formula weight 652.71
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P2 1/n
Unit cell dimensions a= 11.2310(10) A
b = 18.7037(18) A
c = 15.8997(15) A
Volume 3314.5(5) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 28.000
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Extinction coefficient
Largest diff. peak and hole
a 90'
p= 97.074(6)0
Y= 900
4
1.308 Mg/m3
0.428 mm-1
1368
0.13 x 0.10 x 0.07 mm 3
1.69 to 28.00'
-14<=h<= 14, -24<=k<=22, -21 <=l<=20
58456
8003 [R(int) = 0.0972]
100.0 %
Semi-empirical from equivalents
0.9707 and 0.9465
Full-matrix least-squares on F2
8003/0/390
1.018
RI = 0.0475, wR2 = 0.1082
R1 = 0.0858, wR2 = 0.1274
na
1.474 and -1.162 e.A-3
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Table 5. Crystal data and structure refinement for 24.
Identification code C34H36MoN4
Empirical formula C34 H36 Mo N4
Formula weight 596.61
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P21/c
Unit cell dimensions a = 14.9819(3) A
b = 11.6518(3)^ A
c = 17.4969(4) A
Volume 2909.37(12) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 27.49'
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Extinction coefficient
Largest diff. peak and hole
ac= 90'
P= 107.7250(10)0
Y = 900
4
1.362 Mg/m3
0.480 mm-1
1240
0.12 x 0.04 x 0.03 mm3
1.43 to 27.49'
-1 8<=h<=19, -14<=k<=15, -22<=l<=22
63038
6668 [R(int) = 0.0434]
99.8 %
Semi-empirical from equivalents
0.9857 and 0.9446
Full-matrix least-squares on F2
6668/0/356
1.034
R1 = 0.0242, wR2 = 0.0549
RI = 0.0339, wR2 = 0.0587
na
0.386 and -0.323 e.^-3
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Table 6. Crystal data and structure refinement for 28.
Identification code d10116
Empirical formula C60 H70 Mo N4
Formula weight 943.14
Temperature 100(2) K
Wavelength 1.54178 A
Crystal system Monoclinic
Space group P21/c
Unit cell dimensions a = 25.0928(4) A
b = 25.8149(4) A
c = 17.2021(3) A
Volume 10592.7(3) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 69.310
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
a= 90'
p= 108.0810(10)0
y= 900
8
1.183 Mg/m 3
2.321 mm- 1
4000
0.30 x 0.20 x 0.10 mm 3
1.85 to 69.31
-30<=h<=30, -3 1<=k<=31, -20<=l<=19
200905
19616 [R(int) = 0.0398]
99.0 %
Semi-empirical from equivalents
0.8011 and 0.5427
Full-matrix least-squares on F2
19616 / 2996 / 1398
1.223
R1 = 0.0652, wR2 = 0.1714
R1 = 0.0708, wR2 = 0.1744
3.266 and -1.408 e.A-3
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CHAPTER 5
Preparation of Mo(NR)(CHCMe 2Ph)(X)(Y) Complexes:
Examining the Effect of Sigma and Pi Donor Ligands on Reactivity and Selectivity
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INTRODUCTION
DFT calculations performed by Odile Eisenstein provided a picture of the transition states
that high-oxidation molybdenum, tungsten, and rhenium catalysts undergo during the course of
an olefin-metathesis reaction.' It was pointed-out that catalysts of the type M(NR)(CHR')(X)(Y),
where X is a good sigma-donor ligand and Y is a poor one, are better catalysts in general than
either bisalkoxide or dialkyl analogs. In addition, the study found that catalysts composed of
group VI metals (M = Mo, W) were better catalysts than M = Re. According to the calculations
the lower activation barriers for olefin coordination and olefin dissociation of
M(NR)(CHR')(X)(Y) than for either M(NR)(CHR')(X) 2 or M(NR)(CHR')(Y) 2 is the key reason
for the enhanced reactivity of the X/Y catalysts.
More recently, Eisenstein discussed another DFT result where M(NR)(CHR')(X)(OSiH 3)
catalysts containing X = pyrrolide or alkyl were compared.7 In this case, it was found that the
transition states are similar for both complexes. The main differences concern intercoversion of
the TBP metallacyclobutane structure and the SP metallacyclobutane structures. When X = alkyl
the barrier of interconversion is much higher (~ 20 kcal/mol) than when X = pyr (~ 12 kcal/mol).
Nevertheless, if conversion to the SP metallacyclobutane does take place, then the reaction
coordinate towards p-H elimination can take place more easily when X = alkyl (Ea ~ 23
kcal/mol) than when X = pyr (Ea - 29 kcal/mol). Many other decomposition pathways can
follow, but since p-H elimination has the highest activation energy, it is the rate-determining step
of decomposition of a metallacyclobutane.
Catalysts investigated in the Schrock and Hoveyda laboratories that contained four different
ligands were the monoalkoxidemonopyrrolide (MAP) species, where X = pyrrolide and Y =
alkoxide, phenoxide. 2 This type of high-oxidation state molybdenum alkylidene catalyst opened
the door to olefin metathesis reactions that were not achievable in the past. These reactions
include, but are not limited to, the stereoselective synthesis of natural alkaloids,3 P-selective
enyne RCM,2 ,4 Z-selective coupling reactions such as ROMP of dicarbomethoxynorbornadiene 5
and cross-coupling of vinylic and allylic substrates. Synthetic access to the first MAP species
was possible after it was discovered that Mo(NR)(CHR')(R" 2Pyr)2 precursors can exchange a
pyrrolide ligand for an alkoxide/phenoxide through protonolysis of the pyrrolide with one
equivalent of a(n) alcohol/phenol 2 or more recently with Mo(NR)(CHR')(Pyr) 2(bipy) in the
presence of ZnCl2(dioxane) and one equivalent of a bulky phenol (see Chapter 4, Section 4.2).
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Figure 1 - Possible ligand combinations and their denominations.
Figure 1 depicts the corresponding high-oxidation state molybdenum catalysts that can be
generated by changing the X and Y ligands in Mo(NR)(CHCMe 2Ph)(X)(Y). When X # Y two
broad classes of compounds are those where the common ligand is an alkoxide/phenoxide
(MAX) and those where the common ligand is a pyrrolide (MXP). MAP complexes can then be
considered to be a shared subunit of all possible MAX and MXP complexes and for clarity we
will continue referring to them as MAPs.
Excluding MAPs, many MAX and MXP complexes can be prepared by varying the X ligand.
Some of the combinations are given in Figure 1. The only MAX compounds that have been
made in the past contain alkyl, chloride, triflate, or alkoxide ligands; while the only MXP class
of compounds made contain carboxylate (see Chapter 2, Section 2.2) or triflate ligands.' 9 Few
MAX and MXP complexes have been prepared, in comparison, to MAP species.
The first MAX catalysts produced by the Schrock group were synthesized from
Mo(NR)(CH 2-t-Bu) 3Cl complexes by substituting the chloro group with phenoxides and heating
the resulting complex to generate Mo(NR)(CH-t-Bu)(CH 2-t-Bu)(OAr) MAX species where X =
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alkyl.8'9 Similar catalysts with smaller alkoxides or with chloride instead of OAr could not be
isolated due to their fast bimolecular decomposition. However, MAX compounds containing a
chloro ligand are now known for molybdenum catalysts that contain the very bulky 2,6-
dimesitylphenylimido ligand, which is capable of stabilizing the metal complex and which also
allows the alkylidene group to be present in the anti form (with relation to the imido group) both
14in solution and the solid state
The first MAX species made which contained a triflate group was achieved by Dr. Marinescu
by treating Mo(NAd)(CHCMe 2Ph)(OTf) 2(DME) with one equivalent of lithium 2,2',4,4',6,6'-
hexaisopropylterphenoxide (LiOHIPT), which generated Mo(NAd)(CHCMe 2Ph)(OTf)(OHIPT)
as the final complex' 5 . This MAX complex could be used to generate mixed-alkoxide MAX
species or new MAP complexes via salt-metathesis of the triflate group with alkoxides or
substituted-pyrrolides respectively (Scheme 1).
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Scheme 1 - Pathways to synthesize Mo(NAd)(CHCMe 2Ph)(2-MesC 4H3N)(OHIPT).
In this chapter the synthesis and reactivity of new MAX species that contain carboxylate,
phenoxide, amide, and aryl ligands will be discussed. Catalytic reactions of all MAX complexes
along with their MAP and MXP counterparts will be presented and a few conclusions will be
drawn from these data.
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RESULTS AND DISCUSSION
5.1 Synthesis, characterization and structural studies of MAX complexes
5.1.1 Reaction between Mo(NR)(CHR')(OTf) 2(DME) and lithium salts.
Syntheses of the Mo(NR)(CHR')(OTf)(OHIPT) specie shown in Scheme 1, does not appear to
be successful as R is varied. For instance, when Mo(NArM)(CHCMe2Ph)(OTf)2DME (Arm = 2-
mesitylphenyl) and Mo(NArT)(CHCMe 3)(OTf)2DME (ArT = 2-(2',4',6'-triisopropylphenyl)
were each treated with one equivalent of LiOHIPT the alkylidene peaks corresponding to the
starting materials disappeared over time, but no new alkylidene species was formed. In addition,
HIPTOH was formed during the course of the reaction. Similarly, reaction of LiOHIPT with
bistriflate complexes containing commercially-available aromatic imido groups render isolation
of monotriflate species impractical. It is hypothesized that the presence of the less basic
aromatic imido groups could lower the pKa of the alkylidene proton to the point where it is
susceptible to deprotonation by a strong base (e.g. HIPTO-) forming an alkylidyne complex.
Equation 1 depicts this proposed reaction.
ArAr I N
NR' R'
TfO LiOHIPT Mo (1)
.... 4o H - HIPTO-H + TfO
C6D6  \ OTf
Arm= 2-MesC 6H4
ArT = 2-TRIPC6H4
Since Mo(NAd)(CHCMe 2Ph)(OTf)(OHIPT) can be prepared, analogs that contain the same
aliphatic imido ligand were sought. Lithium aryls were chosen mainly because they are
intermediates in the synthesis of terphenols like HMTOH (hexamethylterphenol), TIPTOH
(tetraisopropylterphenol), and HIPTOH (hexaisopropylterphenol)l0 and can be readily
synthesized from the corresponding aryl iodides as shown in equation 2.
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n-BuLi
R2 RI R, R2 -35 0C to RT R2 R1 Li R1  R2 (2)
R1 R, 12 h R1 R1
HMT: R, = R2 = Me (85%)
TIPT: R, = i-Pr, R2 = H (74%)
HIPT: R1 = R2 = i-Pr (74%)
When Mo(NAd)(CHCMe 2Ph)(OTf)2DME is treated with one equivalent of HMT-Li, TIPT-
Li, or HIPT-Li the alkylidene peak corresponding to the starting material disappears completely,
but no new alkylidene is formed. Apparent decomposition is reminiscent of past attempts to
make bisamide species with the general formula Mo(NR)(CHR')(NR" 2)2 starting from the
bistriflate precursor; all were plagued by decomposition reactions which made isolation of the
desired species not possible. However, it was later shown that bisamides could be prepared if the
triflate groups were replaced with OCMe(CF 3) 2 groups first.
5.1.2 Reaction between Mo(NAr)(CHCMe 2Ph)(OC(CF 3)2(CH 3))2 and carboxylic acids.
Exchanging triflates with hexafluoro-t-butoxides (ORF6) via salt-metathesis of the bistriflate
affords the classical high-oxidation molybdenum bisalkoxide alkylidene complexes
Mo(NR)(CHR')(ORF6) 2, which when treated with 2 equivalents of LiNPh2 form the
corresponding Mo(NR)(CHR')(NPh 2)2 complexes without byproduct formation or
decomposition. Therefore, Mo(NR)(CHR')(ORF6) 2 was chosen as the starting point for synthesis
of MAX species. It is worth pointing out that it is also possible to protonate the alkoxides with
carboxylic acids, something that could not be done with bistriflate complexes.
The reaction between bisalkoxide Mo(NAr)(CHCMe 2Ph)(ORF6)2 and one equivalent of 2,6-
bis(4'-methylphenyl)benzoic acid (TermeCO 2H) yielded the MAX species
Ar Ar
Ph O OH Et20 Ph(3
± ~ RT Ph(3)
RF60 Mo + R 'F-Mo
RF60 -HORF6 O
TerMeCO 2H Y
TerMe
1 (45%)
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Mo(NAr)(CHCMe 2Ph)(ORF6)(O2CTerMe), 1, in moderate yield as orange crystals (equation
3). The main reason for the low yield is due to formation of biscarboxylate complex. In fact, if
the reaction is too concentrated or if the solution containing the carboxylic acid is added too
quickly, the yield can be even lower and, in the most extreme case, insufficient to isolate.
The proton NMR spectrum of 1 shows one alkylidene peak at 13.07 ppm and a set of quartets
in its 19F NMR spectrum, which is consistent with C1 symmetry at the metal center. The 19F
NMR feature is very characteristic of MAX species that contain only one ORF6 ligand and serves
as the indicative spectroscopic signature that such species have been made (Figure 2). In
particular, 19F NMR is a useful probe during test reactions.
As with the monocarboxylate complexes presented in Chapter 2, MAX complexes that
contain carboxylate ligands can only be made when the imido group is 2,6-iPr2C6H3 (Ar).
Attempts to make analogous MAX species with smaller imido ligands only yield biscarboxylates
as the major products. Reactions with 2,6-bis(2',4',6'-trimethylphenyl)benzoic acid
(HMTCO 2H) and Mo(NR)(CHCMe 2Ph)(ORF6) 2 (R = 2,6-dimethylphenyl; 1-adamantyl; 2-
isopropyl) also did not yield MAX species. However, although substitution of one ORF6 ligand
by carboxyates has limited scope the next section reports that a wider variety of complexes can
be made through salt-metathesis with phenoxides, amides, and even aryls.
19F
(-) 77.50 -78.00 -78.50
1H
10.0 5.0
Figure 2 - 1H NMR (bottom) and 19F NMR (top) spectra of compound 1.
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5.1.3 Reaction between Mo(NR)(CHCMe 2Ph)(OC(CF 3)2(CH 3))2 and lithium salts.
It was mentioned in Section 5.1.1 that preparation of terphenyl lithium compounds can be
prepared easily from the terphenyl iodides by treatment of the latter with n-butyl lithium at - 35
C. In turn, terphenyl lithium derivatives can be turned into terphenols and terphenyl amines.
Both terphenols and terphenyl amines have been used in the past in our group (see Chapters 3
and 4, and reference 14). Examples are those that contain a HMT (2,6-dimesityl phenyl) group.
LiOHMT, LiN(H)HMT, and LiHMT can all be prepared readily, as shown in Scheme 2.
HMT-I
n-BuLi
-35oC
1. TosN3
2. LAH 1. PhNO 2
3. n-BuLi Li 2. n-BuLi
-35oC-35o 0C
HMTN(H)Li 35 C 3 HMTOLi
HMTLi
Scheme 2 - Synthesis of HMTLi, HMTOLi and HMTN(H)Li starting from HMT-I.
When bisalkoxide complexes of the general formula Mo(NR)(CHCMe 2Ph)(ORF6)2 are
treated with one equivalent of HMTOLi, MAX species of the kind
Mo(NR)(CHCMe 2Ph)(ORF6)(OHMT) can be formed for R = Ar (2); R = 2,6-Me2C6H3 (Ar', 3);
R = 2-iPrC6H4 (ArPr , 4); and R = 1-adamantyl (Ad, 5) in moderate to good yields (43-80%,
equation 4). Complexes 3-4 can be made without any byproduct formation, but syntheses of
complex 2, which contains the bigger (Ar) imido group is not free from byproducts, as suggested
by formation of HMTOH, which is hypothesized to arise through deprotonation of the alkylidene
C-H bond. As a result, multiple recrystallizations must be performed to obtain pure 2, which
explains its lower yield compared to the rest of the complexes. Elemental analysis for complex 2
has not been obtained.
The 1H NMR of complexes 2-5 shows a single alkylidene peak present between 11.70 and
11.40 ppm. In addition, a singlet that integrates to three protons and corresponds to one of the
methyl resonances appears at around 0.80 ppm (complexes 2-4) and 1.20 (complex 5). The 19F
NMR of each complex shows a set of quartets, confirming the formation of the desired MAX
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species. This synthetic method for preparation of MAX species is a vast improvement over the
reaction between bistriflates complexes Mo(NR)(CHCMe 2Ph)(OTf) 2(DME) and LiOHIPT. The
analogous reaction between Mo(NR)(CHCMe 2Ph)(OTf)2(DME) and LiOHMT does not yield
OTf/OHMT species for any combination of imido groups.
R R
I I
NhOL Et2O N PPh RT Ph (4)
RF60 %'I.Mo +RF60 \NMo
IF6O 
- LiORF6  MRF60 HMTO
HMTOLi
2 R = Ar; (43 %)
3 R = Ar'; (80 %)
4 R = AriPr; (71%)
5 R = Ad; (59 %)
All MAX species (except 3) are highly crystalline and can be recrystallized from pentane at
- 35 0C. The structure of complex 5 is shown in Figure 3. Complex 5 crystallizes out in the
triclinic space group P1 with only one molecule present in the asymmetric unit. One of the
mesityl groups in the HMTO ligand faces parallel to the imido group while the other is
positioned in the empty COO face of the tetrahedron. The Mo(l)-C(1), Mo(1)-N(1), Mo(1)-
O(1), and Mo(l)-O(2) bond lengths are typical of those found in MAP species. The Mo(1)-C(1)-
C(2) bond angle is also typical of MAP species in the syn configuration. The Mo(l)-N(1)-C(1 1)
bond angle is close to linear, which is common for high-oxidation state molybdenum alkylidene
imido complexes. The Mo(1)-O(1)-C(21) bond angle is slightly less than the Mo(1)-O(2)-C(31)
bond angle (145.23(12)0 and 154.38(10)' respectively) and it is attributed to the greater sterics of
the HMTO ligand compared to ORF6.
R Li R
N Ph Et2  N
Ph RT Ph (5)
RF60 %'.Mo +RF60 \%Mo
F 6 O '- LiORF6  o
RF60 HMT(H)N
6 R = Ar', (48 %)
7 R = AriPr, (92 %)
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When Mo(NR)(CHCMe 2Ph)(ORF6)2 is treated with one equivalent of LiN(H)HMT at RT in
Et2 0, only complexes 6 (R = Ar') and 7 (R = ArI") can be obtained (equation 5). Complex 7 is
highly crystalline, while 6 is not as crystalline and elemental analysis has not passed
successfully. Proton NMR spectra of both complexes show only one alkylidene peak at 11.86
ppm for 6 and at 11.72 ppm for 7 and one NH resonance at 7.82 ppm for 6 and 7.99 ppm for 7.
Similarly to complexes 2-5, both 6 and 7 do have a methyl peak resonance at 1.00 and 0.80 ppm
respectively. The '9F NMR of both complexes shows a set of quartets indicating a complex with
C1 symmetry.
0(2)
Figure 3 - The solid state structure of 5 (50% probability ellipsoids). Selected bond lengths (A)
and bond angles (0): Mo(l)-C(1) = 1.8821(16), Mo(1)-N(1) = 1.7028(14), Mo(1)-O(1) =
1.9444(12), Mo(1)-O(2) = 1.9230(11), Mo(1)-C(1)-C(2) = 141.90(12), Mo(l)-N(1)-C(1 1) =
169.14(12) Mo(1)-O(1)-C(21) = 145.23(12), Mo(1)-O(2)-C(31) = 154.38(10).
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As it was observed above, during the salt metathesis reaction between
Mo(NAr)(CHCMe 2Ph)(ORF6)2 and LiN(H)HMT, substantial side products are produced due to
the higher basicity of lithium amide compared to that of LiOHMT. It is worth noting that the
same reaction carried out with smaller amides (e.g. LiNPh2) yields salt-metathesis products with
no side products.12 Byproduct formation during salt-metathesis reactions with LiOHMT or
LiN(H)HMT is attributed to the higher steric demands of the terphenyl ligands. In the case of
the Mo(NAd)(CHCMe 2Ph)(ORF6)2, substitution takes place but the product is not crystalline and
could not be purified.
1)
N(1)
Figure 4 - The solid state structure of 7 (50% probability ellipsoids). Selected bond lengths (A)
and bond angles (0): Mo(1)-C(1) = 1.8833(16), Mo(1)-N(1) = 1.7261(13), Mo(1)-N(2) =
1.9950(13), Mo(1)-O(1) = 1.9518(1 1), Mo, Mo(1)-C(1)-C(2) = 144.78(12), Mo(1)-N(1)-C(11) =
173.09(12), Mo(1)-N(2)-C(31) = 133.32(11), Mo(1)-O(1)-C(21) = 140.93(10).
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The crystal structure of 7 is shown in Figure 4. Complex 7 crystallizes in the monoclinic
space group P21/c and its structure is best described as a distorted tetrahedron. The HMTN(H)
group points its mesityl arms towards the NNO and the CNN faces of the tetrahedron, leaving
the CON(amide) face exposed. The Mo(l)-N(l) and Mo(1)-O(1) bond distances of 7
(1.7261(13) A and 1.9518(1 1) A respectively) are slightly longer than those of 5 (1.7028(14) A
and 1.9444(12) A respectively), but the Mo(l)-C(1) bond lengths of 7 (1.8833(16) A) and 5
(1.8821(16) A) are very similar. In addition, the Mo(l)-N(1)-C(1 1) bond angle of 7
(173.09(12)0) is larger than that of 5 (169.14(12)') while the Mo(1)-O(1)-C(21) of 7
(140.93(12)0) is shorter than that of 5 (145.23(12)). The differences in the bond lengths and
angles of the imido ligands are reflected by the different steric interactions encountered by each
imido group. In the case of 7 Ar'p is slightly larger than Ad, which explains the slight elongation
of the bond. On the other hand, the Mo(l)-N(1)-C(l 1) bond angle in 5 is shorter than 7 because
the mesityl arm of the HMTO ligand (complex 5) points directly towards the imido ligand,
whereas, the analogous interaction in 7 is absent, thus creating a larger and more linear bond.
The differences in the Mo(1)-O(l) bond lengths and the Mo(1)-O(1)-C(21) bond angles of 5
and 7 can be rationalized by comparison of the a-donating and a-donating abilities of the HMTO
and HMTN(H) ligands respectively. Since HMTO is less effective both as a a-donor and a r-
donor, compared to HMTN(H), it has a lesser trans-influence on the ORF6, which explains why
the Mo(1)-O(1) bond length is longer and the Mo(1)-O(1)-C(21) bond angle is shorter for 7 than
for 5. Finally, the Mo(l)-N(2) bond distance (1.9950(13) A) of 7 is similar to the analogous
distances in Mo(NAr)(CHCMe 2Ph)(NPh 2)2 species 2 (2.007(3) and 2.009(3) A), but the Mo(1)-
N(2)-C(31) bond angle (133.32(11)0) of 7 is significantly larger than those of the bisamide
complex (118.61(19)0 and 117.6(3)0). This difference could be attributed to the difference in
sterics of both amide ligands; however, a possible N-H agostic interaction is not discounted and
could, in part, be responsible for the discrepancy in bond angles.
R R
NPh Li Et2O
L RT Ph (6)
RF60 Mo + --- RF60 *vMo
RF6 - LiORF6  4R-6 HMT
8 R = Ad, RT; (95 %)
9 R = Arm , RT; (oil)
10 R = Ar', 80 'C; (90 % conv)
11 R=Ar,80'C;(18%conv)
168
When Mo(NR)(CHCMe 2Ph)(ORF6)2 was treated with one equivalent of LiHMT, at RT
overnight, Mo(NR)(CHCMe 2Ph)(ORF6)(HMT) species (R = Ad, 8; R = 3,5-Me2C6H3 (Arm), 9)
could be generated in solution. Unfortunately, 9 is not a crystalline complex and could not be
purified by recrystallization even from TMS at - 35 "C. On the other hand, 8 is obtained as a
yellow crystalline compound (equation 6). 'H NMR of 8 reveals the presence of only one
alkylidene product at 10.99 ppm and 19F NMR reveals the characteristic set of quartets.
Figure 5a - The solid state structure of 8 (50% probability ellipsoids).. Selected bond lengths
(A) and bond angles (0): Mo(1)-C(1) = 1.891(8), Mo(l)-N(1) = 1.701(6), Mo(1)-C(21) =
2.193(7), Mo(l)-O(1) = 1.940(6), Mo(1)-O(1A) = 1.933(14), Mo(1)-O(1B) = 1.928(15), Mo(1)-
C(1)-C(2) = 144.2(6), Mo(1)-N(1)-C(ll) = 162.0(5), Mo(l)-O(1)-C(51) = 155.6(9), Mo(1)-
O(lA)-C(51A) = 153(3), Mo(1)-O(1B)-C(51B) = 158(7).
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In the case where R = Ar' (10) the reaction reaches 90 % completion after 5 days at 80 *C
and two new alkylidene resonances at 11.7 ppm (78%) and 11.0 ppm (12 %) are observed in its
proton NMR spectrum. Unfortunately isolation of either species was not possible by
recrystallization. In the case where R = Ar (11) only 18% of a new species is formed after 5
days at 80 *C.
Complex 8 was recrystallized from pentane at -35 *C to yield X-ray quality crystals and its
structure is shown in Figure 5a. Complex 8 crystallizes in the triclinic group P1 and its structure
is described as a distorted tetrahedron. A three-part disorder is observed for the (CF3 )2 CH 3CO
group and a front view picture is shown in Figure 5b. The Mo(l)-N(1)-C(1 1) angle of 162.0(5)0
is a bit shorter than that of complex 5 (169.14(12)0) and it is due to the closer proximity of the
mesityl ring in 8. However, the Mo(1)-N(l) bond length of 8 (1.701(6) A) is similar to that of 5
(1.7028(14) A) and to analogous MAX species8 9 . The Mo(l)-O(1)-C(51) angle (155.6(9)0) of 8
is larger than the Mo(l)-O(1)-C(21) angle (145.23(12)0) of 5. On the other hand, the Mo(1)-O(l)
bond length of 8 (1.940(6) A) is very similar to the Mo(1)-O(l) bond length (1.9444(12) A). The
differences in bond angles of the ORF6 fragments are due to the presence (HMTO) or absence
(HMT) of a good i-donor ligand. Thus, in complex 8, the ORF6 ligand does not compete for a-
bonding and has a more linear bond angle.
F(2B) F(3)
F 
~F(2) 
F1
(3B)
F(9A)
F(1l)
F(9B)
C051A)
51) (5)
51 F(5A)
F(8A)K A (7B) (1A (1
0(1
Mo(4A)
F8B)
F(6A)
F(6)
Figure 5b - Front view of the three-part disorder of the alkoxide group of compound 8 (50%
probability ellipsoids). Selected bond lengths (A) and angles (0) are shown. Mo(l)-O(l) =
1.940(6), Mo(l)-O(1A) = 1.933(14), Mo(l)-O(1B) = 1.928(15), Mo(l)-O(1)-C(51) = 155.6(9),
Mo(1)-O(lA)-C(51A) = 153(3), Mo(1)-O(lB)-C(51B) = 158(7).
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The Mo(1)-C(21) bond length (2.193(7) A) is similar to metal-alkyl lengths like those of
Mo(NArT)2(CH 3)2 (ArT = 2-(2',4',6'-triisopropylphenyl)phenyl; 2.127(2) A and 2.121(2)A,
Chapter 3) and as a result, the distance between the metal center and the HMT group is about 1 A
shorter than the distance found in Mo(NAr m)(CHCMe 2Ph)(2,5-Me 2Pyr)(OHMT) (3.199 A,
Chapter 3), Mo(NArLPr)(CHCMe 2Ph)(Pyr)(OHMT) (3.166 A, Chapter 4), 5 (3.193 A), and 7
(3.130 A). Moreover, the Mo-HMT distance in 8 is about 2 A shorter than in
Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(O 2CTerme). Figure 6, shows the Mo-0 2CTerme, Mo-OHMT,
Mo-N(H)HMT, and Mo-HMT fragments of Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(O 2CTerMe), 5, 7,
and 8 respectively for comparison.
C 301002
Mo(1)-C(31)= 4.051 A Mo(1)-C(31)= 3.193 A
Fragment from Mo(NAr)(CHR)(Me 2PyrXO2CTerM.) Fragment from 5
Mo(1)-C(31) 3.130 A Mo(1)-C(21) =2.176 A
Fragment from 7 Fragment from 8
Figure 6 - The solid state structures (50 % probability ellipsoids) of the carboxylate fragment of
Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(O2CTerme) (top left), the phenoxide fragment of 5 (top right),
the amido fragment of 7 (bottom left), and the phenyl fragment of 8 (bottom right). Selected
distances and bond lengths (A) shown below each fragment.
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When the Mo-Aryl distances of each of the fragments are considered, the results observed
during the preparation of MAX complexes from (NAr)(CHCMe2Ph)(ORF6)2 can be easily
rationalized. For instance, the long distance between the terphenyl group of the O2CTerMe ligand
and the metal center is long enough that MAX species containing this ligand can only be made
when the imido group is NAr because it provides enough steric crowding to favor
monosubstitution slightly more over disubstitution. Decreasing the size of the imido ligand to
any extent leads to disubstitution. If the distance between the metal center and the terphenyl is
decreased to about 3 A then synthesis of MAX species containing both big (Ar) and small (Ar',
Ar , Ad) imido groups is possible. However, decreasing the distance between the metal center
and the aryl group to 2 A makes the resulting MAX complexes very crowded and only the
complex with the smallest imido (Ad) can be produced.
R R
NPh iPr Li iPr Et2O N
RFO MPh ~Q T RT NPh (7)
RF60 irMo + ~r iPr RF6i0 \FMO
RF6 
- LiORF6 TI
RF6LiTIPT
LTIPT 12 R = Ad, 80 OC; (100 % conv)
13 R = Ar', 80 OC; (28 % conv)
14 R = Ar, 80 OC; (7 % conv)
Finally, increasing the size of the aryl group from hexamethylterphenyl (HMT) to
tetraisopropylterphenyl (TIPT) has only detrimental effects (equation 7). For example heating a
mixture of Mo(NR)(CHCMe 2Ph)(ORF6) 2 and LiTIPT at 80 0C for 2 weeks only generates 7% of
14 (R = Ar) and 28% of 13 (R = Ar'). Moreover, 82% of 12 (R = Ad) can be obtained as a
mixture of products after heating at 80 0C for 17 h. However, after 5 days at 80 "C only one
product resonance remains (Figure 7). Attemps to isolate the pure product have been
unsuccessful.
5.1.4 Reaction between Mo(NAd)(CHCMe 2Ph)(OR)2 complexes and LiHMT
With the synthetic success of 8, other MAX species containing the adamantyl imido group
were pursued. Two bisalkoxide complexes of interest were used as potential starting materials:
Mo(NAd)(CHCMe 2Ph)(ORF9)2 (ORF9 = OC(CF3)3) and Li[Mo(NAd)(CHCMe 2Ph)(OiPrF6 ) 3]l
(OiPrF6 = OCH(CF3)2). Mo(NAd)(CHCMe 2Ph)(OiPr F6)2 cannot be used as the starting material
because it is not stable towards disproportionation. When Li[Mo(NAd)(CHCMe 2Ph)(OiPrF6 )3 is
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17 h [Mo](OFd)
4 d
5 d
I I I
11.5C
I I I I
11.01
Figure 7 - 'H NMR spectra
C over a period of 5 d.
of the reaction between Mo(NAd)(CHR)(ORF6)2 and LiTIPT at 80
treated with one equivalent of LiHMT at 80 C for 3 d less than 2% of a new alkylidene species
is made (equation 8). It is believed that slow conversion is due to the negative charge of the ate
complex, but the sterics around the metal center may also detriment the progress of this reaction.
At this point, this molecule is no longer being pursued.
Ad
F6  1 PhOiPr %Mo
OiPrF6 OiPrF6
C6D 6
+ LiHMT
80 C
3 d
Ad
N Ph
OiPrF6NMo
HMT
< 2% formed
On the other hand, Mo(NAd)(CHCMe 2Ph)(ORF9)2, 15, can be synthesized
Mo(NAd)(CHCMe 2Ph)(OTf)2DME resulting in 66% of a yellow solid (equation 9). This
first reported synthesis of complex 15. In the 'H NMR spectrum of 15, both the anti (JCH
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-35 OC
+ 2 LiOC(CF 3)3
-2 LiOTf
Ad
N
Ph
RF9O \'Mo
44
ORF9
15 (66%)
151.9 Hz) and syn (JCH = 121.9 Hz) isomers are observed in 25% and 75% respectively (Figure
8). Similarly, the 19F NMR spectrum of 15, has two resonances that integrate 1:3 in relation to
each other. It is known that alkylidene rotation at the metal slows down considerably with the
electron-withdrawing ability of the alkoxide ligands" and observation of both isomers in
solution is in accordance with that.
Preliminary work suggests that reaction between Mo(NAd)(CHCMe 2Ph)(ORF9) 2 and one
equivalent of LiHMT takes place in the same manner as 8 and after 12 h at RT the isomeric
resonances of the starting material completely disappear while a new one appears at 11.3 ppm
corresponding to the desired MAX species Mo(NAd)(CHR)(ORF9)(HMT), 16, (Figure 8).
A
B
121.9 Hz
151.9 Hz
14.50 14.00 135[ 130 12.50 12.00 11.5[ 11c 10.50
ppm (1)
Figure 8 - Alkylidene region in the 'H NMR of Mo(NAd)(CHR)(ORF9)(HMT), A, and
Mo(NAd)(CHR)(ORF 9) 2, B.
174
(9)
5.2 Reactivity Studies
In this section the reactivity of MAX species 1-8 will be compared to the analgous MXP
(Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(O2CTerme), la, Me2Pyr = 2,5-Me2C4H2N)) and MAX
(Mo(NR)(CHCMe 2Ph)(Pyr)(OHMT) (R = Ar, 2a; R = Ar', 3a; R = ArP, 4a; R = Ad, Sa; Pyr =
pyrrolide)) complexes. The reactions screened are the ring closing metathesis (RCM) of diallyl
ether, the homocouplings of 1-hexene and 1-octene, and the ring opening metathesis
polymerization (ROMP) of 2,3-dicarbomethoxynorbonadiene (DCMNBD). All reactions are
discussed below.
5.2.1 RCM of diallyl ether
0 5 mol % [Mo] O
C6D 6 (10)
- C 2 H4
DAE
The RCM of diallyl ether (DAE) is one of the most basic test reactions for the catalylic
activity and stability of new alkylidene complexes in the presence of ethylene. MAX species of
the type Mo(NR)(CHCMe 3)(Np)(OR') (R Ar or CPh3; R' = Ad, OCMe3, OC6F5 , or OAr),
where the X ligand is an alkyl have been evaluated in the past with DAE8 '9 and it was found that
the catalysts were inefficient when the imido and/or the alkoxide ligands were electron-rich
ligands. Therefore, complexes 1-8 are good choices as catalysts because they all have an
electron-poor alkoxide (ORF6).
MAX species 1-8, MAP species 2a-5a, and MXP species la were evaluated by reacting 11
iimoles of each catalyst with 20 equivalents of DAE in 0.7 mL of C6D within a Teflon-sealed J-
Young tube. The reactions were monitored during a period of 20-60 min and 15 h after mixing
and the results are shown in Table 1. To arrive at meaningful conclusions, Table 2 will be
analyzed in two sections: a) catalysts that have the same imido ligand and b) catalysts that have
all common ligands, except for the imido ligand.
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Table 1 - RCM of DAE with MAP, MAX, and MXP catalysts
Catalyst R X Y [Mo], mM Eq. Subs. Conversion, Time
91%, 20 m
1 Ar ORF6 0 2CTerme 15 20 98%, 2 h
98%, 15 h
33%, 30 m
la Ar Me2Pyr O2CTerme 17 20 94%, 2 h
96%, 22 h
91%, 40 m
2 Ar ORF6 OHMT 15 20 91%, 2.5 h
91%, 15 h
97%, 30 m
2a Ar Pyr OHMT 17 20 97%, 2.3 h
97%, 15 h
95%, 40 m
3 Ar' ORF6 OHMT 15 20 95%, 2.5 h
95%, 15 h
95%, 40 m
3a Ar' Pyr OHMT 18 20 95%, 2.3 h
96%, 15 h
96%, 40 m
4 Ar'' ORF6 OHMT 15 20 96%, 2.5 h
96%, 15 h
93%, 40 m
4a Ar'' Pyr OHMT 18 20 93%, 2.3 h
93%, 15 h
2%, 50 m
5 Ad ORF6 OHMT 15 20 4%, 2.6 h
12%, 15 h
94%, 1 h
5a Ad Pyr OHMT 17 20 94%, 2.5 h
94%, 15 h
35%, 30 m
6 Ar' ORF6 N(H)HMT 16 20 50%, 2.5 h
69%, 12 h
57%, 30 m
7 Ar'P' ORF6 N(H)HMT 15 20 64%, 2.5 h
65%, 12 h
26%, 50 m
8 Ad ORF6 HMT 15 20 87%,15 h
I_ I I 1 1 93%, 22 h
Catalysts 1, la, 2, and 2a share the Ar imido group. All catalysts are competent, with 2a
being the most reactive, which reaches 97% completion within 20 min. Catalyst 2 reaches 91%
completion after 40 min and stays steady even after 15 h, which could mean it is no longer active
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due to decomposition. On the other hand, catalyst 1 reaches 91% conversion within 20 min,
continues up to 98% conversion after 2 h, and remains steady thereafter. Catalyst la reacts
slowly in comparison with only 33% conversion after 30 min, but reaches up to 96% conversion
after 22 h. The fact that the presence of a i 2-bound carboxylate ligand diminishes the activity of
the catalyst when a pyrrolide ligand is present instead of ORF6 suggests that having a more
electron-deficient metal center is better for this reaction; however, this is the opposite trend
observed when instead of a carboxylate, HMTO is present.
Catalysts 3, 3a, and 6 share the Ar' imido ligand and both 3 and 3a are very active catalysts with
virtually the same activity. On the other hand, catalyst 6 is very slow, reaching only 35%
completion after 30 min and reaching only 69% completion after 12 h. In this case the presence
of the better ir-donating HMTN(H) ligand makes the metal center more electron rich than those
of either 3 or 3a and diminishes its activity in comparison. Similarly, catalysts 4 and 4a, which
bear the ArPr imido ligand, are very active reaching 96% and 93% completion respectively, after
40 min, but catalyst 7 is slow reaching only 57% completion after 30 min and 65% after 12 h.
Catalysts 5, Sa, and 8 share the Ad imido ligand and their reactivity suggests that the ligand
combination of 5 is not ideal for catalysis since the conversion of DAE only reaches 12% after
15 h. On the other hand, catalyst 5a reaches 94% completion within 1 h. and remains steady.
Catalyst 8 reacts slowly, reaching only 26% conversion after 50 min, but reaching 93%
completion after 22 h. In both 5a and 8 the ligand combination involves a poor sigma donor
(ORF6) and a good sigma donor (Pyr and HMT).
Comparison of all MAX catalysts shows that catalysts 1, that contains two poor sigma donor
ligands, 3 and 4, which have one poor sigma donor and a better one, are the most competent of
them all. They are followed closely in activity by 2, which contains the bigger Ar imido ligand
(in comparison to 3 and 4). Catalysts 6-8 are all slow, but 8 is slightly more active because the
bulky HMT ligand is not a good xr-donor. Finally, 5 has the worst activity among all the MAX
catalysts and its poor reactivity may arise from fast degenerate metathesis reactions taking place
at similar rates than the productive reaction.
Comparison of MXP and MAP complexes la-Sa shows that catalysts 2a and 3a are slightly
better than 4a and Sa, but all perform very well nonetheless. On the other hand, catalyst la
performs poorly in comparison mainly due to the 2-binding of the carboxylate ligand, which
makes the metal center less electron-poor. Overall, MAX species 2-5 are just as competent as
MAP complexes 2a-5a. MAX complex 1 is better than MXP complex la and MAX complexes
6-8 are slow in comparison to 2a-5a.
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5.2.2 Homocoupling of 1-hexene
2 mol % [Mo]
___ C6 D 6  (11)
- 1/2 C2H4
The second reaction that was used to evaluate the usefulness of MAX species 1-8, MAP
species 2a-5a, and MXP species la was the homocoupling of 1-hexene by reacting 11 Imoles of
each catalyst with 50 equivalents of 1-hexene in 1.5 mL of C6D6 in an open vial under inert-gas
atmosphere. The vial was kept open to allow removal of ethylene gas (a byproduct of the
reaction) and to reach complete conversion. The reactions were stirred at RT for 1 h, with the
exception of 2 cases. The reaction was evaluated by 'H and 13C NMR and the results are shown
in Table 2. The same analysis used for the interpretation of Table 2 will be used here.
Catalysts 1-2 and 2a are 98-99% complete after 1 h of mixing; whereas, catalyst lb reaches
only 82% conversion after the same period of time. In the case of 1-2 and 2a the product is 82-
84% trans-5-decene, but with la the product is only 53% trans-5-decene. This result shows that
although la is slow in comparison, it is more selective for formation of cis bonds.
Catalysts 3, 3a, and 6 attain high conversion (96-99%) after 1 h and give 83-86% trans-5-
decene as the product. Similarly, catalysts 4, 4a, and 7 attain high conversion (94-99%) after 1 h
and give product that is 87%, 81%, and 85% trans-5-decene respectively.
Catalysts that contain the Ad imido ligand vary in their results drastically. Complex 5a
reaches 92% conversion after 1 h and yields 89% trans-5-decene as the product; whereas,
catalyst 5 reaches only 71% conversion and levels off at 74% conversion after 5 h, which is only
54% trans product. Finally, catalyst 8 is the slowest, reaching only 10% conversion after 5 h.
These results are similar to the findings of RCM of DAE, where 5 and 8 are slow and 5a
performs best.
Comparison of all MAX species shows that species 1-4, 6-7 are very efficient catalysts for
homocoupling of 1-hexene yielding 5-decene product that is 84-87% trans in content. 5 is slow
in comparison and gives 5-decene product with significant lower trans content (54%), while 8 is
very slow. Similarly, MAP catalysts 2a-5a are also very efficient catalysts and yield 5-decene
product that is 81-89% trans in content. IXP catalyst la is slow in comparison and yields 5-
decene that is only 53% trans in content.
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Table 2 - Homocoupling of 1 -hexene with MAP, MAX, and MXP catalysts
Catalyst R X Y [Mol, mM Eq. Subs. Conversion, Time
1 Ar ORF6 0 2CTerme 8 50 98%, 84% trans, 1 h
la Ar Me2Pyr O2CTerMe 9 50 82%, 53% trans, 1 h
2 Ar ORF6 OHMT 8 50 99%, 84% trans, 1 h
2a Ar Pyr OHMT 9 50 99%, 82% trans, 1 h
3 Ar' ORF6 OHMT 8 50 99%, 86% trans, 1 h
3a Ar' Pyr OHMT 9 50 99%, 86% trans, 1 h
4 Ar Wr ORF6 OHMT 8 50 99%, 87% trans, 1 h
4a Ar'Pr Pyr OHMT 9 50 99%, 81% trans, 1 h
71%, 3 h
5 Ad ORF6 OHMT 8 50 74%, 54% trans, 5 h
5a Ad Pyr OHMT 9 50 92%, 89% trans, 1 h
6 Ar' ORF6 N(H)HMT 8 50 96%, 83% trans, 1 h
7 Ar Wr ORF6 N(H)HMT 7 50 94%, 85% trans, 1 h
8 Ad ORF6 HMT 8 50 10%, 5 h
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5.2.3 Homocoupling of 1-octene
2 mol % [Mo]
C6D6 1/2 5 5 (12)
- 1/2 C2H4
Since the homocoupling reactions with 1-hexene yielded almost primarily product containing
trans bonds, we looked at the homocoupling reaction of a slightly larger olefin, 1-octene. The
reactions were carried out with 6 pmoles of each catalyst and 50 equivalents of 1-octene in 0.75
mL of C6D6 in an open vial under inert-gas atmosphere and the reaction was evaluated by 1H
NMR in CDCl 3. The results are shown in Table 3.
Comparison of the homocoupling reactions of 1-octene with catalysts 1-2 and la-2a shows
that 1, 2, and 2a are all very efficient at catalyzing the reaction under 1 h, but the product, in all
cases, is primarily trans (81-83%). On the other hand, la takes 4 h to reach 16% completion;
however, the product is only 57% trans. These results are very similar to those obtained with 1-
hexene.
Catalysts 3, 3a, and 6 catalyzed the conversion to completion within 1 h and the product is
80-85% trans. Similarly, catalysts 4, 4a, and 7 convert 1-octene completely to product with
81%, 73%, and 83% trans bonds respectively.
Catalyst 5 is slow, giving only 26% conversion after 1 h, but reaching 75% conversion after 5
h. During the course of the reaction it is observed that the content of cis versus trans bonds
changes. For instance, after 1 h the product is composed of 62% cis bonds, but after 4 h the
product is only 55% cis. After 5 h the product is only 52% cis. This data suggests that catalyst 5
is not slow, but very reactive. In other words, 5 reacts with not only the starting material, but
also the product leading to isomerism of the internal olefin bond. For comparison, catalyst Sa
catalyzes the reaction within 1 h, but the product is 82% trans. In the case of 8 the reaction is
too slow to get conclusive results.
Comparison of MAX complexes 1-8 shows that among catalysts 1-4 and 6-7 there is no
discernable difference with all catalyzing the reaction to completion within 1 h and yielding 80-
83% trans-7-tetradecene. Complex 5; however, yields initially product with 62% cis bonds, but
as the reaction continues 5 isomerizes the product to yield 7-tetradecene with lower cis content.
Complex 8 is too bulky to carried out the reaction efficiently within a reasonable period of time.
On the other hand, MAP complexes 2a-5a are all fast and yield product that has mostly trans
bonds. In the case of 4a, which has the smallest aromatic imido ligand, the amount of trans
bonds is the lowest (73%) even in comparison with 5a, which contains the adamantyl imido
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Similarly to the results with 1-hexene, la is a slow catalyst for this reaction and
yields product that has higher cis content than any of the MAP species.
Table 3 - Homocoupling of 1-octene with MAP, MAX, and MXP catalysts
Catalyst R X Y [Mol, mM Eq. Subs. Conversion, Time
1 Ar ORF6 0 2CTerme 7.5 50 99% conv, 83% trans, 1 h
la Ar Me2Pyr O2CTerme 8.3 50 16% cony, 57% trans, 4 h
2 Ar ORF6 OHMT 7.4 50 99% cony, 81% trans, 1 h
2a Ar Pyr OHMT 8.3 50 99% cony, 82% trans, 1 h
3 Ar' ORF6 OHMT 7.8 50 99% cony, 80% trans, 1 h
3a Ar' Pyr OHMT 9.0 50 99% cony, 85% trans, 1 h
4 ArWr ORF6 OHMT 7.7 50 99% conv, 81% trans, 1 h
4a Ar Wr Pyr OHMT 8.6 50 99% cony, 73% trans, 1 h
26% cony, 62% cis, 1 h
5 Ad ORF6 OHMT 7.5 50 59% cony, 55% cis, 4 h
75% cony, 52% cis, 5 h
5a Ad Pyr OHMT 13.8 50 99% cony, 82% trans, 1 h
6 Ar' ORF6 N(H)HMT 7.8 50 99% conv, 83% trans, 1 h
7 ArPr ORF6 N(H)HMT 7.7 50 99% cony, 82% trans, 1 h
8 Ad ORF6 HMT 7.7 50 Slow
181
ligand (82%).
5.2.4 ROMP of DCMNBD
MeO2C ,,CO2Me
CO2Me 1-2 mol % [Mo] (13)C6H6  ___
CO2Me MeO 2C CO 2M 1/2
DCMNBD
Since substrates 1-hexene and 1 -octene proved too small for complexes 1-7 and la-5a to be
effective Z-selective catalysts, ROMP of 2,3-dicarbomethoxynorbornadiene (DCMNBD) was
investigated because it is considerably more bulky and because it has served as a reliable means
of studying the overall reactivity and selectivity of catalysts in the past (see Chapters 3 and 4).
The reactions were carried out using 6 pimoles of catalyst and 50 equivalents of DCMNBD in 1.2
mL of toluene at RT. The resulting polymer was analyzed by 'H and 13 C NMR methods and the
results are shown in Table 4.
Comparison of catalysts 1-2 and la-2a shows that 1 and la are not effective catalysts for this
reaction, whereas 2 and 2a polymerize DCMNBD within 2 h to form polymer that is > 98% cis.
Presence of a 5-coordinate complex (1 and la) coupled with the bulkiness of DCMNBD make
the polymerization inefficient, even for 1, which can homocouple 1-hexene and 1-octene. In the
case of 2 the polymer is 78% isotactic; whereas 2a is all syndiotactic. This result shows the
crucial difference between using the ORF6 ligand instead of pyrrolide and suggests that the
required inversion at the metal, which is known for MAP complexes, may not take place readily
for MAX complexes.
Complexes 3, 3a, and 6 are fast and efficient catalysts for the polymerization of DCMNBD.
All are high Z-selective catalysts, with 3a giving > 98% cis-syndiotactic polymer. Similarly, 3
yields polymer that is 95% cis, but only 73% syndiotactic. Compared to 2, complex 3 shows
major improvement towards syndiotactic selectivity and this is attributed to the smaller size of
the imido ligand. Finally, 6 yields polymer that is also 95% cis, but 71% isotactic. From these
results it can be said that MAP complexes are most efficient for yielding all-syndiotactic
polymer; whereas MAX complexes tend to yield a considerable amount of isotactic polymer. In
the case of 6, which has a good i-donor ligand, the amount of isotacticity is very similar to that
obtained with 2 and shows that electronics are the main influence on the regioselectivity of the
catalysts.
Complexes 4, 4a, and 7 show a similar trend of results as those of 3, 3a, and 6. MAP catalyst
3a yields polymer that is > 98% cis-syndiotactic and MAX catalyst 3 yields polymer that is
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>98% cis and 95% syndiotactic. Thus, decreasing the size of the imido ligand in MAX species
(2 vs 3 vs 4) tends to give higher content of syndiotactic polymer; however, this only applies
when discussing aryl imidos (see discussion of 5 below). Complex 7 yields polymer that is 90%
cis and 54% isotactic. In comparison to 6, complex 7 gives lower content of isotactic polymer
Table 4 - ROMP of DCMNBD with MAP, MAX, and MXP catalysts
Catalyst R X Y [Mo], mM Eq. Subs. Polymer Structure
1 Ar ORF6 0 2CTerMe 4.7 50 Slow
la Ar Me 2Pyr O2CTerme 5.2 50 Slow
2 Ar ORF6 OHMT 4.6 50 > 98% cis; 78% isotactic
2a Ar Pyr OHMT 5.2 50 > 98% cis, syndiotactic
3 Ar' ORF6 OHMT 4.9 50 95% cis, 73% syndiotactic
3a Ar' Pyr OHMT 5.6 50 > 98% cis, syndiotactic
4 Ar ORF6 OHMT 4.8 50 98% cis, 95% syndiotactic
4a Ar Wr Pyr OHMT 5.4 50 > 98% cis, syndiotactic
5 Ad ORF6 OHMT 4.7 50 90% cis, 76% syndiotactic
5a Ad Pyr OHMT 8.6 100 > 98% cis, syndiotactic
6 Ar' ORF6 N(H)HMT 4.9 50 95% cis, 71% isotactic
7 Ar ORF6 N(H)HMT 4.8 50 90% cis, 54% isotactic
8 Ad ORF6 HMT 4.8 100 83 % cis, 91% syndiotactic
(5 d)
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but the difference is not as pronounced as that between complexes 2 and 3. This difference is
also attributed to the better 2-donating effect of N(H)HMT, compared to OHMT.
Complexes 5 and Sa polymerize DCMNBD within 2 h and yield polymer that is 90% cis-
76% syndiotactic and > 98% cis-syndiotactic respectively. The lower syndiotactic content of 5,
compared to 4, suggests that using electron-rich imidos (alkyl instead of phenyl) decreases the
overall selectivity of syndiotactic polymer; moreover, it also gives another example that
electronic tuning is a major contributor of how selective MAX catalysts can be. Complex 8 is a
very slow catalyst for this reaction, which takes 5 d to polymerize 50 equivalents of DCMNBD.
The polymer formed is 83% cis and 91% syndiotactic, which makes it more regioselective than 5
with respect to tacticity but less selective with respect to Z-selectivity.
CONCLUSION
The synthesis of seven MAX complexes via salt metathesis of Mo(NR)(CHCMe 2Ph)(ORF6)2
with LiOHMT, LiN(H)HMT, and LiHMT was presented here. In addition, the preparation of a
MAX complex containing a carboxylate ligand was effected by protonolysis of
Mo(NAr)(CHCMe 2Ph)(ORF6) 2 with TerMeCO 2H. Synthesis of these molecules from bistriflate
precursors is not possible, which shows that the use of good leaving groups that are weakly basic
are required for efficient preparation. The size of the imido ligand affects the outcome of the
synthesis. Preparation of MAX complexes that contain a carboxylate ligand are only possible
when R = Ar, but MAX species that contain HMTO can be made for imidos of varying sizes.
On the other hand, MAX complexes that contain N(H)HMT can only be made for intermediate-
sized imido ligands; while MAX complexes that contain HMT can only be made with the
smallest imido ligands. The structures of 5, 7, and 8 were investigated by X-ray studies and they
show that 7 differs significantly from 5 and 8. Finally, the catalytic activity of MAX and
analogous MAP and MXP species were studied by the RCM reaction of DAE, the homocoupling
reaction of 1-hexene and 1-octene, and ROMP of DCMNBD. In reactions where only cis and
trans bonds are involved MAX species behave similarly to MAP species, but 1 and 5 behave
considerably different from la and 5a, which are rather slow catalysts and tend to homocouple
olefins to make bonds with more cis content. Complex 8 is slow but stable in the presence of
ethylene. On the other hand, polymerization of DCMNBD has drastic results which show that
MAX species are prone to forming highly isotactic polymer if large imido ligands and/or good x-
donor ligands are present. Whether or not formation of isotactic polymer is due to retention of
configuration at the metal is not known from these studies, but investigation of MAX complexes
using chiral phenoxides or amides may yield the answer.
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EXPERIMENTAL
General. All reactions and manipulations of air and moisture sensitive compounds were handled
in oven-dried glassware (150 C, 2 h) under a N2 atmosphere either in a dual Schlenk line or in
vacuum atmosphere glove box. HPLC grade solvents (benzene, toluene, diethyl ether,
tetrahydrofuran, pentane, and methylene chloride), were purge with N2 and passed through
activated alumina and stored over molecular sieves 12 hours prior to use. 1,2-dimethoxyethane
was dried in an oven-dried Schlenk flask with sodium and benzophenone ketal, vacuumed
transferred into another oven-dried Schlenk flask and stored over molecular sieves 12 hours prior
to use. n-BuLi, F90H were bought from VWR and used as received. Diallyl ether, 1-hexene,
and 1 -octene were bought from Sigma-Aldrich and dried over activated 3 A molecular sieves
overnight before use. DCMNBD, 20  Mo(NAd)(CHCMe 2Ph)(OTf)2(DME) and
Mo(NR)(CHCMe 2Ph)(ORF6)2 complexes," LiOHMT, LiN(H)HMT, LiHMT, LiTIPT and
LiHIPT' 0 were prepared according to literature procedures. Benzene-d 6 was stored over
molecular sieves 12 hours prior to use. All NMR spectra were recorded with a Bruker 400 MHz
spectrometer. Elemental analyses were performed by Midwest Microlab, LLC.
Mo(NAr)(CHCMe 2Ph)(ORF6)(O2CTerme) (1). Mo(NAr)(CHCMe 2Ph)(ORF6) 2 (0.207 g,
0.270 mmol) was dissolved in Et20 (5.00 mL) and cooled down to - 35 C for 1 h. In a separate
vial, TerMeCO2H (0.082 g, 0.270 mmol) was dissolved in Et2O (5.00 mL) and also cooled down
to - 35 0C for 1 h. Then, the carboxylic acid solution was added dropwise to the bisalkoxide
solution and left stirring at RT for 1 h. The volatiles were removed under reduced pressure and
the crude was dissolved in a minimal amount of pentane and place at - 35 "C for a few days to
generate orange crystals of pure 1 (0.109 g, 45 %): 'H NMR (400 MHz, C6D6) 6 13.07 (s, 1H,
Mo=CH, JCH = 125.8 Hz), 7.59 (d, 4H, p-tolyl), 7.52 (dd, 2H, aromatic), 7.42-7.28 (overlapping
peaks, 7H, aromatic), 7.23 (td, 1H, aromatic), 7.17-7.14 (t, 1H, aromatic), 4.02 (sept, 2H,
CHMe2 ), 2.17 (s, 6H, p-MeC6H 4), 1.95 (s, 3H, CH), 1.82 (s, 3H, CH3), 1.67 (s, 3H, CH 3), 1.48
(d, 6H, CHMe2), 1.29 (d, 6H, CHMe2); 13C NMR (100 MHz, C6D6) 6 289.3 (Mo=CHCMe2Ph),
189.3 (TerMeCO2Mo), 152.4, 149.2, 149.2, 140.9, 138.0, 137.6, 134.0, 130.2, 129.5, 128.8,
128.7, 128.6, 128.6, 126.6, 126.3, 123.2, 55.3, 32.4, 29.3, 28.5, 24.4, 23.5, 20.9, 18.3; '9F NMR
(376 MHz, C6D6) 6 - 77.7 (q, 3F, CF3), - 78.1 (q, 3F, CF 3). Anal. Calcd for C47H49F6MoNO 3: C,
63.72; H, 5.58, N, 1.58. Found: C, 63.54; H, 5.31; N, 1.47.
Mo(NAr)(CHCMe 2Ph)(ORF6)(OHMT) (2). Mo(NAr)(CHCMe 2Ph)(ORF6)2 (0.312 g, 0.408
mmol) was dissolved in Et2O and LiOHMT (0.137 g, 0.407 mmol) was added in one portion.
The reaction mixture was left stirring at RT overnight. The volatiles were removed and the
crude was dissolved in minimal pentane and placed at - 35 C overnight to yield orange
185
crystalline solid (0.160 g, 43%): 'H NMR (400 MHz, C6D6 ) 6 11.59 (s, 1H, Mo=CHCMe 2Ph,
JCH = 124.2 Hz), 7.25-6.85 (overlapping peaks, 15H, aromatics), 3.45 (sept, 2H, CHMe2), 2.30
(s, 12H, HMTO), 2.20 (s, 6H, HMTO), 1.79 (s, 3H, CH), 1.31 (d, 6H, CH.Me2), 1.25 (s, 3H,
CH), 1.18 (d, 6H, CHMe2), 0.78 (s, 3H, CH); 3C NMR (100 MHz, C6D6) 6 281.3
(Mo=CHCMe 2Ph), 158.4, 153.4, 148.7, 143.0, 136.6, 132.3, 130.0, 129.2, 128.4, 128.4, 126.4,
125.6, 123.3, 123.1, 122.9, 54.3, 31.6, 29.8, 28.3, 24.3, 23.8, 20.9, 20.8, 19.2; '9F NMR (376
MHz, C6D6) 6 - 77.2 (q, 3F, CF), - 77.7 (q, 3F, CF3). Anal. Calcd for C5oH57F6MoNO 2 : C,
65.71; H, 6.29, N, 1.53.
Mo(NAr')(CHCMe 2Ph)(ORF6)(OHMT) (3). The procedure is the same as that of 2,
employing Mo(NAr')(CHCMe 2Ph)(ORF6) 2 (0.306 g, 0.431 mmol) and LiOHMT (0.145 g, 0.431
mmol) to yield yellow solid (0.298 g, 80%): 'H NMR (400 MHz, C6D6 ) 6 11.40 (s, 1H,
Mo=CHCMe2Ph, JCH = 123.8 Hz), 7.05-6.55 (overlapping peaks, 15H, aromatics), 2.19 (s, 6H,
HMTO), 2.15 (s, 6H, HMTO), 2.06 (s, 6H, Ar' CH), 2.03 (s, 6H, HMTO), 1.45 (s, 3H, CH 3),
1.22 (s, 3H, CH 3), 0.80 (s, 3H, CH 3); 13 C NMR (100 MHz, C6 D6 ) 6 281.7 (Mo=CHCMe 2Ph),
158.0, 156.0, 148.6, 136.6, 136.4, 136.2, 135.7, 135.3, 132.0, 129.6, 129.1, 128.4, 128.1, 128.0,
126.9, 126.5, 126.2, 126.0, 125.9, 122.6, 53.6, 40.3, 31.1, 29.6, 29.1, 20.8, 20.6, 19.5, 19.2; 19F
NMR (376 MHz, C6D6 ) 6 - 77.4 (q, 3F, CF3), - 77.6 (q, 3F, CF3). Anal. Calcd for
C4 6H4 4F6MoNO 2 : C, 64.41; H, 5.76, N, 1.63. Found: C, 64.83; H, 5.86; N, 1.30.
Mo(NAr' )(CHCMe 2Ph)(ORF6)(OHMT) (4). The procedure is the same as that of 2,
employing Mo(NAriPr)(CHCMe 2Ph)(ORF6)2 (0.360 g, 0.498 mmol) and LiOHMT (0.168 g,
0.499 mmol) to yield orange crystalline solid (0.367 g, 71%). 'H NMR (400 MHz, C6 D6 ) 6
11.20 (s, 1H, Mo=CHCMe2Ph, JCH = 124.5 Hz), 7.14 (dd, 2H, aromatic), 7.08 (td, 2H, ArWr ),
7.02-6.78 (overlapping peaks, 8H, aromatics), 6.76 (s, 2H, HMTO), 6.67 (s, 2H, HMTO), 3.31
(sept, 1H, CHMe2), 2.14 (s, 6H, HMTO), 2.08 (s, 6H, HMTO), 2.04 (s, 6H, HMTO), 1.49 (s, 3H,
CH), 1.43 (s, 3H, CH), 1.15 (d, 3H, CH(Me)CH 3), 1.13 (d, 3H, CH(CH)Me), 0.94 (s, 3H,
CH3 ); 13 C NMR (100 MHz, C6D6 ) 6 281.7 (Mo=CHCMe 2Ph), 157.9, 155.3, 149.0, 146.7, 136.5,
136.4, 136.0, 135.4, 132.1, 129.7, 128.7, 128.4, 127.9, 127.9, 126.2, 125.5, 122.9, 54.3, 32.4,
30.5, 28.2, 23.6, 21.1, 20.9, 20.5, 18.6; 19F NMR (375 MHz, C6 D6) 6 - 77.7 (q, 3F, CF 3), - 78.1
(1, 3F, CF 3). Anal. Calcd for C4 7H5 1F6 MoNO 2: C, 64.75; H, 5.90, N, 1.61. Found: C, 64.60; H,
6.01; N, 1.41.
Mo(NAd)(CHCMe 2Ph)(ORF6)(OHMT) (5). The procedure is the same as that of 2,
employing Mo(NAd)(CHCMe 2Ph)(ORF6)2 (0-190 g, 0.257 mmol) and LiOHMT (0.086 g, 0.256
mmol) to yield yellow crystalline solid (0.135 g, 59%): 'H NMR (400 MHz, C6D6) 6 10.64 (s,
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1H, Mo=CHCMe 2Ph, JCH = 122.7 Hz), 7.25-7.08 (overlapping peaks, 4H, aromatics), 7.05-6.93
(overlapping peaks 3H, aromatics), 6.92-6.53 (overlapping peaks 3H, aromatics), 6.72 (s, 2H,
HMTO), 2.26 (s, 6H, HMTO), 2.20 (s, 6H, HMTO), 1.97 (s, 6H, HMTO), 1.80 (s, 3H, Ad),
1.70-1.50 (overlapping peaks, 9H, MoCHCMe2Ph + Ad), 1.47-1.30 (overlapping peaks, 9H,
MoCHCMe2Ph + Ad), 1.16 (s, 3H, CH 3); "C NMR (100 MHz, C6D6) 6 276.0
(Mo=CHCMe 2Ph), 158.7, 150.3, 137.5, 136.6, 136.4, 136.3, 131.9, 130.5, 129.2, 128.7, 126.7,
126.1, 122.2, 76.9, 50.5, 43.7, 35.6, 33.2, 31.0, 29.9, 21.1, 20.7, 20.6; 19F NMR (376 MHz,
C6D6) 6 - 77.4 (q, 3F, CF3), - 78.1 (q, 3F, CF3). Anal. Calcd for C48H55F6MoNO 2: C, 64.93; H,
6.24, N, 1.58. Found: C, 64.95; H, 6.12; N, 1.56.
Mo(NAr')(CHCMe 2Ph)(ORF6)(N(H)HMT) (6). The procedure is the same as that of 2,
employing Mo(NAr')(CHCMe 2Ph)(ORF6)2 (0.209 g, 0.295 mmol) and LiN(H)HMT (0.099 g,
0.295 mmol) to yield yellow solid (0.120 g, 48%): 'H NMR (400 MHz, C6D6) 6 11.86 (s, 1H,
Mo=CHCMe 2Ph, JCH = 121.2 Hz), 7.82 (s, 1H, MoN(H)HMT), 7.25-7.10 (overlapping peaks,
3H, aromatics), 7.00-6.55 (overlapping peaks, 1 1H, aromatics), 6.40 (s br, 1H, aromatic), 2.38 (s,
3H, CH 3), 2.23 (s, 6H, CH 3), 2.19 (s, 3H, CH3), 2.10 (s, 3H, CH), 2.03 (s, 6H, CH), 1.67 (s, 3H,
CH3), 1.19 (s, 3H, CH 3), 1.16 (s, 3H, CH 3), 1.00 (s, 3H, CH 3); 13 C NMR (100 MHz, C6D6) 6
287.3 (Mo=CHCMe 2Ph), 156.1, 149.5, 148.2, 135.6, 131.3, 130.7, 130.2, 129.2, 129.2, 128.9,
128.6, 127.1, 126.1, 125.8, 121.1, 54.5, 30.5, 28.8, 21.2, 20.6, 20.5, 20.3, 20.0, 19.4, 19.3; 19F
NMR (376 MHz, C6D6) 6 - 76.7 (q, 3F, CF3), - 77.2 (q, 3F, CH 3). Anal. Calcd for
C46H5OF6MoN 2 0: C, 64.48; H, 5.88, N, 3.27.
Mo(NArwr)(CHCMe 2Ph)(ORF6)(N(H)HMT) (7). The procedure is the same as that of 2,
employing Mo(NAriPr)(CHCMe 2Ph)(ORF6)2 (0.296 g, 0.409 mmol) and LiN(H)HMT (0.137 g,
0.408 mmol) to yield orange crystalline solid (0.326 g, 92%): 'H NMR (400 MHz, C6D6) 6;
11.72 (s, 1H, Mo=CHCMe 2Ph, JCH 117.9 Hz), 7.99 (s, 1H, MoN(H)HMT), 7.23 (dd, 1H,
aromatic), 7.08 (dd, 1H, aromatic), 7.05-6.70 (overlapping peaks, 12H, aromatics), 6.72 (s br,
2H, aromatic), 3.22 (sept, 1H, CHMe 2), 2.31 (s, 6H, CH 3), 2.24 (s, 6H, CH 3), 1.94 (s br, 6H,
CH), 1.53 (s, 3H, CH 3), 1.25 (d, 3H, CH(Me)CH 3), 1.19 (s, 3H, CH 3), 1.12 (d, 3H,
CH(CH 3)Me), 0.82 (s, 3H, CH 3); 13 C NMR (100 MHz, C6D6) 6286.5 (Mo=CHCMe2Ph), 155.5,
149.4, 148.0, 146.1, 137.9, 137.4, 137.4, 135.5, 130.3, 129.0, 128.5, 128.2, 126.3, 125.7, 125.6,
125.5, 121.5, 55.6, 30.4, 30.1, 27.8, 24.4, 22.6, 21.2, 20.5, 19.4; '9F NMR (376 MHz, C6D6) 6 -
77.1 (q, 3F, CF3), - 77.7 (q, 3F, CH 3). Anal. Calcd for C47H52F6MoN 20: C, 64.82; H, 6.02, N,
3.22. Found: C, 64.43; H, 5.89; N, 3.15.
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Mo(NAd)(CHCMe 2Ph)(ORF6)(HMT) (8) Mo(NAd)(CHCMe 2Ph)(ORF6)2DME (0.300 g,
0.362 mmol) and LiHMT (0.116 g, 0.362 mmol) were mixed together in 3.00 mL of toluene at
RT and left stirring for 12 h. Then, the solution was placed at -35 "C overnight and then passed
through Celite. The Celite was washed with cold toluene until the color was gone and the
solvent was removed from the filtrate under reduced pressure. The crude was triturated with
pentane 3 times and twice with TMS to induce precipitation of the product, which was collected
by filtration (0.308 g, 95%). X-ray quality crystals were grown by dissolving 8 (0.060 g) in a
minimal amount of pentane and placing the solution at - 35 0C a few days: 'H NMR (400 MHz,
C6D6) 6 10.99 (s, 1H, MoCH, JCH 120.2 Hz), 7.40 (d, 2H, HMT), 7.20-7.10 (in, 3H, Ph), 7.03
(t, 1H, HMT), 6.90 (s, 2H, Mes), 6.84 (in, 2H, Ph), 6.79 (s, 2H, Mes), 2.23 (s, 6H, o-Mes), 2.21
(s, 6H, o-Mes), 2.16 (s, 6H, p-Mes), 1.71 (s, 3H, Ad), 1.44 (s, 6H, CMe2Ph), 1.36 (s, 6H,
CMe2Ph syn), 1.33 (s, 6H, Ad), 1.13 (s, 3H, (CF3)2CH 3C); 13C NMR (100 MHz, C6D6) 6 279.4
(MoCH, JCH 120.23 Hz), 173.7 (CF3), 150.9, 150.5, 145.6, 136.7, 136.2, 136.0, 135.7, 129.7,
129.5, 129.3, 128.1, 125.9, 77.6, 53.5, 42.5, 35.6, 35.2, 30.4, 30.0, 22.1, 21.8, 21.1; 19F NMR
(375 MHz, C6D6) 6 -77.2 (q, IF), -77.9 (q, IF). Anal. Calcd for C48H55F6MoNO: C, 66.12; H,
6.36, N, 1.61. Found: C, 66.37; H, 6.30; N, 1.74.
Mo(NAd)(CHCMe 2Ph)(ORF9)2 (15) Mo(NAd)(CHCMe 2Ph)(OTf) 2DME (0.503 g, 0.658
mmol) was suspended in Et2O and stored at -35 "C for 1 h. Then, LiORF9 (0.319 g, 1.32 mmol)
was added in one portion and the mixture was allowed to warm-up to RT and stir for 12 h. The
solvent was removed under vacuo; the crude solid redissolved in CH2Cl 2 and passed through
Celite to remove LiOTf. Solvent was removed from the filtrate under reduced pressure and the
crude was triturated with pentane to precipitate a yellow solid, which was collected by filtration
(0.370 g, 66%): 'H NMR (400 MHz, C6D6) 6 13.65 (s, 0.35H, MoCH, JCH = 151.9 Hz), 12.61 (s,
1H, MoCH, JCH = 121.9 Hz), 7.30 (d, 1H, Ar syn), 7.24-7.14 (in, 4H, Ar anti + syn), 7.06-6.98
(in, 1.5H, Ar anti + syn), 3.20-2.90 (overlapping peaks, 3.5H, DME anti), 2.05 (s, 2H, CMe2Ph
anti), 1.82 (in, 8H, Ad anti + syn), 1.73 (s br, 4H, Ad anti + syn), 1.47 (s, 6H, CMe2Ph syn), 1.28
(in, 8H, Ad anti + syn); 13C NMR (100 MHz, C6D6) 6 307.7 (MoCH, JCH = 151.9 Hz), 292.6
(MoCH, JCH 121.9 Hz), 149.9 (CF 3 anti), 149.0 (CF 3 syn), 128.8, 128.7, 127.1, 126.8, 126.7,
125.7, 122.9, 120.0, 84.0 (C(CF 3)3 anti), 81.8 (C(CF 3)3 syn), 53.7 (CMe 2Ph anti), 50.6 (CMe 2Ph
syn), 43.8, 43.1, 35.4, 31.1, 29.8, 29.6, 26.7; '9F NMR (376 MHz, C6D6) 6 -74.5 (s, IF, syn), -
74.7 (s, 0.35F, anti). Anal. Calcd for C11 6Hu18 F72Mo4N401 0 : C, 40.04; H, 3.42, N, 1.61. Found:
C, 40.00; H, 3.50; N, 1.50.
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Mo(NAr')(CHCMe 2Ph)(ORF6)(HMT) (9) Mo(NAr')(CHCMe 2Ph)(ORF6)2(DME) (0.258 g,
0.323 mmol) and LiHMT (0.103 g, 0.321 mmol) were mixed in benzene (2.00 mL) at RT in a
vial, capped and left stirring at 12 h to get 100% of product: 'H NMR (400 MHz, C6 D6) 6 10.90
(s, 1H, Mo=CHCMe 2Ph, JCH = 122.0 Hz), 7.34 (dd, 2H, aromatic), 7.24 (td, 1H, aromatic), 7.15-
7.02 (overlapping peaks, 3H, aromatic), 6.98 (dd, 2H, aromatic), 6.86 (s, 4H, HMT), 6.74 (s, 1H,
Ar'), 6.68 (s, 1H, Ar'), 6.61 (s, 1H, Ar'), 2.21 (s, 6H, CH), 2.18 (s, 3H, CH 3), 2.11 (s, 3H,
CH 3), 2.06 (s, 12H, CH 3), 2.03 (s, 3H, CH 3), 1.32 (s, 3H, CH); 13 C NMR (100 MHz, C6D6) 6
282.8 (MoCHCMe 2Ph); '9F NMR (376 MHz, C6D6) 6 -77.4 (q, 3F, CF3), - 78.6 (q, 3F, CF3 ).
Mo(NAr')(CHCMe 2Ph)(ORF6)(HMT) (10) Mo(NAr')(CHCMe 2Ph)(ORF6)2 (0-010 g, 0.014
mmol) and LiHMT (0.005 g, 0.0 14 mmol) were mixed together and heated at 80 C for 5 d to get
90% of products: 'H NMR (400 MHz, C6D6 ) 6 10.93 (s, 1H, Mo=CHCMe 2Ph, 90%).
Mo(NAr)(CHCMe 2Ph)(ORF6)(HMT) (11) Mo(NAr)(CHCMe 2Ph)(ORF6)2 (0-010 g, 0.013
mmol) and LiHMT (0.004 g, 0.013 mmol) were mixed and heated at 80 C for 5 d to get 18% of
products: 'H NMR (400 MHz, C6D6) 6 10.90 (s, 1H, Mo=CHCMe 2Ph).
Mo(NAd)(CHCMe 2Ph)(ORF6)(TIPT) (12) Mo(NAd)(CHCMe 2Ph)(ORF6)2DME (0.300 g,
0.362 mmol) and LiTIPT (0.146 g, 361 mmol) were mixed together and heated at 80 0C for 5 d
to get full conversion to a single product: 'H NMR (400 MHz, C6D6) 6 11.75 (s, 1H,
Mo=CHCMe 2Ph).
Mo(NAr')(CHCMe 2Ph)(ORF6)(TIPT) (13) Mo(NAr')(CHCMe 2Ph)(ORF6) 2 (0-010 g, 0.014
mmol) and LiTIPT (0.006 g, 0.014 mmol) were mixed together and heated at 80 C for 2 wk to
get 28% of products: 'H NMR (400 MHz, C6D6) 6 12.14 (s, 1H, Mo=CHCMe 2Ph), 11.26 (s,
0.6H, Mo=CHCMe2Ph), 10.95 (s, 1H, Mo=CHCMe2Ph).
Mo(NAr)(CHCMe 2Ph)(ORF6)(TIPT) (14) Mo(NAr)(CHCMe 2Ph)(ORF6)2 (0.010 g, 0.013
mmol) and LiTIPT (0.005 g, 0.013 mmol) were mixed and heated at 80 0C for 5 d to get 7% of
products: 'H NMR (400 MHz, C6D6) 6 12.24 (s, 1H, Mo=CHCMe 2Ph), 11.35 (s, 0.75H,
Mo=CHCMe2Ph).
Mo(NAd)(CHCMe 2Ph)(ORF9)(HMT) (16) Mo(NAd)(CHCMe 2Ph)(ORF9) 2 (0.300 g, 0.354
mmol) and LiHMT (0.113 g, 0.354 mmol) were mixed together in toluene (3.00 mL) at RT for
12 h to get a single product: 'H NMR (400 MHz, C6D6 ) 6 11.24 (s, 1H, Mo=CHCMe 2Ph, JCH
189
119.2 Hz), 7.40-6.70 (overlapping peaks, 12H, aromatics), 2.22 (s, 6H, CH 3), 2.21 (s, 3H, CH),
2.19 (s, 6H, CH), 2.07 (s, 6H, CH), 1.68 (s, 3H, Ad), 1.50-1.40 (overlapping peaks, 6H, Ad +
CH 3), 1.30 (s, 6H, Ad), 0.96 (s, 3H, Ad); 13 C NMR (100 MHz, C6D6) 6 285.3 (MoCHCMe2Ph),
174.4, 150.8, 150.4, 145.7, 141.9, 139.4, 136.5, 136.4, 135.7, 130.7, 130.3, 129.6, 129.4, 128.5,
128.3, 127.7, 126.5, 126.0, 79.2 (OC(CF 3)3), 54.4, 41.9, 35.4, 29.9, 22.0, 21.7, 21.1, 21.1, 20.0;
'
9F NMR (376 MHz, C6D6) 6 -73.4 (s, 9F, CF).
RCM of DAE Complexes 1-8 and la-5a (0.010 g, 0.011 mmol) were dissolved in 0.70 mL
of C6D6 and place inside a J-Young tube. Then, DAE (0.022 g, 0.230 mmol) was added to it and
the NMR tube was sealed and monitored over the course of 1 day.
Homocoupling of 1-hexene Complexes 1-8 and la-5a (0.010 g, 0.011 mmol) were dissolved
in 1.50 mL of C6D6 in a vial. Then, 1-hexene (0.075-0.080 mL, 0.570 mmol) was added to it
and the solution was stirred in an open vial, under a nitrogen-filled atmosphere, for the indicated
time. The solutions were placed in a J-Young tube to monitor its progress by 'H and "C NMR,
based on the spectra of pure cis- and trans-5-decene obtained from Sigma-Aldrich.
Homocoupling of 1-octene Complexes 1-8 and la-5a (0.005 g, 0.006 mmol) were dissolved
in 0.75 mL of C6D6 in a vial. Then, 1-octene (0.043-0.050 mL, 0.300 mmol) was added to it and
the solution was stirred in an open vial, under a nitrogen-filled atmosphere, for the indicated
time. An aliquot was then dissolved in CDCl 3 to monitor its progress by 1H NMR.
ROMP of DCMNBD Complexes 1-8 and la (0.005 g, 0.006 mmol) were dissolved in 0.50
ml of toluene and added to a stirring toluene solution of DCMNBD (0.70 mL, 50 eq, 0.300
mmol). The solution was left stirring for 2 h until it formed a gel. Then, the gel was redissolved
in CH 2Cl 2 (7.00 mL) and quenched with benzaldehyde (0.100 mL) before precipitation from
methanol (60.0 mL) and isolation by vacuum filtration. The dry polymer was examined by 'H
and 13C NMR to determine the tacticity and cis content according to known literature reports.
X-ray Structure Determination Low-temperature diffraction data (#-and w>-scans) were
collected on a Bruker-AXS X8 Kappa Duo diffractometer coupled to a Smart Apex2 CCD
detector with Mo K, radiation (A = 0.71073 A) from an IyS micro-source for the structure of
compounds 5, 7, and 8. All structures were solved by direct methods using SHELXS'6 and refined
against F2 on all data by full-matrix least squares with SHELXL-97 7 using established refinement
techniques. 8 All non-hydrogen atoms were refined anisotropically. All hydrogen atoms were
included into the model at geometrically calculated positions and refined using a riding model
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unless otherwise noted. The isotropic displacement parameters of all hydrogen atoms were fixed to
1.2 times the U value of the atoms they are linked to (1.5 times for methyl groups). All disordered
atoms were refined with the help of similarity restraints on the 1,2- and 1,3-distances and
displacement parameters as well as rigid bond restraints for anisotropic displacement parameters.
Compound 5 crystallizes in the triclinic space group PI . The analyzed crystal was a non-
merohedral twin and it was refined using cell now/SAINT/TWINABS against the HKLF5 format
file. Coordinates for the hydrogen atom of C(1) were taken from the difference Fourier synthesis.
Compound 7 crystallizes in the monoclinic space group P21/c and was refined as stated above.
Compound 8 crystallized in the triclinic space group PI . The crystal used for analysis was a
nonmerohedral twin and the diffraction data was treated with cell now, followed by SAINT,
TWINABS, SHELXL refinement against the HKLF5 format file. The value for R(int) in the CIF
file is taken from the output of TWINABS. There is a three part disorder for the alkoxide ligand
due to rotation. The anisotropic displacement parameters of the F and C atoms of the CF3 groups
were constrained to be equivalent pairwise. As a result of merohedral twin treatment, there are three
more observations than unique reflections. In order to correctly estimate the standard uncertainties,
the third parameter of the L. S. card was set to 238, above the difference between observed and
unique reflections.
Crystal data are shown in Tables 5-7.
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Table 5. Crystal data and structure refinement for 5.
Identification code x12044
Empirical formula C48 H55 F6 Mo N 02
Formula weight 887.87
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Triclinic
Space group P1
Unit cell dimensions a = 11.3519(5) A
Volume
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 31.150
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
b = 11.6306(6) A
c = 18.6057(9) A
2161.43(18) A3
a =102.7680(10)0
P=95.3350(10)0
y =112.9690(10)0
2
1.364 Mg/m3
0.368 mm-1
924
0.23 x 0.22 x 0.10 mm 3
1.98 to 31.15'
-16<=h<=16, -16<=k<=16, 0<=l<=27
13841
13841 [R(int) = 0.0495]
99.2 %
Semi-empirical from equivalents
0.9641 and 0.9201
Full-matrix least-squares on F2
13841 / 49 / 536
1.043
Rl = 0.0354, wR2 = 0.0943
R1 = 0.0374, wR2 = 0.0958
0.894 and -1.196 e.A-3
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Table 6. Crystal data and structure refinement for 7.
Identification code x12055
Empirical formula C47 H52 F6 Mo
Formula weight 870.85
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P21/c
Unit cell dimensions a = 20.7835(19)
b = 10.8355(10)
c = 19.7836(18)
Volume 4315.5(7) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 31.000
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
N2 0
A
A
A
a= 900
p= 104.390(2)0
7 = 900
4
1.340 Mg/m3
0.366 mm-1
1808
0.06 x 0.05 x 0.02 mm3
2.02 to 31.00'
-30<=h<=30, -15<=k<=15, -28<=l<=28
205294
13705 [R(int) = 0.0537]
99.6 %
Semi-empirical from equivalents
0.9927 and 0.9783
Full-matrix least-squares on F2
13705 / 2 / 531
1.061
RI = 0.0327, wR2 = 0.0786
R1 = 0.0432, wR2 = 0.0836
1.422 and -0.642 e.A-3
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Table 7. Crystal data and structure refinement for 8.
Identification code
Empirical formula
Formula weight
Temperature
Wavelength
Crystal system
Space group
Unit cell dimensions
Volume
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 25.000
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
x11109_t5
C48 H54 F6 Mo N O
870.86
100(2) K
0.71073 A
Triclinic
P1
a = 10.6178(9) A
b = 18.8500(16) A
c = 22.2527(19) A
4169.3(6) A3
4
a= 109.268(2)'
p= 96.928(2)0
y 90.162(2)0
1.387 Mg/m3
0.379 mm-1
1812
0.20 x 0.15 x 0.05 mm 3
1.15 to 30.62'
-15<=h<=15, -26<=k<=25, 0<=I<=31
23776
23776 [R(int) = 0.0958]
98.0 %
Semi-empirical from equivalents
0.9813 and 0.9281
Full-matrix least-squares on F2
23538 / 3839 / 1265
1.031
RI = 0.0989, wR2 = 0.2536
RI = 0.1250, wR2 = 0.2788
5.229 and -7.881 e.A- 3
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APPENDIX
Survey of the Catalytic Selectivity of Molybdenum Alkylidene Imido Bisalkoxide and
Molybdenum Alkylidene Imido Alkoxide Pyrrolide Complexes
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INTRODUCTION
The synthesis of long unsaturated polymers containing conjugated double bonds throughout
the chain is of interest to the scientific community due to their important applications in
photophysics.1,2 For instance, they can be used as third-order nonlinear optical materials, such as
optical switches.' In addition, these polymers could display interesting electrical,
photoconductive, and photorefractive properties.2 A main challenge, however, has been the
synthesis of conjugated polymers that are relatively stable to air oxidation, are soluble in
common solvents, and retain planarity along their structure.3'4  Ring closing metathesis
polymerization (RCMP) of substituted 1,6-heptadiynes produces polymers that meet all these
criteria.5 The polymers resulting from RCMP contain 5- and/or 6-membered rings, which are
hypothesized to be formed by a- and p-addition of the alkyne to the metal center, respectively
(Scheme 1).6
E E MoEE
Mo1 diyne diyne 
MO
E - a-addition p-addition E
_ B E : - M o c:E _ _
n
n E = CO2Et
Scheme 1 - Polymeric structural units that arise during RCMP of DEDPM by molybdenum
alkylidene catalysts as a result of a-addition (left) and p-addition (right) of the monomer.
Previous studies showed that with molybdenum imido alkylidene bisalkoxide catalysts, a-
addition of the substrate is preferred, yielding polymer containing 5-membered rings.7- 0 Ru
catalysts that accomplish the same task are also known.' 1-14 On the other hand, when the catalyst
is supported by carboxylate ligands, p-addition prevails and polymers containing mostly 6-
membered rings are obtained.' 5~16  The most selective catalysts towards p-addition are
Mo(NArBu)(CH-t-Bu)(O 2CCPh3)2 (ArtBu = 2-t-BuC 6H 4) and
Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(O 2CTRIP) (Ar = 2,6-i-Pr 2C6H3; Me2Pyr = 2,5-Me2C4H2N;
TRIP = 2,4,6-i-Pr3C6H2; see Chapter 2).
Although molybdenum imido alkylidene catalysts bearing two alkoxide or two carboxylate
ligands produce regioselective a or P product during diyne polymerizations, the similar ring
closing enyne metathesis (RCEM) of disubstituted 2-allyl-2-propargylmalonate, such as diethyl-
2-allyl-2-propargylmalonate (DEAPM), is not catalyzed by either type of catalyst.17 With the
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initial preparation of molybdenum imido alkylidene bispyrrolide catalyst precursors, the group
has begun synthesizing molybdenum imido alkylidene monopyrrolide monoalkoxide catalysts
(see Chapters 3-4) that have been shown to exhibit catalytic activity for the RCEM of this kind
of substrates. 19  As with the diyne pathway, the enyne reaction can form either a or P products
(Scheme 2). Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(OC(CF 3)2Me) catalysts favor the formation of the
p product only, which complements ruthenium catalysts that only favor a-product formation for
the same substrates.
EEEE
E E Mo enyne enyne Mo EE
c-addition P-addition
_ _+- E : -Mo Z D E
E = CO 2Et
Scheme 2 - Cyclic dienes that can be produced by RCM of DEAPM by molybdenum
alkylidene catalysts as a result of a-addition (left) and p-addition (right) of the substrate.
In Section A.2 we survey the reactivity of a variety of MAP and bisalkoxide species towards
the polymerization of DEDPM to the effect of learning what combination of ligands can yield
polymer containing a high number of 5-membered ring structures. The synthesis of two such
complexes is detailed in Section A. 1, along with some other reactions of interest. Preparation of
polymer with only 5-membered rings can open opportunities for detailed spectroscopic studies as
learning tools for biological systems where polyconjugation is known to exist, as well as in the
preparation of new electronic devices.
RESULTS AND DISCUSSION
A.1 Synthesis and characterization of catalysts containing chiral alkoxides or phenoxides.
A.1.1 Preparation, structural studies, and reactivity of diastereomerically pure (R)-
Mo(NAr)(CHCMe 2Ph)(Me 2Pyr)(OR*).
The synthesis of the first monoalkoxide monopyrrolide (MAP) molybdenum alkylidene
complexes established a facile route for the preparation of molybdenum catalysts containing four
different ligands. The preparation of MAP species containing chiral alkoxides or phenoxides
produces diastereomers that can be separated and isolated in certain cases. The use of
diastereomeric MAP complexes in metathesis reactions has vastly improved the reactivity and
selectivity of many previously known molybdenum alkylidene catalysts.3 3
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The first chiral alcohol that was studied in the Schrock group was (2R)-R*OH, which can be
prepared stereospecifically in good yields from camphor using p-chlorophenyl magnesium iodide
in the presence of the Lewis acid LaCl3*2LiCl, according to literature reports (equation 1).3
Treatment of Mo(NAr)(CHCMe 2Ph)(Me2Pyr)2 with one equivalent of the pure alcohol was
found to give a mixture of diastereomers in an initial ratio of 3:1, but was not further investigated
due to the high solubility of the complex in common organic solvents.19"
MgI
+
Cl
LaCl 3*2LiCl
Et 20
(2R)-R*OH
Our goal was to isolate at least one of the diastereomers formed. In order to accomplish this,
a 1.50 g scale reaction between Mo(NAr)(CHCMe 2Ph)(Me2Pyr)2 and one equivalent of (2R)-
R*OH was prepared and the crude product (containing 75% of the R, R diasteromer) was
recrystallized from pentane at -35 0C over a period of days to yield a mixture containing 88% of
the R diastereomer in an overall yield of 28%. Recrystallization of this mixture once more
yielded the pure R-diastereomer in low overall yield (7%). The 'H NMR spectra of the mixture
at all three purification steps is shown in Figure 1, while equation 2 summarizes the purification
procedure.
Ar Ph
N
Et2 0
-350C
(2R)-R*OH
- Me2Pyr
Ar Ph Ar Ph
N N
Ninm--Mo + .M
H R*O'
R*O
Crude product: S-1 (25%) and R-1 (75%)
1 st recrystallization: S-1 (12%) and R-1 (88%); yield = 28%
2"d recrystallization: S-1 (<0.1%) and R-1 (> 99.9%); yield = 7%
200
OH (1)
Cl
(2)
1 ' Recrystallization from Pentane
I I I II  I I I I I I I I I I I I I I I T T ' ' | | I II I I I
12 11 10 9 8 7 6 5 4 3 2 1 0
2nd Recrystallization from Pentane
99.9% ( R)-1
12 11 10 9 8 7 6 5 4 3 2 1 0
Figure 1 - 'H NMR, in C6D6, of the diastereomeric mixture of 1 from the crude (above), first
recrystallized product (middle) and second recrystallized product (below). Overall enrichment of
R-1 is 99.9%.
It can be seen from Figure 1 that the resonances corresponding to the pyrrolide and imido
ligand are broad, which could be a result of restricted rotation of the ligands. To gain better
insight of the environment around the metal of the pure diastereomer, crystals of (R)-1 were
grown from a 1:1 ether/pentane solution and analyzed by X-ray crystallography; the structure of
the complex is shown in Figure 2. The diastereomer (R)-1 crystallized in the orthorhombic space
group P212 121 and it is described as a pseudo-tetrahedral complex. All bond lengths, as well as
the Mo(1)-C(1)-C(2) (147.60(16)0) and the Mo(1)-N(1)-C(1 1) (171.77(16)0) bond angles are
similar to those observed in other MAP species. The configuration of the alkylidene ligand is
syn (directed towards the imido group) and the p-chlorophenyl group of the alkoxide protects the
CON(pyr) face of the molecule.
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CI)
Figure 2 - The solid state structure of (R)-1 (50% probability ellipsoids). Selected bond
distances (A) and angles (*): Mo(l)-N(l) = 1.7285(18), Mo(1)-C(1) = 1.8731(22), Mo(1)-O(l) =
1.9143(15), Mo(1)-N(2) = 2.0367(19), Mo(1)-N(l)-C(11) = 171.77(16), Mo(1)-C(1)-C(2) =
147.60(16), Mo(l)-O(1)-C(31) = 132.35(12).
Pure MAP diastereomers have been shown in the past to be excellent enantioselective
catalysts, specially in the enantioselective ring closing metathesis of an N,N-disubstituted aniline
(A; equation 3) and various natural products.33 When A is treated with 5 mole % of (R)-1,
product B is obtained as a mixture with only 4% ee, which is virtually racemic. On the other
hand, when A is treated with 5 mole % racemic 1 or with 5 mole % 75% (R)-1, product B is
obtained as a mixture containing 10% ee and 15% ee respectively. A rough extrapolation shows
that if 5 mole % (S)-1 were used as the catalyst then product B will be obtained in no more than
20% ee. The difference in reactivity between 1 and other known diastereomerically pure MAP
catalysts shows that the chiral alkoxide (R*O) of 1 is a poor choice of ligand for this type of
reaction. On the other hand, reaction between DEAPM and 5 mole % (R)-1 gives > 99% p-ring
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product (Scheme 2), which is the same result obtained with
Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(OR) (R = C(CF 3)2Me, CH(CF 3)2) species.' 9  It should be
pointed out that the RCM of DEAPM with Mo(NAr)(CHCMe 2Ph)(Me 2Pyr)(OR) (R = C(CH3)3,
CH(CH 3)2, or Ar) polymerize the sample and < 5% ring closed product is observed;' 9 therefore,
R*O is a better ligand than either t-butoxide or isopropoxide for this type of reaction.
5 mol % [1]
N C66 a*N (3)
- C6D6
550C
A B
A.1.2 Preparation and structural study of Mo(NAd)(CHCMe 2Ph)(OR*)2.
Preparation of the first diastereomerically pure MAP catalyst containing a chiral phenoxide
was accomplished with Mo(NAr)(CHCMe 2Ph)(Me 2Pyr)(OR*) (R = (R)-3,3-dibromo-
5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2'-(tert-butyldimethylsiloxide)naphtha-2-ol; Scheme 3)."
Catalysts of this kind have been used successfully for ring closing reactions, and it was desired to
isolate other derivatives where the imido group was smaller than Ar in order to make them more
Z-selective.199 The imido ligand that was chosen for this task was 1-adamantyl (Ad) because it
allows groups on the molybdenacyclobutane to point freely towards it without encountering
steric crowding, thus yielding cis olefin bonds (see Chapter 1). Unfortunately, when
Mo(NAd)(CHCMe 2Ph)(Me2Pyr)2 is treated with one equivalent of ROH a mixture of MAP
diastereomers, bisphenoxide, and bispyrrolide complexes is observed in solution, but only the
bisphenoxide is isolated by recrystallization (32% accounting for R*OH being the limiting
reagent). Mo(NAd)(CHCMe 2Ph)(OR) 2, 21, can be generated in better yields by using two
equivalents of R*OH (equation 4). In contrast, Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(OR*) does not
form any bisphenoxide during the course of the reaction. In fact, the only known route for
preparing Mo(NAr)(CHCMe 2Ph)(OR*)2, 9, is via salt-metathesis of the bistriflate complex
(Scheme 3 ).19f
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Ad Ph
N
QN---lo
.Br
OH+ 2 C 6 H6
'OTBS
R*OH
Ad Ph
NIK -
.Mo
R*O OR*%OR2
21
X-ray quality crystals of 21 can be grown from a pentane : TMS solution and the X-ray crystal
structure of this complex is shown in Figure 3. The complex crystallizes out in the orthorhombic
space group P2 12121 with only one molecule of 21 and a disordered molecule of pentane in the
asymmetric unit. The structure of 21 is best described as pseudo tetrahedral with the metal
located in the tetrahedral hole. The RO ligands bind perpendicular with relation to each other
Ar Ph
N
ON--Mo
NN
2 LiMe2Pyr
- 2 LiOTf
Ar Ph
N
-Mo -- OTfO ~0
Ar Ph
Br
N
+ n OH C6H 6
N-Mo.;
R*OH OTBS R+O
Br
2
Et 2O
RT
ao
-2 NaOTf
Br
R*ONa
Ar Ph
VN
Mo
+R
OR+
9
Scheme 3 - Synthetic scheme for making Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(OR*) and 9.
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and the alkylidene ligand binds syn in relation to the imido group. The Mo(1)-C(1) (1.917(11)
A), the Mo(1)-N(1) (1.709(7) A), and the Mo-O (1.967(5) and 1.949(6) A) bond lengths of 21
are similar to those found for 9. However, the alkylidene ligand remains syn in 21; while the
major isomer of 9 is the anti-alkylidene. As a result, the major differences are found in the
Mo=C-C (21 = 149.1(9)0; 9 = 123.9(4)0) and the Mo=N-R (21 = 159.8(7)", 9 = 174.0(3)") bond
angles of the two molecules. The larger Mo=C-C bond angle in 21, in comparison to 9, is
attributed to the C-H agostic interaction of the syn alkylidene ligand, which is absent in the anti
species. Another feature that is worth pointing out is the very weak interaction between two of
the bromine atoms and the metal center (Mo(1)-Br(1) = 3.248 A, Mo(1)-Br(3) = 3.367 A);
however, due to the long Mo-Br distances their influence may not be consequential to metathesis
reactions.
Figure 3 - The solid state structure of 21 (50% probability ellipsoids) with solvent molecules
omitted for clarity. Selected bond lengths (A) and angles (0): Mo(1)-C(1) = 1.917(1 1), Mo(l)-
N(1) = 1.709(7), Mo(1)-O(1) = 1.967(5), Mo(1)-O(3) = 1.949(6), Mo(1)-C(1)-C(2) = 149.1(9),
Mo(1)-N(1)-C(1 1) = 159.8(7), Mo(1)-O(1)-C(21) = 137.1(5), Mo(1)-O(3)-C(5 1) = 142.2(6).
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In the next section compounds 1, 9, 21, and some compounds that were characterized in the past
will be screened for RCMP of DEDPM to investigate their overall selectivity.
A.2 Catalyst screening for the selective polymerization of 1 3C-labeled DEDPM
A.2.1 Screening with MAP catalysts
A total of 13 MAP catalysts (Figures 4 and 5) were tested for the regioselective polymerization
of dipropargyl malonates by using 13 C-labeled DEDPM and the resulting purple polymer was
analyzed by 3 C NMR methods. The results are summarized in Tables 1 and 2.
Ar
CMe 2Ph
N--Mo
R'O
Figure 4 - Molecular structure of MAP complexes used for polymerization of 13C-labeled
DEDPM in Table 1.
Table 1 shows the polymerization results for 8 MAP species. The catalyst concentrations
range from as low as 8.5 mM to as high as 17 mM in CDCl 3 and either 20 or 25 equivalents of
DEDPM monomer were used. Among all catalysts used, none is particularly selective for either
a or P addition, with most of the catalysts producing polymer containing ~ 50% of each ring in
the organic chain. For instance, catalyst 1, which gives excellent p-selectivity for RCM of
DEAPM, the enyne derivative of DEDPM, is not selective for RCMP of DEDPM and does
produce polymer with equal amounts of 5-membered and 6-membered rings. The same is true
of catalyst 3, which is known to give 100% p product for the RCM of DEAPM, but produces
polymer with barely 61% of 6-membered rings.
Although, most of the results discussed so far do not follow a particular trend, one of the best
results is observed when catalyst 4, which contains the smaller and more electron-donating
isopropoxide ligand, is used. In this case the polymer formed contains 80% 5-membered rings.
Interestingly, this MAP complex is not a good catalyst for the RCM of DEAPM due to fast
oligomerization of DEDPM into intractable products. On the other hand, when the slightly bulky
2,4-di-tert-butyl-6-bromophenoxide ligand of catalyst 8 is used the polymer produced contains
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77% 6-membered rings. Thus the general trend with MAP compounds is that in order to get 5-
membered rings small, electron-rich, alkoxides are needed, but to get 6-membered rings semi-
bulky ligands need to be used, which is similar to the results observed and discussed in Chapter
2.
Table 1 - Polymerization of 13C-DEDPM using MAP catalysts
Catalyst R' [Mol, mM Eq. DEDPM % a
1 R* 17 20 50
2 R* 15 20 43
3 (CF 3)2MeC 9.8 20 39
4 i-Pr 17 20 80
5 Ar 9.9 25 45
6 (t-BuO) 3Si 8.8 25 44
7 Ph 3 Si 11 25 50
8 2,4-(t-bu) 2-6-BrC6H2  8.5 25 23
To investigate whether the pyrrolide in MAP species can have a drastic effect on the
polymerization of DEDPM, Mo(NAr)(CHCMe 2Ph)((RI) 2(R2)2C4N)(OC(CF 3)2CH 3) complexes
(Figure 5) were used to polymerize 3C-labeled DEDPM and the results are shown in Table 2.
When the substituents in the pyrrolide ligand are changed from R1 = Me, 3 , to R1 = Ph, 3b, there
is a slight increase in the amount of 5-membered rings formed (39% vs 44%). Moreover,
increasing the sterics of the pyrrolide ligand by changing R1 = Ph to R1 = i-Pr, 3d, we see a
further increase in the amount of 5-membered rings produced (44% to 53%).
Ar
R2 R1 N CMe2Ph
N ,Mo0
R2|
I B
R1
F3C CF 3
Figure 5 - Molecular structure of MAP complexes that either contain PMe 3 or not and that are
used for polymerization of 13C-labeled DEDPM in Table 2.
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Table 2 - Polymerization of 3 C-DEDPM using MAP and PMe 3-bound MAP catalysts.
Catalyst R1 R2 B [Mo], mM Eq. DEDPM % a
3 Me H ------ 9.8 20 39
3a Me Me PMe 3  8.5 20 39
3b Ph H ------ 8.3 20 44
3c Ph H PMe 3  7.6 25 29
3d i-Pr H ------ 9.1 20 53
3e i-Pr H PMe 3  8.2 25 36
PMe 3 bound to each of the MAP species has a detrimental effect on the amount of 5-
membered rings produced. For instance, the polymers produced with 3c (R1 = Ph) have only
29% 5-membered rings, in contrast to 44% 5-membered rings when 3b is used instead.
Likewise, when 3e (R1 = i-Pr) is used instead of 3d there is a decrease from 53% down to 36% 5-
membered ring. Unfortunately, a direct correlation between 3 and 3a cannot be made because
the sterics of the pyrrolide are not quite the same; however, it is known that in solution PMe3
dissociates almost completely and the results hint that 3 and 3a are not very different sterically.
Overall, the results discussed above suggest that increasing the size of the pyrrolide ligand
favors the number of 5-membered rings produced during polymerization of DEDPM, but ligation
of PMe3 inhibits a-binding of DEDPM more efficiently, decreasing the content of 5-membered
rings formed along the polymeric chain. It is possible that using a small alkoxide in combination
with a big pyrrolide could yield even better results.
A.2.2 Screening with bisalkoxide and bisphenoxide catalysts
In order to obtain a better understanding of how alkoxides and imido groups (Ar' = 2,6-
Me2C6H3, ArCF3 = 2-(CF 3)C6H4, ArtBu = 2-t-BuC 6H4, ArPh = 2-PhC6H4) affect regioselectivity, a
variety of bisalkoxide complexes, of the type shown in Figure 6, were tested with 13C-labeled
DEDPM. The results are shown in Table 3.
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Figure 6 - Molecular structure of bisalkoxide and bisphenoxide complexes used for
polymerization of '3 C-labeled DEDPM in Table 3.
Table 3 - Polymerization of 13 C-DEDPM using bisalkoxide catalysts.
Catalyst R R' [Mo], mM Eq. DEDPM % a
9 Ar R* 5.5 25 22
10 Ar (CF 3)Me2C 10 25 78
11 Ar (CF 3)3 C 7.6 25 48
12 Ar (C6 F5)2MeC 5.6 25 74
13 Ar (t-bu)Me2Si 10 25 69
14 Ar Ar 8.8 25 33
15 Ar' (CF 3)2MeC 9.4 25 60
16 Ar' Ar 9.5 25 54
17 ArCF3  (CF 3)2MeC 8.9 25 52
18 ArtBu (CF 3)2MeC 9.0 20 54
19 ArPh (CF 3)2MeC 8.8 20 51
20 Ad (CF 3)2MeC 8.0 25 22
21 Ad R* 2.2 50 33
Comparing the results of catalysts 9-14 the overall number of 5-membered ring formation in
the polymer chain is higher when catalysts containing alkoxide ligands (10-13), rather than
phenoxide ligands (9 and 14), are used. The same trend is also observed with catalysts that have
the Ar' imido group (15-16), but not with catalysts that have the Ad imido ligand (20-21).
Catalyst 21 gives polymer with 33% 5-membered rings, whereas catalyst 20 gives polymer with
only 22% 5-membered rings. For comparison, catalyst 9 gives polymer with 22% 5-membered
rings, while catalysts 10 and 11 give polymer with 78% and 48% 5-membered rings,
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respectively. The discrepancy between the reactivity of 9 and 21 could be attributed to the fact
that 9 exists mainly as the anti isomer, whereas 21 does not.
Comparing all catalysts that contain the ORF6 group (OC(CF 3)2CH 3; 15, 17-20) we can see that
decreasing the size of the imido ligand has a detrimental effect on the overall amount of 5-
membered rings formed. For instance, catalyst 15 produces polymer with 60% 5-membered
rings, but catalysts 17-19, which have an ortho-substituted phenyl imido ligand, produce
polymer with only 50% 5-membered rings. Decreasing the size of the imido to Ad lowers the
amount of 5-membered rings to only 22%. On the other hand, catalysts with the ArO ligand (14
and 16) have the opposite results. Since no other catalysts were made that contain this ligand, a
precise trend cannot be drawn at this time, but the results suggest that in combination with the
adamantyl imido group, phenoxide ligands are a better choice to make more 5-membered rings.
CONCLUSION
Synthesis of compounds 1 and 21 were presented and both compounds were analyzed by X-
ray studies. Compound 1 is isolated a single diastereomer with the R-configuration at the metal.
Initial reactions show that this catalyst is competent for RCM of DEAPM, but not for other
olefin metathesis reactions. Compound 21 is obtained as the syn isomer and attains a pseudo
octahedral arrangement if the weak bromide interactions are included.
Polymerization of DEDPM with 8 MAP complexes, 9 bisalkoxide complexes, and 4
bisphenoxide complexes were presented. Three trends were found: a) among MAP complexes,
small electron-rich alkoxides or pyrrolides with bulkier substituents on the 2 and 5 positions
produce polymer with higher amount of 5-membered rings; b) among bisalkoxide complexes,
smaller imido ligands increase the content of 5-membered rings and, c) among
bisalkoxide/bisphenoxide complexes, bisalkoxides tend to give polymer containing higher
percentages of 5-membered rings.
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EXPERIMENTAL
General. All reactions and manipulations of air and moisture sensitive compounds were handled
in oven-dried glassware (150 C, 2 hr) under a N2 atmosphere either in a dual Schlenk line or in
vacuum atmosphere glove box. All complexes used for polymerization screening were
synthesized according to published methods' or according to other group semiannuals' .
HPLC grade solvents (toluene, diethyl ether, tetrahydrofuran, pentane, and methylene chloride),
were purged with N2 and passed through activated alumina and stored over molecular sieves 12
hours prior to use. 1,2-dimethoxyethane was dried in an oven-dried Schlenk flask with sodium
and benzophenone ketal, vacuumed transferred into another oven-dried Schlenk flask and stored
over molecular sieves 12 hours prior to use. R*OH , ROH, Mo(NR)(CHCMe 2Ph)(Me2Pyr)2
species19a, MAP complexes'9b-c' 31, 33 and bisalkoxide/bisphenoxide complexes' 9 d-f' 31 were
prepared according to literature reports. All deuterated solvents (d6-benzene and di-chloroform)
were stored over molecular sieves 12 hours prior to use. All the recorded NMR spectra were
obtained with a Bruker 400 MHz spectrometer.
(R)-Mo(NAr)(CHCMe 2Ph)(Me2Pyr)(OR*) (1) Mo(NAr)(CHCMe 2Ph)(Me2Pyr)2 (1.13 g,
1.90 mmol) was dissolved in a minimal amount of ether and placed at -35 C for 1 h. R*OH
(0.503 g, 1.90 mmol) was dissolved in a minimal amount of ether and placed at -35 0C for 1 h.
At the end of the cooling period, the solution containing R*OH was added to the precatalyst
solution dropwise and the mixture was stirred at RT for 45 min. Then, the volatiles were
removed to yield a crude product containing the R and S diastereomers in a ratio of 3:1. Then,
the sample was redissolved in minimal amount of SiMe 4 and placed at -35 0C for 2 days to
generate a yellow-green solid, which was enriched up to 88% with the R isomer (0.405 g, 28%).
This diastereomeric mixture was re-dissolved in a minimal amount of a 4:1 mixture of
SiMe 4:Et2O and recrystallized at -35 0C over a period of a few days to give a yellow green solid
99.9% enriched with the R diastereomer (0.100 g, 7%). Enriched 1 (99.9%; 0.030 g) was
dissolved in a pentane:Et2O 1:1 pentane/diethyl ether solution and placed at -35 C for a couple
of days to produce orange crystals suitable for X-ray diffraction: 'H NMR (400 MHz, CD 2Cl2) 6
10.46 (s, 1H, MoCH, JCH = 120.25 Hz), 7.60-7.10 (m, 12H, aromatics), 5.85 (s br, 2H,
Me2C4H2N), 4.20-3.00 (d br, 2H, CHMe2), 2.68 (s br, 3H, Me2C4H2N), 2.32 (d, 1H, OR * C3),
2.00-1.70 (m, 4H, OR* C3-C5), 1.58 (d, 6H, CHCMe2Ph), 1.35 (s, 3H, OR* C1), 1.26 (s br, 12H,
CHMe2), 1.06 (s, 3H, OR* C8), 0.99 (s, 3H, OR* C9), 0.72 (m, 2H, OR* C6); "C NMR (100
MHz, CD 2 Cl 2) 6 284.14 (MoCHR), 153.3, 148.1, 145.5, 133.1, 129.0 (br, Me2 C2 C2H4N), 128.2,
127.6, 126.1, 125.9, 123 (br Me2C2C2H4N), 108.2 (br, Me2C4H2N), 95.4, 55.4, 54.5, 54.2, 53.9,
50.2, 47.2, 45.8, 31.7, 31.4, 29.2, 28.5 (br, CHMe2), 26.3, 23.8 (br, CHMe2), 21.5, 21.4, 17.4 (br,
CHMe2), 15.6, 14.0, 10.4.
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Mo(NAd)(CHCMe 2Ph)(OR+)2 (21) Mo(NAd)(CHCMe 2Ph)(OTf) 2(DME) (0.227 g, 0.297
mmol) was dissolved in Et20 (7.0 mL) and NaOR (0.350 g, 0.595 mmol) was added in one
portion and the mixture was left reacting at RT for 2 h. Then, the volatiles were removed and the
crude was redissolved in pentane and filtered through celite to remove salts. The solvent was
removed under reduced pressure and the orange solid was collected by filtration (0.264 g, 59%).
21 (0.030 g) was dissolved in a 1:1 pentane:Et 20 solution and placed at -35 *C for a couple of
days to produce orange crystals suitable for X-ray diffraction: 1H NMR (400 MHz, CD 2Cl2 ) 6
12.63 (s, 1H, MoCH, JCH 129.0 Hz), 7.40-6.70 (overlapping peaks, 9H, aromatics), 2.70-1.10
(overlapping peaks, 31H, aliphatics), 1.04 (s, 18H, SiC(CH3)3), 0.94 (s, 6H, aliphatic), 0.48 (s,
3H, SiCH3), 0.21 (s, 3H, SiCH3), 1.00 (s, 3H, SiCH), - 0.02 (s, 3H, SiCH3); 3 C NMR (100
MHz, C6D6 ) 6 281.5 (Mo=CHCMe 2Ph), 161.4, 159.8, 150.3, 148.2, 148.1, 137.8, 136.2, 135.9,
134.3, 133.3, 133.0, 132.1, 132.0, 131.8, 131.6, 131.4, 131.1, 130.6, 130.5, 130.4, 125.8, 125.3,
113.8, 113.6, 112.9, 112.3, 106.5, 77.9, 50.9, 44.1, 36.0, 34.4, 32.6, 31.8, 30.0, 29.7, 29.2, 28.3,
27.7, 27.6, 27.4, 26.8, 26.7, 23.5, 22.7, 21.4, 19.2, 14.3, 13.1, - 2.5, - 2.6, - 2.9, - 3.3.
General procedure for the polymerization of 13 C-labeled DEDPM. The catalyst (0.010 g)
was measured, placed in a vial, and dissolved in about 0.50 mL of CDCl 3; likewise, 20-25
equivalents of 13C-labeled DEDPM were dissolved in 0.50 mL of CDCl3 separately. The
solution containing the catalyst was added to the solution containing the substrate to yield a
purple solution within 2 min. The mixture was monitored by 3 C NMR in the 54-58 ppm region
to determine the amounts of a and p products in solution.
X-ray Structure Determination Low-temperature diffraction data (0-and w-scans) were
collected on a Siemens Platform three-circle diffractometer coupled to a Bruker-AXS Smart
Apex CCD detector with graphite-monochromated Mo Kc radiation (A = 0.71073 A) for the
structure of compound 1 and on a Bruker-AXS X8 Kappa Duo diffractometer coupled to a Smart
Apex2 CCD detector with Mo K, radiation (A = 0.71073 A) from an IpS micro-source for the
structure of compound 21. All structures were solved by direct methods using SHELXS34 and
refined against F2 on all data by full-matrix least squares with SHELXL-97 35 using established
refinement techniques.36 All non-hydrogen atoms were refined anisotropically. All hydrogen
atoms were included into the model at geometrically calculated positions and refined using a riding
model unless otherwise noted. The isotropic displacement parameters of all hydrogen atoms were
fixed to 1.2 times the U value of the atoms they are linked to (1.5 times for methyl groups). All
disordered atoms were refined with the help of similarity restraints on the 1,2- and 1,3-distances and
displacement parameters as well as rigid bond restraints for anisotropic displacement parameters.
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Compounds 1 and 21 crystallize in the orthorhombic space group P212121 . Compound 21
crystallizes with a molecule of pentane that is treated as a two-part disorder. One of the TBS
groups, corresponding to Si(2) is also disordered and treated as a two-part disorder, as well as
C(56) on the one of the BITET rings.
Crystal information can be found in Tables 4 and 5.
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Table 4 - Crystal Data and Structure Refinement Details for 1.
Empirical formula C44 H57 Cl Mo N2 0
Formula weight 761.31
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Orthorhombic
Space group P2 12121
Unit cell dimensions a = 9.756(4) A
b = 19.892(8) A
c = 20.649(8) A
Volume 4007(3) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 29.57'
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole
4
1.262 Mg/m 3
0.428 mm-1
1608
0.25 x 0.20 x 0.10 mm 3
1.97 to 29.57'
-1 3<=h<=13, -27<=k<=27, -28<=1<=28
88176
11246 [R(int) = 0.0723]
100.0 %
Semi-empirical from equivalents
0.9584 and 0.9005
Full-matrix least-squares on F2
11246 / 1 / 456
1.046
RI = 0.0321, wR2 = 0.0589
RI = 0.0401, wR2 = 0.0625
-0.039(19)
0.489 and -0.436 e.A-3
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a = 900
= 900
7 = 900
Table 5 - Crystal data and structure refinement for 21.
Identification code x1 1003
Empirical formula C77 H105 Br4 Mo N 04 Si2
Formula weight 1580.38
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Orthorhombic
Space group P212121
Unit cell dimensions a = 16.0937(12) A a= 900
b = 16.4303(12) A P= 900
c = 28.536(2) A y = 90'
Volume 7545.5(10) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 26.02'
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole
4
1.391 Mg/m3
2.371 mm-1
3264
0.15 x 0.10 x 0.05 mm3
1.43 to 26.020
-1 9<=h<= 19, -20<=k<=20, -3 5<=1<=3 5
94170
14859 [R(int) = 0.0815]
99.9 %
Semi-empirical from equivalents
0.8907 and 0.7175
Full-matrix least-squares on F 2
14859 / 563 / 887
1.037
RI = 0.0752, wR2 = 0.1930
RI = 0.0979, wR2 = 0.2119
0.011(12)
4.049 and -1.376 e.A- 3
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